Announcement

Collapse
No announcement yet.

Canada FluWatch Weekly Reports 2013-2014 Season Weeks 33 and 34

Collapse
This is a sticky topic.
X
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Week 11

    FluWatch report: March 9 to 15, 2014 (Week 11)

    Posted 2014-03-21For readers interested in the <ABBR title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A title="Flu Watch (Version PDF, 113 KB - 6 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w11_14/pdf/fw2014-11-eng.pdf">FluWatch report: March 9 to 15, 2014 (Week 11) (<ABBR title="Portable Document Format">PDF</ABBR> Version - 291 <ABBR title=Kilobytes>KB</ABBR> - 10 pages)

    ?? Help with PDF documents

    Overall Summary
    • In week 11, influenza activity in Canada has increased slightly, with the majority of influenza viruses detected being influenza B. Overall, the influenza A(H1N1) virus remains the most common influenza virus circulating this season, and influenza activity remains within expected levels for this time of year.
    • While the influenza A(H1N1) virus has mostly affected adults 20-64 years of age this season, influenza B is having a greater impact on adults 65 years of age and older, as well as young persons 5 to 19 years of age.
    • As of week 11, 3,570 hospitalizations and 197 deaths have been reported from participating regions, which is comparable to reports in past influenza seasons.
    • A Public Health Agency of Canada survey, conducted in February 2014, estimates that 39% of the Canadian population received the 2013-14 seasonal influenza vaccine, with higher coverage of 69.5% in Canadians aged 65 years and older.

    Influenza/ILI Activity (geographic spread)

    In week 11, influenza activity levels increased slightly. One region in Quebec reported widespread activity and nine regions (BC(1), ON(5), and QC(3)) reported localized activity (Figure 1).
    Figure 1. Map of overall influenza/ILI activity level by province and territory, Canada, Week 11





    Note: Influenza/ILI activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates and reported outbreaks. Please refer to detailed definitions at the end of the report. Maps from previous weeks, including any retrospective updates, are available on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada
    Influenza and Other Respiratory Virus Detections

    The number of positive influenza tests increased slightly, from 743 in week 10 to 750 in week 11, driven by increasing detections of influenza B. The percentage of positive influenza tests increased from 12.3% in week 10 to 13.4% in week 11, with 65% of positive tests being influenza B (Figure 2). The highest percentages of influenza B among positive tests have been reported from Newfoundland & Labrador (29.2%) and Quebec (23.8%), followed by Ontario (11.1%) and British Columbia (8.1%). Despite the late-season circulation of influenza B, the predominant influenza virus this season remains A(H1N1)pdm09 (Table 1). Among the 18,962 cases for which information on age and type/subtype has been received this season, 54.9% were 20-64 years of age (Table 2). Significantly greater proportions of influenza B cases have been ≥65 years of age and 5-19 years of age compared to cases of A(H1N1)pdm09.

    Figure 2. Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14

    Text equivalent for figure 2Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14
    The number of positive tests for RSV has been declining gradually over recent weeks, similar to the trend observed in recent seasons. The number of positive tests for parainfluenza was stable in week 11 and has been on a downward trend since week 02. The number of positive tests for adenovirus and rhinovirus have decreased in recent weeks; and in week 11, detections of coronavirus resumed a decline that started in week 05. The number of positive tests for human metapneumovirus has been higher than during the same period last season and has been similar over the past 5 weeks (Figure 3).
    For more details, see the weekly Respiratory Virus Detections in Canada Report.
    Figure 3. Number of positive laboratory tests for other respiratory viruses by report week, Canada, 2013-14


    Top of Page

    RSV: Respiratory syncytial virus; hMPV: Human metapneumovirus
    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014
    <TABLE id=t1 class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 1: Weekly and cumulative numbers of positive influenza specimens
    by type, subtype and province, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=ar1 rowSpan=3>Reporting provinces <SUP>1</SUP></TH><TH id=ac1 colSpan=5>Weekly
    (March 9, 2013 to March 15, 2014)</TH><TH id=ac8 colSpan=5>Cumulative
    (August 25, 2013 to March 15, 2014)</TH></TR><TR class=bg-colour-yellow><TH id=ac2 colSpan=4 headers=ac1>Influenza A</TH><TH id=ac7 headers=ac1>B</TH><TH id=ac9 colSpan=4 headers=ac8>Influenza A</TH><TH id=ac14 headers=ac8>B</TH></TR><TR class=bg-colour-grey-light><TH id=ac3 headers="ac1 ac2">A Total</TH><TH id=ac4 class=lightred headers="ac1 ac2">A(H1)pdm09</TH><TH id=ac5 class=lightred headers="ac1 ac2">A(H3)</TH><TH id=ac6 class=lightred headers="ac1 ac2">A(UnS)</TH><TH class=alignCenter headers="ac1 ac7">B Total</TH><TH id=ac10 headers="ac8 ac9">A Total</TH><TH id=ac11 class=lightred headers="ac8 ac9">A(H1)pdm09</TH><TH id=ac12 class=lightred headers="ac8 ac9">A(H3)</TH><TH id=ac13 class=lightred headers="ac8 ac9">A(UnS)</TH><TD class=alignCenter headers="ac8 ac14">B Total</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=11><SUP>1 </SUP>Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.
    <SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.</TD></TR></TFOOT><TBODY><TR><TH id=ar2 class=alignLeft headers=ar1>BC</TH><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac3">30</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac4">18</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac5">6</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac6">6</TD><TD class=alignRight headers="ar1 ar2 ac1 ac7">33</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac10">1755</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac11">1592</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac12">50</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac13">113</TD><TD class=alignRight headers="ar1 ar2 ac8 ac14">155</TD></TR><TR><TH id=ar3 class=alignLeft headers=ar1>AB</TH><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac3">46</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac4">5</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac5">4</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac6">37</TD><TD class=alignRight headers="ar1 ar3 ac1 ac7">28</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac10">3719</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac11">3371</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac12">53</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac13">295</TD><TD class=alignRight headers="ar1 ar3 ac8 ac14">151</TD></TR><TR><TH id=ar4 class=alignLeft headers=ar1>SK</TH><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac3">6</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac4">5</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac5">1</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar4 ac1 ac7">10</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac10">1349</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac11">972</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac12">6</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac13">371</TD><TD class=alignRight headers="ar1 ar4 ac8 ac14">44</TD></TR><TR><TH id=ar5 class=alignLeft headers=ar1>MB</TH><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac3">27</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac4">24</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac6">3</TD><TD class=alignRight headers="ar1 ar5 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac10">622</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac11">446</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac12">1</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac13">175</TD><TD class=alignRight headers="ar1 ar5 ac8 ac14">15</TD></TR><TR><TH id=ar6 class=alignLeft headers=ar1>ON</TH><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac3">56</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac4">26</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac5">11</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac6">19</TD><TD class=alignRight headers="ar1 ar6 ac1 ac7">159</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac10">5488</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac11">2416</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac12">265</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac13">2807</TD><TD class=alignRight headers="ar1 ar6 ac8 ac14">682</TD></TR><TR><TH id=ar7 class=alignLeft headers=ar1>QC</TH><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac3">80</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac4">7</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac6">73</TD><TD class=alignRight headers="ar1 ar7 ac1 ac7">242</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac10">5231</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac11">672</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac12">3</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac13">4556</TD><TD class=alignRight headers="ar1 ar7 ac8 ac14">1633</TD></TR><TR><TH id=ar8 class=alignLeft headers=ar1>NB</TH><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac3">8</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac6">8</TD><TD class=alignRight headers="ar1 ar8 ac1 ac7">5</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac10">1488</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac11">370</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac12">1</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac13">1117</TD><TD class=alignRight headers="ar1 ar8 ac8 ac14">23</TD></TR><TR><TH id=ar9 class=alignLeft headers=ar1>NS</TH><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac3">10</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac4">10</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar9 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac10">163</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac11">134</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac12">4</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac13">25</TD><TD class=alignRight headers="ar1 ar9 ac8 ac14">3</TD></TR><TR><TH id=ar10 class=alignLeft headers=ar1>PE</TH><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac3">1</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac4">1</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac10">118</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac11">117</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac12">0</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac13">1</TD><TD class=alignRight headers="ar1 ar10 ac8 ac14">1</TD></TR><TR><TH id=ar11 class=alignLeft headers=ar1>NL</TH><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac3">1</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac6">1</TD><TD class=alignRight headers="ar1 ar11 ac1 ac7">8</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac10">340</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac11">104</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac12">0</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac13">236</TD><TD class=alignRight headers="ar1 ar11 ac8 ac14">140</TD></TR><TR><TH id=ar12 class=alignLeft headers=ar1>Canada</TH><TD class=alignRight headers="ar1 ar12 ac1 ac2 ac3">265</TD><TD class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac4">96</TD><TD class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac5">22</TD><TD class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac6">147</TD><TD class=alignRight headers="ar1 ar12 ac1 ac7">485</TD><TD class=alignRight headers="ar1 ar12 ac8 ac9 ac10">20273</TD><TD class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac11">10194</TD><TD class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac12">383</TD><TD class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac13">9696</TD><TD class=alignRight headers="ar1 ar12 ac8 ac14">2847</TD></TR><TR><TH id=ar13 class=alignLeft headers=ar1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="ar1 ar13 ac1 ac2 ac3">35.3%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac4">36.2%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac5">8.3%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac6">55.5%</TD><TD class=alignRight headers="ar1 ar13 ac1 ac7">64.7%</TD><TD class=alignRight headers="ar1 ar13 ac8 ac9 ac10">87.7%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac11">50.3%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac12">1.9%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac13">47.8%</TD><TD class=alignRight headers="ar1 ar13 ac8 ac14">12.3%</TD></TR></TBODY></TABLE>
    <TABLE id=t2 class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 2. Weekly and cumulative numbers of positive influenza specimens by type, subtype and age-group reported through case-based laboratory reporting<SUP>3</SUP>, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=br1 rowSpan=3>Age groups (years)</TH><TH id=bc1 colSpan=5>Weekly
    (March 9 to March 15, 2014)</TH><TH id=bc8 colSpan=7>Cumulative
    (August 25, 2013 to March 15, 2014)</TH></TR><TR class=bg-colour-yellow><TH id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH id=bc7 headers=bc1>B</TH><TH id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH id=bc14 headers=bc8>B</TH><TH id=bc15 colSpan=2 headers=bc8>Influenza A and B</TH></TR><TR class=bg-colour-grey-light><TH id=bc3 headers="bc1 bc2">A Total</TH><TH id=bc4 class="lightred " headers="bc1 bc2">A(H1) pdm09</TH><TH id=bc5 class="lightred " headers="bc1 bc2">A(H3)</TH><TH id=bc6 class="lightred " headers="bc1 bc2">A (UnS)</TH><TD class=alignCenter headers="bc1 bc7">Total</TD><TH id=bc10 headers="bc8 bc9">A Total</TH><TH id=bc11 class="lightred " headers="bc8 bc9">A(H1) pdm09</TH><TH id=bc12 class="lightred " headers="bc8 bc9">A(H3)</TH><TH id=bc13 class="lightred " headers="bc8 bc9">A (UnS)</TH><TD class=alignCenter headers="bc8 bc14">Total</TD><TH id=bc16 headers="bc8 bc15">#</TH><TH id=bc17 headers="bc8 bc15">%</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=13><SUP id=footnote_t2_1>1 </SUP>Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.
    <SUP id=footnote_t2_2>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    <SUP id=footnote_t2_3>3 </SUP>Table 2 includes specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.</TD></TR></TFOOT><TBODY><TR><TH id=br2 class=alignLeft headers=br1><5</TH><TD class=alignRight headers="br1 br2 bc1 bc2 bc3">36</TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc4">6</TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc5">5</TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc6">25</TD><TD class=alignRight headers="br1 br2 bc1 bc7">30</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc10">3157</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc11">1404</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc12">31</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc13">1722</TD><TD class=alignRight headers="br1 br2 bc8 bc14">277</TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc16">3434</TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc17">18.1%</TD></TR><TR><TH id=br3 class=alignLeft headers=br1>5-19</TH><TD class=alignRight headers="br1 br3 bc1 bc2 bc3">13</TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc4">3</TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc5">1</TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc6">9</TD><TD class=alignRight headers="br1 br3 bc1 bc7">43</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc10">1288</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc11">687</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc12">19</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc13">582</TD><TD class=alignRight headers="br1 br3 bc8 bc14">447</TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc16">1735</TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc17">9.1%</TD></TR><TR><TH id=br4 class=alignLeft headers=br1>20-44</TH><TD class=alignRight headers="br1 br4 bc1 bc2 bc3">39</TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc4">17</TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc5">1</TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc6">21</TD><TD class=alignRight headers="br1 br4 bc1 bc7">45</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc10">4971</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc11">2751</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc12">40</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc13">2180</TD><TD class=alignRight headers="br1 br4 bc8 bc14">462</TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc16">5433</TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc17">28.7%</TD></TR><TR><TH id=br5 class=alignLeft headers=br1>45-64</TH><TD class=alignRight headers="br1 br5 bc1 bc2 bc3">49</TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc4">10</TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc5">1</TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc6">38</TD><TD class=alignRight headers="br1 br5 bc1 bc7">78</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc10">4342</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc11">2339</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc12">45</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc13">1958</TD><TD class=alignRight headers="br1 br5 bc8 bc14">632</TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc16">4974</TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc17">26.2%</TD></TR><TR><TH id=br6 class=alignLeft headers=br1>65+</TH><TD class=alignRight headers="br1 br6 bc1 bc2 bc3">39</TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc4">9</TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc5">1</TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc6">29</TD><TD class=alignRight headers="br1 br6 bc1 bc7">116</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc10">2402</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc11">975</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc12">102</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc13">1325</TD><TD class=alignRight headers="br1 br6 bc8 bc14">849</TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc16">3251</TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc17">17.1%</TD></TR><TR><TH id=br7 class=alignLeft headers=br1>Unknown</TH><TD class=alignRight headers="br1 br7 bc1 bc2 bc3">0</TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc4">0</TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc6">0</TD><TD class=alignRight headers="br1 br7 bc1 bc7">0</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc10">132</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc11">102</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc12">18</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc13">12</TD><TD class=alignRight headers="br1 br7 bc8 bc14">3</TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc16">135</TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc17">0.7%</TD></TR><TR><TH id=br8 class=alignLeft headers=br1>Total</TH><TD class=alignRight headers="br1 br8 bc1 bc2 bc3">176</TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc4">45</TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc5">9</TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc6">122</TD><TD class=alignRight headers="br1 br8 bc1 bc7">312</TD><TD class=alignRight headers="br1 br8 bc8 bc9 bc10">16292</TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc11">8258</TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc12">255</TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc13">7779</TD><TD class=alignRight headers="br1 br8 bc8 bc14">2670</TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc16">18962</TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc17">100.0%</TD></TR><TR><TH id=br9 class=alignLeft headers=br1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="br1 br9 bc1 bc2 bc3">36.1%</TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc4">25.6%</TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc5">5.1%</TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc6">69.3%</TD><TD class=alignRight headers="br1 br9 bc1 bc7">63.9%</TD><TD class=alignRight headers="br1 br9 bc8 bc9 bc10">85.9%</TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc11">50.7%</TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc12">1.6%</TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc13">47.7%</TD><TD class=alignRight headers="br1 br9 bc8 bc14">14.1%</TD><TD class=alignRight></TD><TD class=alignRight></TD></TR></TBODY></TABLE>

    Top of Page

    Influenza Strain Characterizations

    During the 2013-2014 influenza season, the National Microbiology Laboratory (NML) has antigenically characterized 1465 influenza viruses [67 A(H3N2), 1168 A(H1N1)pdm09 and 230 influenza B]. The vast majority (99%) of viruses were similar to the strains recommended by the WHO for the 2013-14 seasonal influenza vaccine. Two A(H1N1)pdm09 viruses showed reduced titres to antiserum against the reference A/California/07/2009 strain. Fifteen influenza B viruses were similar to the strain recommended by the WHO for the 2011-12 vaccine (Figure 4).
    Figure 4. Influenza strain characterizations, Canada, 2013-14, N = 1465

    The NML receives a proportion of the number of influenza positive specimens from provincial laboratories for strain characterization and antiviral resistance testing. Characterization data reflect the results of haemagglutination inhibition (HAI) testing compared to the reference influenza strains recommended by WHO.
    The recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b (e.g. A/Texas/50/2012), and a B/Massachusetts/2/2012-like virus (Yamagata lineage).


    Text equivalent for figure 4Influenza strain characterizations, Canada, 2013-2014, N =3
    Antiviral Resistance

    During the 2013-2014 influenza season, NML has tested 1098 influenza viruses for resistance to oseltamivir and all but two were sensitive. All 1102 viruses tested for resistance to zanamivir were sensitive. All 1264 influenza A viruses tested for amantadine resistance were resistant (Table 3).
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=cr1 rowSpan=2>Virus type and subtype</TH><TH id=cc1 colSpan=2>Oseltamivir</TH><TH id=cc4 colSpan=2>Zanamivir</TH><TH id=cc7 colSpan=2>Amantadine</TH></TR><TR class=bg-colour-yellow><TH id=cc2 headers=cc1># tested</TH><TH id=cc3 headers=cc1># resistant (%)</TH><TH id=cc5 headers=cc4># tested</TH><TH id=cc6 headers=cc4># resistant (%)</TH><TH id=cc8 headers=cc7># tested</TH><TH id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH id=cr2 class="alignLeft lightred" headers=cr1>A (H3N2)</TH><TD class=alignRight headers="cr1 cr2 cc1 cc2">55</TD><TD class=alignRight headers="cr1 cr2 cc1 cc3">0</TD><TD class=alignRight headers="cr1 cr2 cc4 cc5">55</TD><TD class=alignRight headers="cr1 cr2 cc4 cc6">0</TD><TD class=alignRight headers="cr1 cr2 cc7 cc8">91</TD><TD class=alignRight headers="cr1 cr2 cc7 cc9">91 (100%)</TD></TR><TR><TH id=cr3 class="alignLeft lightred" headers=cr1>A (H1N1)</TH><TD class=alignRight headers="cr1 cr3 cc1 cc2">913</TD><TD class=alignRight headers="cr1 cr3 cc1 cc3">2 (0.2%)</TD><TD class=alignRight headers="cr1 cr3 cc4 cc5">918</TD><TD class=alignRight headers="cr1 cr3 cc4 cc6">0</TD><TD class=alignRight headers="cr1 cr3 cc7 cc8">1173</TD><TD class=alignRight headers="cr1 cr3 cc7 cc9">1173 (100%)</TD></TR><TR><TH id=cr4 class="alignLeft lightred" headers=cr1>B</TH><TD class=alignRight headers="cr1 cr4 cc1 cc2">130</TD><TD class=alignRight headers="cr1 cr4 cc1 cc3">0</TD><TD class=alignRight headers="cr1 cr4 cc4 cc5">129</TD><TD class=alignRight headers="cr1 cr4 cc4 cc6">0</TD><TD class=alignRight headers="cr1 cr4 cc7 cc8">NA <SUP>*</SUP></TD><TD class=alignRight headers="cr1 cr4 cc7 cc9">NA <SUP>*</SUP></TD></TR><TR><TH id=cr5 class="alignLeft lightred" headers=cr1>TOTAL</TH><TD class=alignRight headers="cr1 cr5 cc1 cc2">1098</TD><TD class=alignRight headers="cr1 cr5 cc1 cc3">2 (0.2%)</TD><TD class=alignRight headers="cr1 cr5 cc4 cc5">1102</TD><TD class=alignRight headers="cr1 cr5 cc4 cc6">0</TD><TD class=alignRight headers="cr1 cr5 cc7 cc8">1264</TD><TD class=alignRight headers="cr1 cr5 cc7 cc9">1264 (100%)</TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate decreased from 36.9/1,000 in week 10 to 31.2/1,000 in week 11; and was below the expected range for week 11 (Figure 5).
    Figure 5. Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Note: No data available for mean rate for weeks 19 to 39 for the 1996-1997 through 2002-2003 seasons. Delays in the reporting of data may cause data to change retrospectively. The calculation of the average ILI consultation rate over 17 seasons was aligned with influenza activity in each season. In BC, AB, and SK, data is compiled by a provincial sentinel surveillance program for reporting to FluWatch. The number of sentinel physicians in each province or territory is as follows: BC(21), AB(80), SK(11), MB(18), ON(169), QC(14), NB(29), NS(26), PE(4), NL(16), NU(1), NT(14), YT(13). Not all sentinel physicians report every week.
    Text equivalent for figure 5Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Top of Page

    Influenza Outbreak Surveillance

    In week 11, nine new influenza outbreaks were reported: eight in long-term care facilities (LTCF) and one in a hospital (Figure 6). In addition, one outbreak of influenza-like-illness was reported in a school. Among the seven LTCF outbreaks with available data, three were reported to be due to influenza B.
    Figure 6. Overall number of new influenza outbreaks by report week, Canada, 2013-2014

    1 All provinces and territories except NU report outbreaks in long-term care facilities. All provinces and territories with the exception of NU and QC report outbreaks in hospitals. Outbreaks of influenza or influenza-like-illness in other facilities are reported to FluWatch but reporting varies between jurisdictions. Outbreak definitions are included at the end of the report.
    Text equivalent for figure 6Overall number of new influenza outbreaks by report week, Canada, 2013-2014
    Pharmacy Surveillance

    In week 11, the overall proportion of prescriptions for influenza antivirals increased slightly, based on increases in all age-groups except children 2-18 years of age. The proportion of prescriptions for infants (<2 years of age) increased for the second week in a row, however, the number of prescriptions in this age-group is small. Overall this season, the largest proportion of prescriptions for antivirals has been among children 2-18 years of age and adults 19-64 years of age, in keeping with laboratory detections of influenza (Figure 7).
    Figure 7. Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Note: Pharmacy sales data are provided to the Public Health Agency of Canada by Rx Canada Inc. and sourced from major retail drug chains representing over 3,000 stores nationwide (excluding Nunavut) in 85% of Health Regions. Data provided include the number of new antiviral prescriptions (for Tamiflu and Relenza) and the total number of new prescriptions dispensed by Province/Territory and age group. Age-groups: Infant: 0-2y, Child: 2-18y; Adult: 19-64y, Senior: ≥65y.
    Text equivalent for figure 7Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Top of Page

    Sentinel Hospital Influenza Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)
    In week 11, 22 new laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalizations were reported by the Immunization Monitoring Program Active (IMPACT) network, compared to 38 in week 10. In keeping with the increased circulation of influenza B, influenza B was reported in 12 of the 22 cases in week 11 (Figure 8a). Although the number of cases is small, a greater proportion of cases with influenza B this season have been children between 2 and 10 years of age compared to A(H1N1)pdm09. In week 11, one ICU admission was reported in a child 6-23 months of age with influenza A(unsubtyped). No deaths were reported in week 11.
    To date this season, a total of 613 influenza-associated paediatric hospitalizations have been reported by the IMPACT network, 88% of which have been influenza A, and almost all of those subtyped (97%) were A(H1N1)pdm09. Children <5 years of age represent 74% of cases to date (Table 4). Eighty-six ICU admissions have been reported, of which 58 (67%) were children <5 years of age (Figure 9a). All but five were cases with influenza A, and 96% of those subtyped were A(H1N1)pdm09. Among the 79 ICU cases with available data, 51 (65%) were reported to have underlying medical conditions. No deaths have been reported.
    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    Adult Influenza Hospitalizations and Deaths (PCIRN)
    In week 11, 32 new laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations were reported through active surveillance by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network, compared to 55 in week 10. In week 11, there continued to be more hospitalizations associated with influenza B than influenza A (Figure 8b). All but seven hospitalizations occurred among adults ≥45 years of age. No ICU admissions or deaths were reported in week 11.
    To date this season, 1250 influenza-associated hospitalizations have been reported by the PCIRN-SOS network, 1105 (88.4%) with influenza A, predominantly A(H1N1)pdm09 (Table 5). ICU admission was required for 209 hospitalizations, all but eight of which were cases with influenza A (112 A(H1N1)pdm09, five A(H3N2) and 84 A(unsubtyped)). More than three quarters of hospitalizations and approximately 80% of ICU admissions were ≥45 years of age. Of the 168 ICU admissions with available information, 148 (88.1%) were reported to have at least one comorbidity and of the 180 ICU admissions with available information 131 (72.8%) reported not having been vaccinated this season. Fifty-eight deaths have been reported, all but four with influenza A (32 A(H1N1)pdm09, two A(H3N2) and 20 A(unsubtyped)); six cases 20-44 years of age, 27 cases 45-64 years of age and 25 cases ≥65 years of age (Figure 9b).
    Note: PCIRN-SOS conducted passive surveillance from April 30th to November 14th, 2013. Cases reported during this period were identified by laboratory detection of influenza among patients admitted to participating hospitals. Active surveillance began November 15th during which time PCIRN site coordinators investigate cases potentially related to influenza. Data from both active and passive surveillance reported during the 2013-14 season are included in this report. The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION id=t4 class=alignCenter>Table 4 - Cumulative numbers of paediatric hospitalizations with influenza reported by the IMPACT network, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=dr1 rowSpan=3>Age groups </TH><TH id=dc1 colSpan=6>Cumulative (Aug. 25, 2013 to March 15, 2014) </TH></TR><TR class=bg-colour-yellow><TH id=dc2 colSpan=4 headers=dc1>Influenza A </TH><TH id=dc7 headers=dc1>B </TH><TH id=dc8 headers=dc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=dc3 headers="dc1 dc2">A Total </TH><TH id=dc4 class="lightred " headers="dc1 dc2">A(H1) pdm09 </TH><TH id=dc5 class="lightred " headers="dc1 dc2">A(H3) </TH><TH id=dc6 class="lightred " headers="dc1 dc2">A (UnS) </TH><TD class=alignCenter headers="dc1 dc7">Total</TD><TD class=alignCenter headers="dc1 dc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP id=footnote_t4_1>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.</TD></TR></TFOOT><TBODY><TR><TH id=dr2 class=alignLeft headers=dr1>0-5m </TH><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc3">102</TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc4">33</TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc5">0</TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc6">69</TD><TD class=alignRight headers="dr1 dr2 dc1 dc7">3</TD><TD class=alignRight headers="dr1 dr2 dc1 dc8">105 (17%)</TD></TR><TR><TH id=dr3 class=alignLeft headers=dr1>6-23m </TH><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc3">157</TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc4">45</TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc5">1</TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc6">111</TD><TD class=alignRight headers="dr1 dr3 dc1 dc7">9</TD><TD class=alignRight headers="dr1 dr3 dc1 dc8">166 (27%)</TD></TR><TR><TH id=dr4 class=alignLeft headers=dr1>2-4y </TH><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc3">159</TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc4">53</TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc5">3</TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc6">103</TD><TD class=alignRight headers="dr1 dr4 dc1 dc7">24</TD><TD class=alignRight headers="dr1 dr4 dc1 dc8">183 (30%)</TD></TR><TR><TH id=dr5 class=alignLeft headers=dr1>5-9y </TH><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc3">81</TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc4">25</TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc5">0</TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc6">56</TD><TD class=alignRight headers="dr1 dr5 dc1 dc7">30</TD><TD class=alignRight headers="dr1 dr5 dc1 dc8">111 (18%)</TD></TR><TR><TH id=dr6 class=alignLeft headers=dr1>10-16y </TH><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc3">41</TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc4">15</TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc5">1</TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc6">25</TD><TD class=alignRight headers="dr1 dr6 dc1 dc7">7</TD><TD class=alignRight headers="dr1 dr6 dc1 dc8">48 (8%)</TD></TR><TR><TH id=dr7 class=alignLeft headers=dr1>Total </TH><TD class=alignRight headers="dr1 dr7 dc1 dc2 dc3">540</TD><TD class="alignRight lightred" headers="dr1 dr7 dc1 dc2 dc4">171</TD><TD class="alignRight lightred" headers="dr1 dr7 dc1 dc2 dc5">5</TD><TD class="alignRight lightred" headers="dr1 dr7 dc1 dc2 dc6">364</TD><TD class=alignRight headers="dr1 dr7 dc1 dc7">73</TD><TD class=alignRight headers="dr1 dr7 dc1 dc8">613</TD></TR><TR><TH id=dr8 class=alignLeft headers=dr1>% <SUP>1</SUP> </TH><TD class=alignRight headers="dr1 dr8 dc1 dc2 dc3">88.1%</TD><TD class="alignRight lightred" headers="dr1 dr8 dc1 dc2 dc4">31.7%</TD><TD class="alignRight lightred" headers="dr1 dr8 dc1 dc2 dc5">0.9%</TD><TD class="alignRight lightred" headers="dr1 dr8 dc1 dc2 dc6">67.4%</TD><TD class=alignRight headers="dr1 dr8 dc1 dc7">11.9%</TD><TD class=alignRight headers="dr1 dr8 dc1 dc8">100.0%</TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 5 - Cumulative numbers of adult hospitalizations with influenza
    reported by the PCIRN-SOS network, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=er1 rowSpan=3>Age groups </TH><TH id=ec1 class=noWrap colSpan=6>Cumulative (Aug. 25, 2013 to March 15, 2014)<SUP>*</SUP></TH></TR><TR class=bg-colour-yellow><TH id=ec2 colSpan=4 headers=ec1>Influenza A </TH><TH id=ec7 headers=ec1>B </TH><TH id=ec8 headers=ec1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=ec3 headers="ec1 ec2">A Total </TH><TH id=ec4 class="lightred " headers="ec1 ec2">A(H1) pdm09 </TH><TH id=ec5 class="lightred " headers="ec1 ec2">A(H3) </TH><TH id=ec6 class="lightred " headers="ec1 ec2">A(UnS) </TH><TD class=alignCenter headers="ec1 ec7">Total</TD><TD class=alignCenter headers="ec1 ec8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP id=footnote_t5_1>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.

    <SUP id=t5_star>*</SUP> One case for which the influenza type has not yet been reported, and three cases for which the age-group was not reported, are not included in Table 5.</TD></TR></TFOOT><TBODY><TR><TH id=er2 class=alignLeft headers=er1>16-20 </TH><TD class=alignRight headers="er1 er2 ec1 ec2 ec3">13</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec4">3</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec5">0</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec6">10</TD><TD class=alignRight headers="er1 er2 ec1 ec7">1</TD><TD class=alignRight headers="er1 er2 ec1 ec8">14 (1%)</TD></TR><TR><TH id=er3 class=alignLeft headers=er1>20-44 </TH><TD class=alignRight headers="er1 er3 ec1 ec2 ec3">241</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec4">127</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec5">4</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec6">110</TD><TD class=alignRight headers="er1 er3 ec1 ec7">10</TD><TD class=alignRight headers="er1 er3 ec1 ec8">251 (20%)</TD></TR><TR><TH id=er4 class=alignLeft headers=er1>45-64 </TH><TD class=alignRight headers="er1 er4 ec1 ec2 ec3">433</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec4">201</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec5">5</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec6">227</TD><TD class=alignRight headers="er1 er4 ec1 ec7">35</TD><TD class=alignRight headers="er1 er4 ec1 ec8">468 (38%)</TD></TR><TR><TH id=er5 class=alignLeft headers=er1>65+ </TH><TD class=alignRight headers="er1 er5 ec1 ec2 ec3">415</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec4">201</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec5">32</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec6">182</TD><TD class=alignRight headers="er1 er5 ec1 ec7">98</TD><TD class=alignRight headers="er1 er5 ec1 ec8">513 (41%)</TD></TR><TR><TH id=er6 class=alignLeft headers=er1>Total </TH><TD class=alignRight headers="er1 er6 ec1 ec2 ec3">1102</TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec4">532</TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec5">41</TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec6">529</TD><TD class=alignRight headers="er1 er6 ec1 ec7">144</TD><TD class=alignRight headers="er1 er6 ec1 ec8">1246</TD></TR><TR><TH id=er7 class=alignLeft headers=er1>%<SUP>1</SUP></TH><TD class=alignRight headers="er1 er7 ec1 ec2 ec3">88%</TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec4">48%</TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec5">4%</TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec6">48%</TD><TD class=alignRight headers="er1 er7 ec1 ec7">12%</TD><TD class=alignRight headers="er1 er7 ec1 ec8">100%</TD></TR></TBODY></TABLE>
    Figure 8. Number of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)


    Text equivalent for figure 8aNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    * See footnote above following the section related to PCIRN-SOS data.
    Text equivalent for figure 8bNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Adult hospitalizations (>16 year of age, PCIRN-SOS)
    Figure 9. Percentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)

    Text equivalent for figure 9aPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Text equivalent for figure 9bPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Top of Page

    Provincial/Territorial Influenza Hospitalizations and Deaths

    In week 11, 94 laboratory-confirmed influenza-associated hospitalizations were reported from participating provinces and territories.* As with other surveillance indicators in week 11, the majority were cases of influenza B (52, 55.3%). Among the five ICU admissions reported in week 11, three were adults 45-64 years of age. One death was reported in week 11, an adult ≥65 years of age with influenza B. The number of new influenza-associated hospitalizations and deaths reported for the current week may include cases from Ontario that occurred in previous weeks, as a result of retrospective updates to the cumulative total.
    To date this season, 3,570 influenza-associated hospitalizations have been reported, 93.2% with influenza A. The majority (57.4%) of hospitalizations have been cases 45 years of age of older. A significantly greater proportion of cases of influenza B have been ≥65 years of age compared to cases of A(H1N1)pdm09 this season (Table 6). A total of 324 ICU admissions have been reported this season, of which 66.6% were among adults 20-64 years of age. A total of 197 deaths have been reported. The highest proportion of deaths has been among adults 20-64 years of age (49.7%), followed by adults ≥65 years of age (40.6%). In keeping with the late-season circulation, influenza B has been increasingly reported among severe cases of influenza. To date this season, influenza B has been reported in 6.8% of hospitalizations, 1.5% of ICU admissions, and 5.6 % of deaths. It is important to note that the hospitalization or death does not have to be attributable to influenza, a positive laboratory test is sufficient for reporting. Detailed clinical information (e.g. underlying medical conditions) is not known for these cases.
    * Note: Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not distinguished among hospital admissions reported from Ontario. Data may also include cases reported by the IMPACT and PCIRN networks.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION id=t6 class=alignCenter>Table 6. Cumulative number of hospitalizations with influenza reported by the participating provinces and territories, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=fr1 rowSpan=3>Age groups </TH><TH id=fc1 colSpan=6>Cumulative (Aug. 25, 2013 to March 15, 2014)</TH></TR><TR class=bg-colour-yellow><TH id=fc2 colSpan=4 headers=fc1>Influenza A</TH><TH id=fc7 headers=fc1>B</TH><TH id=fc8 headers=fc1>Influenza A and B</TH></TR><TR class=bg-colour-grey-light><TH id=fc3 headers="fc1 fc2">A Total</TH><TH id=fc4 class=lightred headers="fc1 fc2">A(H1) pdm09</TH><TH id=fc5 class=lightred headers="fc1 fc2">A(H3)</TH><TH id=fc6 class=lightred headers="fc1 fc2">A (UnS)</TH><TD class=alignCenter headers="fc1 fc7">Total</TD><TD class=alignCenter headers="fc1 fc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=8><SUP id=footnote_t6_1>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.</TD></TR></TFOOT><TBODY><TR><TH id=fr2 class=alignLeft headers=fr1>0-4 years</TH><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc3">568</TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc4">275</TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc5">6</TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc6">287</TD><TD class=alignRight headers="fr1 fr2 fc1 fc7">36</TD><TD class=alignRight headers="fr1 fr2 fc1 fc8">604 (17%)</TD></TR><TR><TH id=fr3 class=alignLeft headers=fr1>5-14 years</TH><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc3">125</TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc4">64</TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc5">6</TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc6">55</TD><TD class=alignRight headers="fr1 fr3 fc1 fc7">35</TD><TD class=alignRight headers="fr1 fr3 fc1 fc8">160 (4%)</TD></TR><TR><TH id=fr4 class=alignLeft headers=fr1>15-19 years</TH><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc3">34</TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc4">19</TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc5">3</TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc6">12</TD><TD class=alignRight headers="fr1 fr4 fc1 fc7">1</TD><TD class=alignRight headers="fr1 fr4 fc1 fc8">35 (1%)</TD></TR><TR><TH id=fr5 class=alignLeft headers=fr1>20-44 years </TH><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc3">577</TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc4">408</TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc5">4</TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc6">165</TD><TD class=alignRight headers="fr1 fr5 fc1 fc7">15</TD><TD class=alignRight headers="fr1 fr5 fc1 fc8">592 (17%)</TD></TR><TR><TH id=fr6 class=alignLeft headers=fr1>45-64 years </TH><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc3">1052</TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc4">675</TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc5">21</TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc6">356</TD><TD class=alignRight headers="fr1 fr6 fc1 fc7">52</TD><TD class=alignRight headers="fr1 fr6 fc1 fc8">1104 (31%)</TD></TR><TR><TH id=fr7 class=alignLeft headers=fr1>65+ years </TH><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc3">844</TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc4">448</TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc5">63</TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc6">333</TD><TD class=alignRight headers="fr1 fr7 fc1 fc7">100</TD><TD class=alignRight headers="fr1 fr7 fc1 fc8">944 (26%)</TD></TR><TR><TH id=fr10 class=alignLeft headers=fr1>Unknown</TH><TD class=alignRight headers="fc1 fc2 fc3">127</TD><TD class=alignRight headers="fc1 fc2 fc4">92</TD><TD class=alignRight headers="fc1 fc2 fc5">3</TD><TD class=alignRight headers="fc1 fc2 fc6">29</TD><TD class=alignRight headers="fc1 fc7">4</TD><TD class=alignRight headers="fc1 fc8">128 (4%)</TD></TR><TR><TH id=fr8 class=alignLeft headers=fr1>Total </TH><TD class=alignRight headers="fr1 fr8 fc1 fc2 fc3">3327</TD><TD class="alignRight lightred" headers="fr1 fr8 fc1 fc2 fc4">1981</TD><TD class="alignRight lightred" headers="fr1 fr8 fc1 fc2 fc5">106</TD><TD class="alignRight lightred" headers="fr1 fr8 fc1 fc2 fc6">1237</TD><TD class=alignRight headers="fr1 fr8 fc1 fc7">243</TD><TD class=alignRight headers="fr1 fr8 fc1 fc8">3567</TD></TR><TR><TH id=fr9 class=alignLeft headers=fr1>Percentage <SUP>1</SUP> </TH><TD class=alignRight headers="fr1 fr9 fc1 fc2 fc3">93.3%</TD><TD class="alignRight lightred" headers="fr1 fr9 fc1 fc2 fc4">59.5%</TD><TD class="alignRight lightred" headers="fr1 fr9 fc1 fc2 fc5">3.2%</TD><TD class="alignRight lightred" headers="fr1 fr9 fc1 fc2 fc6">37.2%</TD><TD class=alignRight headers="fr1 fr9 fc1 fc7">6.8%</TD><TD class=alignRight headers="fr1 fr9 fc1 fc8">100%</TD></TR></TBODY></TABLE>
    See additional data on Reported Influenza Hospitalizations and Deaths in Canada: 2009-10 to 2013-14 on the Public Health Agency of Canada website.

    .../

    Leave a comment:


  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Week 10

    FluWatch report: March 2 to 8, 2014 (Week 10)

    Posted 2014-03-14For readers interested in the <ABBR title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A title="Flu Watch (Version PDF, 113 KB - 6 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w10_14/pdf/fw2014-10-eng.pdf">FluWatch report: March 2 to 8, 2014 (Week 10) (<ABBR title="Portable Document Format">PDF</ABBR> Version - 291 <ABBR title=Kilobytes>KB</ABBR> - 10 pages)

    ?? Help with PDF documents

    Overall Summary
    • In week 10, influenza activity in Canada continues to decrease overall, and is consistent with activity at this time in past influenza seasons.
    • The influenza A(H1N1) virus remains the most common influenza virus circulating this season. Circulation of influenza B virus continues to increase in recent weeks, resulting in increased paediatric and adult hospitalizations.
    • While the influenza A(H1N1) virus has mostly affected adults 20-64 years of age, influenza B cases are having a greater impact on adults 65 year of age and older.
    • As of week 10, 3,450 hospitalizations and 189 deaths have been reported from participating regions, which is comparable to reports in past influenza seasons.

    Influenza/ILI Activity (geographic spread)

    In week 10, influenza activity levels continued to decline. No region reported widespread activity and eight regions (SK(1), ON(5), and QC(2)) reported localized activity (Figure 1).
    Figure 1. Map of overall influenza/ILI activity level by province and territory, Canada, Week 10





    Note: Influenza/ILI activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates and reported outbreaks. Please refer to detailed definitions at the end of the report. Maps from previous weeks, including any retrospective updates, are available on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada
    Influenza and Other Respiratory Virus Detections

    The number of positive influenza tests continued to decrease, from 842 in week 09 to 752 in week 10. The percentage of positive influenza tests was similar to last week at 12.5% (Figure 2). Cumulative influenza virus detections to date have been predominantly influenza A (89%), and among those subtyped, 97% (10,089/10,458) were A(H1N1)pdm09. The percentage of positive tests for influenza B has been rising slowly in recent weeks, and was approximately equal to detections of influenza A in week 10 (Table 1). Among the 18,182 cases for which information on age and type/subtype has been received this season, 55.4% were 20-64 years of age (Table 2).
    Figure 2. Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14

    Text equivalent for figure 2Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14
    The number of positive tests for RSV has been declining gradually over recent weeks. The number of positive tests for parainfluenza, adenovirus and rhinovirus decreased in week 10, but increased for coronavirus, interrupting a decline since week 05. The number of positive tests for human metapneumovirus has been higher than during the same period last season and declined slightly in week 10 (Figure 3).
    For more details, see the weekly Respiratory Virus Detections in Canada Report.
    Figure 3. Number of positive laboratory tests for other respiratory viruses by report week, Canada, 2013-14


    Top of Page

    RSV: Respiratory syncytial virus; hMPV: Human metapneumovirus
    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 1: Weekly and cumulative numbers of positive influenza specimens
    by type, subtype and province, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=ar1 rowSpan=3>Reporting provinces <SUP>1</SUP></TH><TH id=ac1 colSpan=5>Weekly
    (March 2, 2013 to March 8, 2014)</TH><TH id=ac8 colSpan=5>Cumulative
    (August 25, 2013 to March 8, 2014)</TH></TR><TR class=bg-colour-yellow><TH id=ac2 colSpan=4 headers=ac1>Influenza A</TH><TH id=ac7 headers=ac1>B</TH><TH id=ac9 colSpan=4 headers=ac8>Influenza A</TH><TH id=ac14 headers=ac8>B</TH></TR><TR class=bg-colour-grey-light><TH id=ac3 headers="ac1 ac2">A Total</TH><TH id=ac4 class=lightred headers="ac1 ac2">A(H1)pdm09</TH><TH id=ac5 class=lightred headers="ac1 ac2">A(H3)</TH><TH id=ac6 class=lightred headers="ac1 ac2">A(UnS)</TH><TH class=alignCenter headers="ac1 ac7">B Total</TH><TH id=ac10 headers="ac8 ac9">A Total</TH><TH id=ac11 class=lightred headers="ac8 ac9">A(H1)pdm09</TH><TH id=ac12 class=lightred headers="ac8 ac9">A(H3)</TH><TH id=ac13 class=lightred headers="ac8 ac9">A(UnS)</TH><TD class=alignCenter headers="ac8 ac14">B Total</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=11><SUP>1 </SUP>Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.
    <SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.</TD></TR></TFOOT><TBODY><TR><TH id=ar2 class=alignLeft headers=ar1>BC</TH><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac3">35</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac4">22</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac5">9</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac6">4</TD><TD class=alignRight headers="ar1 ar2 ac1 ac7">28</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac10">1734</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac11">1575</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac12">53</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac13">106</TD><TD class=alignRight headers="ar1 ar2 ac8 ac14">124</TD></TR><TR><TH id=ar3 class=alignLeft headers=ar1>AB</TH><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac3">63</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac4">31</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac5">1</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac6">31</TD><TD class=alignRight headers="ar1 ar3 ac1 ac7">17</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac10">3671</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac11">3360</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac12">49</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac13">262</TD><TD class=alignRight headers="ar1 ar3 ac8 ac14">122</TD></TR><TR><TH id=ar4 class=alignLeft headers=ar1>SK</TH><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac3">11</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac4">5</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac5">1</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac6">5</TD><TD class=alignRight headers="ar1 ar4 ac1 ac7">7</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac10">1343</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac11">967</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac12">5</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac13">371</TD><TD class=alignRight headers="ar1 ar4 ac8 ac14">34</TD></TR><TR><TH id=ar5 class=alignLeft headers=ar1>MB</TH><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac3">23</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac4">15</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac6">8</TD><TD class=alignRight headers="ar1 ar5 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac10">595</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac11">422</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac12">1</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac13">172</TD><TD class=alignRight headers="ar1 ar5 ac8 ac14">15</TD></TR><TR><TH id=ar6 class=alignLeft headers=ar1>ON</TH><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac3">82</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac4">33</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac5">9</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac6">40</TD><TD class=alignRight headers="ar1 ar6 ac1 ac7">128</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac10">5433</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac11">2386</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac12">253</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac13">2794</TD><TD class=alignRight headers="ar1 ar6 ac8 ac14">523</TD></TR><TR><TH id=ar7 class=alignLeft headers=ar1>QC</TH><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac3">130</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac4">14</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac6">116</TD><TD class=alignRight headers="ar1 ar7 ac1 ac7">179</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac10">5151</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac11">665</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac12">3</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac13">4483</TD><TD class=alignRight headers="ar1 ar7 ac8 ac14">1391</TD></TR><TR><TH id=ar8 class=alignLeft headers=ar1>NB</TH><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac3">25</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac4">4</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac6">21</TD><TD class=alignRight headers="ar1 ar8 ac1 ac7">6</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac10">1480</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac11">370</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac12">1</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac13">1109</TD><TD class=alignRight headers="ar1 ar8 ac8 ac14">18</TD></TR><TR><TH id=ar9 class=alignLeft headers=ar1>NS</TH><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac3">7</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac4">7</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar9 ac1 ac7">1</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac10">153</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac11">124</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac12">4</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac13">25</TD><TD class=alignRight headers="ar1 ar9 ac8 ac14">3</TD></TR><TR><TH id=ar10 class=alignLeft headers=ar1>PE</TH><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac3">1</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac4">1</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac7">1</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac10">117</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac11">116</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac12">0</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac13">1</TD><TD class=alignRight headers="ar1 ar10 ac8 ac14">1</TD></TR><TR><TH id=ar11 class=alignLeft headers=ar1>NL</TH><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac3">7</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac6">7</TD><TD class=alignRight headers="ar1 ar11 ac1 ac7">1</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac10">339</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac11">104</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac12">0</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac13">235</TD><TD class=alignRight headers="ar1 ar11 ac8 ac14">132</TD></TR><TR><TH id=ar12 class=alignLeft headers=ar1>Canada</TH><TD class=alignRight headers="ar1 ar12 ac1 ac2 ac3">384</TD><TD class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac4">132</TD><TD class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac5">20</TD><TD class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac6">232</TD><TD class=alignRight headers="ar1 ar12 ac1 ac7">368</TD><TD class=alignRight headers="ar1 ar12 ac8 ac9 ac10">20016</TD><TD class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac11">10089</TD><TD class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac12">369</TD><TD class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac13">9558</TD><TD class=alignRight headers="ar1 ar12 ac8 ac14">2363</TD></TR><TR><TH id=ar13 class=alignLeft headers=ar1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="ar1 ar13 ac1 ac2 ac3">51.1%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac4">34.4%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac5">5.2%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac6">60.4%</TD><TD class=alignRight headers="ar1 ar13 ac1 ac7">48.9%</TD><TD class=alignRight headers="ar1 ar13 ac8 ac9 ac10">89.4%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac11">50.4%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac12">1.8%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac13">47.8%</TD><TD class=alignRight headers="ar1 ar13 ac8 ac14">10.6%</TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 2. Weekly and cumulative numbers of positive influenza specimens by type, subtype and age-group reported through case-based laboratory reporting<SUP>3</SUP>, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=br1 rowSpan=3>Age groups (years)</TH><TH id=bc1 colSpan=5>Weekly
    (March 2 to March 8, 2014)</TH><TH id=bc8 colSpan=7>Cumulative
    (August 25, 2013 to March 8, 2014)</TH></TR><TR class=bg-colour-yellow><TH id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH id=bc7 headers=bc1>B</TH><TH id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH id=bc14 headers=bc8>B</TH><TH id=bc15 colSpan=2 headers=bc8>Influenza A and B</TH></TR><TR class=bg-colour-grey-light><TH id=bc3 headers="bc1 bc2">A Total</TH><TH id=bc4 class="lightred " headers="bc1 bc2">A(H1) pdm09</TH><TH id=bc5 class="lightred " headers="bc1 bc2">A(H3)</TH><TH id=bc6 class="lightred " headers="bc1 bc2">A (UnS)</TH><TD class=alignCenter headers="bc1 bc7">Total</TD><TH id=bc10 headers="bc8 bc9">A Total</TH><TH id=bc11 class="lightred " headers="bc8 bc9">A(H1) pdm09</TH><TH id=bc12 class="lightred " headers="bc8 bc9">A(H3)</TH><TH id=bc13 class="lightred " headers="bc8 bc9">A (UnS)</TH><TD class=alignCenter headers="bc8 bc14">Total</TD><TH id=bc16 headers="bc8 bc15">#</TH><TH id=bc17 headers="bc8 bc15">%</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=13><SUP>1 </SUP>Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.
    <SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    <SUP>3 </SUP>Table 2 includes specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.</TD></TR></TFOOT><TBODY><TR><TH id=br2 class=alignLeft headers=br1><5</TH><TD class=alignRight headers="br1 br2 bc1 bc2 bc3">44</TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc4">10</TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc6">34</TD><TD class=alignRight headers="br1 br2 bc1 bc7">22</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc10">3098</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc11">1377</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc12">24</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc13">1697</TD><TD class=alignRight headers="br1 br2 bc8 bc14">235</TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc16">3333</TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc17">18.3%</TD></TR><TR><TH id=br3 class=alignLeft headers=br1>5-19</TH><TD class=alignRight headers="br1 br3 bc1 bc2 bc3">18</TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc4">5</TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc6">13</TD><TD class=alignRight headers="br1 br3 bc1 bc7">33</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc10">1268</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc11">676</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc12">18</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc13">574</TD><TD class=alignRight headers="br1 br3 bc8 bc14">355</TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc16">1623</TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc17">8.9%</TD></TR><TR><TH id=br4 class=alignLeft headers=br1>20-44</TH><TD class=alignRight headers="br1 br4 bc1 bc2 bc3">52</TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc4">21</TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc5">1</TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc6">30</TD><TD class=alignRight headers="br1 br4 bc1 bc7">18</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc10">4913</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc11">2680</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc12">36</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc13">2197</TD><TD class=alignRight headers="br1 br4 bc8 bc14">385</TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc16">5298</TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc17">29.1%</TD></TR><TR><TH id=br5 class=alignLeft headers=br1>45-64</TH><TD class=alignRight headers="br1 br5 bc1 bc2 bc3">44</TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc4">12</TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc6">32</TD><TD class=alignRight headers="br1 br5 bc1 bc7">50</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc10">4269</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc11">2292</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc12">40</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc13">1937</TD><TD class=alignRight headers="br1 br5 bc8 bc14">507</TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc16">4776</TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc17">26.3%</TD></TR><TR><TH id=br6 class=alignLeft headers=br1>65+</TH><TD class=alignRight headers="br1 br6 bc1 bc2 bc3">36</TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc4">10</TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc6">26</TD><TD class=alignRight headers="br1 br6 bc1 bc7">71</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc10">2337</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc11">949</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc12">96</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc13">1292</TD><TD class=alignRight headers="br1 br6 bc8 bc14">683</TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc16">3020</TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc17">16.6%</TD></TR><TR><TH id=br7 class=alignLeft headers=br1>Unknown</TH><TD class=alignRight headers="br1 br7 bc1 bc2 bc3">0</TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc4">0</TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc6">0</TD><TD class=alignRight headers="br1 br7 bc1 bc7">0</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc10">130</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc11">100</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc12">17</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc13">13</TD><TD class=alignRight headers="br1 br7 bc8 bc14">2</TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc16">132</TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc17">0.7%</TD></TR><TR><TH id=br8 class=alignLeft headers=br1>Total</TH><TD class=alignRight headers="br1 br8 bc1 bc2 bc3">194</TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc4">58</TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc5">1</TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc6">135</TD><TD class=alignRight headers="br1 br8 bc1 bc7">194</TD><TD class=alignRight headers="br1 br8 bc8 bc9 bc10">16015</TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc11">8074</TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc12">231</TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc13">7710</TD><TD class=alignRight headers="br1 br8 bc8 bc14">2167</TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc16">18182</TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc17">100.0%</TD></TR><TR><TH id=br9 class=alignLeft headers=br1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="br1 br9 bc1 bc2 bc3">50.0%</TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc4">29.9%</TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc5">0.5%</TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc6">69.6%</TD><TD class=alignRight headers="br1 br9 bc1 bc7">50.0%</TD><TD class=alignRight headers="br1 br9 bc8 bc9 bc10">88.1%</TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc11">50.4%</TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc12">1.4%</TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc13">48.1%</TD><TD class=alignRight headers="br1 br9 bc8 bc14">11.9%</TD><TD class=alignRight></TD><TD class=alignRight></TD></TR></TBODY></TABLE>

    Top of Page

    Influenza Strain Characterizations

    During the 2013-2014 influenza season, the National Microbiology Laboratory (NML) has antigenically characterized 1401 influenza viruses [64 A(H3N2), 1131 A(H1N1)pdm09 and 206 influenza B]. The vast majority (99%) of viruses were similar to the strains recommended by the WHO for the 2013-14 seasonal influenza vaccine. Two A(H1N1)pdm09 viruses showed reduced titres to antiserum against the reference A/California/07/2009 strain. Fourteen influenza B viruses were similar to the strain recommended by the WHO for the 2011-12 vaccine (Figure 4).
    Figure 4. Influenza strain characterizations, Canada, 2013-14, N = 1401

    The NML receives a proportion of the number of influenza positive specimens from provincial laboratories for strain characterization and antiviral resistance testing. Characterization data reflect the results of haemagglutination inhibition (HAI) testing compared to the reference influenza strains recommended by WHO.
    The recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b (e.g. A/Texas/50/2012), and a B/Massachusetts/2/2012-like virus (Yamagata lineage).


    Text equivalent for figure 4Influenza strain characterizations, Canada, 2013-2014, N =3
    Antiviral Resistance

    During the 2013-2014 influenza season, NML has tested 996 influenza viruses for resistance to oseltamivir and all but two were sensitive. All 993 viruses tested for resistance to zanamivir were sensitive. All 1165 influenza A viruses tested for amantadine resistance were resistant (Table 3).
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=cr1 rowSpan=2>Virus type and subtype</TH><TH id=cc1 colSpan=2>Oseltamivir</TH><TH id=cc4 colSpan=2>Zanamivir</TH><TH id=cc7 colSpan=2>Amantadine</TH></TR><TR class=bg-colour-yellow><TH id=cc2 headers=cc1># tested</TH><TH id=cc3 headers=cc1># resistant (%)</TH><TH id=cc5 headers=cc4># tested</TH><TH id=cc6 headers=cc4># resistant (%)</TH><TH id=cc8 headers=cc7># tested</TH><TH id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH id=cr2 class="alignLeft lightred" headers=cr1>A (H3N2)</TH><TD class=alignRight headers="cr1 cr2 cc1 cc2">53</TD><TD class=alignRight headers="cr1 cr2 cc1 cc3">0</TD><TD class=alignRight headers="cr1 cr2 cc4 cc5">53</TD><TD class=alignRight headers="cr1 cr2 cc4 cc6">0</TD><TD class=alignRight headers="cr1 cr2 cc7 cc8">88</TD><TD class=alignRight headers="cr1 cr2 cc7 cc9">88 (100%)</TD></TR><TR><TH id=cr3 class="alignLeft lightred" headers=cr1>A (H1N1)</TH><TD class=alignRight headers="cr1 cr3 cc1 cc2">883</TD><TD class=alignRight headers="cr1 cr3 cc1 cc3">2 (0.2%)</TD><TD class=alignRight headers="cr1 cr3 cc4 cc5">830</TD><TD class=alignRight headers="cr1 cr3 cc4 cc6">0</TD><TD class=alignRight headers="cr1 cr3 cc7 cc8">1077</TD><TD class=alignRight headers="cr1 cr3 cc7 cc9">1077 (100%)</TD></TR><TR><TH id=cr4 class="alignLeft lightred" headers=cr1>B</TH><TD class=alignRight headers="cr1 cr4 cc1 cc2">110</TD><TD class=alignRight headers="cr1 cr4 cc1 cc3">0</TD><TD class=alignRight headers="cr1 cr4 cc4 cc5">110</TD><TD class=alignRight headers="cr1 cr4 cc4 cc6">0</TD><TD class=alignRight headers="cr1 cr4 cc7 cc8">NA <SUP>*</SUP></TD><TD class=alignRight headers="cr1 cr4 cc7 cc9">NA <SUP>*</SUP></TD></TR><TR><TH id=cr5 class="alignLeft lightred" headers=cr1>TOTAL</TH><TD class=alignRight headers="cr1 cr5 cc1 cc2">996</TD><TD class=alignRight headers="cr1 cr5 cc1 cc3">2 (0.2%)</TD><TD class=alignRight headers="cr1 cr5 cc4 cc5">993</TD><TD class=alignRight headers="cr1 cr5 cc4 cc6">0</TD><TD class=alignRight headers="cr1 cr5 cc7 cc8">1165</TD><TD class=alignRight headers="cr1 cr5 cc7 cc9">1165 (100%)</TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate increased from 32.7/1,000 in week 09 to 39.8/1,000 in week 10; but is still within the expected range for this time of year (Figure 5).
    Figure 5. Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Note: No data available for mean rate for weeks 19 to 39 for the 1996-1997 through 2002-2003 seasons. Delays in the reporting of data may cause data to change retrospectively. The calculation of the average ILI consultation rate over 17 seasons was aligned with influenza activity in each season. In BC, AB, and SK, data is compiled by a provincial sentinel surveillance program for reporting to FluWatch. The number of sentinel physicians in each province or territory is as follows: BC(21), AB(80), SK(11), MB(18), ON(169), QC(14), NB(29), NS(26), PE(4), NL(16), NU(1), NT(14), YT(13). Not all sentinel physicians report every week.
    Text equivalent for figure 5Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Top of Page

    Influenza Outbreak Surveillance

    In week 10, five new influenza outbreaks in long-term care facilities were reported, the same number as in week (Figure 6). In addition, two outbreaks of influenza-like-illness were reported in schools.
    Figure 6. Overall number of new influenza outbreaks by report week, Canada, 2013-2014

    1 All provinces and territories except NU report outbreaks in long-term care facilities. All provinces and territories with the exception of NU and QC report outbreaks in hospitals. Outbreaks of influenza or influenza-like-illness in other facilities are reported to FluWatch but reporting varies between jurisdictions. Outbreak definitions are included at the end of the report.
    Text equivalent for figure 6Overall number of new influenza outbreaks by report week, Canada, 2013-2014
    Pharmacy Surveillance

    In week 10, the overall proportion of prescriptions for influenza antivirals continued to decrease. The largest proportion of prescriptions for antivirals continuing to be among children 2-18 years of age and adults 19-64 years of age, although the proportion of prescriptions for infants increased in week 10 (Figure 7).
    Figure 7. Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Note: Pharmacy sales data are provided to the Public Health Agency of Canada by Rx Canada Inc. and sourced from major retail drug chains representing over 3,000 stores nationwide (excluding Nunavut) in 85% of Health Regions. Data provided include the number of new antiviral prescriptions (for Tamiflu and Relenza) and the total number of new prescriptions dispensed by Province/Territory and age group. Age-groups: Infant: 0-2y, Child: 2-18y; Adult: 19-64y, Senior: ≥65y.
    Text equivalent for figure 7Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Top of Page

    Sentinel Hospital Influenza Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)
    In week 10, 35 new laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalizations were reported by the Immunization Monitoring Program Active (IMPACT) network, compared to 26 in week 09. In week 10, influenza A was reported in 23 cases and influenza B in 12 cases. A greater proportion of cases have been reported with influenza B cases in recent weeks, following the trend in laboratory detections (Figure 8a). Although the number of cases is small, a greater proportion of cases with influenza B this season have been children between 2 and 10 years of age compared to A(H1N1)pdm09. In week 10, one ICU admission was reported in a child 5-9 years of age with influenza B. No deaths were reported in week 10.
    To date this season, a total of 591 influenza-associated paediatric hospitalizations have been reported by the IMPACT network, 90% of which have been influenza A, and almost all of those subtyped (97%) were A(H1N1)pdm09. Children <5 years of age represent 74% of cases to date (Table 4). Eighty-two ICU admissions have been reported, of which 55 (67%) were children <5 years of age (Figure 9a). All but four were cases with influenza A, and 96% of those subtyped were A(H1N1)pdm09. Among the 72 ICU cases with available data, 47 (65%) were reported to have underlying medical conditions. No deaths have been reported.
    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    Adult Influenza Hospitalizations and Deaths (PCIRN)
    In week 10, 36 new laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations were reported through active surveillance by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network, compared to 35 in week 09. In week 10, influenza B-associated hospitalizations surpassed those associated with influenza A for the first time this season. Among cases in week 10, 16 (44.4%) were influenza A, and 20 were influenza B (Figure 8b). All but five hospitalizations occurred among adults ≥45 years of age. No ICU admissions or deaths were reported in week 10.
    To date this season, 1176 influenza-associated hospitalizations have been reported by the PCIRN-SOS network, 1074 (91.3%) with influenza A, predominantly A(H1N1)pdm09 (Table 5). ICU admission was required for 201 hospitalizations, all but seven of which were cases with influenza A (110 A(H1N1)pdm09, five A(H3N2) and 79 A(unsubtyped)). More than three quarters of hospitalizations and approximately 80% of ICU admissions were ≥45 years of age. Of the 163 ICU admissions with available information, 143 (87.7%) were reported to have at least one comorbidity and of the 172 ICU admissions with available information 125 (72.7%) reported not having been vaccinated this season. Fifty-six deaths have been reported, all but three with influenza A (32 A(H1N1)pdm09, two A(H3N2) and 19 A(unsubtyped)); six cases 20-44 years of age, 27 cases 45-64 years of age and 23 cases ≥65 years of age (Figure 9b).
    Note: PCIRN-SOS conducted passive surveillance from April 30th to November 14th, 2013. Cases reported during this period were identified by laboratory detection of influenza among patients admitted to participating hospitals. Active surveillance began November 15th during which time PCIRN site coordinators investigate cases potentially related to influenza. Data from both active and passive surveillance reported during the 2013-14 season are included in this report. The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION id=t4 class=alignCenter>Table 4 - Cumulative numbers of paediatric hospitalizations with influenza reported by the IMPACT network, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=dr1 rowSpan=3>Age groups </TH><TH id=dc1 colSpan=6>Cumulative (Aug. 25, 2013 to March 8, 2014) </TH></TR><TR class=bg-colour-yellow><TH id=dc2 colSpan=4 headers=dc1>Influenza A </TH><TH id=dc7 headers=dc1>B </TH><TH id=dc8 headers=dc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=dc3 headers="dc1 dc2">A Total </TH><TH id=dc4 class="lightred " headers="dc1 dc2">A(H1) pdm09 </TH><TH id=dc5 class="lightred " headers="dc1 dc2">A(H3) </TH><TH id=dc6 class="lightred " headers="dc1 dc2">A (UnS) </TH><TD class=alignCenter headers="dc1 dc7">Total</TD><TD class=alignCenter headers="dc1 dc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.</TD></TR></TFOOT><TBODY><TR><TH id=dr2 class=alignLeft headers=dr1>0-5m </TH><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc3">101</TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc4">30</TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc5">0</TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc6">71</TD><TD class=alignRight headers="dr1 dr2 dc1 dc7">3</TD><TD class=alignRight headers="dr1 dr2 dc1 dc8">104 (18%)</TD></TR><TR><TH id=dr3 class=alignLeft headers=dr1>6-23m </TH><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc3">153</TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc4">44</TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc5">1</TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc6">108</TD><TD class=alignRight headers="dr1 dr3 dc1 dc7">7</TD><TD class=alignRight headers="dr1 dr3 dc1 dc8">160 (27%)</TD></TR><TR><TH id=dr4 class=alignLeft headers=dr1>2-4y </TH><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc3">156</TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc4">51</TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc5">3</TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc6">102</TD><TD class=alignRight headers="dr1 dr4 dc1 dc7">18</TD><TD class=alignRight headers="dr1 dr4 dc1 dc8">174 (29%)</TD></TR><TR><TH id=dr5 class=alignLeft headers=dr1>5-9y </TH><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc3">80</TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc4">23</TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc5">0</TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc6">57</TD><TD class=alignRight headers="dr1 dr5 dc1 dc7">27</TD><TD class=alignRight headers="dr1 dr5 dc1 dc8">107 (18%)</TD></TR><TR><TH id=dr6 class=alignLeft headers=dr1>10-16y </TH><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc3">40</TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc4">15</TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc5">1</TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc6">24</TD><TD class=alignRight headers="dr1 dr6 dc1 dc7">6</TD><TD class=alignRight headers="dr1 dr6 dc1 dc8">46 (8%)</TD></TR><TR><TH id=dr7 class=alignLeft headers=dr1>Total </TH><TD class=alignRight headers="dr1 dr7 dc1 dc2 dc3">530</TD><TD class="alignRight lightred" headers="dr1 dr7 dc1 dc2 dc4">163</TD><TD class="alignRight lightred" headers="dr1 dr7 dc1 dc2 dc5">5</TD><TD class="alignRight lightred" headers="dr1 dr7 dc1 dc2 dc6">362</TD><TD class=alignRight headers="dr1 dr7 dc1 dc7">61</TD><TD class=alignRight headers="dr1 dr7 dc1 dc8">591</TD></TR><TR><TH id=dr8 class=alignLeft headers=dr1>% <SUP>1</SUP> </TH><TD class=alignRight headers="dr1 dr8 dc1 dc2 dc3">89.7%</TD><TD class="alignRight lightred" headers="dr1 dr8 dc1 dc2 dc4">30.8%</TD><TD class="alignRight lightred" headers="dr1 dr8 dc1 dc2 dc5">0.9%</TD><TD class="alignRight lightred" headers="dr1 dr8 dc1 dc2 dc6">68.3%</TD><TD class=alignRight headers="dr1 dr8 dc1 dc7">10.3%</TD><TD class=alignRight headers="dr1 dr8 dc1 dc8">100.0%</TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 5 - Cumulative numbers of adult hospitalizations with influenza
    reported by the PCIRN-SOS network, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=er1 rowSpan=3>Age groups </TH><TH id=ec1 class=noWrap colSpan=6>Cumulative (Aug. 25, 2013 to March 8, 2014)<SUP>*</SUP></TH></TR><TR class=bg-colour-yellow><TH id=ec2 colSpan=4 headers=ec1>Influenza A </TH><TH id=ec7 headers=ec1>B </TH><TH id=ec8 headers=ec1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=ec3 headers="ec1 ec2">A Total </TH><TH id=ec4 class="lightred " headers="ec1 ec2">A(H1) pdm09 </TH><TH id=ec5 class="lightred " headers="ec1 ec2">A(H3) </TH><TH id=ec6 class="lightred " headers="ec1 ec2">A(UnS) </TH><TD class=alignCenter headers="ec1 ec7">Total</TD><TD class=alignCenter headers="ec1 ec8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.

    <SUP id=t5_star>*</SUP> One case for which the influenza type has not yet been reported, and three cases for which the age-group was not reported, are not included in Table 5.</TD></TR></TFOOT><TBODY><TR><TH id=er2 class=alignLeft headers=er1>16-20 </TH><TD class=alignRight headers="er1 er2 ec1 ec2 ec3">13 </TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec4">3 </TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec5">0 </TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec6">10 </TD><TD class=alignRight headers="er1 er2 ec1 ec7">1 </TD><TD class=alignRight headers="er1 er2 ec1 ec8">14 (1%) </TD></TR><TR><TH id=er3 class=alignLeft headers=er1>20-44 </TH><TD class=alignRight headers="er1 er3 ec1 ec2 ec3">234 </TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec4">126 </TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec5">4 </TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec6">104 </TD><TD class=alignRight headers="er1 er3 ec1 ec7">6 </TD><TD class=alignRight headers="er1 er3 ec1 ec8">240 (20%) </TD></TR><TR><TH id=er4 class=alignLeft headers=er1>45-64 </TH><TD class=alignRight headers="er1 er4 ec1 ec2 ec3">423 </TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec4">194 </TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec5">4 </TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec6">225 </TD><TD class=alignRight headers="er1 er4 ec1 ec7">25 </TD><TD class=alignRight headers="er1 er4 ec1 ec8">448 (38%) </TD></TR><TR><TH id=er5 class=alignLeft headers=er1>65+ </TH><TD class=alignRight headers="er1 er5 ec1 ec2 ec3">401 </TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec4">193 </TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec5">31 </TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec6">177 </TD><TD class=alignRight headers="er1 er5 ec1 ec7">69 </TD><TD class=alignRight headers="er1 er5 ec1 ec8">470 (40%) </TD></TR><TR><TH id=er6 class=alignLeft headers=er1>Total </TH><TD class=alignRight headers="er1 er6 ec1 ec2 ec3">1071 </TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec4">516 </TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec5">39 </TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec6">516 </TD><TD class=alignRight headers="er1 er6 ec1 ec7">101 </TD><TD class=alignRight headers="er1 er6 ec1 ec8">1172 </TD></TR><TR><TH id=er7 class=alignLeft headers=er1>%<SUP>1</SUP></TH><TD class=alignRight headers="er1 er7 ec1 ec2 ec3">91% </TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec4">48% </TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec5">4% </TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec6">48% </TD><TD class=alignRight headers="er1 er7 ec1 ec7">9% </TD><TD class=alignRight headers="er1 er7 ec1 ec8">100% </TD></TR></TBODY></TABLE>
    Figure 8. Number of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)


    Text equivalent for figure 8aNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    * See footnote above following the section related to PCIRN-SOS data.
    Text equivalent for figure 8bNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Adult hospitalizations (>16 year of age, PCIRN-SOS)
    Figure 9. Percentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)

    Text equivalent for figure 9aPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Text equivalent for figure 9bPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Top of Page

    Provincial/Territorial Influenza Hospitalizations and Deaths

    In week 10, 194 laboratory-confirmed influenza-associated hospitalizations were reported from participating provinces and territories.* The majority were cases of influenza A (136, 70.1%), of which 58 (42.6%) were A(H1N1)pdm09, 12 (8.8%) were A(H3N2), and 66 (48.5%) were A(unsubtyped). The proportion of cases with influenza B has been increasing in recent weeks. Five of the seven ICU admissions in week 10 included age information: four of which were adults ≥45 years of age; all but one with influenza A. Seven deaths were reported, four of which were adults 65 years of age and older. The number of new influenza-associated hospitalizations and deaths reported for the current week may include cases from Ontario that occurred in previous weeks, as a result of retrospective updates to the cumulative total.
    To date this season, 3,450 influenza-associated hospitalizations have been reported, 94.5% with influenza A. The majority (57.7%) of hospitalizations have been cases 45 years of age of older (Table 6). A total of 316 ICU admissions have been reported this season, of which 66.5% were among adults 20-64 years of age. A total of 189 deaths have been reported. The highest proportion of deaths has been among adults 20-64 years of age (50.3%), followed by adults ≥65 years of age (40.2%). Influenza B has been detected infrequently among severe cases of influenza to date this season: in only 5.5% of hospitalizations, 1.3% of ICU admissions, and 5.3 % of deaths. It is important to note that the hospitalization or death does not have to be attributable to influenza, a positive laboratory test is sufficient for reporting. Detailed clinical information (e.g. underlying medical conditions) is not known for these cases.
    * Note: Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not distinguished among hospital admissions reported from Ontario. Data may also include cases reported by the IMPACT and PCIRN networks.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION id=t6 class=alignCenter>Table 6. Cumulative number of hospitalizations with influenza reported by the participating provinces and territories, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=fr1 rowSpan=3>Age groups </TH><TH id=fc1 colSpan=6>Cumulative (Aug. 25, 2013 to March 8, 2014)</TH></TR><TR class=bg-colour-yellow><TH id=fc2 colSpan=4 headers=fc1>Influenza A</TH><TH id=fc7 headers=fc1>B</TH><TH id=fc8 headers=fc1>Influenza A and B</TH></TR><TR class=bg-colour-grey-light><TH id=fc3 headers="fc1 fc2">A Total</TH><TH id=fc4 class=lightred headers="fc1 fc2">A(H1) pdm09</TH><TH id=fc5 class=lightred headers="fc1 fc2">A(H3)</TH><TH id=fc6 class=lightred headers="fc1 fc2">A (UnS)</TH><TD class=alignCenter headers="fc1 fc7">Total</TD><TD class=alignCenter headers="fc1 fc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=8><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.</TD></TR></TFOOT><TBODY><TR><TH id=fr2 class=alignLeft headers=fr1>0-4 years</TH><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc3">554 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc4">273 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc5">6 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc6">275 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc7">31 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc8">585 (17%) </TD></TR><TR><TH id=fr3 class=alignLeft headers=fr1>5-14 years</TH><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc3">121 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc4">62 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc5">5 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc6">54 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc7">26 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc8">147 (4%) </TD></TR><TR><TH id=fr4 class=alignLeft headers=fr1>15-19 years</TH><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc3">32 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc4">19 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc5">2 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc6">11 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc7">1 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc8">33 (1%) </TD></TR><TR><TH id=fr5 class=alignLeft headers=fr1>20-44 years </TH><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc3">571 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc4">404 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc5">4 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc6">163 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc7">11 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc8">582 (17%) </TD></TR><TR><TH id=fr6 class=alignLeft headers=fr1>45-64 years </TH><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc3">1038 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc4">667 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc5">20 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc6">351 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc7">40 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc8">1078 (31%) </TD></TR><TR><TH id=fr7 class=alignLeft headers=fr1>65+ years </TH><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc3">830 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc4">440 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc5">59 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc6">331 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc7">77 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc8">907 (26%) </TD></TR><TR><TH id=fr10 class=alignLeft headers=fr1>Unknown</TH><TD class=alignRight headers="fr1 fr10 fc1 fc2 fc3">114 </TD><TD class=alignRight headers="fr1 fr10 fc1 fc2 fc4">87 </TD><TD class=alignRight headers="fr1 fr10 fc1 fc2 fc5">3 </TD><TD class=alignRight headers="fr1 fr10 fc1 fc2 fc6">24 </TD><TD class=alignRight headers="fr1 fr10 fc1 fc7">4 </TD><TD class=alignRight headers="fr1 fr10 fc1 fc8">118 (3%) </TD></TR><TR><TH id=fr8 class=alignLeft headers=fr1>Total </TH><TD class=alignRight headers="fr1 fr8 fc1 fc2 fc3">3260 </TD><TD class="alignRight lightred" headers="fr1 fr8 fc1 fc2 fc4">1952 </TD><TD class="alignRight lightred" headers="fr1 fr8 fc1 fc2 fc5">99 </TD><TD class="alignRight lightred" headers="fr1 fr8 fc1 fc2 fc6">1209 </TD><TD class=alignRight headers="fr1 fr8 fc1 fc7">190 </TD><TD class=alignRight headers="fr1 fr8 fc1 fc8">3450 </TD></TR><TR><TH id=fr9 class=alignLeft headers=fr1>Percentage <SUP>1</SUP> </TH><TD class=alignRight headers="fr1 fr9 fc1 fc2 fc3">94.5% </TD><TD class="alignRight lightred" headers="fr1 fr9 fc1 fc2 fc4">59.9% </TD><TD class="alignRight lightred" headers="fr1 fr9 fc1 fc2 fc5">3.0% </TD><TD class="alignRight lightred" headers="fr1 fr9 fc1 fc2 fc6">37.1% </TD><TD class=alignRight headers="fr1 fr9 fc1 fc7">5.5% </TD><TD class=alignRight headers="fr1 fr9 fc1 fc8">100% </TD></TR></TBODY></TABLE>
    See additional data on Reported Influenza Hospitalizations and Deaths in Canada: 2009-10 to 2013-14 on the Public Health Agency of Canada website.

    .../

    Leave a comment:


  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Week 9

    FluWatch report: February 23 to March 1, 2014 (Week 09)

    Posted 2014-03-07For readers interested in the <ABBR title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A title="Flu Watch (Version PDF, 113 KB - 6 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w09_14/pdf/fw2014-09-eng.pdf">FluWatch report: February 23 to March 1, 2014 (Week 09) (<ABBR title="Portable Document Format">PDF</ABBR> Version - 291 <ABBR title=Kilobytes>KB</ABBR> - 10 pages)

    ?? Help with PDF documents


    Overall Summary
    • In week 09, influenza activity in Canada continues to decrease, following a pattern similar to the 2012-13 season.
    • The influenza A(H1N1) virus remains the most common influenza virus circulating this season, affecting a greater proportion of adults 20-64 years of age compared to last season.
    • Circulation of influenza B virus continues to increase.
    • The number of sentinel paediatric and adult hospitalizations continues to decline. To week 09, 3,238 hospitalizations and 182 deaths have been reported. Compared to the same period last season, fewer hospitalizations but a similar number of deaths have been reported.
    • A Canadian vaccine effectiveness study has estimated that immunization with the 2013-14 seasonal influenza vaccine has been 58.5% effective in reducing influenza-related hospitalizations (McNeil S, Shinde V, Andrew M et al.).
    Influenza/ILI Activity (geographic spread)

    In week 09, influenza activity levels continued to decline. One region in Quebec reported widespread activity and seven regions in eastern Canada (ON(4), QC(2) and NS(1)) reported localized activity (Figure 1).
    Figure 1. Map of overall influenza/ILI activity level by province and territory, Canada, Week 09





    Note: Influenza/ILI activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates and reported outbreaks. Please refer to detailed definitions at the end of the report. Maps from previous weeks, including any retrospective updates, are available on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada
    Influenza and Other Respiratory Virus Detections

    The number of positive influenza tests continued to decrease, from 985 in week 08 to 864 in week 09. The percentage of positive influenza tests decreased from 13.9% to 13.3% (Figure 2). Cumulative influenza virus detections to date remain predominantly influenza A (91%), and among those subtyped, 97% (9,933/10,290) were A(H1N1)pdm09. However, the percentage of positive tests for influenza B has been rising slowly in recent weeks to 36.7% of influenza detections in week 09 (Table 1). Among the 17,709 cases for which information on age and type/subtype has been received this season, 55.8% were 20-64 years of age (Table 2).
    Figure 2. Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14

    Text equivalent for figure 2Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14
    The number of positive tests for RSV declined slightly in week 09. The number of positive tests for parainfluenza increased slightly in week 09, interrupting the decline observed since early January. The number of positive tests for rhinovirus has been relatively stable, while the number of positive tests for coronavirus and human metapneumovirus has been declining over recent weeks (Figure 3).
    For more details, see the weekly Respiratory Virus Detections in Canada Report.
    Figure 3. Number of positive laboratory tests for other respiratory viruses by report week, Canada, 2013-14


    Top of Page

    RSV: Respiratory syncytial virus; hMPV: Human metapneumovirus
    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 1: Weekly and cumulative numbers of positive influenza specimens
    by type, subtype and province, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=ar1 rowSpan=3>Reporting provinces <SUP>1</SUP></TH><TH id=ac1 colSpan=5>Weekly
    (February 23, 2013 to March 1, 2014)
    </TH><TH id=ac8 colSpan=5>Cumulative
    (August 25, 2013 to March 1, 2014)
    </TH></TR><TR class=bg-colour-yellow><TH id=ac2 colSpan=4 headers=ac1>Influenza A</TH><TH id=ac7 headers=ac1>B</TH><TH id=ac9 colSpan=4 headers=ac8>Influenza A</TH><TH id=ac14 headers=ac8>B</TH></TR><TR class=bg-colour-grey-light><TH id=ac3 headers="ac1 ac2">A Total</TH><TH id=ac4 class=lightred headers="ac1 ac2">A(H1)pdm09</TH><TH id=ac5 class=lightred headers="ac1 ac2">A(H3)</TH><TH id=ac6 class=lightred headers="ac1 ac2">A(UnS)</TH><TH class=alignCenter headers="ac1 ac7">B Total</TH><TH id=ac10 headers="ac8 ac9">A Total</TH><TH id=ac11 class=lightred headers="ac8 ac9">A(H1)pdm09</TH><TH id=ac12 class=lightred headers="ac8 ac9">A(H3)</TH><TH id=ac13 class=lightred headers="ac8 ac9">A(UnS)</TH><TD class=alignCenter headers="ac8 ac14">B Total</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=11><SUP>1 </SUP>Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.
    <SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=ar2 class=alignLeft headers=ar1>BC</TH><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac3">73</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac4">50</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac5">13</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac6">10</TD><TD class=alignRight headers="ar1 ar2 ac1 ac7">20</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac10">1731</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac11">1573</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac12">58</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac13">100</TD><TD class=alignRight headers="ar1 ar2 ac8 ac14">98</TD></TR><TR><TH id=ar3 class=alignLeft headers=ar1>AB</TH><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac3">43</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac4">16</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac5">1</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac6">26</TD><TD class=alignRight headers="ar1 ar3 ac1 ac7">15</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac10">3585</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac11">3297</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac12">44</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac13">244</TD><TD class=alignRight headers="ar1 ar3 ac8 ac14">105</TD></TR><TR><TH id=ar4 class=alignLeft headers=ar1>SK</TH><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac3">15</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac4">12</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac6">3</TD><TD class=alignRight headers="ar1 ar4 ac1 ac7">3</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac10">1332</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac11">962</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac12">4</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac13">366</TD><TD class=alignRight headers="ar1 ar4 ac8 ac14">27</TD></TR><TR><TH id=ar5 class=alignLeft headers=ar1>MB</TH><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac3">34</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac4">29</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac6">5</TD><TD class=alignRight headers="ar1 ar5 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac10">572</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac11">407</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac12">1</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac13">164</TD><TD class=alignRight headers="ar1 ar5 ac8 ac14">15</TD></TR><TR><TH id=ar6 class=alignLeft headers=ar1>ON</TH><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac3">105</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac4">32</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac5">12</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac6">61</TD><TD class=alignRight headers="ar1 ar6 ac1 ac7">94</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac10">5352</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac11">2341</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac12">242</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac13">2769</TD><TD class=alignRight headers="ar1 ar6 ac8 ac14">395</TD></TR><TR><TH id=ar7 class=alignLeft headers=ar1>QC</TH><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac3">214</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac4">35</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac6">179</TD><TD class=alignRight headers="ar1 ar7 ac1 ac7">174</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac10">5021</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac11">651</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac12">3</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac13">4367</TD><TD class=alignRight headers="ar1 ar7 ac8 ac14">1212</TD></TR><TR><TH id=ar8 class=alignLeft headers=ar1>NB</TH><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac3">37</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac4">2</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac6">35</TD><TD class=alignRight headers="ar1 ar8 ac1 ac7">2</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac10">1455</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac11">366</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac12">1</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac13">1088</TD><TD class=alignRight headers="ar1 ar8 ac8 ac14">12</TD></TR><TR><TH id=ar9 class=alignLeft headers=ar1>NS</TH><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac3">17</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac4">15</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac6">2</TD><TD class=alignRight headers="ar1 ar9 ac1 ac7">1</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac10">146</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac11">117</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac12">4</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac13">25</TD><TD class=alignRight headers="ar1 ar9 ac8 ac14">2</TD></TR><TR><TH id=ar10 class=alignLeft headers=ar1>PE</TH><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac3">1</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac4">1</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac10">116</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac11">115</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac12">0</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac13">1</TD><TD class=alignRight headers="ar1 ar10 ac8 ac14">0</TD></TR><TR><TH id=ar11 class=alignLeft headers=ar1>NL</TH><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac3">8</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac6">8</TD><TD class=alignRight headers="ar1 ar11 ac1 ac7">8</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac10">332</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac11">104</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac12">0</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac13">228</TD><TD class=alignRight headers="ar1 ar11 ac8 ac14">131</TD></TR><TR><TH id=ar12 class=alignLeft headers=ar1>Canada</TH><TD class=alignRight headers="ar1 ar12 ac1 ac2 ac3">547</TD><TD class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac4">192</TD><TD class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac5">26</TD><TD class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac6">329</TD><TD class=alignRight headers="ar1 ar12 ac1 ac7">317</TD><TD class=alignRight headers="ar1 ar12 ac8 ac9 ac10">19642</TD><TD class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac11">9933</TD><TD class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac12">357</TD><TD class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac13">9352</TD><TD class=alignRight headers="ar1 ar12 ac8 ac14">1997</TD></TR><TR><TH id=ar13 class=alignLeft headers=ar1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="ar1 ar13 ac1 ac2 ac3">63.3%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac4">35.1%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac5">4.8%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac6">60.1%</TD><TD class=alignRight headers="ar1 ar13 ac1 ac7">36.7%</TD><TD class=alignRight headers="ar1 ar13 ac8 ac9 ac10">90.8%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac11">50.6%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac12">1.8%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac13">47.6%</TD><TD class=alignRight headers="ar1 ar13 ac8 ac14">9.2%</TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 2. Weekly and cumulative numbers of positive influenza specimens by type, subtype and age-group reported through case-based laboratory reporting<SUP>3</SUP>, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=br1 rowSpan=3>Age groups (years)</TH><TH id=bc1 colSpan=5>Weekly
    (February 23 to March 1, 2014)
    </TH><TH id=bc8 colSpan=7>Cumulative
    (August 25, 2013 to March 1, 2014)
    </TH></TR><TR class=bg-colour-yellow><TH id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH id=bc7 headers=bc1>B</TH><TH id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH id=bc14 headers=bc8>B</TH><TH id=bc15 colSpan=2 headers=bc8>Influenza A and B</TH></TR><TR class=bg-colour-grey-light><TH id=bc3 headers="bc1 bc2">A Total</TH><TH id=bc4 class="lightred " headers="bc1 bc2">A(H1) pdm09</TH><TH id=bc5 class="lightred " headers="bc1 bc2">A(H3)</TH><TH id=bc6 class="lightred " headers="bc1 bc2">A (UnS)</TH><TD class=alignCenter headers="bc1 bc7">Total</TD><TH id=bc10 headers="bc8 bc9">A Total</TH><TH id=bc11 class="lightred " headers="bc8 bc9">A(H1) pdm09</TH><TH id=bc12 class="lightred " headers="bc8 bc9">A(H3)</TH><TH id=bc13 class="lightred " headers="bc8 bc9">A (UnS)</TH><TD class=alignCenter headers="bc8 bc14">Total</TD><TH id=bc16 headers="bc8 bc15">#</TH><TH id=bc17 headers="bc8 bc15">%</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=13><SUP>1 </SUP>Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.
    <SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    <SUP>3 </SUP>Table 2 includes specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=br2 class=alignLeft headers=br1><5</TH><TD class=alignRight headers="br1 br2 bc1 bc2 bc3">67</TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc4">16</TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc6">51</TD><TD class=alignRight headers="br1 br2 bc1 bc7">28</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc10">3034</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc11">1358</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc12">23</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc13">1653</TD><TD class=alignRight headers="br1 br2 bc8 bc14">212</TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc16">3246</TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc17">18.3%</TD></TR><TR><TH id=br3 class=alignLeft headers=br1>5-19</TH><TD class=alignRight headers="br1 br3 bc1 bc2 bc3">19</TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc4">4</TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc6">15</TD><TD class=alignRight headers="br1 br3 bc1 bc7">37</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc10">1246</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc11">669</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc12">18</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc13">559</TD><TD class=alignRight headers="br1 br3 bc8 bc14">317</TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc16">1563</TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc17">8.8%</TD></TR><TR><TH id=br4 class=alignLeft headers=br1>20-44</TH><TD class=alignRight headers="br1 br4 bc1 bc2 bc3">74</TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc4">22</TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc6">52</TD><TD class=alignRight headers="br1 br4 bc1 bc7">39</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc10">4843</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc11">2644</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc12">33</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc13">2166</TD><TD class=alignRight headers="br1 br4 bc8 bc14">361</TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc16">5204</TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc17">29.4%</TD></TR><TR><TH id=br5 class=alignLeft headers=br1>45-64</TH><TD class=alignRight headers="br1 br5 bc1 bc2 bc3">76</TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc4">28</TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc5">1</TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc6">47</TD><TD class=alignRight headers="br1 br5 bc1 bc7">47</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc10">4217</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc11">2269</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc12">40</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc13">1908</TD><TD class=alignRight headers="br1 br5 bc8 bc14">453</TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc16">4670</TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc17">26.4%</TD></TR><TR><TH id=br6 class=alignLeft headers=br1>65+</TH><TD class=alignRight headers="br1 br6 bc1 bc2 bc3">57</TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc4">17</TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc5">3</TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc6">37</TD><TD class=alignRight headers="br1 br6 bc1 bc7">63</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc10">2292</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc11">936</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc12">95</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc13">1261</TD><TD class=alignRight headers="br1 br6 bc8 bc14">602</TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc16">2894</TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc17">16.3%</TD></TR><TR><TH id=br7 class=alignLeft headers=br1>Unknown</TH><TD class=alignRight headers="br1 br7 bc1 bc2 bc3">4</TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc4">1</TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc5">3</TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc6">0</TD><TD class=alignRight headers="br1 br7 bc1 bc7">0</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc10">130</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc11">100</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc12">17</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc13">13</TD><TD class=alignRight headers="br1 br7 bc8 bc14">2</TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc16">132</TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc17">0.7%</TD></TR><TR><TH id=br8 class=alignLeft headers=br1>Total</TH><TD class=alignRight headers="br1 br8 bc1 bc2 bc3">297</TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc4">88</TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc5">7</TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc6">202</TD><TD class=alignRight headers="br1 br8 bc1 bc7">214</TD><TD class=alignRight headers="br1 br8 bc8 bc9 bc10">15762</TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc11">7976</TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc12">226</TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc13">7560</TD><TD class=alignRight headers="br1 br8 bc8 bc14">1947</TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc16">17709</TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc17">100.0%</TD></TR><TR><TH id=br9 class=alignLeft headers=br1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="br1 br9 bc1 bc2 bc3">58.1%</TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc4">29.6%</TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc5">2.4%</TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc6">68.0%</TD><TD class=alignRight headers="br1 br9 bc1 bc7">41.9%</TD><TD class=alignRight headers="br1 br9 bc8 bc9 bc10">89.0%</TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc11">50.6%</TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc12">1.4%</TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc13">48.0%</TD><TD class=alignRight headers="br1 br9 bc8 bc14">11.0%</TD><TD class=alignRight></TD><TD class=alignRight></TD></TR></TBODY></TABLE>

    Top of Page

    Influenza Strain Characterizations

    During the 2013-2014 influenza season, the National Microbiology Laboratory (NML) has antigenically characterized 1248 influenza viruses [55 A(H3N2), 1022 A(H1N1)pdm09 and 171 influenza B]. The vast majority (99%) of viruses were similar to the strains recommended by the WHO for the 2013-14 seasonal influenza vaccine. Two A(H1N1)pdm09 viruses showed reduced titres to antiserum against the reference A/California/07/2009 strain. Thirteen influenza B viruses were similar to the strain recommended by the WHO for the 2011-12 vaccine (Figure 4).
    Figure 4. Influenza strain characterizations, Canada, 2013-14, N = 1248

    The NML receives a proportion of the number of influenza positive specimens from provincial laboratories for strain characterization and antiviral resistance testing. Characterization data reflect the results of haemagglutination inhibition (HAI) testing compared to the reference influenza strains recommended by WHO.
    The recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b (e.g. A/Texas/50/2012), and a B/Massachusetts/2/2012-like virus (Yamagata lineage).


    Text equivalent for figure 4Influenza strain characterizations, Canada, 2013-2014, N =3
    Antiviral Resistance

    During the 2013-2014 influenza season, NML has tested 883 influenza viruses for resistance to oseltamivir and all but two were sensitive. All 882 viruses tested for resistance to zanamivir were sensitive. All 1104 influenza A viruses tested for amantadine resistance were resistant (Table 3).
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=cr1 rowSpan=2>Virus type and subtype</TH><TH id=cc1 colSpan=2>Oseltamivir</TH><TH id=cc4 colSpan=2>Zanamivir</TH><TH id=cc7 colSpan=2>Amantadine</TH></TR><TR class=bg-colour-yellow><TH id=cc2 headers=cc1># tested</TH><TH id=cc3 headers=cc1># resistant (%)</TH><TH id=cc5 headers=cc4># tested</TH><TH id=cc6 headers=cc4># resistant (%)</TH><TH id=cc8 headers=cc7># tested</TH><TH id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH id=cr2 class="alignLeft lightred" headers=cr1>A (H3N2)</TH><TD class=alignRight headers="cr1 cr2 cc1 cc2">48</TD><TD class=alignRight headers="cr1 cr2 cc1 cc3">0</TD><TD class=alignRight headers="cr1 cr2 cc4 cc5">48</TD><TD class=alignRight headers="cr1 cr2 cc4 cc6">0</TD><TD class=alignRight headers="cr1 cr2 cc7 cc8">76</TD><TD class=alignRight headers="cr1 cr2 cc7 cc9">76 (100%)</TD></TR><TR><TH id=cr3 class="alignLeft lightred" headers=cr1>A (H1N1)</TH><TD class=alignRight headers="cr1 cr3 cc1 cc2">742</TD><TD class=alignRight headers="cr1 cr3 cc1 cc3">2 (0.3%)</TD><TD class=alignRight headers="cr1 cr3 cc4 cc5">741</TD><TD class=alignRight headers="cr1 cr3 cc4 cc6">0</TD><TD class=alignRight headers="cr1 cr3 cc7 cc8">1028</TD><TD class=alignRight headers="cr1 cr3 cc7 cc9">1028 (100%)</TD></TR><TR><TH id=cr4 class="alignLeft lightred" headers=cr1>B</TH><TD class=alignRight headers="cr1 cr4 cc1 cc2">93</TD><TD class=alignRight headers="cr1 cr4 cc1 cc3">0</TD><TD class=alignRight headers="cr1 cr4 cc4 cc5">93</TD><TD class=alignRight headers="cr1 cr4 cc4 cc6">0</TD><TD class=alignRight headers="cr1 cr4 cc7 cc8">NA <SUP>*</SUP></TD><TD class=alignRight headers="cr1 cr4 cc7 cc9">NA <SUP>*</SUP></TD></TR><TR><TH id=cr5 class="alignLeft lightred" headers=cr1>TOTAL</TH><TD class=alignRight headers="cr1 cr5 cc1 cc2">883</TD><TD class=alignRight headers="cr1 cr5 cc1 cc3">2 (0.2%)</TD><TD class=alignRight headers="cr1 cr5 cc4 cc5">882</TD><TD class=alignRight headers="cr1 cr5 cc4 cc6">0</TD><TD class=alignRight headers="cr1 cr5 cc7 cc8">1104</TD><TD class=alignRight headers="cr1 cr5 cc7 cc9">1104 (100%)</TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate increased from 20.3/1,000 in week 08 to 32.7/1,000 in week 09; which is within the expected range for week 09 (Figure 5).
    Figure 5. Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Note: No data available for mean rate for weeks 19 to 39 for the 1996-1997 through 2002-2003 seasons. Delays in the reporting of data may cause data to change retrospectively. The calculation of the average ILI consultation rate over 17 seasons was aligned with influenza activity in each season. In BC, AB, and SK, data is compiled by a provincial sentinel surveillance program for reporting to FluWatch. The number of sentinel physicians in each province or territory is as follows: BC(21), AB(80), SK(11), MB(18), ON(169), QC(14), NB(29), NS(26), PE(4), NL(16), NU(1), NT(14), YT(13). Not all sentinel physicians report every week.
    Text equivalent for figure 5Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Top of Page

    Influenza Outbreak Surveillance

    In week 09, five new influenza outbreaks in long-term care facilities were reported (Figure 6). In addition, one outbreak of influenza-like-illness was reported in a school.
    Figure 6. Overall number of new influenza outbreaks by report week, Canada, 2013-2014

    1 All provinces and territories except NU report outbreaks in long-term care facilities. All provinces and territories with the exception of NU and QC report outbreaks in hospitals. Outbreaks of influenza or influenza-like-illness in other facilities are reported to FluWatch but reporting varies between jurisdictions. Outbreak definitions are included at the end of the report.
    Text equivalent for figure 6Overall number of new influenza outbreaks by report week, Canada, 2013-2014
    Pharmacy Surveillance

    In week 09, the proportion of prescriptions for influenza antivirals continued to decrease, with the largest proportion of prescriptions for antivirals continuing to be among children 2-18 years of age and adults 19-64 years of age (Figure 7). Within these age-groups, higher proportions of prescriptions for antivirals were observed among persons between 5 and 45 years of age.
    Figure 7. Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Note: Pharmacy sales data are provided to the Public Health Agency of Canada by Rx Canada Inc. and sourced from major retail drug chains representing over 3,000 stores nationwide (excluding Nunavut) in 85% of Health Regions. Data provided include the number of new antiviral prescriptions (for Tamiflu and Relenza) and the total number of new prescriptions dispensed by Province/Territory and age group. Age-groups: Infant: 0-2y, Child: 2-18y; Adult: 19-64y, Senior: ≥65y.
    Text equivalent for figure 7Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Top of Page

    Sentinel Hospital Influenza Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)
    In week 09, 18 new laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalizations were reported by the Immunization Monitoring Program Active (IMPACT) network, compared to 30 in week 08. In week 09, influenza A was reported in 14 cases and influenza B in four cases. A greater proportion of cases have been reported with influenza B cases in recent weeks, following the trend in laboratory detections (Figure 8a). Although the number of cases is small, a greater proportion of cases with influenza B have been children between 2 and 10 years of age compared to the younger age-groups affected by A(H1N1)pdm09 this season. No ICU admissions or deaths were reported in week 09.
    To date this season, a total of 542 influenza-associated paediatric hospitalizations have been reported by the IMPACT network, 92% of which have been influenza A, and almost all of those subtyped (97%) were A(H1N1)pdm09. Children ≥2 years of age represent 55% of cases to date (Table 4). Seventy-nine ICU admissions have been reported, of which 46 (58%) were children ≥2 years of age (Figure 9a). Among the 77 ICU admission for which the influenza type reported, all but four were cases with influenza A, and 96% of those subtyped were A(H1N1)pdm09. Among the 67 ICU cases with available data, 45 (67%) were reported to have underlying medical conditions. No deaths have been reported.
    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    Adult Influenza Hospitalizations and Deaths (PCIRN)
    In week 09, 21 new laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations reported through active surveillance by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network, compared to 44 in week 08. There has been a steady decline in the number of new cases over recent weeks, and a greater number of cases of influenza B. Among cases in week 09, 14 (66.7%) were influenza A, and seven were influenza B (Figure 8b). All but two hospitalizations occurred among adults ≥45 years of age. Three ICU admissions were reported in week 09, all ≥45 years of age, two with influenza A and one with influenza B. No deaths were reported in week 09.
    To date this season, 1104 influenza-associated hospitalizations have been reported by the PCIRN-SOS network, 1036 (93.8%) with influenza A, predominantly A(H1N1)pdm09 (Table 5). ICU admission was required for 192 hospitalizations, all but seven of which were cases with influenza A (107 A(H1N1)pdm09, four A(H3N2) and 74 A(unsubtyped)). More than three quarters of hospitalizations and approximately 80% of ICU admissions were ≥45 years of age. Of the 156 ICU admissions with available information, 137 (87.8%) were reported to have at least one comorbidity and of the 165 ICU admissions with available information 119 (72.1%) reported not having been vaccinated this season. Fifty-three deaths have been reported, all but two with influenza A (32 A(H1N1)pdm09, two A(H3N2) and 17 A(unsubtyped)); five cases 20-44 years of age, 26 cases 45-64 years of age and 22 cases ≥65 years of age (Figure 9b).
    Note: PCIRN-SOS conducted passive surveillance from April 30th to November 14th, 2013. Cases reported during this period were identified by laboratory detection of influenza among patients admitted to participating hospitals. Active surveillance began November 15th during which time PCIRN site coordinators investigate cases potentially related to influenza. Data from both active and passive surveillance reported during the 2013-14 season are included in this report. The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION id=t4 class=alignCenter>Table 4 - Cumulative numbers of paediatric hospitalizations with influenza reported by the IMPACT network, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=dr1 rowSpan=3>Age groups </TH><TH id=dc1 colSpan=6>Cumulative (Aug. 25, 2013 to March 1, 2014) </TH></TR><TR class=bg-colour-yellow><TH id=dc2 colSpan=4 headers=dc1>Influenza A </TH><TH id=dc7 headers=dc1>B </TH><TH id=dc8 headers=dc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=dc3 headers="dc1 dc2">A Total </TH><TH id=dc4 class="lightred " headers="dc1 dc2">A(H1) pdm09 </TH><TH id=dc5 class="lightred " headers="dc1 dc2">A(H3) </TH><TH id=dc6 class="lightred " headers="dc1 dc2">A (UnS) </TH><TD class=alignCenter headers="dc1 dc7">Total</TD><TD class=alignCenter headers="dc1 dc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=dr2 class=alignLeft headers=dr1>0-5m </TH><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc3">96 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc4">28 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc6">68 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc7">2 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc8">98 (18%) </TD></TR><TR><TH id=dr3 class=alignLeft headers=dr1>6-23m </TH><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc3">142 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc4">39 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc5">1 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc6">102 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc7">5 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc8">147 (27%) </TD></TR><TR><TH id=dr4 class=alignLeft headers=dr1>2-4y </TH><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc3">148 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc4">47 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc5">2 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc6">99 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc7">15 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc8">163 (30%) </TD></TR><TR><TH id=dr5 class=alignLeft headers=dr1>5-9y </TH><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc3">75 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc4">22 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc5">1 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc6">52 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc7">20 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc8">95 (18%) </TD></TR><TR><TH id=dr6 class=alignLeft headers=dr1>10-16y </TH><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc3">35 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc4">13 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc6">22 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc7">4 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc8">39 (7%) </TD></TR><TR><TH id=dr7 class=alignLeft headers=dr1>Total </TH><TD class=alignRight headers="dr1 dr7 dc1 dc2 dc3">496 </TD><TD class="alignRight lightred" headers="dr1 dr7 dc1 dc2 dc4">149 </TD><TD class="alignRight lightred" headers="dr1 dr7 dc1 dc2 dc5">4 </TD><TD class="alignRight lightred" headers="dr1 dr7 dc1 dc2 dc6">343 </TD><TD class=alignRight headers="dr1 dr7 dc1 dc7">46 </TD><TD class=alignRight headers="dr1 dr7 dc1 dc8">542 </TD></TR><TR><TH id=dr8 class=alignLeft headers=dr1>% <SUP>1</SUP> </TH><TD class=alignRight headers="dr1 dr8 dc1 dc2 dc3">91.5% </TD><TD class="alignRight lightred" headers="dr1 dr8 dc1 dc2 dc4">30.0% </TD><TD class="alignRight lightred" headers="dr1 dr8 dc1 dc2 dc5">0.8% </TD><TD class="alignRight lightred" headers="dr1 dr8 dc1 dc2 dc6">69.2% </TD><TD class=alignRight headers="dr1 dr8 dc1 dc7">8.5% </TD><TD class=alignRight headers="dr1 dr8 dc1 dc8">100.0% </TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 5 - Cumulative numbers of adult hospitalizations with influenza
    reported by the PCIRN-SOS network, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=er1 rowSpan=3>Age groups </TH><TH id=ec1 class=noWrap colSpan=6>Cumulative (Aug. 25, 2013 to March 1, 2014)<SUP>*</SUP></TH></TR><TR class=bg-colour-yellow><TH id=ec2 colSpan=4 headers=ec1>Influenza A </TH><TH id=ec7 headers=ec1>B </TH><TH id=ec8 headers=ec1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=ec3 headers="ec1 ec2">A Total </TH><TH id=ec4 class="lightred " headers="ec1 ec2">A(H1) pdm09 </TH><TH id=ec5 class="lightred " headers="ec1 ec2">A(H3) </TH><TH id=ec6 class="lightred " headers="ec1 ec2">A(UnS) </TH><TD class=alignCenter headers="ec1 ec7">Total</TD><TD class=alignCenter headers="ec1 ec8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.

    <SUP id=t5_star>*</SUP> One case for which the influenza type has not yet been reported, and three cases for which the age-group was not reported, are not included in Table 5.
    </TD></TR></TFOOT><TBODY><TR><TH id=er2 class=alignLeft headers=er1>16-20 </TH><TD class=alignRight headers="er1 er2 ec1 ec2 ec3">13</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec4">3</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec5">0</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec6">10</TD><TD class=alignRight headers="er1 er2 ec1 ec7">1</TD><TD class=alignRight headers="er1 er2 ec1 ec8">14 (1%)</TD></TR><TR><TH id=er3 class=alignLeft headers=er1>20-44 </TH><TD class=alignRight headers="er1 er3 ec1 ec2 ec3">225</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec4">123</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec5">4</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec6">98</TD><TD class=alignRight headers="er1 er3 ec1 ec7">4</TD><TD class=alignRight headers="er1 er3 ec1 ec8">229 (21%)</TD></TR><TR><TH id=er4 class=alignLeft headers=er1>45-64 </TH><TD class=alignRight headers="er1 er4 ec1 ec2 ec3">411</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec4">191</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec5">4</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec6">216</TD><TD class=alignRight headers="er1 er4 ec1 ec7">13</TD><TD class=alignRight headers="er1 er4 ec1 ec8">424 (39%)</TD></TR><TR><TH id=er5 class=alignLeft headers=er1>65+ </TH><TD class=alignRight headers="er1 er5 ec1 ec2 ec3">384</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec4">189</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec5">29</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec6">166</TD><TD class=alignRight headers="er1 er5 ec1 ec7">49</TD><TD class=alignRight headers="er1 er5 ec1 ec8">433 (39%)</TD></TR><TR><TH id=er6 class=alignLeft headers=er1>Total </TH><TD class=alignRight headers="er1 er6 ec1 ec2 ec3">1033</TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec4">506</TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec5">37</TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec6">490</TD><TD class=alignRight headers="er1 er6 ec1 ec7">67</TD><TD class=alignRight headers="er1 er6 ec1 ec8">1100</TD></TR><TR><TH id=er7 class=alignLeft headers=er1>%<SUP>1</SUP></TH><TD class=alignRight headers="er1 er7 ec1 ec2 ec3">94%</TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec4">49%</TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec5">4%</TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec6">47%</TD><TD class=alignRight headers="er1 er7 ec1 ec7">6%</TD><TD class=alignRight headers="er1 er7 ec1 ec8">100%</TD></TR></TBODY></TABLE>
    Figure 8. Number of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)


    Text equivalent for figure 8aNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    * See footnote above following the section related to PCIRN-SOS data.
    Text equivalent for figure 8bNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Adult hospitalizations (>16 year of age, PCIRN-SOS)
    Figure 9. Percentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)

    Text equivalent for figure 9aPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Text equivalent for figure 9bPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Top of Page

    Provincial/Territorial Influenza Hospitalizations and Deaths

    In week 09, 134 laboratory-confirmed influenza-associated hospitalizations were reported from participating provinces and territories.* The majority were cases of influenza A (101, 75.4%), of which 57 (56.4%) were A(H1N1)pdm09, four (4.0%) was A(H3N2), and 40 (39.6%) were A(unsubtyped). The proportion of cases with influenza B has been increasing in recent weeks. Six ICU admissions were reported in week 09, all with influenza A: three adults 45-64 years of age, one ≥65 years of age, and two with age not reported. Nine deaths were reported, two thirds of which were adults 65 years of age and older. The number of new influenza-associated hospitalizations and deaths reported for the current week may include cases from Ontario that occurred in previous weeks, as a result of retrospective updates to the cumulative total.
    To date this season, 3,238 influenza-associated hospitalizations have been reported, 95.9% with influenza A. The majority (57.6%) of hospitalizations have been cases 45 years of age of older (Table 6). A total of 307 ICU admissions have been reported this season, of which 67.1% were among adults 20-64 years of age. A total of 182 deaths have been reported. The highest proportion of deaths has been among adults 20-64 years of age (51.1%), followed by adults ≥65 years of age (39.6%). Influenza B has been detected infrequently among severe cases of influenza to date this season: in only 4.1% of hospitalizations, 1.0% of ICU admissions, and 4.4 % of deaths. It is important to note that the hospitalization or death does not have to be attributable to influenza, a positive laboratory test is sufficient for reporting. Detailed clinical information (e.g. underlying medical conditions) is not known for these cases.
    * Note: Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not distinguished among hospital admissions reported from Ontario. Data may also include cases reported by the IMPACT and PCIRN networks.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION id=t6 class=alignCenter>Table 6. Cumulative number of hospitalizations with influenza reported by the participating provinces and territories, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=fr1 rowSpan=3>Age groups </TH><TH id=fc1 colSpan=6>Cumulative (Aug. 25, 2013 to March 1, 2014)</TH></TR><TR class=bg-colour-yellow><TH id=fc2 colSpan=4 headers=fc1>Influenza A</TH><TH id=fc7 headers=fc1>B</TH><TH id=fc8 headers=fc1>Influenza A and B</TH></TR><TR class=bg-colour-grey-light><TH id=fc3 headers="fc1 fc2">A Total</TH><TH id=fc4 class=lightred headers="fc1 fc2">A(H1) pdm09</TH><TH id=fc5 class=lightred headers="fc1 fc2">A(H3)</TH><TH id=fc6 class=lightred headers="fc1 fc2">A (UnS)</TH><TD class=alignCenter headers="fc1 fc7">Total</TD><TD class=alignCenter headers="fc1 fc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=8><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=fr2 class=alignLeft headers=fr1>0-4 years</TH><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc3">530</TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc4">261</TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc5">6</TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc6">263</TD><TD class=alignRight headers="fr1 fr2 fc1 fc7">22</TD><TD class=alignRight headers="fr1 fr2 fc1 fc8">552 (17%)</TD></TR><TR><TH id=fr3 class=alignLeft headers=fr1>5-14 years</TH><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc3">116</TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc4">60</TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc5">5</TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc6">51</TD><TD class=alignRight headers="fr1 fr3 fc1 fc7">15</TD><TD class=alignRight headers="fr1 fr3 fc1 fc8">131 (4%)</TD></TR><TR><TH id=fr4 class=alignLeft headers=fr1>15-19 years</TH><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc3">32</TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc4">19</TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc5">2</TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc6">11</TD><TD class=alignRight headers="fr1 fr4 fc1 fc7">1</TD><TD class=alignRight headers="fr1 fr4 fc1 fc8">33 (1%)</TD></TR><TR><TH id=fr5 class=alignLeft headers=fr1>20-44 years </TH><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc3">543</TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc4">391</TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc5">3</TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc6">149</TD><TD class=alignRight headers="fr1 fr5 fc1 fc7">9</TD><TD class=alignRight headers="fr1 fr5 fc1 fc8">552 (17%)</TD></TR><TR><TH id=fr6 class=alignLeft headers=fr1>45-64 years </TH><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc3">999</TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc4">652</TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc5">17</TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc6">330</TD><TD class=alignRight headers="fr1 fr6 fc1 fc7">24</TD><TD class=alignRight headers="fr1 fr6 fc1 fc8">1023 (32%)</TD></TR><TR><TH id=fr7 class=alignLeft headers=fr1>65+ years </TH><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc3">784</TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc4">422</TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc5">50</TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc6">312</TD><TD class=alignRight headers="fr1 fr7 fc1 fc7">58</TD><TD class=alignRight headers="fr1 fr7 fc1 fc8">842 (26%)</TD></TR><TR><TH id=fr10 class=alignLeft headers=fr1>Unknown</TH><TD class=alignRight headers="fr1 fr10 fc1 fc2 fc3">101</TD><TD class=alignRight headers="fr1 fr10 fc1 fc2 fc4">79</TD><TD class=alignRight headers="fr1 fr10 fc1 fc2 fc5">3</TD><TD class=alignRight headers="fr1 fr10 fc1 fc2 fc6">19</TD><TD class=alignRight headers="fr1 fr10 fc1 fc7">4</TD><TD class=alignRight headers="fr1 fr10 fc1 fc8">105 (3%)</TD></TR><TR><TH id=fr8 class=alignLeft headers=fr1>Total </TH><TD class=alignRight headers="fr1 fr8 fc1 fc2 fc3">3105</TD><TD class="alignRight lightred" headers="fr1 fr8 fc1 fc2 fc4">1884</TD><TD class="alignRight lightred" headers="fr1 fr8 fc1 fc2 fc5">86</TD><TD class="alignRight lightred" headers="fr1 fr8 fc1 fc2 fc6">1135</TD><TD class=alignRight headers="fr1 fr8 fc1 fc7">133</TD><TD class=alignRight headers="fr1 fr8 fc1 fc8">3238</TD></TR><TR><TH id=fr9 class=alignLeft headers=fr1>Percentage <SUP>1</SUP> </TH><TD class=alignRight headers="fr1 fr9 fc1 fc2 fc3">95.9%</TD><TD class="alignRight lightred" headers="fr1 fr9 fc1 fc2 fc4">60.7%</TD><TD class="alignRight lightred" headers="fr1 fr9 fc1 fc2 fc5">2.8%</TD><TD class="alignRight lightred" headers="fr1 fr9 fc1 fc2 fc6">36.6%</TD><TD class=alignRight headers="fr1 fr9 fc1 fc7">4.1%</TD><TD class=alignRight headers="fr1 fr9 fc1 fc8">100%</TD></TR></TBODY></TABLE>
    See additional data on Reported Influenza Hospitalizations and Deaths in Canada: 2009-10 to 2013-14 on the Public Health Agency of Canada website.

    .../

    Leave a comment:


  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Week 8

    FluWatch report: February 16 to 22, 2014 (Week 08)

    Posted 2014-02-28For readers interested in the <ABBR title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A title="Flu Watch (Version PDF, 113 KB - 6 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w08_14/pdf/fw2014-08-eng.pdf">FluWatch report: February 16 to 22, 2014 (Week 08) (<ABBR title="Portable Document Format">PDF</ABBR> Version - 291 <ABBR title=Kilobytes>KB</ABBR> - 10 pages)

    ?? Help with PDF documents


    Overall Summary
    • In week 08, overall influenza activity continued to decrease in Canada except in the eastern provinces which experienced a later start to the influenza season.
    • The influenza A(H1N1) virus remains the most common influenza virus circulating this season although influenza B virus detections continue to increase.
    • Adults 20-64 years of age continue to be more affected by influenza this season. However, the increasing circulation of influenza B may result in greater impact on older adults and children in the coming weeks.
    • To week 08, 3,093 hospitalizations and 171 deaths have been reported, which is fewer than were reported during the same period last season.
    • Overall influenza activity in Canada during the 2013-14 season has been similar to the 2012-13 season and is within expected levels for this time of year.
    Influenza/ILI Activity (geographic spread)

    In week 08, influenza activity levels continued to decline. No regions reported widespread activity and ten regions in eastern Canada (ON(5), QC(3) and NS(2)) reported localized activity (Figure 1).
    Figure 1. Map of overall influenza/ILI activity level by province and territory, Canada, Week 08





    Note: Influenza/ILI activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates and reported outbreaks. Please refer to detailed definitions at the end of the report. Maps from previous weeks, including any retrospective updates, are available on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada
    Influenza and Other Respiratory Virus Detections

    The number of positive influenza tests continued to decrease, from 1,315 in week 07 to 1,014 in week 08. The percentage of positive influenza tests decreased from 16.9% to 14.3% (Figure 2). Laboratory detections continue to follow a similar trend to the 2012-13 season, despite the difference in the predominant circulating virus. Cumulative influenza virus detections to date remain predominantly influenza A (92%), and among those subtyped, 97% (9,724/10,060) were A(H1N1)pdm09. However, the percentage of positive tests for influenza B has been rising slowly in recent weeks to 28.7% of influenza detections in week 08 (Table 1). A similar late-season wave of influenza B was observed during the 2012-13 and 2010-11 influenza seasons. Among the 16,968 cases for which information on age and type/subtype has been received this season, 56.1% were 20-64 years of age (Table 2).
    Figure 2. Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14

    Text equivalent for figure 2Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14
    The percentages of positive tests for RSV, human metapneumovirus and rhinovirus have been increasing over recent weeks. The percentage of positive tests for coronavirus and parainfluenza have been declining (Figure 3).
    For more details, see the weekly Respiratory Virus Detections in Canada Report.
    Figure 3. Number of positive laboratory tests for other respiratory viruses by report week, Canada, 2013-14


    Top of Page

    RSV: Respiratory syncytial virus; hMPV: Human metapneumovirus
    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 1: Weekly and cumulative numbers of positive influenza specimens
    by type, subtype and province, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=ar1 rowSpan=3>Reporting provinces <SUP>1</SUP></TH><TH id=ac1 colSpan=5>Weekly
    (February 16, 2013 to February 22, 2014)
    </TH><TH id=ac8 colSpan=5>Cumulative
    (August 25, 2013 to February 22, 2014)
    </TH></TR><TR class=bg-colour-yellow><TH id=ac2 colSpan=4 headers=ac1>Influenza A</TH><TH id=ac7 headers=ac1>B</TH><TH id=ac9 colSpan=4 headers=ac8>Influenza A</TH><TH id=ac14 headers=ac8>B</TH></TR><TR class=bg-colour-grey-light><TH id=ac3 headers="ac1 ac2">A Total</TH><TH id=ac4 class=lightred headers="ac1 ac2">A(H1)pdm09</TH><TH id=ac5 class=lightred headers="ac1 ac2">A(H3)</TH><TH id=ac6 class=lightred headers="ac1 ac2">A(UnS)</TH><TH class=alignCenter headers="ac1 ac7">B Total</TH><TH id=ac10 headers="ac8 ac9">A Total</TH><TH id=ac11 class=lightred headers="ac8 ac9">A(H1)pdm09</TH><TH id=ac12 class=lightred headers="ac8 ac9">A(H3)</TH><TH id=ac13 class=lightred headers="ac8 ac9">A(UnS)</TH><TD class=alignCenter headers="ac8 ac14">B Total</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=11><SUP>1 </SUP>Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.
    <SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=ar2 class=alignLeft headers=ar1>BC</TH><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac3">80 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac4">43 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac5">8 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac6">29 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac7">12 </TD><TD class=alignCenter headers="ar1 ar2 ac8 ac9 ac10">1687 </TD><TD class=alignCenter headers="ar1 ar2 ac8 ac9 ac11">1526 </TD><TD class=alignCenter headers="ar1 ar2 ac8 ac9 ac12">51 </TD><TD class=alignCenter headers="ar1 ar2 ac8 ac9 ac13">110 </TD><TD class=alignCenter headers="ar1 ar2 ac8 ac14">77 </TD></TR><TR><TH id=ar3 class=alignLeft headers=ar1>AB</TH><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac3">75 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac4">35 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac5">3 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac6">37 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac7">7 </TD><TD class=alignCenter headers="ar1 ar3 ac8 ac9 ac10">3542 </TD><TD class=alignCenter headers="ar1 ar3 ac8 ac9 ac11">3265 </TD><TD class=alignCenter headers="ar1 ar3 ac8 ac9 ac12">42 </TD><TD class=alignCenter headers="ar1 ar3 ac8 ac9 ac13">235 </TD><TD class=alignCenter headers="ar1 ar3 ac8 ac14">90 </TD></TR><TR><TH id=ar4 class=alignLeft headers=ar1>SK</TH><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac3">17 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac4">11 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac6">6 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac7">3 </TD><TD class=alignCenter headers="ar1 ar4 ac8 ac9 ac10">1317 </TD><TD class=alignCenter headers="ar1 ar4 ac8 ac9 ac11">950 </TD><TD class=alignCenter headers="ar1 ar4 ac8 ac9 ac12">4 </TD><TD class=alignCenter headers="ar1 ar4 ac8 ac9 ac13">363 </TD><TD class=alignCenter headers="ar1 ar4 ac8 ac14">24 </TD></TR><TR><TH id=ar5 class=alignLeft headers=ar1>MB</TH><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac3">31 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac4">29 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac6">2 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar5 ac8 ac9 ac10">538 </TD><TD class=alignCenter headers="ar1 ar5 ac8 ac9 ac11">378 </TD><TD class=alignCenter headers="ar1 ar5 ac8 ac9 ac12">1 </TD><TD class=alignCenter headers="ar1 ar5 ac8 ac9 ac13">159 </TD><TD class=alignCenter headers="ar1 ar5 ac8 ac14">15 </TD></TR><TR><TH id=ar6 class=alignLeft headers=ar1>ON</TH><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac3">98 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac4">19 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac5">14 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac6">65 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac7">80 </TD><TD class=alignCenter headers="ar1 ar6 ac8 ac9 ac10">5248 </TD><TD class=alignCenter headers="ar1 ar6 ac8 ac9 ac11">2305 </TD><TD class=alignCenter headers="ar1 ar6 ac8 ac9 ac12">230 </TD><TD class=alignCenter headers="ar1 ar6 ac8 ac9 ac13">2713 </TD><TD class=alignCenter headers="ar1 ar6 ac8 ac14">305 </TD></TR><TR><TH id=ar7 class=alignLeft headers=ar1>QC</TH><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac3">323 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac4">37 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac6">286 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac7">178 </TD><TD class=alignCenter headers="ar1 ar7 ac8 ac9 ac10">4807 </TD><TD class=alignCenter headers="ar1 ar7 ac8 ac9 ac11">616 </TD><TD class=alignCenter headers="ar1 ar7 ac8 ac9 ac12">3 </TD><TD class=alignCenter headers="ar1 ar7 ac8 ac9 ac13">4188 </TD><TD class=alignCenter headers="ar1 ar7 ac8 ac14">1038 </TD></TR><TR><TH id=ar8 class=alignLeft headers=ar1>NB</TH><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac3">71 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac6">71 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac7">2 </TD><TD class=alignCenter headers="ar1 ar8 ac8 ac9 ac10">1418 </TD><TD class=alignCenter headers="ar1 ar8 ac8 ac9 ac11">364 </TD><TD class=alignCenter headers="ar1 ar8 ac8 ac9 ac12">1 </TD><TD class=alignCenter headers="ar1 ar8 ac8 ac9 ac13">1053 </TD><TD class=alignCenter headers="ar1 ar8 ac8 ac14">10 </TD></TR><TR><TH id=ar9 class=alignLeft headers=ar1>NS</TH><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac3">14 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac4">11 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac6">3 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar9 ac8 ac9 ac10">129 </TD><TD class=alignCenter headers="ar1 ar9 ac8 ac9 ac11">102 </TD><TD class=alignCenter headers="ar1 ar9 ac8 ac9 ac12">4 </TD><TD class=alignCenter headers="ar1 ar9 ac8 ac9 ac13">23 </TD><TD class=alignCenter headers="ar1 ar9 ac8 ac14">1 </TD></TR><TR><TH id=ar10 class=alignLeft headers=ar1>PE</TH><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac3">7 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac4">6 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac6">1 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar10 ac8 ac9 ac10">115 </TD><TD class=alignCenter headers="ar1 ar10 ac8 ac9 ac11">114 </TD><TD class=alignCenter headers="ar1 ar10 ac8 ac9 ac12">0 </TD><TD class=alignCenter headers="ar1 ar10 ac8 ac9 ac13">1 </TD><TD class=alignCenter headers="ar1 ar10 ac8 ac14">0 </TD></TR><TR><TH id=ar11 class=alignLeft headers=ar1>NL</TH><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac3">7 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac6">7 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac7">9 </TD><TD class=alignCenter headers="ar1 ar11 ac8 ac9 ac10">324 </TD><TD class=alignCenter headers="ar1 ar11 ac8 ac9 ac11">104 </TD><TD class=alignCenter headers="ar1 ar11 ac8 ac9 ac12">0 </TD><TD class=alignCenter headers="ar1 ar11 ac8 ac9 ac13">220 </TD><TD class=alignCenter headers="ar1 ar11 ac8 ac14">123 </TD></TR><TR><TH id=ar12 class=alignLeft headers=ar1>Canada</TH><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac3">723 </TD><TD class="alignCenter lightred" headers="ar1 ar12 ac1 ac2 ac4">191 </TD><TD class="alignCenter lightred" headers="ar1 ar12 ac1 ac2 ac5">25 </TD><TD class="alignCenter lightred" headers="ar1 ar12 ac1 ac2 ac6">507 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac7">291 </TD><TD class=alignCenter headers="ar1 ar12 ac8 ac9 ac10">19125 </TD><TD class="alignCenter lightred" headers="ar1 ar12 ac8 ac9 ac11">9724 </TD><TD class="alignCenter lightred" headers="ar1 ar12 ac8 ac9 ac12">336 </TD><TD class="alignCenter lightred" headers="ar1 ar12 ac8 ac9 ac13">9065 </TD><TD class=alignCenter headers="ar1 ar12 ac8 ac14">1683 </TD></TR><TR><TH id=ar13 class=alignLeft headers=ar1>Percentage<SUP>2</SUP></TH><TD class=alignCenter headers="ar1 ar13 ac1 ac2 ac3">71.3% </TD><TD class="alignCenter lightred" headers="ar1 ar13 ac1 ac2 ac4">26.4% </TD><TD class="alignCenter lightred" headers="ar1 ar13 ac1 ac2 ac5">3.5% </TD><TD class="alignCenter lightred" headers="ar1 ar13 ac1 ac2 ac6">70.1% </TD><TD class=alignCenter headers="ar1 ar13 ac1 ac7">28.7% </TD><TD class=alignCenter headers="ar1 ar13 ac8 ac9 ac10">91.9% </TD><TD class="alignCenter lightred" headers="ar1 ar13 ac8 ac9 ac11">50.8% </TD><TD class="alignCenter lightred" headers="ar1 ar13 ac8 ac9 ac12">1.8% </TD><TD class="alignCenter lightred" headers="ar1 ar13 ac8 ac9 ac13">47.4% </TD><TD class=alignCenter headers="ar1 ar13 ac8 ac14">8.1% </TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 2. Weekly and cumulative numbers of positive influenza specimens by type, subtype and age-group reported through case-based laboratory reporting<SUP>3</SUP>, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=br1 rowSpan=3>Age groups (years)</TH><TH id=bc1 colSpan=5>Weekly
    (February 16 to February 22, 2014)
    </TH><TH id=bc8 colSpan=7>Cumulative
    (August 25, 2013 to February 22, 2014)
    </TH></TR><TR class=bg-colour-yellow><TH id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH id=bc7 headers=bc1>B</TH><TH id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH id=bc14 headers=bc8>B</TH><TH id=bc15 colSpan=2 headers=bc8>Influenza A and B</TH></TR><TR class=bg-colour-grey-light><TH id=bc3 headers="bc1 bc2">A Total</TH><TH id=bc4 class="lightred " headers="bc1 bc2">A(H1) pdm09</TH><TH id=bc5 class="lightred " headers="bc1 bc2">A(H3)</TH><TH id=bc6 class="lightred " headers="bc1 bc2">A (UnS)</TH><TD class=alignCenter headers="bc1 bc7">Total</TD><TH id=bc10 headers="bc8 bc9">A Total</TH><TH id=bc11 class="lightred " headers="bc8 bc9">A(H1) pdm09</TH><TH id=bc12 class="lightred " headers="bc8 bc9">A(H3)</TH><TH id=bc13 class="lightred " headers="bc8 bc9">A (UnS)</TH><TD class=alignCenter headers="bc8 bc14">Total</TD><TH id=bc16 headers="bc8 bc15">#</TH><TH id=bc17 headers="bc8 bc15">%</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=13><SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    <SUP>3 </SUP>Table 2 includes specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=br2 class=alignLeft headers=br1><5</TH><TD class=alignCenter headers="br1 br2 bc1 bc2 bc3">102 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc4">24 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc5">2 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc6">76 </TD><TD class=alignCenter headers="br1 br2 bc1 bc7">20 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc10">2936 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc11">1324 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc12">23 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc13">1589 </TD><TD class=alignCenter headers="br1 br2 bc8 bc14">173 </TD><TD class=alignCenter headers="br1 br2 bc8 bc15 bc16">3109 </TD><TD class=alignCenter headers="br1 br2 bc8 bc15 bc17">18.3% </TD></TR><TR><TH id=br3 class=alignLeft headers=br1>5-19</TH><TD class=alignCenter headers="br1 br3 bc1 bc2 bc3">32 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc4">7 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc6">25 </TD><TD class=alignCenter headers="br1 br3 bc1 bc7">30 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc10">1216 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc11">654 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc12">18 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc13">544 </TD><TD class=alignCenter headers="br1 br3 bc8 bc14">261 </TD><TD class=alignCenter headers="br1 br3 bc8 bc15 bc16">1477 </TD><TD class=alignCenter headers="br1 br3 bc8 bc15 bc17">8.7% </TD></TR><TR><TH id=br4 class=alignLeft headers=br1>20-44</TH><TD class=alignCenter headers="br1 br4 bc1 bc2 bc3">109 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc4">24 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc5">1 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc6">84 </TD><TD class=alignCenter headers="br1 br4 bc1 bc7">48 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc10">4729 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc11">2581 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc12">33 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc13">2115 </TD><TD class=alignCenter headers="br1 br4 bc8 bc14">305 </TD><TD class=alignCenter headers="br1 br4 bc8 bc15 bc16">5034 </TD><TD class=alignCenter headers="br1 br4 bc8 bc15 bc17">29.7% </TD></TR><TR><TH id=br5 class=alignLeft headers=br1>45-64</TH><TD class=alignCenter headers="br1 br5 bc1 bc2 bc3">102 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc4">20 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc6">82 </TD><TD class=alignCenter headers="br1 br5 bc1 bc7">44 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc10">4102 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc11">2215 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc12">37 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc13">1850 </TD><TD class=alignCenter headers="br1 br5 bc8 bc14">389 </TD><TD class=alignCenter headers="br1 br5 bc8 bc15 bc16">4491 </TD><TD class=alignCenter headers="br1 br5 bc8 bc15 bc17">26.5% </TD></TR><TR><TH id=br6 class=alignLeft headers=br1>65+</TH><TD class=alignCenter headers="br1 br6 bc1 bc2 bc3">96 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc4">21 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc5">3 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc6">72 </TD><TD class=alignCenter headers="br1 br6 bc1 bc7">58 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc10">2211 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc11">900 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc12">88 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc13">1223 </TD><TD class=alignCenter headers="br1 br6 bc8 bc14">519 </TD><TD class=alignCenter headers="br1 br6 bc8 bc15 bc16">2730 </TD><TD class=alignCenter headers="br1 br6 bc8 bc15 bc17">16.1% </TD></TR><TR><TH id=br7 class=alignLeft headers=br1>Unknown</TH><TD class=alignCenter headers="br1 br7 bc1 bc2 bc3">7 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc5">5 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc6">2 </TD><TD class=alignCenter headers="br1 br7 bc1 bc7">1 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc10">125 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc11">98 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc12">14 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc13">13 </TD><TD class=alignCenter headers="br1 br7 bc8 bc14">2 </TD><TD class=alignCenter headers="br1 br7 bc8 bc15 bc16">127 </TD><TD class=alignCenter headers="br1 br7 bc8 bc15 bc17">0.7% </TD></TR><TR><TH id=br8 class=alignLeft headers=br1>Total</TH><TD class=alignCenter headers="br1 br8 bc1 bc2 bc3">448 </TD><TD class="alignCenter lightred " headers="br1 br8 bc1 bc2 bc4">96 </TD><TD class="alignCenter lightred " headers="br1 br8 bc1 bc2 bc5">11 </TD><TD class="alignCenter lightred " headers="br1 br8 bc1 bc2 bc6">341 </TD><TD class=alignCenter headers="br1 br8 bc1 bc7">201 </TD><TD class=alignCenter headers="br1 br8 bc8 bc9 bc10">15319 </TD><TD class="alignCenter lightred " headers="br1 br8 bc8 bc9 bc11">7772 </TD><TD class="alignCenter lightred " headers="br1 br8 bc8 bc9 bc12">213 </TD><TD class="alignCenter lightred " headers="br1 br8 bc8 bc9 bc13">7334 </TD><TD class=alignCenter headers="br1 br8 bc8 bc14">1649 </TD><TD class=alignCenter headers="br1 br8 bc8 bc15 bc16">16968 </TD><TD class=alignCenter headers="br1 br8 bc8 bc15 bc17">100.0% </TD></TR><TR><TH id=br9 class=alignLeft headers=br1>Percentage<SUP>2</SUP></TH><TD class=alignCenter headers="br1 br9 bc1 bc2 bc3">69.0% </TD><TD class="alignCenter lightred " headers="br1 br9 bc1 bc2 bc4">21.4% </TD><TD class="alignCenter lightred " headers="br1 br9 bc1 bc2 bc5">2.5% </TD><TD class="alignCenter lightred " headers="br1 br9 bc1 bc2 bc6">76.1% </TD><TD class=alignCenter headers="br1 br9 bc1 bc7">31.0% </TD><TD class=alignCenter headers="br1 br9 bc8 bc9 bc10">90.3% </TD><TD class="alignCenter lightred " headers="br1 br9 bc8 bc9 bc11">50.7% </TD><TD class="alignCenter lightred " headers="br1 br9 bc8 bc9 bc12">1.4% </TD><TD class="alignCenter lightred " headers="br1 br9 bc8 bc9 bc13">47.9% </TD><TD class=alignCenter headers="br1 br9 bc8 bc14">9.7% </TD><TD class=alignCenter></TD><TD class=alignCenter></TD></TR></TBODY></TABLE>

    Top of Page

    Influenza Strain Characterizations

    During the 2013-2014 influenza season, the National Microbiology Laboratory (NML) has antigenically characterized 1150 influenza viruses [49 A(H3N2), 956 A(H1N1)pdm09 and 145 influenza B]. The vast majority (99%) of viruses were similar to the strains recommended by the WHO for the 2013-14 seasonal influenza vaccine. Two A(H1N1)pdm09 viruses showed reduced titres to antiserum against the reference A/California/07/2009 strain. Eleven influenza B viruses were similar to the strain recommended by the WHO for the 2011-12 vaccine (Figure 4).
    Figure 4. Influenza strain characterizations, Canada, 2013-14, N = 1150

    The NML receives a proportion of the number of influenza positive specimens from provincial laboratories for strain characterization and antiviral resistance testing. Characterization data reflect the results of haemagglutination inhibition (HAI) testing compared to the reference influenza strains recommended by WHO.
    The recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b (e.g. A/Texas/50/2012), and a B/Massachusetts/2/2012-like virus (Yamagata lineage).


    Text equivalent for figure 4Influenza strain characterizations, Canada, 2013-2014, N =3
    Antiviral Resistance

    During the 2013-2014 influenza season, NML has tested 774 influenza viruses for resistance to oseltamivir and 772 viruses for resistance to zanamivir, and all were sensitive. All 939 influenza A viruses tested for amantadine resistance were resistant (Table 3).
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=cr1 rowSpan=2>Virus type and subtype</TH><TH id=cc1 colSpan=2>Oseltamivir</TH><TH id=cc4 colSpan=2>Zanamivir</TH><TH id=cc7 colSpan=2>Amantadine</TH></TR><TR class=bg-colour-yellow><TH id=cc2 headers=cc1># tested</TH><TH id=cc3 headers=cc1># resistant (%)</TH><TH id=cc5 headers=cc4># tested</TH><TH id=cc6 headers=cc4># resistant (%)</TH><TH id=cc8 headers=cc7># tested</TH><TH id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH id=cr2 class="alignLeft lightred" headers=cr1>A (H3N2)</TH><TD class=alignCenter headers="cr1 cr2 cc1 cc2">45</TD><TD class=alignCenter headers="cr1 cr2 cc1 cc3">0</TD><TD class=alignCenter headers="cr1 cr2 cc4 cc5">45</TD><TD class=alignCenter headers="cr1 cr2 cc4 cc6">0</TD><TD class=alignCenter headers="cr1 cr2 cc7 cc8">74</TD><TD class=alignCenter headers="cr1 cr2 cc7 cc9">74 (100%)</TD></TR><TR><TH id=cr3 class="alignLeft lightred" headers=cr1>A (H1N1)</TH><TD class=alignCenter headers="cr1 cr3 cc1 cc2">654</TD><TD class=alignCenter headers="cr1 cr3 cc1 cc3">0</TD><TD class=alignCenter headers="cr1 cr3 cc4 cc5">652</TD><TD class=alignCenter headers="cr1 cr3 cc4 cc6">0</TD><TD class=alignCenter headers="cr1 cr3 cc7 cc8">865</TD><TD class=alignCenter headers="cr1 cr3 cc7 cc9">865 (100%)</TD></TR><TR><TH id=cr4 class="alignLeft lightred" headers=cr1>B</TH><TD class=alignCenter headers="cr1 cr4 cc1 cc2">75</TD><TD class=alignCenter headers="cr1 cr4 cc1 cc3">0</TD><TD class=alignCenter headers="cr1 cr4 cc4 cc5">75</TD><TD class=alignCenter headers="cr1 cr4 cc4 cc6">0</TD><TD class=alignCenter headers="cr1 cr4 cc7 cc8">NA <SUP>*</SUP></TD><TD class=alignCenter headers="cr1 cr4 cc7 cc9">NA <SUP>*</SUP></TD></TR><TR><TH id=cr5 class="alignLeft lightred" headers=cr1>TOTAL</TH><TD class=alignCenter headers="cr1 cr5 cc1 cc2">774</TD><TD class=alignCenter headers="cr1 cr5 cc1 cc3">0</TD><TD class=alignCenter headers="cr1 cr5 cc4 cc5">772</TD><TD class=alignCenter headers="cr1 cr5 cc4 cc6">0</TD><TD class=alignCenter headers="cr1 cr5 cc7 cc8">939</TD><TD class=alignCenter headers="cr1 cr5 cc7 cc9">939 (100%)</TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate decreased from 45.4/1,000 in week 07 to 22.0/1,000 in week 08; which is below the expected range for week 08 (Figure 5).
    Figure 5. Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Note: No data available for mean rate for weeks 19 to 39 for the 1996-1997 through 2002-2003 seasons. Delays in the reporting of data may cause data to change retrospectively. The calculation of the average ILI consultation rate over 17 seasons was aligned with influenza activity in each season. In BC, AB, and SK, data is compiled by a provincial sentinel surveillance program for reporting to FluWatch. The number of sentinel physicians in each province or territory is as follows: BC(21), AB(80), SK(11), MB(18), ON(169), QC(14), NB(29), NS(26), PE(4), NL(16), NU(1), NT(14), YT(13). Not all sentinel physicians report every week.
    Text equivalent for figure 5Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Top of Page

    Influenza Outbreak Surveillance

    In week 08, 11 new influenza outbreaks were reported: one in a hospital and ten in long-term care facilities (Figure 6). In addition, five outbreaks of influenza-like-illness were reported: four in schools and one in another facility or community.
    Figure 6. Overall number of new influenza outbreaks by report week, Canada, 2013-2014

    1 All provinces and territories except NU report outbreaks in long-term care facilities. All provinces and territories with the exception of NU and QC report outbreaks in hospitals. Outbreaks of influenza or influenza-like-illness in other facilities are reported to FluWatch but reporting varies between jurisdictions. Outbreak definitions are included at the end of the report.
    Text equivalent for figure 6Overall number of new influenza outbreaks by report week, Canada, 2013-2014
    Pharmacy Surveillance

    In week 08, the proportion of prescriptions for influenza antivirals continued to decrease, following the downward trend in laboratory detections of influenza. The largest proportion of prescriptions for antivirals continued to be among children 2-18 years of age followed by adults 19-64 years of age (Figure 7). Within these age-groups, higher proportions of prescriptions for antivirals were observed among children >5 years of age and adults <45 years of age.
    Figure 7. Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Note: Pharmacy sales data are provided to the Public Health Agency of Canada by Rx Canada Inc. and sourced from major retail drug chains representing over 3,000 stores nationwide (excluding Nunavut) in 85% of Health Regions. Data provided include the number of new antiviral prescriptions (for Tamiflu and Relenza) and the total number of new prescriptions dispensed by Province/Territory and age group. Age-groups: Infant: 0-2y, Child: 2-18y; Adult: 19-64y, Senior: ≥65y.
    Text equivalent for figure 7Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Top of Page

    Sentinel Hospital Influenza Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)
    In week 08, 28 new laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalizations were reported by the Immunization Monitoring Program Active (IMPACT) network, compared to 42 in week 07. In week 08, influenza A was reported in 17 cases and influenza B in 11 cases. An increasing number of influenza B cases have been reported in the past two weeks (Figure 8a). Twenty-two (79%) of the cases in week 08 were ≥2 years of age. Two ICU admissions were reported in week 08, one 5-9 years of age and one 10-16 years of age. No deaths were reported.
    To date this season, a total of 520 influenza-associated paediatric hospitalizations have been reported by the IMPACT network, 92% of which have been influenza A, and almost all of those subtyped (98%) were A(H1N1)pdm09. Children ≥2 years of age represent 54.6% of cases to date (Table 4). Seventy-nine ICU admissions have been reported, of which 46 (58%) were children ≥2 years of age (Figure 9a). Among the 76 ICU admission for which the influenza type reported, all but four were cases with influenza A, and 96% of those subtyped were A(H1N1)pdm09. Among the 65 ICU cases with available data, 44 (68%) were reported to have underlying medical conditions. No deaths have been reported.
    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    Adult Influenza Hospitalizations and Deaths (PCIRN)
    In week 08, 27 new laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations reported through active surveillance by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network, compared to 45 in week 07. There has been a steady decline in the number of new cases over recent weeks. Among cases in week 08, 22 (81.5%) were influenza A, and four were influenza B (Figure 8b). The majority of hospitalizations occurred among adults ≥45 years of age (20; 74%). Three ICU admissions were reported in week 08, all 45-64 years of age with influenza A. No deaths were reported in week 08.
    To date this season, 1030 influenza-associated hospitalizations have been reported by the PCIRN-SOS network, 980 (95.1%) with influenza A, predominantly A(H1N1)pdm09 (Table 5). ICU admission was required for 180 hospitalizations, all but five of which were cases with influenza A (102 A(H1N1)pdm09, three A(H3N2) and 70 A(unsubtyped). More than three quarters of hospitalizations and approximately 80% of ICU admissions were ≥45 years of age. Of the 152 ICU admissions with available information, 133 (87.5%) were reported to have at least one comorbidity and of the 155 ICU admissions with available information 112 (72.3%) reported not having been vaccinated this season. Fifty-one deaths have been reported, all but one with influenza A (32 A(H1N1)pdm09, one A(H3N2) and 17 A(unsubtyped)); five cases 20-44 years of age, 26 cases 45-64 years of age and 20 cases ≥65 years of age (Figure 9b).
    Note: PCIRN-SOS conducted passive surveillance from April 30th to November 14th, 2013. Cases reported during this period were identified by laboratory detection of influenza among patients admitted to participating hospitals. Active surveillance began November 15th during which time PCIRN site coordinators investigate cases potentially related to influenza. Data from both active and passive surveillance reported during the 2013-14 season are included in this report. The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION id=t4 class=alignCenter>Table 4 - Cumulative numbers of paediatric hospitalizations with influenza reported by the IMPACT network, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=dr1 rowSpan=3>Age groups </TH><TH id=dc1 colSpan=6>Cumulative (Aug. 25, 2013 to February 22, 2014) </TH></TR><TR class=bg-colour-yellow><TH id=dc2 colSpan=4 headers=dc1>Influenza A </TH><TH id=dc7 headers=dc1>B </TH><TH id=dc8 headers=dc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=dc3 headers="dc1 dc2">A Total </TH><TH id=dc4 class="lightred " headers="dc1 dc2">A(H1) pdm09 </TH><TH id=dc5 class="lightred " headers="dc1 dc2">A(H3) </TH><TH id=dc6 class="lightred " headers="dc1 dc2">A (UnS) </TH><TD class=alignCenter headers="dc1 dc7">Total</TD><TD class=alignCenter headers="dc1 dc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=dr2 class=alignLeft headers=dr1>0-5m </TH><TD class=alignCenter headers="dr1 dr2 dc1 dc2 dc3">92 </TD><TD class=alignCenter headers="dr1 dr2 dc1 dc2 dc4">27 </TD><TD class=alignCenter headers="dr1 dr2 dc1 dc2 dc5">0 </TD><TD class=alignCenter headers="dr1 dr2 dc1 dc2 dc6">65 </TD><TD class=alignCenter headers="dr1 dr2 dc1 dc7">2 </TD><TD class=alignCenter headers="dr1 dr2 dc1 dc8">94 (18%) </TD></TR><TR><TH id=dr3 class=alignLeft headers=dr1>6-23m </TH><TD class=alignCenter headers="dr1 dr3 dc1 dc2 dc3">137 </TD><TD class=alignCenter headers="dr1 dr3 dc1 dc2 dc4">38 </TD><TD class=alignCenter headers="dr1 dr3 dc1 dc2 dc5">1 </TD><TD class=alignCenter headers="dr1 dr3 dc1 dc2 dc6">98 </TD><TD class=alignCenter headers="dr1 dr3 dc1 dc7">5 </TD><TD class=alignCenter headers="dr1 dr3 dc1 dc8">142 (27%) </TD></TR><TR><TH id=dr4 class=alignLeft headers=dr1>2-4y </TH><TD class=alignCenter headers="dr1 dr4 dc1 dc2 dc3">146 </TD><TD class=alignCenter headers="dr1 dr4 dc1 dc2 dc4">46 </TD><TD class=alignCenter headers="dr1 dr4 dc1 dc2 dc5">2 </TD><TD class=alignCenter headers="dr1 dr4 dc1 dc2 dc6">98 </TD><TD class=alignCenter headers="dr1 dr4 dc1 dc7">14 </TD><TD class=alignCenter headers="dr1 dr4 dc1 dc8">160 (31%) </TD></TR><TR><TH id=dr5 class=alignLeft headers=dr1>5-9y </TH><TD class=alignCenter headers="dr1 dr5 dc1 dc2 dc3">73 </TD><TD class=alignCenter headers="dr1 dr5 dc1 dc2 dc4">22 </TD><TD class=alignCenter headers="dr1 dr5 dc1 dc2 dc5">0 </TD><TD class=alignCenter headers="dr1 dr5 dc1 dc2 dc6">51 </TD><TD class=alignCenter headers="dr1 dr5 dc1 dc7">17 </TD><TD class=alignCenter headers="dr1 dr5 dc1 dc8">90 (17%) </TD></TR><TR><TH id=dr6 class=alignLeft headers=dr1>10-16y </TH><TD class=alignCenter headers="dr1 dr6 dc1 dc2 dc3">31 </TD><TD class=alignCenter headers="dr1 dr6 dc1 dc2 dc4">13 </TD><TD class=alignCenter headers="dr1 dr6 dc1 dc2 dc5">0 </TD><TD class=alignCenter headers="dr1 dr6 dc1 dc2 dc6">18 </TD><TD class=alignCenter headers="dr1 dr6 dc1 dc7">3 </TD><TD class=alignCenter headers="dr1 dr6 dc1 dc8">34 (7%) </TD></TR><TR><TH id=dr7 class=alignLeft headers=dr1>Total </TH><TD class=alignCenter headers="dr1 dr7 dc1 dc2 dc3">479 </TD><TD class="lightred alignCenter" headers="dr1 dr7 dc1 dc2 dc4">146 </TD><TD class="lightred alignCenter" headers="dr1 dr7 dc1 dc2 dc5">3 </TD><TD class="lightred alignCenter" headers="dr1 dr7 dc1 dc2 dc6">330 </TD><TD class=alignCenter headers="dr1 dr7 dc1 dc7">41 </TD><TD class=alignCenter headers="dr1 dr7 dc1 dc8">520 </TD></TR><TR><TH id=dr8 class=alignLeft headers=dr1>% <SUP>1</SUP> </TH><TD class=alignCenter headers="dr1 dr8 dc1 dc2 dc3">92.1% </TD><TD class="lightred alignCenter" headers="dr1 dr8 dc1 dc2 dc4">30.5% </TD><TD class="lightred alignCenter" headers="dr1 dr8 dc1 dc2 dc5">0.6% </TD><TD class="lightred alignCenter" headers="dr1 dr8 dc1 dc2 dc6">68.9% </TD><TD class=alignCenter headers="dr1 dr8 dc1 dc7">7.9% </TD><TD class=alignCenter headers="dr1 dr8 dc1 dc8">100.0% </TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 5 - Cumulative numbers of adult hospitalizations with influenza
    reported by the PCIRN-SOS network, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=er1 rowSpan=3>Age groups </TH><TH id=ec1 class=noWrap colSpan=6>Cumulative (Aug. 25, 2013 to February 22, 2014)<SUP>*</SUP></TH></TR><TR class=bg-colour-yellow><TH id=ec2 colSpan=4 headers=ec1>Influenza A </TH><TH id=ec7 headers=ec1>B </TH><TH id=ec8 headers=ec1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=ec3 headers="ec1 ec2">A Total </TH><TH id=ec4 class=lightred headers="ec1 ec2">A(H1) pdm09 </TH><TH id=ec5 class=lightred headers="ec1 ec2">A(H3) </TH><TH id=ec6 class=lightred headers="ec1 ec2">A(UnS) </TH><TD class=alignCenter headers="ec1 ec7">Total</TD><TD class=alignCenter headers="ec1 ec8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP id=footnote_t5_1>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.

    <SUP id=footnote_t5_star>*</SUP>One case for which the influenza type has not yet been reported, and four cases for which the age-group was not reported, are not included in Table 5.
    </TD></TR></TFOOT><TBODY><TR><TH id=er2 class=alignLeft headers=er1>16-20 </TH><TD class=alignCenter headers="er1 er2 ec1 ec2 ec3">11</TD><TD class=alignCenter headers="er1 er2 ec1 ec2 ec4">3</TD><TD class=alignCenter headers="er1 er2 ec1 ec2 ec5">0</TD><TD class=alignCenter headers="er1 er2 ec1 ec2 ec6">8</TD><TD class=alignCenter headers="er1 er2 ec1 ec7">1</TD><TD class=alignCenter headers="er1 er2 ec1 ec8">12 (1%)</TD></TR><TR><TH id=er3 class=alignLeft headers=er1>20-44 </TH><TD class=alignCenter headers="er1 er3 ec1 ec2 ec3">218</TD><TD class=alignCenter headers="er1 er3 ec1 ec2 ec4">117</TD><TD class=alignCenter headers="er1 er3 ec1 ec2 ec5">3</TD><TD class=alignCenter headers="er1 er3 ec1 ec2 ec6">98</TD><TD class=alignCenter headers="er1 er3 ec1 ec7">3</TD><TD class=alignCenter headers="er1 er3 ec1 ec8">221 (22%)</TD></TR><TR><TH id=er4 class=alignLeft headers=er1>45-64 </TH><TD class=alignCenter headers="er1 er4 ec1 ec2 ec3">395</TD><TD class=alignCenter headers="er1 er4 ec1 ec2 ec4">182</TD><TD class=alignCenter headers="er1 er4 ec1 ec2 ec5">4</TD><TD class=alignCenter headers="er1 er4 ec1 ec2 ec6">209</TD><TD class=alignCenter headers="er1 er4 ec1 ec7">10</TD><TD class=alignCenter headers="er1 er4 ec1 ec8">405 (40%)</TD></TR><TR><TH id=er5 class=alignLeft headers=er1>65+ </TH><TD class=alignCenter headers="er1 er5 ec1 ec2 ec3">352</TD><TD class=alignCenter headers="er1 er5 ec1 ec2 ec4">178</TD><TD class=alignCenter headers="er1 er5 ec1 ec2 ec5">22</TD><TD class=alignCenter headers="er1 er5 ec1 ec2 ec6">152</TD><TD class=alignCenter headers="er1 er5 ec1 ec7">35</TD><TD class=alignCenter headers="er1 er5 ec1 ec8">387 (38%)</TD></TR><TR><TH id=er6 class=alignLeft headers=er1>Total </TH><TD class=alignCenter headers="er1 er6 ec1 ec2 ec3">976</TD><TD class="alignCenter lightred" headers="er1 er6 ec1 ec2 ec4">480</TD><TD class="alignCenter lightred" headers="er1 er6 ec1 ec2 ec5">29</TD><TD class="alignCenter lightred" headers="er1 er6 ec1 ec2 ec6">467</TD><TD class=alignCenter headers="er1 er6 ec1 ec7">49</TD><TD class=alignCenter headers="er1 er6 ec1 ec8">1025</TD></TR><TR><TH id=er7 class=alignLeft headers=er1>% <SUP>1</SUP></TH><TD class=alignCenter headers="er1 er7 ec1 ec2 ec3">95%</TD><TD class="alignCenter lightred " headers="er1 er7 ec1 ec2 ec4">49%</TD><TD class="alignCenter lightred " headers="er1 er7 ec1 ec2 ec5">3%</TD><TD class="alignCenter lightred " headers="er1 er7 ec1 ec2 ec6">48%</TD><TD class=alignCenter headers="er1 er7 ec1 ec7">5%</TD><TD class=alignCenter headers="er1 er7 ec1 ec8">100%</TD></TR></TBODY></TABLE>
    Figure 8. Number of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)


    Text equivalent for figure 8aNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    * See footnote above following the section related to PCIRN-SOS data.
    Text equivalent for figure 8bNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Adult hospitalizations (>16 year of age, PCIRN-SOS)
    Figure 9. Percentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)

    Text equivalent for figure 9aPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Text equivalent for figure 9bPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Top of Page

    Provincial/Territorial Influenza Hospitalizations and Deaths

    In week 08, 119 laboratory-confirmed influenza-associated hospitalizations were reported from participating provinces and territories.* The majority were cases of influenza A (103, 86.6%), of which 36 (35.0%) were A(H1N1)pdm09, one (1.0%) was A(H3N2), and 66 (64.1%) were A(unsubtyped). Seven of the eight ICU admissions reported in week 08 included age information, of which six were adults 20-64 years of age. Thirteen deaths were reported, 11 of which were adults ≥45 years of age. The number of new influenza-associated hospitalizations and deaths reported for the current week may include cases from Ontario that occurred in previous weeks, as a result of retrospective updates to the cumulative total.
    To date this season, 3,093 influenza-associated hospitalizations have been reported, 96.8% with influenza A. The majority (57.5%) of hospitalizations have been cases 45 years of age of older (Table 6). A total of 298 ICU admissions have been reported this season, of which 67.4% were among adults 20-64 years of age. A total of 171 deaths have been reported. The highest proportion of deaths has been among adults 20-64 years of age (52.6%), followed by adults ≥65 years of age (38.0%). Influenza B has been detected infrequently among severe cases of influenza to date this season: in only 3.2% of hospitalizations, 1.0% of ICU admissions, and 4.1 % of deaths. It is important to note that the hospitalization or death does not have to be attributable to influenza, a positive laboratory test is sufficient for reporting. Detailed clinical information (e.g. underlying medical conditions) is not known for these cases.
    * Note: Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not distinguished among hospital admissions reported from Ontario. Data may also include cases reported by the IMPACT and PCIRN networks.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION id=t6 class=alignCenter>Table 6. Cumulative number of hospitalizations with influenza reported by the participating provinces and territories, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=fr1 rowSpan=3>Age groups </TH><TH id=fc1 colSpan=6>Cumulative (Aug. 25, 2013 to Fabruary 22, 2014)</TH></TR><TR class=bg-colour-yellow><TH id=fc2 colSpan=4 headers=fc1>Influenza A</TH><TH id=fc7 headers=fc1>B</TH><TH id=fc8 headers=fc1>Influenza A and B</TH></TR><TR class=bg-colour-grey-light><TH id=fc3 headers="fc1 fc2">A Total</TH><TH id=fc4 class=lightred headers="fc1 fc2">A(H1) pdm09</TH><TH id=fc5 class=lightred headers="fc1 fc2">A(H3)</TH><TH id=fc6 class=lightred headers="fc1 fc2">A (UnS)</TH><TD class=alignCenter headers="fc1 fc7">Total</TD><TD class=alignCenter headers="fc1 fc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=8><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=fr2 class=alignLeft headers=fr1>0-4 years</TH><TD class=alignCenter headers="fr1 fr2 fc1 fc2 fc3">515 </TD><TD class=alignCenter headers="fr1 fr2 fc1 fc2 fc4">259 </TD><TD class=alignCenter headers="fr1 fr2 fc1 fc2 fc5">6 </TD><TD class=alignCenter headers="fr1 fr2 fc1 fc2 fc6">250 </TD><TD class=alignCenter headers="fr1 fr2 fc1 fc7">19 </TD><TD class=alignCenter headers="fr1 fr2 fc1 fc8">534 (17%) </TD></TR><TR><TH id=fr3 class=alignLeft headers=fr1>5-14 years</TH><TD class=alignCenter headers="fr1 fr3 fc1 fc2 fc3">112 </TD><TD class=alignCenter headers="fr1 fr3 fc1 fc2 fc4">57 </TD><TD class=alignCenter headers="fr1 fr3 fc1 fc2 fc5">5 </TD><TD class=alignCenter headers="fr1 fr3 fc1 fc2 fc6">50 </TD><TD class=alignCenter headers="fr1 fr3 fc1 fc7">11 </TD><TD class=alignCenter headers="fr1 fr3 fc1 fc8">123 (4%) </TD></TR><TR><TH id=fr4 class=alignLeft headers=fr1>15-19 years</TH><TD class=alignCenter headers="fr1 fr4 fc1 fc2 fc3">28 </TD><TD class=alignCenter headers="fr1 fr4 fc1 fc2 fc4">17 </TD><TD class=alignCenter headers="fr1 fr4 fc1 fc2 fc5">2 </TD><TD class=alignCenter headers="fr1 fr4 fc1 fc2 fc6">9 </TD><TD class=alignCenter headers="fr1 fr4 fc1 fc7">1 </TD><TD class=alignCenter headers="fr1 fr4 fc1 fc8">29 (1%) </TD></TR><TR><TH id=fr5 class=alignLeft headers=fr1>20-44 years </TH><TD class=alignCenter headers="fr1 fr5 fc1 fc2 fc3">525 </TD><TD class=alignCenter headers="fr1 fr5 fc1 fc2 fc4">377 </TD><TD class=alignCenter headers="fr1 fr5 fc1 fc2 fc5">3 </TD><TD class=alignCenter headers="fr1 fr5 fc1 fc2 fc6">145 </TD><TD class=alignCenter headers="fr1 fr5 fc1 fc7">6 </TD><TD class=alignCenter headers="fr1 fr5 fc1 fc8">531 (17%) </TD></TR><TR><TH id=fr6 class=alignLeft headers=fr1>45-64 years </TH><TD class=alignCenter headers="fr1 fr6 fc1 fc2 fc3">965 </TD><TD class=alignCenter headers="fr1 fr6 fc1 fc2 fc4">626 </TD><TD class=alignCenter headers="fr1 fr6 fc1 fc2 fc5">16 </TD><TD class=alignCenter headers="fr1 fr6 fc1 fc2 fc6">323 </TD><TD class=alignCenter headers="fr1 fr6 fc1 fc7">17 </TD><TD class=alignCenter headers="fr1 fr6 fc1 fc8">982 (32%) </TD></TR><TR><TH id=fr7 class=alignLeft headers=fr1>65+ years </TH><TD class=alignCenter headers="fr1 fr7 fc1 fc2 fc3">750 </TD><TD class=alignCenter headers="fr1 fr7 fc1 fc2 fc4">402 </TD><TD class=alignCenter headers="fr1 fr7 fc1 fc2 fc5">46 </TD><TD class=alignCenter headers="fr1 fr7 fc1 fc2 fc6">302 </TD><TD class=alignCenter headers="fr1 fr7 fc1 fc7">45 </TD><TD class=alignCenter headers="fr1 fr7 fc1 fc8">795 (26%) </TD></TR><TR><TH id=fr10 class=alignLeft headers=fr1>Unknown</TH><TD class=alignCenter headers="fr1 fr10 fc1 fc2 fc3">98 </TD><TD class=alignCenter headers="fr1 fr10 fc1 fc2 fc4">78 </TD><TD class=alignCenter headers="fr1 fr10 fc1 fc2 fc5">3 </TD><TD class=alignCenter headers="fr1 fr10 fc1 fc2 fc6">17 </TD><TD class=alignCenter headers="fr1 fr10 fc1 fc7">1 </TD><TD class=alignCenter headers="fr1 fr10 fc1 fc8">99 (3%) </TD></TR><TR><TH id=fr8 class=alignLeft headers=fr1>Total </TH><TD class=alignCenter headers="fr1 fr8 fc1 fc2 fc3">2993 </TD><TD class="alignCenter lightred" headers="fr1 fr8 fc1 fc2 fc4">1816 </TD><TD class="alignCenter lightred" headers="fr1 fr8 fc1 fc2 fc5">81 </TD><TD class="alignCenter lightred" headers="fr1 fr8 fc1 fc2 fc6">1096 </TD><TD class=alignCenter headers="fr1 fr8 fc1 fc7">100 </TD><TD class=alignCenter headers="fr1 fr8 fc1 fc8">3093 </TD></TR><TR><TH id=fr9 class=alignLeft headers=fr1>Percentage <SUP>1</SUP> </TH><TD class=alignCenter headers="fr1 fr9 fc1 fc2 fc3">96.8% </TD><TD class="alignCenter lightred" headers="fr1 fr9 fc1 fc2 fc4">60.7% </TD><TD class="alignCenter lightred" headers="fr1 fr9 fc1 fc2 fc5">2.7% </TD><TD class="alignCenter lightred" headers="fr1 fr9 fc1 fc2 fc6">36.6% </TD><TD class=alignCenter headers="fr1 fr9 fc1 fc7">3.2% </TD><TD class=alignCenter headers="fr1 fr9 fc1 fc8">100% </TD></TR></TBODY></TABLE>
    See additional data on Reported Influenza Hospitalizations and Deaths in Canada: 2009-10 to 2013-14 on the Public Health Agency of Canada website.

    .../

    Leave a comment:


  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Week 6

    FluWatch report: February 2 to 8, 2014 (Week 06)

    Posted 2014-02-14For readers interested in the <ABBR title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A title="Flu Watch (Version PDF, 113 KB - 6 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w06_14/pdf/fw2014-06-eng.pdf">FluWatch report: February 2 to 8, 2014 (Week 06) (<ABBR title="Portable Document Format">PDF</ABBR> Version - 291 <ABBR title=Kilobytes>KB</ABBR> - 10 pages)

    ?? Help with PDF documents


    Overall Summary
    • In week 06, overall influenza activity continued to decrease in Canada, with the exception of ongoing activity in the more eastern provinces which experienced a later start to the influenza season.
    • The influenza A(H1N1) virus remains the most common influenza virus circulating this season although influenza B virus detections continue to increase.
    • Adults 20-64 years of age continue to be more affected by influenza this season.
    • To week 06, 2,818 hospitalizations have been reported, which is slightly lower compared to the same period last season. One hundred and forty-three deaths have been reported.
    • Overall influenza activity in Canada during the 2013-14 season has been similar to the 2012-13 season and is within expected levels for this time of year.
    Influenza/ILI Activity (geographic spread)

    In week 06, one region in Manitoba reported widespread activity, and 11 regions (in BC(1), AB(1), ON(6), QC(2) and NS(1)) reported localized activity (Figure 1). Influenza activity levels are declining, with fewer regions reporting widespread or localized activity.
    Figure 1. Map of overall influenza/ILI activity level by province and territory, Canada, Week 06





    Note: Influenza/ILI activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates and reported outbreaks. Please refer to detailed definitions at the end of the report. Maps from previous weeks, including any retrospective updates, are available on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada
    Influenza and Other Respiratory Virus Detections

    The number of positive influenza tests continued to decrease, from 2,183 in week 05 to 1,811 in week 06. The percentage of positive influenza tests decreased from 21.5% to 20.0% (Figure 2). Cumulative influenza virus detections to date remain predominantly influenza A (94%), and among those subtyped, 97% (9,203/9,505) were A(H1N1)pdm09. However, the percentage of positive tests for influenza B has been rising slowly in recent weeks to 12.8% of influenza detections in week 06 (Table 1). Among the 15,051 cases for which information on age and type/subtype has been received this season, 56.9% were 20-64 years of age and 15.6% were ≥65 years of age, which is different from the proportions observed during the 2012-13 season when 33.1% of cases were 20-64 years of age and 41.2% were ≥65 years of age (Table 2).
    Figure 2. Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14

    Text equivalent for figure 2Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14
    The number of positive tests for RSV continued the gradual increase observed since late November 2013. The percentage of the total number of tests that were positive has fluctuated during this period, but increased during the past three weeks. RSV in Canada shows a seasonal pattern with a broad peak over the winter months. The number of positive tests for other respiratory viruses has been relatively stable in recent weeks (Figure 3).
    For more details, see the weekly Respiratory Virus Detections in Canada Report.
    Figure 3. Number of positive laboratory tests for other respiratory viruses by report week, Canada, 2013-14


    Top of Page

    RSV: Respiratory syncytial virus; hMPV: Human metapneumovirus
    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 1: Weekly and cumulative numbers of positive influenza specimens
    by type, subtype and province, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=ar1 rowSpan=3>Reporting provinces <SUP>1</SUP></TH><TH id=ac1 colSpan=5>Weekly
    (February 2, 2013 to February 8, 2014)
    </TH><TH id=ac8 colSpan=5>Cumulative
    (August 25, 2013 to February 8, 2014)
    </TH></TR><TR class=bg-colour-yellow><TH id=ac2 colSpan=4 headers=ac1>Influenza A</TH><TH id=ac7 headers=ac1>B</TH><TH id=ac9 colSpan=4 headers=ac8>Influenza A</TH><TH id=ac14 headers=ac8>B</TH></TR><TR class=bg-colour-grey-light><TH id=ac3 headers="ac1 ac2">A Total</TH><TH id=ac4 class=lightred headers="ac1 ac2">A(H1)pdm09</TH><TH id=ac5 class=lightred headers="ac1 ac2">A(H3)</TH><TH id=ac6 class=lightred headers="ac1 ac2">A(UnS)</TH><TH class=alignCenter headers="ac1 ac7">B Total</TH><TH id=ac10 headers="ac8 ac9">A Total</TH><TH id=ac11 class=lightred headers="ac8 ac9">A(H1)pdm09</TH><TH id=ac12 class=lightred headers="ac8 ac9">A(H3)</TH><TH id=ac13 class=lightred headers="ac8 ac9">A(UnS)</TH><TD class=alignCenter headers="ac8 ac14">B Total</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=11><SUP>1 </SUP>Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.
    <SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=ar2 class=alignLeft headers=ar1>BC</TH><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac3">123</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac4">100</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac5">11</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac6">12</TD><TD class=alignRight headers="ar1 ar2 ac1 ac7">8</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac10">1562</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac11">1436</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac12">54</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac13">72</TD><TD class=alignRight headers="ar1 ar2 ac8 ac14">52</TD></TR><TR><TH id=ar3 class=alignLeft headers=ar1>AB</TH><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac3">127</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac4">86</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac5">3</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac6">38</TD><TD class=alignRight headers="ar1 ar3 ac1 ac7">16</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac10">3394</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac11">3186</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac12">36</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac13">172</TD><TD class=alignRight headers="ar1 ar3 ac8 ac14">74</TD></TR><TR><TH id=ar4 class=alignLeft headers=ar1>SK</TH><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac3">77</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac4">57</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac5">1</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac6">19</TD><TD class=alignRight headers="ar1 ar4 ac1 ac7">6</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac10">1254</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac11">905</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac12">3</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac13">346</TD><TD class=alignRight headers="ar1 ar4 ac8 ac14">16</TD></TR><TR><TH id=ar5 class=alignLeft headers=ar1>MB</TH><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac3">55</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac4">43</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac6">12</TD><TD class=alignRight headers="ar1 ar5 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac10">473</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac11">319</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac12">1</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac13">153</TD><TD class=alignRight headers="ar1 ar5 ac8 ac14">13</TD></TR><TR><TH id=ar6 class=alignLeft headers=ar1>ON</TH><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac3">356</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac4">104</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac5">15</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac6">237</TD><TD class=alignRight headers="ar1 ar6 ac1 ac7">60</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac10">4922</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac11">2198</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac12">200</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac13">2524</TD><TD class=alignRight headers="ar1 ar6 ac8 ac14">170</TD></TR><TR><TH id=ar7 class=alignLeft headers=ar1>QC</TH><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac3">625</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac4">88</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac6">537</TD><TD class=alignRight headers="ar1 ar7 ac1 ac7">130</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac10">4024</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac11">537</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac12">3</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac13">3484</TD><TD class=alignRight headers="ar1 ar7 ac8 ac14">710</TD></TR><TR><TH id=ar8 class=alignLeft headers=ar1>NB</TH><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac3">141</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac6">141</TD><TD class=alignRight headers="ar1 ar8 ac1 ac7">2</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac10">1298</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac11">364</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac12">1</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac13">933</TD><TD class=alignRight headers="ar1 ar8 ac8 ac14">6</TD></TR><TR><TH id=ar9 class=alignLeft headers=ar1>NS</TH><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac3">14</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac4">13</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac6">1</TD><TD class=alignRight headers="ar1 ar9 ac1 ac7">1</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac10">100</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac11">76</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac12">4</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac13">20</TD><TD class=alignRight headers="ar1 ar9 ac8 ac14">1</TD></TR><TR><TH id=ar10 class=alignLeft headers=ar1>PE</TH><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac3">30</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac4">30</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac10">78</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac11">78</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac12">0</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac13">0</TD><TD class=alignRight headers="ar1 ar10 ac8 ac14">0</TD></TR><TR><TH id=ar11 class=alignLeft headers=ar1>NL</TH><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac3">32</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac6">32</TD><TD class=alignRight headers="ar1 ar11 ac1 ac7">8</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac10">290</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac11">104</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac12">0</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac13">186</TD><TD class=alignRight headers="ar1 ar11 ac8 ac14">107</TD></TR><TR><TH id=ar12 class=alignLeft headers=ar1>Canada</TH><TD class=alignRight headers="ar1 ar12 ac1 ac2 ac3">1580</TD><TD class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac4">521</TD><TD class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac5">30</TD><TD class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac6">1029</TD><TD class=alignRight headers="ar1 ar12 ac1 ac7">231</TD><TD class=alignRight headers="ar1 ar12 ac8 ac9 ac10">17395</TD><TD class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac11">9203</TD><TD class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac12">302</TD><TD class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac13">7890</TD><TD class=alignRight headers="ar1 ar12 ac8 ac14">1149</TD></TR><TR><TH id=ar13 class=alignLeft headers=ar1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="ar1 ar13 ac1 ac2 ac3">87.2%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac4">33.0%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac5">1.9%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac6">65.1%</TD><TD class=alignRight headers="ar1 ar13 ac1 ac7">12.8%</TD><TD class=alignRight headers="ar1 ar13 ac8 ac9 ac10">93.8%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac11">52.9%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac12">1.7%</TD><TD class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac13">45.4%</TD><TD class=alignRight headers="ar1 ar13 ac8 ac14">6.2%</TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 2. Weekly and cumulative numbers of positive influenza specimens by type, subtype and age-group reported through case-based laboratory reporting<SUP>3</SUP>, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=br1 rowSpan=3>Age groups (years)</TH><TH id=bc1 colSpan=5>Weekly
    (February 2 to February 8, 2014)
    </TH><TH id=bc8 colSpan=7>Cumulative
    (August 25, 2013 to February 8, 2014)
    </TH></TR><TR class=bg-colour-yellow><TH id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH id=bc7 headers=bc1>B</TH><TH id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH id=bc14 headers=bc8>B</TH><TH id=bc15 colSpan=2 headers=bc8>Influenza A and B</TH></TR><TR class=bg-colour-grey-light><TH id=bc3 headers="bc1 bc2">A Total</TH><TH id=bc4 class="lightred " headers="bc1 bc2">A(H1) pdm09</TH><TH id=bc5 class="lightred " headers="bc1 bc2">A(H3)</TH><TH id=bc6 class="lightred " headers="bc1 bc2">A (UnS)</TH><TD class=alignCenter headers="bc1 bc7">Total</TD><TH id=bc10 headers="bc8 bc9">A Total</TH><TH id=bc11 class="lightred " headers="bc8 bc9">A(H1) pdm09</TH><TH id=bc12 class="lightred " headers="bc8 bc9">A(H3)</TH><TH id=bc13 class="lightred " headers="bc8 bc9">A (UnS)</TH><TD class=alignCenter headers="bc8 bc14">Total</TD><TH id=bc16 headers="bc8 bc15">#</TH><TH id=bc17 headers="bc8 bc15">%</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=13><SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    <SUP>3 </SUP>Table 2 includes specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=br2 class=alignLeft headers=br1><5</TH><TD class=alignRight headers="br1 br2 bc1 bc2 bc3">185</TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc4">52</TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc6">133</TD><TD class=alignRight headers="br1 br2 bc1 bc7">17</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc10">2617</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc11">1226</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc12">20</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc13">1371</TD><TD class=alignRight headers="br1 br2 bc8 bc14">124</TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc16">2741</TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc17">18.2%</TD></TR><TR><TH id=br3 class=alignLeft headers=br1>5-19</TH><TD class=alignRight headers="br1 br3 bc1 bc2 bc3">77</TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc4">17</TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc6">60</TD><TD class=alignRight headers="br1 br3 bc1 bc7">38</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc10">1104</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc11">614</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc12">16</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc13">474</TD><TD class=alignRight headers="br1 br3 bc8 bc14">178</TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc16">1282</TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc17">8.5%</TD></TR><TR><TH id=br4 class=alignLeft headers=br1>20-44</TH><TD class=alignRight headers="br1 br4 bc1 bc2 bc3">229</TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc4">71</TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc5">1</TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc6">157</TD><TD class=alignRight headers="br1 br4 bc1 bc7">33</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc10">4329</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc11">2421</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc12">26</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc13">1882</TD><TD class=alignRight headers="br1 br4 bc8 bc14">206</TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc16">4535</TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc17">30.1%</TD></TR><TR><TH id=br5 class=alignLeft headers=br1>45-64</TH><TD class=alignRight headers="br1 br5 bc1 bc2 bc3">232</TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc4">74</TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc5">4</TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc6">154</TD><TD class=alignRight headers="br1 br5 bc1 bc7">40</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc10">3742</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc11">2068</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc12">36</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc13">1638</TD><TD class=alignRight headers="br1 br5 bc8 bc14">289</TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc16">4031</TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc17">26.8%</TD></TR><TR><TH id=br6 class=alignLeft headers=br1>65+</TH><TD class=alignRight headers="br1 br6 bc1 bc2 bc3">147</TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc4">39</TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc5">4</TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc6">104</TD><TD class=alignRight headers="br1 br6 bc1 bc7">39</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc10">1960</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc11">817</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc12">78</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc13">1065</TD><TD class=alignRight headers="br1 br6 bc8 bc14">390</TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc16">2350</TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc17">15.6%</TD></TR><TR><TH id=br7 class=alignLeft headers=br1>Unknown</TH><TD class=alignRight headers="br1 br7 bc1 bc2 bc3">9</TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc4">7</TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc6">2</TD><TD class=alignRight headers="br1 br7 bc1 bc7">0</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc10">112</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc11">95</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc12">7</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc13">10</TD><TD class=alignRight headers="br1 br7 bc8 bc14">0</TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc16">112</TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc17">0.7%</TD></TR><TR><TH id=br8 class=alignLeft headers=br1>Total</TH><TD class=alignRight headers="br1 br8 bc1 bc2 bc3">879</TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc4">260</TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc5">9</TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc6">610</TD><TD class=alignRight headers="br1 br8 bc1 bc7">167</TD><TD class=alignRight headers="br1 br8 bc8 bc9 bc10">13864</TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc11">7241</TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc12">183</TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc13">6440</TD><TD class=alignRight headers="br1 br8 bc8 bc14">1,187</TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc16">15051</TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc17">100.0%</TD></TR><TR><TH id=br9 class=alignLeft headers=br1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="br1 br9 bc1 bc2 bc3">84.0%</TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc4">29.6%</TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc5">1.0%</TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc6">69.4%</TD><TD class=alignRight headers="br1 br9 bc1 bc7">16.0%</TD><TD class=alignRight headers="br1 br9 bc8 bc9 bc10">92.1%</TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc11">52.2%</TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc12">1.3%</TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc13">46.5%</TD><TD class=alignRight headers="br1 br9 bc8 bc14">7.9%</TD><TD class=alignRight></TD><TD class=alignRight></TD></TR></TBODY></TABLE>

    Top of Page

    Influenza Strain Characterizations

    During the 2013-2014 influenza season, the National Microbiology Laboratory (NML) has antigenically characterized 894 influenza viruses [48 A(H3N2), 755 A(H1N1)pdm09 and 91 influenza B]. The vast majority (99%) of viruses were similar to the strains recommended by the WHO for the 2013-14 seasonal influenza vaccine. Two A(H1N1)pdm09 viruses showed reduced titres to antiserum against the reference A/California/07/2009 strain. Nine influenza B viruses were similar to the strain recommended by the WHO for the 2011-12 vaccine (Figure 4).
    Figure 4. Influenza strain characterizations, Canada, 2013-14, N = 894

    The NML receives a proportion of the number of influenza positive specimens from provincial laboratories for strain characterization and antiviral resistance testing. Characterization data reflect the results of haemagglutination inhibition (HAI) testing compared to the reference influenza strains recommended by WHO.
    The recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b (e.g. A/Texas/50/2012), and a B/Massachusetts/2/2012-like virus (Yamagata lineage).


    Text equivalent for figure 4Influenza strain characterizations, Canada, 2013-2014, N =3
    Antiviral Resistance

    During the 2013-2014 influenza season, NML has tested 561 influenza viruses for resistance to oseltamivir and 552 viruses for resistance to zanamivir, and all were sensitive. All 549 influenza A viruses tested for amantadine resistance were resistant (Table 3).
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=cr1 rowSpan=2>Virus type and subtype</TH><TH id=cc1 colSpan=2>Oseltamivir</TH><TH id=cc4 colSpan=2>Zanamivir</TH><TH id=cc7 colSpan=2>Amantadine</TH></TR><TR class=bg-colour-yellow><TH id=cc2 headers=cc1># tested</TH><TH id=cc3 headers=cc1># resistant (%)</TH><TH id=cc5 headers=cc4># tested</TH><TH id=cc6 headers=cc4># resistant (%)</TH><TH id=cc8 headers=cc7># tested</TH><TH id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH id=cr2 class="alignLeft lightred" headers=cr1>A (H3N2)</TH><TD class=alignRight headers="cr1 cr2 cc1 cc2">41</TD><TD class=alignRight headers="cr1 cr2 cc1 cc3">0</TD><TD class=alignRight headers="cr1 cr2 cc4 cc5">41</TD><TD class=alignRight headers="cr1 cr2 cc4 cc6">0</TD><TD class=alignRight headers="cr1 cr2 cc7 cc8">53</TD><TD class=alignRight headers="cr1 cr2 cc7 cc9">53 (100%)</TD></TR><TR><TH id=cr3 class="alignLeft lightred" headers=cr1>A (H1N1)</TH><TD class=alignRight headers="cr1 cr3 cc1 cc2">472</TD><TD class=alignRight headers="cr1 cr3 cc1 cc3">0</TD><TD class=alignRight headers="cr1 cr3 cc4 cc5">463</TD><TD class=alignRight headers="cr1 cr3 cc4 cc6">0</TD><TD class=alignRight headers="cr1 cr3 cc7 cc8">496</TD><TD class=alignRight headers="cr1 cr3 cc7 cc9">496 (100%)</TD></TR><TR><TH id=cr4 class="alignLeft lightred" headers=cr1>B</TH><TD class=alignRight headers="cr1 cr4 cc1 cc2">48</TD><TD class=alignRight headers="cr1 cr4 cc1 cc3">0</TD><TD class=alignRight headers="cr1 cr4 cc4 cc5">48</TD><TD class=alignRight headers="cr1 cr4 cc4 cc6">0</TD><TD class=alignRight headers="cr1 cr4 cc7 cc8">NA <SUP>*</SUP></TD><TD class=alignRight headers="cr1 cr4 cc7 cc9">NA <SUP>*</SUP></TD></TR><TR><TH id=cr5 class="alignLeft lightred" headers=cr1>TOTAL</TH><TD class=alignRight headers="cr1 cr5 cc1 cc2">561</TD><TD class=alignRight headers="cr1 cr5 cc1 cc3">0</TD><TD class=alignRight headers="cr1 cr5 cc4 cc5">552</TD><TD class=alignRight headers="cr1 cr5 cc4 cc6">0</TD><TD class=alignRight headers="cr1 cr5 cc7 cc8">549</TD><TD class=alignRight headers="cr1 cr5 cc7 cc9">549 (100%)</TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate continued to decrease from 32.5/1,000 in week 05 to 27.2/1,000 in week 06; which is within the expected range for week 06 (Figure 5).
    Figure 5. Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Note: No data available for mean rate for weeks 19 to 39 for the 1996-1997 through 2002-2003 seasons. Delays in the reporting of data may cause data to change retrospectively. The calculation of the average ILI consultation rate over 17 seasons was aligned with influenza activity in each season. In BC, AB, and SK, data is compiled by a provincial sentinel surveillance program for reporting to FluWatch. The number of sentinel physicians in each province or territory is as follows: BC(21), AB(80), SK(11), MB(18), ON(169), QC(14), NB(29), NS(26), PE(4), NL(16), NU(1), NT(14), YT(13). Not all sentinel physicians report every week.
    Text equivalent for figure 5Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Top of Page

    Influenza Outbreak Surveillance

    In week 06, 13 new influenza outbreaks were reported: three in hospitals and 10 in long-term care (Figure 6). In addition, six outbreaks of influenza-like-illness were reported: one in a school and five in other facilities or communities.
    Figure 6. Overall number of new influenza outbreaks by report week, Canada, 2013-2014

    1 All provinces and territories except NU report outbreaks in long-term care facilities. All provinces and territories with the exception of NU and QC report outbreaks in hospitals. Outbreaks of influenza or influenza-like-illness in other facilities are reported to FluWatch but reporting varies between jurisdictions. Outbreak definitions are included at the end of the report.
    Text equivalent for figure 6Overall number of new influenza outbreaks by report week, Canada, 2013-2014
    Pharmacy Surveillance

    In week 06, the proportion of prescriptions for influenza antivirals continued to decrease for all age groups, following the downward trend in laboratory detections of influenza. The largest proportion of prescriptions for antivirals continued to be among children 2-18 years of age followed by adults 19-64 years of age (Figure 7).
    Figure 7. Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Note: Pharmacy sales data are provided to the Public Health Agency of Canada by Rx Canada Inc. and sourced from major retail drug chains representing over 3,000 stores nationwide (excluding Nunavut) in 85% of Health Regions. Data provided include the number of new antiviral prescriptions (for Tamiflu and Relenza) and the total number of new prescriptions dispensed by Province/Territory and age group. Age-groups: Infant: 0-2y, Child: 2-18y; Adult: 19-64y, Senior: ≥65y.
    Text equivalent for figure 7Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Top of Page

    Sentinel Hospital Influenza Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)
    In week 06, 32 new laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalizations were reported by the Immunization Monitoring Program Active (IMPACT) network, compared to 55 in week 05, indicating that the number of new cases may be starting to decline. In week 06, influenza A was reported in 28 cases and influenza B in four cases (Figure 8a). Twenty-two (69%) of the cases were <5 years of age. Four ICU admissions were reported in week 06, one child under 6 months of age, one 6-23 months of age, one 2-4 years of age, and one 5-9 years of age; all with influenza A. No deaths were reported.
    To date this season, a total of 450 influenza-associated paediatric hospitalizations have been reported by the IMPACT network, 95% of which have been influenza A, and almost all of those subtyped were A(H1N1)pdm09. Children under 5 years of age represent 77.8% of cases to date (Table 4). Sixty-eight ICU admissions have been reported; all but three cases with influenza A (the majority A(H1N1)pdm09), and 29 (43%) among children under 2 years of age (Figure 9a). Among the 56 ICU cases with available data, 38 (68%) were reported to have underlying medical conditions. No deaths have been reported.
    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    Adult Influenza Hospitalizations and Deaths (PCIRN)
    In week 06, 40 new laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations reported through active surveillance by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network, compared to 52 in week 05. There has been a steady decline in the number of new cases over recent weeks. Among cases in week 06, 35 (87.5%) were influenza A, of which two were A(H1N1)pdm09 and 33 were A(unsubtyped). Four cases with influenza B and one case without information on the influenza type were reported (Figure 8b). The majority of hospitalizations occurred among adults ≥45 years of age (30; 75%). Three ICU admissions were reported in week 06: one case <20 years of age, one case 45-64 years of age and one case ≥65 years of age. No deaths were reported in week 06.
    To date this season, 887 influenza-associated hospitalizations have been reported by the PCIRN-SOS network, 851 (95.9%) with influenza A, predominantly A(H1N1)pdm09 (Table 5). ICU admission was required for 155 hospitalizations, all but five of which were cases with influenza A. More than three quarters of hospitalizations and approximately 80% of ICU admissions were ≥45 years of age. Of the 134 ICU admissions with available information, 86.6% (116/134) were reported to have at least one comorbidity. Of the 133 ICU admissions with information on influenza vaccination, 97 (72.9%) reported not having been vaccinated this season. Forty-three deaths have been reported, all with influenza A (26 A(H1N1)pdm09, one A(H3N2) and 13 A(unsubtyped)); five cases 20-44 years of age, 23 cases 45-64 years of age and 15 cases ≥65 years of age (Figure 9b).
    Note: PCIRN-SOS conducted passive surveillance from April 30th to November 14th, 2013. Cases reported during this period were identified by laboratory detection of influenza among patients admitted to participating hospitals. Active surveillance began November 15th during which time PCIRN site coordinators investigate cases potentially related to influenza. Data from both active and passive surveillance reported during the 2013-14 season are included in this report. The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION id=t4 class=alignCenter>Table 4 - Cumulative numbers of paediatric hospitalizations with influenza reported by the IMPACT network, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=dr1 rowSpan=3>Age groups </TH><TH id=dc1 colSpan=6>Cumulative (Aug. 25, 2013 to February 8, 2014) </TH></TR><TR class=bg-colour-yellow><TH id=dc2 colSpan=4 headers=dc1>Influenza A </TH><TH id=dc7 headers=dc1>B </TH><TH id=dc8 headers=dc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=dc3 headers="dc1 dc2">A Total </TH><TH id=dc4 class="lightred " headers="dc1 dc2">A(H1) pdm09 </TH><TH id=dc5 class="lightred " headers="dc1 dc2">A(H3) </TH><TH id=dc6 class="lightred " headers="dc1 dc2">A (UnS) </TH><TD class=alignCenter headers="dc1 dc7">Total</TD><TD class=alignCenter headers="dc1 dc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=dr2 class=alignLeft headers=dr1>0-5m </TH><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc3">83</TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc4">23</TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc5">0</TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc6">60</TD><TD class=alignRight headers="dr1 dr2 dc1 dc7">2</TD><TD class=alignRight headers="dr1 dr2 dc1 dc8">85 (19%)</TD></TR><TR><TH id=dr3 class=alignLeft headers=dr1>6-23m </TH><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc3">127</TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc4">38</TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc5">1</TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc6">88</TD><TD class=alignRight headers="dr1 dr3 dc1 dc7">4</TD><TD class=alignRight headers="dr1 dr3 dc1 dc8">131 (29%)</TD></TR><TR><TH id=dr4 class=alignLeft headers=dr1>2-4y </TH><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc3">125</TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc4">43</TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc5">2</TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc6">80</TD><TD class=alignRight headers="dr1 dr4 dc1 dc7">9</TD><TD class=alignRight headers="dr1 dr4 dc1 dc8">134 (30%)</TD></TR><TR><TH id=dr5 class=alignLeft headers=dr1>5-9y </TH><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc3">64</TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc4">18</TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc5">0</TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc6">46</TD><TD class=alignRight headers="dr1 dr5 dc1 dc7">7</TD><TD class=alignRight headers="dr1 dr5 dc1 dc8">71 (16%)</TD></TR><TR><TH id=dr6 class=alignLeft headers=dr1>10-16y </TH><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc3">27</TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc4">11</TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc5">0</TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc6">16</TD><TD class=alignRight headers="dr1 dr6 dc1 dc7">2</TD><TD class=alignRight headers="dr1 dr6 dc1 dc8">29 (6%)</TD></TR><TR><TH id=dr7 class=alignLeft headers=dr1>Total </TH><TD class=alignRight headers="dr1 dr7 dc1 dc2 dc3">426</TD><TD class="alignRight lightred" headers="dr1 dr7 dc1 dc2 dc4">133</TD><TD class="alignRight lightred" headers="dr1 dr7 dc1 dc2 dc5">3</TD><TD class="alignRight lightred" headers="dr1 dr7 dc1 dc2 dc6">290</TD><TD class=alignRight headers="dr1 dr7 dc1 dc7">24</TD><TD class=alignRight headers="dr1 dr7 dc1 dc8">450</TD></TR><TR><TH id=dr8 class=alignLeft headers=dr1>% <SUP>1</SUP> </TH><TD class=alignRight headers="dr1 dr8 dc1 dc2 dc3">94.7%</TD><TD class="alignRight lightred" headers="dr1 dr8 dc1 dc2 dc4">31.2%</TD><TD class="alignRight lightred" headers="dr1 dr8 dc1 dc2 dc5">0.7%</TD><TD class="alignRight lightred" headers="dr1 dr8 dc1 dc2 dc6">68.1%</TD><TD class=alignRight headers="dr1 dr8 dc1 dc7">5.3%</TD><TD class=alignRight headers="dr1 dr8 dc1 dc8">100.0%</TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 5 - Cumulative numbers of adult hospitalizations with influenza
    reported by the PCIRN-SOS network, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=er1 rowSpan=3>Age groups </TH><TH id=ec1 class=noWrap colSpan=6>Cumulative (Aug. 25, 2013 to February 8, 2014)<SUP>*</SUP></TH></TR><TR class=bg-colour-yellow><TH id=ec2 colSpan=4 headers=ec1>Influenza A </TH><TH id=ec7 headers=ec1>B </TH><TH id=ec8 headers=ec1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=ec3 headers="ec1 ec2">A Total </TH><TH id=ec4 class="lightred " headers="ec1 ec2">A(H1) pdm09 </TH><TH id=ec5 class="lightred " headers="ec1 ec2">A(H3) </TH><TH id=ec6 class="lightred " headers="ec1 ec2">A(UnS) </TH><TD class=alignCenter headers="ec1 ec7">Total</TD><TD class=alignCenter headers="ec1 ec8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP id=footnote_t5_1>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.

    <SUP id=footnote_t5_star>*</SUP>Three cases for which the influenza type has not yet been reported, and five cases for which the age-group was not reported, are not included in Table 5.
    </TD></TR></TFOOT><TBODY><TR><TH id=er2 class=alignLeft headers=er1>16-20 </TH><TD class=alignRight headers="er1 er2 ec1 ec2 ec3">7</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec4">3</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec5">0</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec6">4</TD><TD class=alignRight headers="er1 er2 ec1 ec7">1</TD><TD class=alignRight headers="er1 er2 ec1 ec8">8 (1%)</TD></TR><TR><TH id=er3 class=alignLeft headers=er1>20-44 </TH><TD class=alignRight headers="er1 er3 ec1 ec2 ec3">191</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec4">105</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec5">2</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec6">84</TD><TD class=alignRight headers="er1 er3 ec1 ec7">2</TD><TD class=alignRight headers="er1 er3 ec1 ec8">193 (22%)</TD></TR><TR><TH id=er4 class=alignLeft headers=er1>45-64 </TH><TD class=alignRight headers="er1 er4 ec1 ec2 ec3">339</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec4">157</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec5">3</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec6">179</TD><TD class=alignRight headers="er1 er4 ec1 ec7">5</TD><TD class=alignRight headers="er1 er4 ec1 ec8">344 (39%)</TD></TR><TR><TH id=er5 class=alignLeft headers=er1>65+ </TH><TD class=alignRight headers="er1 er5 ec1 ec2 ec3">309</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec4">159</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec5">15</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec6">135</TD><TD class=alignRight headers="er1 er5 ec1 ec7">25</TD><TD class=alignRight headers="er1 er5 ec1 ec8">334 (38%)</TD></TR><TR><TH id=er6 class=alignLeft headers=er1>Total </TH><TD class=alignRight headers="er1 er6 ec1 ec2 ec3">846</TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec4">424</TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec5">20</TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec6">402</TD><TD class=alignRight headers="er1 er6 ec1 ec7">33</TD><TD class=alignRight headers="er1 er6 ec1 ec8">879</TD></TR><TR><TH id=er7 class=alignLeft headers=er1>% <SUP>1</SUP></TH><TD class=alignRight headers="er1 er7 ec1 ec2 ec3">96%</TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec4">50%</TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec5">2%</TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec6">48%</TD><TD class=alignRight headers="er1 er7 ec1 ec7">4%</TD><TD class=alignRight headers="er1 er7 ec1 ec8">100%</TD></TR></TBODY></TABLE>
    Figure 8. Number of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)


    Text equivalent for figure 8aNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    * See footnote above following the section related to PCIRN-SOS data.
    Text equivalent for figure 8bNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Adult hospitalizations (>16 year of age, PCIRN-SOS)
    Figure 9. Percentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)

    * One ICU admission for which age information is not available has not been included in Figure 9a.
    Text equivalent for figure 9aPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Text equivalent for figure 9bPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Top of Page

    Provincial/Territorial Influenza Hospitalizations and Deaths

    In week 06, 208 laboratory-confirmed influenza-associated hospitalizations were reported from participating provinces and territories.<SUP>*</SUP> The majority were cases of influenza A (198, 95.2%), of which 96 (48.5%) were A(H1N1)pdm09, 8 (4.0%) were A(H3N2), and 94 (47.5%) were A(unsubtyped). Among the 12 ICU admissions reported in week 06, the majority (7, 58.3%) were adults 20-64 years of age. Fourteen deaths were reported, over half of which were adults 20-64 years of age. The number of new influenza-associated hospitalizations and deaths reported for the current week may include cases from Ontario that occurred in previous weeks, as a result of retrospective updates to the cumulative total.
    To date this season, 2,818 influenza-associated hospitalizations have been reported, 97.4% with influenza A. The majority (57.7%) of hospitalizations have been cases 45 years of age of older (Table 6). A total of 277 ICU admissions have been reported this season, and 70.4% were among adults 20-64 years of age. A total of 143 deaths have been reported. The highest proportion of deaths has been among adults 20-64 years of age (55.9%), followed by adults ≥65 years of age (35.7%). Influenza B has been detected infrequently among severe cases of influenza to date this season: in only 2.6% of hospitalizations, 1.1% of ICU admissions, and 1.4% of deaths. It is important to note that the hospitalization or death does not have to be attributable to influenza, a positive laboratory test is sufficient for reporting. Detailed clinical information (e.g. underlying medical conditions) is not known for these cases.
    * Note: Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not distinguished among hospital admissions reported from Ontario. Data may also include cases reported by the IMPACT and PCIRN networks.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION id=t6 class=alignCenter>Table 6. Cumulative number of hospitalizations with influenza reported by the participating provinces and territories, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=fr1 rowSpan=3>Age groups </TH><TH id=fc1 colSpan=6>Cumulative (Aug. 25, 2013 to February 8, 2014)* </TH></TR><TR class=bg-colour-yellow><TH id=fc2 colSpan=4 headers=fc1>Influenza A </TH><TH id=fc7 headers=fc1>B </TH><TH id=fc8 headers=fc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=fc3 headers="fc1 fc2">A Total </TH><TH id=fc4 class=lightred headers="fc1 fc2">A(H1) pdm09 </TH><TH id=fc5 class=lightred headers="fc1 fc2">A(H3) </TH><TH id=fc6 class=lightred headers="fc1 fc2">A (UnS) </TH><TD class=alignCenter headers="fc1 fc7">Total</TD><TD class=alignCenter headers="fc1 fc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=8><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    * Seventy-seven cases for which age information is not available have not been included in Table 6.
    </TD></TR></TFOOT><TBODY><TR><TH id=fr2 class=alignLeft headers=fr1>0-4 years </TH><TD class=alignRight headers="fr10 fr11 fc9 fc10 fc13">466</TD><TD class=alignRight headers="fr10 fr11 fc9 fc10 fc14">239</TD><TD class=alignRight headers="fr10 fr11 fc9 fc10 fc15">6</TD><TD class=alignRight headers="fr10 fr11 fc9 fc10 fc16">221</TD><TD class=alignRight headers="fr10 fr11 fc9 fc11">16</TD><TD class=alignRight headers="fr10 fr11 fc9 fc12">482 (18%)</TD></TR><TR><TH id=fr3 class=alignLeft headers=fr1>5-14 years </TH><TD class=alignRight headers="fr10 fr12 fc9 fc10 fc13">104</TD><TD class=alignRight headers="fr10 fr12 fc9 fc10 fc14">56</TD><TD class=alignRight headers="fr10 fr12 fc9 fc10 fc15">5</TD><TD class=alignRight headers="fr10 fr12 fc9 fc10 fc16">43</TD><TD class=alignRight headers="fr10 fr12 fc9 fc11">8</TD><TD class=alignRight headers="fr10 fr12 fc9 fc12">112 (4%)</TD></TR><TR><TH id=fr4 class=alignLeft headers=fr1>15-19 years </TH><TD class=alignRight headers="fr10 fr13 fc9 fc10 fc13">27</TD><TD class=alignRight headers="fr10 fr13 fc9 fc10 fc14">16</TD><TD class=alignRight headers="fr10 fr13 fc9 fc10 fc15">2</TD><TD class=alignRight headers="fr10 fr13 fc9 fc10 fc16">9</TD><TD class=alignRight headers="fr10 fr13 fc9 fc11">1</TD><TD class=alignRight headers="fr10 fr13 fc9 fc12">28 (1%)</TD></TR><TR><TH id=fr5 class=alignLeft headers=fr1>20-44 years </TH><TD class=alignRight headers="fr10 fr14 fc9 fc10 fc13">488</TD><TD class=alignRight headers="fr10 fr14 fc9 fc10 fc14">357</TD><TD class=alignRight headers="fr10 fr14 fc9 fc10 fc15">3</TD><TD class=alignRight headers="fr10 fr14 fc9 fc10 fc16">128</TD><TD class=alignRight headers="fr10 fr14 fc9 fc11">4</TD><TD class=alignRight headers="fr10 fr14 fc9 fc12">492 (18%)</TD></TR><TR><TH id=fr6 class=alignLeft headers=fr1>45-64 years </TH><TD class=alignRight headers="fr10 fr15 fc9 fc10 fc13">887</TD><TD class=alignRight headers="fr10 fr15 fc9 fc10 fc14">586</TD><TD class=alignRight headers="fr10 fr15 fc9 fc10 fc15">16</TD><TD class=alignRight headers="fr10 fr15 fc9 fc10 fc16">285</TD><TD class=alignRight headers="fr10 fr15 fc9 fc11">11</TD><TD class=alignRight headers="fr10 fr15 fc9 fc12">898 (33%)</TD></TR><TR><TH id=fr7 class=alignLeft headers=fr1>65+ years </TH><TD class=alignRight headers="fr10 fr16 fc9 fc10 fc13">697</TD><TD class=alignRight headers="fr10 fr16 fc9 fc10 fc14">384</TD><TD class=alignRight headers="fr10 fr16 fc9 fc10 fc15">44</TD><TD class=alignRight headers="fr10 fr16 fc9 fc10 fc16">269</TD><TD class=alignRight headers="fr10 fr16 fc9 fc11">32</TD><TD class=alignRight headers="fr10 fr16 fc9 fc12">729 (27%)</TD></TR><TR><TH id=fr8 class=alignLeft headers=fr1>Total </TH><TD class=alignRight headers="fr10 fr17 fc9 fc10 fc13">2669</TD><TD class="alignRight lightred" headers="fr10 fr17 fc9 fc10 fc14">1638</TD><TD class="alignRight lightred" headers="fr10 fr17 fc9 fc10 fc15">76</TD><TD class="alignRight lightred" headers="fr10 fr17 fc9 fc10 fc16">955</TD><TD class=alignRight headers="fr10 fr17 fc9 fc11">72</TD><TD class=alignRight headers="fr10 fr17 fc9 fc12">2741</TD></TR><TR><TH id=fr9 class=alignLeft headers=fr1>Percentage <SUP>1</SUP> </TH><TD class=alignRight headers="fr10 fr18 fc9 fc10 fc13">97.4%</TD><TD class="alignRight lightred" headers="fr10 fr18 fc9 fc10 fc14">61.4%</TD><TD class="alignRight lightred" headers="fr10 fr18 fc9 fc10 fc15">2.8%</TD><TD class="alignRight lightred" headers="fr10 fr18 fc9 fc10 fc16">35.8%</TD><TD class=alignRight headers="fr10 fr18 fc9 fc11">2.6%</TD><TD class=alignRight headers="fr10 fr18 fc9 fc12">100%</TD></TR></TBODY></TABLE>
    See additional data on Reported Influenza Hospitalizations and Deaths in Canada: 2009-10 to 2013-14 on the Public Health Agency of Canada website.

    .../

    Leave a comment:


  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Week 5

    FluWatch report: January 26 to February 1, 2014 (Week 05)

    Posted 2014-02-07For readers interested in the <ABBR title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A title="Flu Watch (Version PDF, 113 KB - 6 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w05_14/pdf/fw2014-05-eng.pdf">FluWatch report: January 26 to February 1, 2014 (Week 05) (<ABBR title="Portable Document Format">PDF</ABBR> Version - 291 <ABBR title=Kilobytes>KB</ABBR> - 10 pages)

    ?? Help with PDF documents


    Overall Summary
    • In week 05, overall influenza activity continued to decrease in Canada, with most activity identified in eastern provinces.
    • The influenza A(H1N1) virus remains the most common influenza virus circulating this season. A Canadian vaccine effectiveness study has estimated that immunization with the 2013-14 seasonal influenza vaccine has been 74% effective in reducing doctors? visits (Skowronski, Chambers, Sabaiduc et al., 2014). Influenza B virus detections are also starting to increase.
    • Adults 20-64 years of age continue to be more affected by influenza this season.
    • To week 05, 2,588 hospitalizations have been reported, slightly decreased compared to the same period last season. However, a greater proportion of hospitalizations have been admitted to the ICU. One hundred and thirty-eight deaths have been reported, which represents a similar proportion of deaths compared to last year.
    • Overall influenza activity in Canada during the 2013-14 season has been similar to the 2012-13 season and is within expected levels for this time of year.
    Influenza/ILI Activity (geographic spread)

    In week 05, one region in Quebec and one in Manitoba reported widespread activity, and 15 regions (in AB(1), ON(6), QC(4), NB(3) and NS(1)) reported localized activity (Figure 1). Compared to week 04, activity was stable or decreased in regions in AB, ON, PE, NL and NU; stable in BC, SK, NT and YT; and stable or increased in regions in MB and QC. A mixed pattern of activity was reported among regions in NB and NS.
    Figure 1. Map of overall influenza/ILI activity level by province and territory, Canada, Week 05





    Note: Influenza/ILI activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates and reported outbreaks. Please refer to detailed definitions at the end of the report. Maps from previous weeks, including any retrospective updates, are available on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada
    Influenza and Other Respiratory Virus Detections

    The number of positive influenza tests decreased for the third week in a row, from 2,568 in week 04 to 2,219 in week 05. The percentage of positive influenza tests decreased from 23.5% to 21.9% (Figure 2). Cumulative influenza virus detections to date remain predominantly influenza A (95%), and among those subtyped, 97% (8,679/8,977) were A(H1N1)pdm09. However, the percentage of positive tests for influenza B has been rising slowly in recent weeks to 9.5% of influenza detections in week 05 (Table 1). Among the 13,241 cases for which information on age and type/subtype has been received this season, 57.4% were 20-64 years of age and 15.5% were ≥65 years of age, which is different from the proportions observed during the 2012-13 season when 33.1% of cases were 20-64 years of age and 41.2% were ≥65 years of age (Table 2).
    Figure 2. Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14

    Text equivalent for figure 2Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14
    The number of positive tests for RSV continued the gradual increase observed since late November 2013. The percentage of the total number of tests that were positive has fluctuated during this period, but increased during the past two weeks. RSV in Canada shows a seasonal pattern with a broad peak over the winter months. The percentage of positive tests for coronavirus and human metapneumovirus continued to increase in week 05 (Figure 3).
    For more details, see the weekly Respiratory Virus Detections in Canada Report.
    Figure 3. Number of positive laboratory tests for other respiratory viruses by report week, Canada, 2013-14


    Top of Page

    RSV: Respiratory syncytial virus; hMPV: Human metapneumovirus
    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 1: Weekly and cumulative numbers of positive influenza specimens
    by type, subtype and province, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=ar1 rowSpan=3>Reporting provinces <SUP>1</SUP></TH><TH id=ac1 colSpan=5>Weekly
    (January 26, 2013 to February 1, 2014)
    </TH><TH id=ac8 colSpan=5>Cumulative
    (August 25, 2013 to February 1, 2014)
    </TH></TR><TR class=bg-colour-yellow><TH id=ac2 colSpan=4 headers=ac1>Influenza A</TH><TH id=ac7 headers=ac1>B</TH><TH id=ac9 colSpan=4 headers=ac8>Influenza A</TH><TH id=ac14 headers=ac8>B</TH></TR><TR class=bg-colour-grey-light><TH id=ac3 headers="ac1 ac2">A Total</TH><TH id=ac4 class=lightred headers="ac1 ac2">A(H1)pdm09</TH><TH id=ac5 class=lightred headers="ac1 ac2">A(H3)</TH><TH id=ac6 class=lightred headers="ac1 ac2">A(UnS)</TH><TH class=alignCenter headers="ac1 ac7">B Total</TH><TH id=ac10 headers="ac8 ac9">A Total</TH><TH id=ac11 class=lightred headers="ac8 ac9">A(H1)pdm09</TH><TH id=ac12 class=lightred headers="ac8 ac9">A(H3)</TH><TH id=ac13 class=lightred headers="ac8 ac9">A(UnS)</TH><TD class=alignCenter headers="ac8 ac14">B Total</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=11><SUP>1 </SUP>Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.
    <SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=ar2 class=alignLeft headers=ar1>BC</TH><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac3">165 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac4">127 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac5">16 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac6">22 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac7">7 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac10">1474 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac11">1347 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac12">69 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac13">58 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac14">44 </TD></TR><TR><TH id=ar3 class=alignLeft headers=ar1>AB</TH><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac3">151 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac4">103 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac5">2 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac6">46 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac7">14 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac10">3268 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac11">3086 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac12">33 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac13">149 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac14">57 </TD></TR><TR><TH id=ar4 class=alignLeft headers=ar1>SK</TH><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac3">94 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac4">67 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac5">1 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac6">26 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac7">6 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac10">1177 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac11">848 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac12">2 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac13">327 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac14">10 </TD></TR><TR><TH id=ar5 class=alignLeft headers=ar1>MB</TH><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac3">71 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac4">55 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac6">16 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac10">418 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac11">276 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac12">1 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac13">141 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac14">13 </TD></TR><TR><TH id=ar6 class=alignLeft headers=ar1>ON</TH><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac3">474 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac4">127 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac5">24 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac6">323 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac7">25 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac10">4566 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac11">2094 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac12">185 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac13">2287 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac14">110 </TD></TR><TR><TH id=ar7 class=alignLeft headers=ar1>QC</TH><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac3">715 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac4">100 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac5">1 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac6">614 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac7">140 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac10">3375 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac11">425 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac12">3 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac13">2947 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac14">580 </TD></TR><TR><TH id=ar8 class=alignLeft headers=ar1>NB</TH><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac3">234 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac4">30 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac6">204 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac7">1 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac10">1157 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac11">364 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac12">1 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac13">792 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac14">4 </TD></TR><TR><TH id=ar9 class=alignLeft headers=ar1>NS</TH><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac3">23 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac4">20 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac5">2 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac6">1 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac10">86 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac11">63 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac12">4 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac13">19 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac14">0 </TD></TR><TR><TH id=ar10 class=alignLeft headers=ar1>PE</TH><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac3">29 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac4">29 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac6">0 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac10">72 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac11">72 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac13">0 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac14">0 </TD></TR><TR><TH id=ar11 class=alignLeft headers=ar1>NL</TH><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac3">53 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac4">0 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac6">53 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac7">17 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac10">258 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac11">104 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac13">154 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac14">99 </TD></TR><TR><TH id=ar12 class=alignLeft headers=ar1>Canada</TH><TD class=alignRight headers="ar1 ar12 ac1 ac2 ac3">2009 </TD><TD class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac4">658 </TD><TD class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac5">46 </TD><TD class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac6">1305 </TD><TD class=alignRight headers="ar1 ar12 ac1 ac7">210 </TD><TD class=alignRight headers="ar1 ar12 ac8 ac9 ac10">15851 </TD><TD class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac11">8679 </TD><TD class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac12">298 </TD><TD class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac13">6874 </TD><TD class=alignRight headers="ar1 ar12 ac8 ac14">917 </TD></TR><TR><TH id=ar13 class=alignLeft headers=ar1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="ar1 ar13 ac1 ac2 ac3">90.5% </TD><TD class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac4">32.8% </TD><TD class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac5">2.3% </TD><TD class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac6">65.0% </TD><TD class=alignRight headers="ar1 ar13 ac1 ac7">9.5% </TD><TD class=alignRight headers="ar1 ar13 ac8 ac9 ac10">94.5% </TD><TD class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac11">54.8% </TD><TD class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac12">1.9% </TD><TD class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac13">43.4% </TD><TD class=alignRight headers="ar1 ar13 ac8 ac14">5.5% </TD></TR></TBODY></TABLE>

    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 2. Weekly and cumulative numbers of positive influenza specimens by type, subtype and age-group reported through case-based laboratory reporting<SUP>3</SUP>, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=br1 rowSpan=3>Age groups (years)</TH><TH id=bc1 colSpan=5>Weekly
    (January 26 to February 1, 2014)
    </TH><TH id=bc8 colSpan=7>Cumulative
    (August 25, 2013 to February 1, 2014)
    </TH></TR><TR class=bg-colour-yellow><TH id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH id=bc7 headers=bc1>B</TH><TH id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH id=bc14 headers=bc8>B</TH><TH id=bc15 colSpan=2 headers=bc8>Influenza A and B</TH></TR><TR class=bg-colour-grey-light><TH id=bc3 headers="bc1 bc2">A Total</TH><TH id=bc4 class="lightred " headers="bc1 bc2">A(H1) pdm09</TH><TH id=bc5 class="lightred " headers="bc1 bc2">A(H3)</TH><TH id=bc6 class="lightred " headers="bc1 bc2">A (UnS)</TH><TD class=alignCenter headers="bc1 bc7">Total</TD><TH id=bc10 headers="bc8 bc9">A Total</TH><TH id=bc11 class="lightred " headers="bc8 bc9">A(H1) pdm09</TH><TH id=bc12 class="lightred " headers="bc8 bc9">A(H3)</TH><TH id=bc13 class="lightred " headers="bc8 bc9">A (UnS)</TH><TD class=alignCenter headers="bc8 bc14">Total</TD><TH id=bc16 headers="bc8 bc15">#</TH><TH id=bc17 headers="bc8 bc15">%</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=13><SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    <SUP>3 </SUP>Table 2 includes specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=br2 class=alignLeft headers=br1><5</TH><TD class=alignRight headers="br1 br2 bc1 bc2 bc3">218 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc4">53 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc6">165 </TD><TD class=alignRight headers="br1 br2 bc1 bc7">15 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc10">2307 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc11">1122 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc12">18 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc13">1167 </TD><TD class=alignRight headers="br1 br2 bc8 bc14">98 </TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc16">2405 </TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc17">18.2% </TD></TR><TR><TH id=br3 class=alignLeft headers=br1>5-19</TH><TD class=alignRight headers="br1 br3 bc1 bc2 bc3">89 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc4">26 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc6">63 </TD><TD class=alignRight headers="br1 br3 bc1 bc7">24 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc10">963 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc11">562 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc12">15 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc13">386 </TD><TD class=alignRight headers="br1 br3 bc8 bc14">126 </TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc16">1089 </TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc17">8.2% </TD></TR><TR><TH id=br4 class=alignLeft headers=br1>20-44</TH><TD class=alignRight headers="br1 br4 bc1 bc2 bc3">246 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc4">89 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc5">2 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc6">155 </TD><TD class=alignRight headers="br1 br4 bc1 bc7">27 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc10">3886 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc11">2241 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc12">23 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc13">1622 </TD><TD class=alignRight headers="br1 br4 bc8 bc14">161 </TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc16">4047 </TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc17">30.6% </TD></TR><TR><TH id=br5 class=alignLeft headers=br1>45-64</TH><TD class=alignRight headers="br1 br5 bc1 bc2 bc3">215 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc4">69 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc5">1 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc6">145 </TD><TD class=alignRight headers="br1 br5 bc1 bc7">32 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc10">3321 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc11">1891 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc12">29 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc13">1401 </TD><TD class=alignRight headers="br1 br5 bc8 bc14">234 </TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc16">3555 </TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc17">26.8% </TD></TR><TR><TH id=br6 class=alignLeft headers=br1>65+</TH><TD class=alignRight headers="br1 br6 bc1 bc2 bc3">126 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc4">26 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc5">1 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc6">99 </TD><TD class=alignRight headers="br1 br6 bc1 bc7">53 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc10">1713 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc11">740 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc12">56 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc13">917 </TD><TD class=alignRight headers="br1 br6 bc8 bc14">338 </TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc16">2051 </TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc17">15.5% </TD></TR><TR><TH id=br7 class=alignLeft headers=br1>Unknown</TH><TD class=alignRight headers="br1 br7 bc1 bc2 bc3">0 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc4">0 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc6">0 </TD><TD class=alignRight headers="br1 br7 bc1 bc7">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc10">94 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc11">81 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc12">5 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc13">8 </TD><TD class=alignRight headers="br1 br7 bc8 bc14">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc16">94 </TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc17">0.7% </TD></TR><TR><TH id=br8 class=alignLeft headers=br1>Total</TH><TD class=alignRight headers="br1 br8 bc1 bc2 bc3">894 </TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc4">263 </TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc5">4 </TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc6">627 </TD><TD class=alignRight headers="br1 br8 bc1 bc7">151 </TD><TD class=alignRight headers="br1 br8 bc8 bc9 bc10">12284 </TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc11">6637 </TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc12">146 </TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc13">5501 </TD><TD class=alignRight headers="br1 br8 bc8 bc14">957 </TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc16">13241 </TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc17">100.0% </TD></TR><TR><TH id=br9 class=alignLeft headers=br1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="br1 br9 bc1 bc2 bc3">85.6% </TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc4">29.4% </TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc5">0.4% </TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc6">70.1% </TD><TD class=alignRight headers="br1 br9 bc1 bc7">14.4% </TD><TD class=alignRight headers="br1 br9 bc8 bc9 bc10">92.8% </TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc11">54.0% </TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc12">1.2% </TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc13">44.8% </TD><TD class=alignRight headers="br1 br9 bc8 bc14">7.2% </TD><TD class=alignRight></TD><TD class=alignRight></TD></TR></TBODY></TABLE>

    Top of Page

    Influenza Strain Characterizations

    During the 2013-2014 influenza season, the National Microbiology Laboratory (NML) has antigenically characterized 750 influenza viruses [43 A(H3N2), 635 A(H1N1)pdm09 and 72 influenza B]. The vast majority (99%) of viruses were similar to the strains recommended by the WHO for the 2013-14 seasonal influenza vaccine. Two A(H1N1)pdm09 viruses showed reduced titres to antiserum against the reference A/California/07/2009 strain. Six influenza B viruses were similar to the strain recommended by the WHO for the 2011-12 vaccine (Figure 4).
    Figure 4. Influenza strain characterizations, Canada, 2013-14, N = 750

    The NML receives a proportion of the number of influenza positive specimens from provincial laboratories for strain characterization and antiviral resistance testing. Characterization data reflect the results of haemagglutination inhibition (HAI) testing compared to the reference influenza strains recommended by WHO.
    The recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b (e.g. A/Texas/50/2012), and a B/Massachusetts/2/2012-like virus (Yamagata lineage).


    Text equivalent for figure 4Influenza strain characterizations, Canada, 2013-2014, N =3
    Antiviral Resistance

    During the 2013-2014 influenza season, NML has tested 483 influenza viruses for resistance to oseltamivir and 479 viruses for resistance to zanamivir, and all were sensitive. All 418 influenza A viruses tested for amantadine resistance were resistant (Table 3).
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=cr1 rowSpan=2>Virus type and subtype</TH><TH id=cc1 colSpan=2>Oseltamivir</TH><TH id=cc4 colSpan=2>Zanamivir</TH><TH id=cc7 colSpan=2>Amantadine</TH></TR><TR class=bg-colour-yellow><TH id=cc2 headers=cc1># tested</TH><TH id=cc3 headers=cc1># resistant (%)</TH><TH id=cc5 headers=cc4># tested</TH><TH id=cc6 headers=cc4># resistant (%)</TH><TH id=cc8 headers=cc7># tested</TH><TH id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH id=cr2 class="alignLeft lightred" headers=cr1>A (H3N2)</TH><TD class=alignRight headers="cr1 cr2 cc1 cc2">34 </TD><TD class=alignRight headers="cr1 cr2 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr2 cc4 cc5">34 </TD><TD class=alignRight headers="cr1 cr2 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr2 cc7 cc8">40 </TD><TD class=alignRight headers="cr1 cr2 cc7 cc9">40 (100%) </TD></TR><TR><TH id=cr3 class="alignLeft lightred" headers=cr1>A (H1N1)</TH><TD class=alignRight headers="cr1 cr3 cc1 cc2">404</TD><TD class=alignRight headers="cr1 cr3 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr3 cc4 cc5">400</TD><TD class=alignRight headers="cr1 cr3 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr3 cc7 cc8">378</TD><TD class=alignRight headers="cr1 cr3 cc7 cc9">378 (100%) </TD></TR><TR><TH id=cr4 class="alignLeft lightred" headers=cr1>B</TH><TD class=alignRight headers="cr1 cr4 cc1 cc2">45</TD><TD class=alignRight headers="cr1 cr4 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr4 cc4 cc5">45</TD><TD class=alignRight headers="cr1 cr4 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr4 cc7 cc8">NA <SUP>*</SUP></TD><TD class=alignRight headers="cr1 cr4 cc7 cc9">NA <SUP>*</SUP></TD></TR><TR><TH id=cr5 class="alignLeft lightred" headers=cr1>TOTAL</TH><TD class=alignRight headers="cr1 cr5 cc1 cc2">483</TD><TD class=alignRight headers="cr1 cr5 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr5 cc4 cc5">479 </TD><TD class=alignRight headers="cr1 cr5 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr5 cc7 cc8">418</TD><TD class=alignRight headers="cr1 cr5 cc7 cc9">418 (100%) </TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate continued to decrease from 34.6/1,000 in week 04 to 28.8/1,000 in week 05; which is within the expected range for week 05 (Figure 5).
    Figure 5. Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Note: No data available for mean rate for weeks 19 to 39 for the 1996-1997 through 2002-2003 seasons. Delays in the reporting of data may cause data to change retrospectively. The calculation of the average ILI consultation rate over 17 seasons was aligned with influenza activity in each season. In BC, AB, and SK, data is compiled by a provincial sentinel surveillance program for reporting to FluWatch. The number of sentinel physicians in each province or territory is as follows: BC(21), AB(80), SK(11), MB(18), ON(169), QC(14), NB(29), NS(26), PE(4), NL(16), NU(1), NT(14), YT(13). Not all sentinel physicians report every week.
    Text equivalent for figure 5Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Top of Page

    Influenza Outbreak Surveillance

    In week 05, ten new influenza outbreaks were reported in long-term care facilities (Figure 6). In addition, five outbreaks of influenza-like-illness were reported: three in schools and two in other facilities or communities.
    Figure 6. Overall number of new influenza outbreaks by report week, Canada, 2013-2014

    1 All provinces and territories except NU report outbreaks in long-term care facilities. All provinces and territories with the exception of NU and QC report outbreaks in hospitals. Outbreaks of influenza or influenza-like-illness in other facilities are reported to FluWatch but reporting varies between jurisdictions. Outbreak definitions are included at the end of the report.
    Text equivalent for figure 6 Overall number of new influenza outbreaks by report week, Canada, 2013-2014
    Pharmacy Surveillance

    The rate of prescriptions for influenza antivirals declined for the third week in a row, following the downward trend in laboratory detections of influenza. In week 05, the largest proportion of prescriptions for antivirals continued to be among children 2-18 years of age followed by adults 19-64 years of age. The proportion of prescriptions for antivirals increased for infants <2 years of age in week 05 (Figure 7).
    Figure 7. Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Note: Pharmacy sales data are provided to the Public Health Agency of Canada by Rx Canada Inc. and sourced from major retail drug chains representing over 3,000 stores nationwide (excluding Nunavut) in 85% of Health Regions. Data provided include the number of new antiviral prescriptions (for Tamiflu and Relenza) and the total number of new prescriptions dispensed by Province/Territory and age group. Age-groups: Infant: 0-2y, Child: 2-18y; Adult: 19-64y, Senior: ≥65y.
    Text equivalent for figure 7Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Top of Page

    Sentinel Hospital Influenza Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)
    In week 05, 50 new laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalizations were reported by the Immunization Monitoring Program Active (IMPACT) network, compared to 56 in week 04. All but one of the hospitalizations in week 05 were cases with influenza A (Figure 8a). Forty-one (82%) of the cases were <5 years of age. Eight ICU admissions were reported in week 05, one child under 6 months of age, two children 6-23 months of age, three 2-4 years of age, and two 5-9 years of age; all with influenza A. No deaths were reported.
    To date this season, a total of 410 influenza-associated paediatric hospitalizations have been reported by the IMPACT network, 95% of which have been influenza A, and almost all of those subtyped were A(H1N1)pdm09. Children under 5 years of age represent 78.5% of cases to date (Table 4). Sixty-five ICU admissions have been reported; all but three cases with influenza A (the majority A(H1N1)pdm09), and 26 (40%) have been among children under 2 years of age (Figure 9a). Among the 55 ICU cases with available data, 38 (69%) were reported to have underlying medical conditions. No deaths have been reported.
    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    Adult Influenza Hospitalizations and Deaths (PCIRN)
    In week 05, 28 new laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations reported through active surveillance by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network, compared to 84 in week 04. Among cases in week 05, 26 (92.9%) were influenza A, of which four were A(H1N1)pdm09 and 22 were A(unsubtyped). One case with influenza B and one case without information on the influenza type were reported (Figure 8b). The majority of hospitalizations occurred among adults ≥45 years of age (22; 78.6%). Three ICU admissions were reported in week 05: one case in an adult 45-64 years of age and two cases ≥65 years of age. One death was reported in an adult 45-64 years of age with influenza A(unsubtyped).
    To date this season, 767 influenza-associated hospitalizations have been reported by the PCIRN-SOS network, 736 (96.0%) with influenza A, predominantly A(H1N1)pdm09 (Table 5). ICU admission was required for 137 hospitalizations, all but six of which were cases with influenza A. More than three quarters of hospitalizations and over 85% of ICU admissions were ≥45 years of age. Of the 125 ICU admissions with available information, 85.6% (107/125) were reported to have at least one comorbidity. Of the 115 ICU admissions with information on influenza vaccination, 83 (72.2%) reported not having been vaccinated this season. Thirty-eight deaths have been reported, all with influenza A (22 A(H1N1)pdm09, one A(H3N2) and 15 A(unsubtyped)); five cases 20-44 years of age, 19 cases 45-64 years of age and 14 cases ≥65 years of age (Figure 9b).
    Note: PCIRN-SOS conducted passive surveillance from April 30th to November 14th, 2013. Cases reported during this period were identified by laboratory detection of influenza among patients admitted to participating hospitals. Active surveillance began November 15th during which time PCIRN site coordinators investigate cases potentially related to influenza. Data from both active and passive surveillance reported during the 2013-14 season are included in this report. The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION id=t4 class=alignCenter>Table 4 - Cumulative numbers of paediatric hospitalizations with influenza reported by the IMPACT network, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=dr1 rowSpan=3>Age groups </TH><TH id=dc1 colSpan=6>Cumulative (Aug. 25, 2013 to February 1, 2014) </TH></TR><TR class=bg-colour-yellow><TH id=dc2 colSpan=4 headers=dc1>Influenza A </TH><TH id=dc7 headers=dc1>B </TH><TH id=dc8 headers=dc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=dc3 headers="dc1 dc2">A Total </TH><TH id=dc4 class="lightred " headers="dc1 dc2">A(H1) pdm09 </TH><TH id=dc5 class="lightred " headers="dc1 dc2">A(H3) </TH><TH id=dc6 class="lightred " headers="dc1 dc2">A (UnS) </TH><TD class=alignCenter headers="dc1 dc7">Total</TD><TD class=alignCenter headers="dc1 dc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=dr2 class=alignLeft headers=dr1>0-5m </TH><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc3">78 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc4">22 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc6">56 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc7">2 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc8">80 (20%) </TD></TR><TR><TH id=dr3 class=alignLeft headers=dr1>6-23m </TH><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc3">114 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc4">36 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc5">1 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc6">77 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc7">4 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc8">118 (29%) </TD></TR><TR><TH id=dr4 class=alignLeft headers=dr1>2-4y </TH><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc3">116 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc4">39 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc5">2 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc6">75</TD><TD class=alignRight headers="dr1 dr4 dc1 dc7">8 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc8">124 (30%) </TD></TR><TR><TH id=dr5 class=alignLeft headers=dr1>5-9y </TH><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc3">58 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc4">18 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc6">40 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc7">4 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc8">62 (15%) </TD></TR><TR><TH id=dr6 class=alignLeft headers=dr1>10-16y </TH><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc3">24 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc4">11 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc6">13 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc7">2 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc8">26 (6%) </TD></TR><TR><TH id=dr7 class=alignLeft headers=dr1>Total </TH><TD class=alignRight headers="dr1 dr7 dc1 dc2 dc3">390 </TD><TD class="alignRight lightred" headers="dr1 dr7 dc1 dc2 dc4">126 </TD><TD class="alignRight lightred" headers="dr1 dr7 dc1 dc2 dc5">3 </TD><TD class="alignRight lightred" headers="dr1 dr7 dc1 dc2 dc6">261 </TD><TD class=alignRight headers="dr1 dr7 dc1 dc7">20 </TD><TD class=alignRight headers="dr1 dr7 dc1 dc8">410 </TD></TR><TR><TH id=dr8 class=alignLeft headers=dr1>% <SUP>1</SUP> </TH><TD class=alignRight headers="dr1 dr8 dc1 dc2 dc3">95.1% </TD><TD class="alignRight lightred" headers="dr1 dr8 dc1 dc2 dc4">32.3% </TD><TD class="alignRight lightred" headers="dr1 dr8 dc1 dc2 dc5">0.8% </TD><TD class="alignRight lightred" headers="dr1 dr8 dc1 dc2 dc6">66.9% </TD><TD class=alignRight headers="dr1 dr8 dc1 dc7">4.9% </TD><TD class=alignRight headers="dr1 dr8 dc1 dc8">100.0% </TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 5 - Cumulative numbers of adult hospitalizations with influenza
    reported by the PCIRN-SOS network, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=er1 rowSpan=3>Age groups </TH><TH id=ec1 class=noWrap colSpan=6>Cumulative (Aug. 25, 2013 to February 1, 2014)<SUP>*</SUP></TH></TR><TR class=bg-colour-yellow><TH id=ec2 colSpan=4 headers=ec1>Influenza A </TH><TH id=ec7 headers=ec1>B </TH><TH id=ec8 headers=ec1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=ec3 headers="ec1 ec2">A Total </TH><TH id=ec4 class="lightred " headers="ec1 ec2">A(H1) pdm09 </TH><TH id=ec5 class="lightred " headers="ec1 ec2">A(H3) </TH><TH id=ec6 class="lightred " headers="ec1 ec2">A(UnS) </TH><TD class=alignCenter headers="ec1 ec7">Total</TD><TD class=alignCenter headers="ec1 ec8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP id=footnote_t5_1>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.

    <SUP id=footnote_t5_star>*</SUP> Five cases for which the influenza type has not yet been reported, and five cases for which the age-group was not reported, are not included in Table 5.
    </TD></TR></TFOOT><TBODY><TR><TH id=er2 class=alignLeft headers=er1>16-20 </TH><TD class=alignRight headers="er1 er2 ec1 ec2 ec3">5 </TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec4">2 </TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec5">0 </TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec6">3 </TD><TD class=alignRight headers="er1 er2 ec1 ec7">1 </TD><TD class=alignRight headers="er1 er2 ec1 ec8">6 (1%) </TD></TR><TR><TH id=er3 class=alignLeft headers=er1>20-44 </TH><TD class=alignRight headers="er1 er3 ec1 ec2 ec3">166 </TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec4">94 </TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec5">2 </TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec6">70 </TD><TD class=alignRight headers="er1 er3 ec1 ec7">2 </TD><TD class=alignRight headers="er1 er3 ec1 ec8">168 (22%) </TD></TR><TR><TH id=er4 class=alignLeft headers=er1>45-64 </TH><TD class=alignRight headers="er1 er4 ec1 ec2 ec3">301 </TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec4">143 </TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec5">3 </TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec6">155 </TD><TD class=alignRight headers="er1 er4 ec1 ec7">5 </TD><TD class=alignRight headers="er1 er4 ec1 ec8">306 (40%) </TD></TR><TR><TH id=er5 class=alignLeft headers=er1>65+ </TH><TD class=alignRight headers="er1 er5 ec1 ec2 ec3">259 </TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec4">141 </TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec5">13 </TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec6">105 </TD><TD class=alignRight headers="er1 er5 ec1 ec7">18 </TD><TD class=alignRight headers="er1 er5 ec1 ec8">277 (37%) </TD></TR><TR><TH id=er6 class=alignLeft headers=er1>Total </TH><TD class=alignRight headers="er1 er6 ec1 ec2 ec3">731 </TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec4">380 </TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec5">18 </TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec6">333 </TD><TD class=alignRight headers="er1 er6 ec1 ec7">26 </TD><TD class=alignRight headers="er1 er6 ec1 ec8">757 </TD></TR><TR><TH id=er7 class=alignLeft headers=er1>% <SUP>1</SUP></TH><TD class=alignRight headers="er1 er7 ec1 ec2 ec3">97% </TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec4">52% </TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec5">2% </TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec6">46% </TD><TD class=alignRight headers="er1 er7 ec1 ec7">3% </TD><TD class=alignRight headers="er1 er7 ec1 ec8">100% </TD></TR></TBODY></TABLE>
    Figure 8. Number of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)


    Text equivalent for figure 8aNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    * See footnote above following the section related to PCIRN-SOS data.
    Text equivalent for figure 8bNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Adult hospitalizations (>16 year of age, PCIRN-SOS)
    Figure 9. Percentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)

    * One ICU admission for which age information is not available has not been included in Figure 9a.
    Text equivalent for figure 9aPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Text equivalent for figure 9bPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Top of Page


    Provincial/Territorial Influenza Hospitalizations and Deaths

    In week 05, 244 laboratory-confirmed influenza-associated hospitalizations were reported from participating provinces and territories.<SUP>*</SUP> The majority were cases of influenza A (236, 96.7%), of which 99 (41.9%) were A(H1N1)pdm09, 7 (3.0%) were A(H3N2), and 130 (55.1%) were A(unsubtyped). Among the 15 ICU admissions reported in week 05, the majority (11, 73.3%) were adults 20-64 years of age. Twenty-one deaths were reported, just over half of which were adults 20-64 years of age. The number of new influenza-associated hospitalizations and deaths reported for the current week may include cases from Ontario that occurred in previous weeks, as a result of retrospective updates to the cumulative total.

    To date this season, 2,588 influenza-associated hospitalizations have been reported, 97.6% with influenza A. The majority (58%) of hospitalizations have been cases 45 years of age of older (Table 6). A total of 250 ICU admissions have been reported this season, and 71% were among adults 20-64 years of age. A total of 138 deaths have been reported. The highest proportion of deaths has been among adults 20-64 years of age (51%), followed by adults ≥65 years of age (36%). Influenza B has been detected infrequently among severe cases of influenza to date this season: in only 2.4% of hospitalizations, 0.4% of ICU admissions, and 1.4% of deaths. It is important to note that the hospitalization or death does not have to be attributable to influenza, a positive laboratory test is sufficient for reporting. Detailed clinical information (e.g. underlying medical conditions) is not known for these cases.

    * Note: Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not distinguished among hospital admissions reported from Ontario. Data may also include cases reported by the IMPACT and PCIRN networks.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION id=t6 class=alignCenter>Table 6. Cumulative number of hospitalizations with influenza reported by the participating provinces and territories, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=fr1 rowSpan=3>Age groups </TH><TH id=fc1 colSpan=6>Cumulative (Aug. 25, 2013 to February 1, 2014)* </TH></TR><TR class=bg-colour-yellow><TH id=fc2 colSpan=4 headers=fc1>Influenza A </TH><TH id=fc7 headers=fc1>B </TH><TH id=fc8 headers=fc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=fc3 headers="fc1 fc2">A Total </TH><TH id=fc4 class=lightred headers="fc1 fc2">A(H1) pdm09 </TH><TH id=fc5 class=lightred headers="fc1 fc2">A(H3) </TH><TH id=fc6 class=lightred headers="fc1 fc2">A (UnS) </TH><TD class=alignCenter headers="fc1 fc7">Total</TD><TD class=alignCenter headers="fc1 fc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=8><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    * Sixty-one cases for which age information is not available have not been included in Table 6.
    </TD></TR></TFOOT><TBODY><TR><TH id=fr2 class=alignLeft headers=fr1>0-4 years </TH><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc3">440 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc4">232 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc5">5 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc6">203 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc7">14 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc8">454 (18%) </TD></TR><TR><TH id=fr3 class=alignLeft headers=fr1>5-14 years </TH><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc3">92 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc4">51 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc5">3 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc6">38 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc7">6 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc8">98 (4%) </TD></TR><TR><TH id=fr4 class=alignLeft headers=fr1>15-19 years </TH><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc3">26 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc4">16 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc5">2 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc6">8 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc7">1 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc8">27 (1%) </TD></TR><TR><TH id=fr5 class=alignLeft headers=fr1>20-44 years </TH><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc3">449 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc4">333 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc5">3 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc6">113 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc7">4 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc8">453 (18%) </TD></TR><TR><TH id=fr6 class=alignLeft headers=fr1>45-64 years </TH><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc3">816 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc4">542 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc5">14 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc6">260 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc7">8 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc8">824 (33%) </TD></TR><TR><TH id=fr7 class=alignLeft headers=fr1>65+ years </TH><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc3">642 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc4">361 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc5">41 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc6">240 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc7">29 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc8">671 (27%) </TD></TR><TR><TH id=fr8 class=alignLeft headers=fr1>Total </TH><TD class=alignRight headers="fr1 fr8 fc1 fc2 fc3">2465 </TD><TD class="alignRight lightred" headers="fr1 fr8 fc1 fc2 fc4">1535 </TD><TD class="alignRight lightred" headers="fr1 fr8 fc1 fc2 fc5">68 </TD><TD class="alignRight lightred" headers="fr1 fr8 fc1 fc2 fc6">862 </TD><TD class=alignRight headers="fr1 fr8 fc1 fc7">62 </TD><TD class=alignRight headers="fr1 fr8 fc1 fc8">2527 </TD></TR><TR><TH id=fr9 class=alignLeft headers=fr1>Percentage <SUP>1</SUP> </TH><TD class=alignRight headers="fr1 fr9 fc1 fc2 fc3">97.5% </TD><TD class="alignRight lightred" headers="fr1 fr9 fc1 fc2 fc4">62.3% </TD><TD class="alignRight lightred" headers="fr1 fr9 fc1 fc2 fc5">2.8% </TD><TD class="alignRight lightred" headers="fr1 fr9 fc1 fc2 fc6">35.0% </TD><TD class=alignRight headers="fr1 fr9 fc1 fc7">2.5% </TD><TD class=alignRight headers="fr1 fr9 fc1 fc8">100% </TD></TR></TBODY></TABLE>
    See additional data on Reported Influenza Hospitalizations and Deaths in Canada: 2009-10 to 2013-14 on the Public Health Agency of Canada website.
    .../

    Leave a comment:


  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Week 4

    FluWatch report: January 19 to January 25, 2014 (Week 04)

    Posted 2014-01-31For readers interested in the <ABBR title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A title="Flu Watch (Version PDF, 113 KB - 6 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w04_14/pdf/fw2014-04-eng.pdf">FluWatch report: January 19 to January 25, 2014 (Week 04) (<ABBR title="Portable Document Format">PDF</ABBR> Version - 291 <ABBR title=Kilobytes>KB</ABBR> - 10 pages)

    ?? Help with PDF documents


    Overall Summary
    • In week 04, overall influenza activity decreased in Canada, particularly in western Canada and Ontario which experienced an earlier start to the influenza season. Prince Edward Island was the only province reporting widespread influenza activity.
    • The influenza A(H1N1) virus remains the most common influenza virus circulating this season.
    • Overall influenza activity in Canada during the 2013-14 season has been similar to the 2012-13 season and is within expected levels for this time of year, although adults 20-64 years of age have been more affected by influenza this season.
    • To date this season, 2,298 influenza-associated hospitalizations and 113 deaths have been reported by participating provinces and territories.
    Influenza/ILI Activity (geographic spread)

    In week 04, Prince Edward Island reported widespread activity, and 22 regions (in AB(5), ON(7), QC(3), NB(5), NS(1) and NL(1)) reported localized activity (Figure 1). Compared to week 03, activity was stable or decreased in regions in BC, AB, SK, ON and NT; stable in MB and YT; and stable or increased in regions in QC, NS, NB, NL. A mixed pattern of activity was reported among regions in NU.
    Figure 1. Map of overall influenza/ILI activity level by province and territory, Canada, Week 04





    Note: Influenza/ILI activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates and reported outbreaks. Please refer to detailed definitions at the end of the report. Maps from previous weeks, including any retrospective updates, are available on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada
    Influenza and Other Respiratory Virus Detections

    The number of positive influenza tests decreased for the second week in a row, from 3,313 in week 03 to 2,620 in week 04. The percentage of positive influenza tests decreased from 26.7% to 24.3% (Figure 2). Cumulative influenza virus detections to date remain predominantly influenza A (95%), and among those subtyped, 97% (8,029/8,274) were A(H1N1)pdm09. However, the percentage of positive tests for influenza B has been rising slowly in recent weeks to 6.5% of influenza detections in week 04 (Table 1). Among the 11,889 cases for which information on age and type/subtype has been received this season, 58.7% were 20-64 years of age and 15.5% were ≥65 years of age, which is different from the proportions observed during the 2012-13 season when 33.3% of cases were 20-64 years of age and 41.5% were ≥65 years of age (Table 2).
    Figure 2. Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14

    Text equivalent for figure 2Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14
    The number of positive tests for RSV has been stable for the past three weeks, but the percentage of the total number of tests that were positive increased in week 04. RSV in Canada shows a seasonal pattern with a broad peak over the winter months, and the current fluctuations are in keeping with the trend over recent years. The percentage of positive tests for coronavirus and human metapneumovirus increased in week 04, while detections of other respiratory viruses were stable or declining (Figure 3).
    For more details, see the weekly Respiratory Virus Detections in Canada Report.
    Figure 3. Number of positive laboratory tests for other respiratory viruses by report week, Canada, 2013-14


    Top of Page

    RSV: Respiratory syncytial virus; hMPV: Human metapneumovirus
    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 1: Weekly and cumulative numbers of positive influenza specimens
    by type, subtype and province, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=ar1 rowSpan=3>Reporting provinces <SUP>1</SUP></TH><TH id=ac1 colSpan=5>Weekly
    (January 19, 2013 to January 25, 2014)
    </TH><TH id=ac8 colSpan=5>Cumulative
    (August 25, 2013 to January 25, 2014)
    </TH></TR><TR class=bg-colour-yellow><TH id=ac2 colSpan=4 headers=ac1>Influenza A</TH><TH id=ac7 headers=ac1>B</TH><TH id=ac9 colSpan=4 headers=ac8>Influenza A</TH><TH id=ac14 headers=ac8>B</TH></TR><TR class=bg-colour-grey-light><TH id=ac3 headers="ac1 ac2">A Total</TH><TH id=ac4 class=lightred headers="ac1 ac2">A(H1)pdm09</TH><TH id=ac5 class=lightred headers="ac1 ac2">A(H3)</TH><TH id=ac6 class=lightred headers="ac1 ac2">A(UnS)</TH><TH class=alignCenter headers="ac1 ac7">B Total</TH><TH id=ac10 headers="ac8 ac9">A Total</TH><TH id=ac11 class=lightred headers="ac8 ac9">A(H1)pdm09</TH><TH id=ac12 class=lightred headers="ac8 ac9">A(H3)</TH><TH id=ac13 class=lightred headers="ac8 ac9">A(UnS)</TH><TD class=alignCenter headers="ac8 ac14">B Total</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=11><SUP>1 </SUP>Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.
    <SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=ar2 class=alignLeft headers=ar1>BC</TH><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac3">217 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac4">182 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac5">9 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac6">26 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac7">6 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac10">1362 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac11">1251 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac12">50 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac13">61 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac14">38 </TD></TR><TR><TH id=ar3 class=alignLeft headers=ar1>AB</TH><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac3">280 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac4">228 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac5">1 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac6">51 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac7">7 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac10">3115 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac11">2968 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac12">29 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac13">118 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac14">43 </TD></TR><TR><TH id=ar4 class=alignLeft headers=ar1>SK</TH><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac3">133 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac4">121 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac5">1 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac6">11 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac7">3 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac10">1083 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac11">781 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac12">1 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac13">301 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac14">4 </TD></TR><TR><TH id=ar5 class=alignLeft headers=ar1>MB</TH><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac3">103 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac4">94 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac5">1 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac6">8 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac10">347 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac11">221 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac12">1 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac13">125 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac14">13 </TD></TR><TR><TH id=ar6 class=alignLeft headers=ar1>ON</TH><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac3">520 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac4">187 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac5">13 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac6">320 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac7">12 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac10">4092 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac11">1959 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac12">159 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac13">1974 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac14">85 </TD></TR><TR><TH id=ar7 class=alignLeft headers=ar1>QC</TH><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac3">702 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac4">101 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac6">601 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac7">110 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac10">2828 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac11">325 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac12">2 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac13">2501 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac14">476 </TD></TR><TR><TH id=ar8 class=alignLeft headers=ar1>NB</TH><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac3">378 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac4">22 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac6">356 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac7">2 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac10">923 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac11">334 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac12">1 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac13">588 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac14">3 </TD></TR><TR><TH id=ar9 class=alignLeft headers=ar1>NS</TH><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac3">19 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac4">19 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac6">0 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac10">63 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac11">43 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac12">2 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac13">18 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac14">0 </TD></TR><TR><TH id=ar10 class=alignLeft headers=ar1>PE</TH><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac3">24 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac4">24 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac6">0 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac10">43 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac11">43 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac13">0 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac14">0 </TD></TR><TR><TH id=ar11 class=alignLeft headers=ar1>NL</TH><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac3">75 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac4">0 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac6">75 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac7">29 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac10">205 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac11">104 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac13">101 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac14">82 </TD></TR><TR><TH id=ar12 class=alignLeft headers=ar1>Canada</TH><TD class=alignRight headers="ar1 ar12 ac1 ac2 ac3">2451 </TD><TD class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac4">978 </TD><TD class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac5">25 </TD><TD class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac6">1448 </TD><TD class=alignRight headers="ar1 ar12 ac1 ac7">169 </TD><TD class=alignRight headers="ar1 ar12 ac8 ac9 ac10">14061 </TD><TD class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac11">8029 </TD><TD class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac12">245 </TD><TD class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac13">5787 </TD><TD class=alignRight headers="ar1 ar12 ac8 ac14">744 </TD></TR><TR><TH id=ar13 class=alignLeft headers=ar1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="ar1 ar13 ac1 ac2 ac3">93.5% </TD><TD class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac4">39.9% </TD><TD class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac5">1.0% </TD><TD class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac6">59.1% </TD><TD class=alignRight headers="ar1 ar13 ac1 ac7">6.5% </TD><TD class=alignRight headers="ar1 ar13 ac8 ac9 ac10">95.0% </TD><TD class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac11">57.1% </TD><TD class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac12">1.7% </TD><TD class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac13">41.2% </TD><TD class=alignRight headers="ar1 ar13 ac8 ac14">5.0% </TD></TR></TBODY></TABLE>

    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 2. Weekly and cumulative numbers of positive influenza specimens by type, subtype and age-group reported through case-based laboratory reporting<SUP>3</SUP>, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=br1 rowSpan=3>Age groups (years)</TH><TH id=bc1 colSpan=5>Weekly
    (January 19 to January 25, 2014)
    </TH><TH id=bc8 colSpan=7>Cumulative
    (August 25, 2013 to January 25, 2014)
    </TH></TR><TR class=bg-colour-yellow><TH id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH id=bc7 headers=bc1>B</TH><TH id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH id=bc14 headers=bc8>B</TH><TH id=bc15 colSpan=2 headers=bc8>Influenza A and B</TH></TR><TR class=bg-colour-grey-light><TH id=bc3 headers="bc1 bc2">A Total</TH><TH id=bc4 class="lightred " headers="bc1 bc2">A(H1) pdm09</TH><TH id=bc5 class="lightred " headers="bc1 bc2">A(H3)</TH><TH id=bc6 class="lightred " headers="bc1 bc2">A (UnS)</TH><TD class=alignCenter headers="bc1 bc7">Total</TD><TH id=bc10 headers="bc8 bc9">A Total</TH><TH id=bc11 class="lightred " headers="bc8 bc9">A(H1) pdm09</TH><TH id=bc12 class="lightred " headers="bc8 bc9">A(H3)</TH><TH id=bc13 class="lightred " headers="bc8 bc9">A (UnS)</TH><TD class=alignCenter headers="bc8 bc14">Total</TD><TH id=bc16 headers="bc8 bc15">#</TH><TH id=bc17 headers="bc8 bc15">%</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=13><SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    <SUP>3 </SUP>Table 2 includes specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=br2 class=alignLeft headers=br1><5</TH><TD class=alignRight headers="br1 br2 bc1 bc2 bc3">264 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc4">97 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc6">167 </TD><TD class=alignRight headers="br1 br2 bc1 bc7">8 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc10">2041 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc11">1035 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc12">18 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc13">988 </TD><TD class=alignRight headers="br1 br2 bc8 bc14">83 </TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc16">2124 </TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc17">17.7% </TD></TR><TR><TH id=br3 class=alignLeft headers=br1>5-19</TH><TD class=alignRight headers="br1 br3 bc1 bc2 bc3">89 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc4">29 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc5">1 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc6">59 </TD><TD class=alignRight headers="br1 br3 bc1 bc7">24 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc10">847 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc11">514 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc12">14 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc13">319 </TD><TD class=alignRight headers="br1 br3 bc8 bc14">99 </TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc16">946 </TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc17">7.9% </TD></TR><TR><TH id=br4 class=alignLeft headers=br1>20-44</TH><TD class=alignRight headers="br1 br4 bc1 bc2 bc3">325 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc4">121 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc5">1 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc6">203 </TD><TD class=alignRight headers="br1 br4 bc1 bc7">20 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc10">3576 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc11">2094 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc12">19 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc13">1463 </TD><TD class=alignRight headers="br1 br4 bc8 bc14">132 </TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc16">3708 </TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc17">30.9% </TD></TR><TR><TH id=br5 class=alignLeft headers=br1>45-64</TH><TD class=alignRight headers="br1 br5 bc1 bc2 bc3">309 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc4">122 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc5">1 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc6">186 </TD><TD class=alignRight headers="br1 br5 bc1 bc7">28 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc10">3068 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc11">1789 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc12">28 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc13">1251 </TD><TD class=alignRight headers="br1 br5 bc8 bc14">200 </TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc16">3268 </TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc17">27.3% </TD></TR><TR><TH id=br6 class=alignLeft headers=br1>65+</TH><TD class=alignRight headers="br1 br6 bc1 bc2 bc3">136 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc4">39 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc5">1 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc6">96 </TD><TD class=alignRight headers="br1 br6 bc1 bc7">38 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc10">1562 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc11">704 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc12">55 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc13">803 </TD><TD class=alignRight headers="br1 br6 bc8 bc14">281 </TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc16">1843 </TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc17">15.4% </TD></TR><TR><TH id=br7 class=alignLeft headers=br1>Unknown</TH><TD class=alignRight headers="br1 br7 bc1 bc2 bc3">7 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc4">7 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc6">0 </TD><TD class=alignRight headers="br1 br7 bc1 bc7">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc10">94 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc11">81 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc12">5 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc13">8 </TD><TD class=alignRight headers="br1 br7 bc8 bc14">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc16">94 </TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc17">0.8% </TD></TR><TR><TH id=br8 class=alignLeft headers=br1>Total</TH><TD class=alignRight headers="br1 br8 bc1 bc2 bc3">1130 </TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc4">415 </TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc5">4 </TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc6">711 </TD><TD class=alignRight headers="br1 br8 bc1 bc7">118 </TD><TD class=alignRight headers="br1 br8 bc8 bc9 bc10">11188 </TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc11">6217 </TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc12">139 </TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc13">4832 </TD><TD class=alignRight headers="br1 br8 bc8 bc14">795 </TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc16">11983 </TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc17">100.0% </TD></TR><TR><TH id=br9 class=alignLeft headers=br1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="br1 br9 bc1 bc2 bc3">90.5% </TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc4">36.7% </TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc5">0.4% </TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc6">62.9% </TD><TD class=alignRight headers="br1 br9 bc1 bc7">9.5% </TD><TD class=alignRight headers="br1 br9 bc8 bc9 bc10">93.4% </TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc11">55.6% </TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc12">1.2% </TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc13">43.2% </TD><TD class=alignRight headers="br1 br9 bc8 bc14">6.6% </TD><TD class=alignRight></TD><TD class=alignRight></TD></TR></TBODY></TABLE>

    Top of Page

    Influenza Strain Characterizations

    During the 2013-2014 influenza season, the National Microbiology Laboratory (NML) has antigenically characterized 556 influenza viruses [35 A(H3N2), 473 A(H1N1)pdm09 and 48 influenza B]. The vast majority (99%) of viruses were similar to the strains recommended by the WHO for the 2013-14 seasonal influenza vaccine. Two A(H1N1)pdm09 viruses showed reduced titres to antiserum against the reference A/California/07/2009 strain. Five influenza B viruses were similar to the strain recommended by the WHO for the 2011-12 vaccine (Figure 4).
    Figure 4. Influenza strain characterizations, Canada, 2013-14, N = 556

    The NML receives a proportion of the number of influenza positive specimens from provincial laboratories for strain characterization and antiviral resistance testing. Characterization data reflect the results of haemagglutination inhibition (HAI) testing compared to the reference influenza strains recommended by WHO.
    The recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b (e.g. A/Texas/50/2012), and a B/Massachusetts/2/2012-like virus (Yamagata lineage).


    Text equivalent for figure 4Influenza strain characterizations, Canada, 2013-2014, N =3
    Antiviral Resistance

    During the 2013-2014 influenza season, NML has tested 397 influenza viruses for resistance to oseltamivir and 390 viruses for resistance to zanamivir, and all were sensitive. All 341 influenza A viruses tested for amantadine resistance were resistant (Table 3).
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=cr1 rowSpan=2>Virus type and subtype</TH><TH id=cc1 colSpan=2>Oseltamivir</TH><TH id=cc4 colSpan=2>Zanamivir</TH><TH id=cc7 colSpan=2>Amantadine</TH></TR><TR class=bg-colour-yellow><TH id=cc2 headers=cc1># tested</TH><TH id=cc3 headers=cc1># resistant (%)</TH><TH id=cc5 headers=cc4># tested</TH><TH id=cc6 headers=cc4># resistant (%)</TH><TH id=cc8 headers=cc7># tested</TH><TH id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH id=cr2 class="alignLeft lightred" headers=cr1>A (H3N2)</TH><TD class=alignRight headers="cr1 cr2 cc1 cc2">29 </TD><TD class=alignRight headers="cr1 cr2 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr2 cc4 cc5">29 </TD><TD class=alignRight headers="cr1 cr2 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr2 cc7 cc8">37 </TD><TD class=alignRight headers="cr1 cr2 cc7 cc9">37 (100%) </TD></TR><TR><TH id=cr3 class="alignLeft lightred" headers=cr1>A (H1N1)</TH><TD class=alignRight headers="cr1 cr3 cc1 cc2">325</TD><TD class=alignRight headers="cr1 cr3 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr3 cc4 cc5">319</TD><TD class=alignRight headers="cr1 cr3 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr3 cc7 cc8">304</TD><TD class=alignRight headers="cr1 cr3 cc7 cc9">304 (100%) </TD></TR><TR><TH id=cr4 class="alignLeft lightred" headers=cr1>B</TH><TD class=alignRight headers="cr1 cr4 cc1 cc2">43</TD><TD class=alignRight headers="cr1 cr4 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr4 cc4 cc5">42</TD><TD class=alignRight headers="cr1 cr4 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr4 cc7 cc8">NA <SUP>*</SUP></TD><TD class=alignRight headers="cr1 cr4 cc7 cc9">NA <SUP>*</SUP></TD></TR><TR><TH id=cr5 class="alignLeft lightred" headers=cr1>TOTAL</TH><TD class=alignRight headers="cr1 cr5 cc1 cc2">397</TD><TD class=alignRight headers="cr1 cr5 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr5 cc4 cc5">390 </TD><TD class=alignRight headers="cr1 cr5 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr5 cc7 cc8">341</TD><TD class=alignRight headers="cr1 cr5 cc7 cc9">341 (100%) </TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate decreased from 65.4/1,000 in week 03 to 39.8/1,000 in week 04; which is within the expected range for week 04 (Figure 5).
    Figure 5. Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Note: No data available for mean rate for weeks 19 to 39 for the 1996-1997 through 2002-2003 seasons. Delays in the reporting of data may cause data to change retrospectively. The calculation of the average ILI consultation rate over 17 seasons was aligned with influenza activity in each season. In BC, AB, and SK, data is compiled by a provincial sentinel surveillance program for reporting to FluWatch. The number of sentinel physicians in each province or territory is as follows: BC(21), AB(80), SK(11), MB(18), ON(169), QC(14), NB(29), NS(26), PE(4), NL(16), NU(1), NT(14), YT(13). Not all sentinel physicians report every week.
    Text equivalent for figure 5Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Top of Page

    Influenza Outbreak Surveillance

    In week 04, four new influenza outbreaks were reported in long-term care facilities (Figure 6). In addition, three outbreaks of influenza-like-illness were reported in other facilities or communities.
    Figure 6. Overall number of new influenza outbreaks by report week, Canada, 2013-2014

    1 All provinces and territories except NU report outbreaks in long-term care facilities. All provinces and territories with the exception of NU and QC report outbreaks in hospitals. Outbreaks of influenza or influenza-like-illness in other facilities are reported to FluWatch but reporting varies between jurisdictions. Outbreak definitions are included at the end of the report.
    Text equivalent for figure 6 Overall number of new influenza outbreaks by report week, Canada, 2013-2014
    Pharmacy Surveillance

    The rate of prescriptions for influenza antivirals declined for the second week in a row, following the downward trend in laboratory detections of influenza. In week 04, the largest proportion of prescriptions for antivirals continued to be among children 2-18 years of age followed by adults 19-64 years of age. The proportion of prescriptions for antivirals increased for infants <2 years of age and adults ≥65 years of age in week 04 (Figure 7).
    Figure 7. Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Note: Pharmacy sales data are provided to the Public Health Agency of Canada by Rx Canada Inc. and sourced from major retail drug chains representing over 3,000 stores nationwide (excluding Nunavut) in 85% of Health Regions. Data provided include the number of new antiviral prescriptions (for Tamiflu and Relenza) and the total number of new prescriptions dispensed by Province/Territory and age group. Age-groups: Infant: 0-2y, Child: 2-18y; Adult: 19-64y, Senior: ≥65y.
    Text equivalent for figure 7Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Top of Page

    Sentinel Hospital Influenza Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)
    In week 04, 51 new laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalizations were reported by the Immunization Monitoring Program Active (IMPACT) network, compared to 62 in week 03. All but three of the hospitalizations in week 04 were cases with influenza A (Figure 8a). Thirty-two (63%) of the cases were <5 years of age. Eleven ICU admissions were reported in week 04, one child under 6 months of age, two children 6-23 months of age, two 2-4 years of age, and six 5-9 years of age; all but one with influenza A. No deaths were reported.
    To date this season, a total of 359 influenza-associated paediatric hospitalizations have been reported by the IMPACT network, 95% of which have been influenza A, and almost all of those subtyped were A(H1N1)pdm09 (Table 4). Two hundred and eighty cases (78%) have been under 5 years of age. Fifty-eight ICU admissions have been reported; all but three cases with influenza A (the majority A(H1N1)pdm09), and 44.8% have been among children under 2 years of age (Figure 9a). Among the 52 ICU cases with available data, 35 (67%) were reported to have underlying medical conditions. No deaths have been reported.
    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    Adult Influenza Hospitalizations and Deaths (PCIRN)
    In week 04, 60 new laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations reported through active surveillance by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network, compared to 99 in week 03. Among cases in week 04, 56 (93.3%) were influenza A, of which 12 were A(H1N1)pdm09, one was A(H3N2) and 43 were A(unsubtyped). Two cases with influenza B were reported (Figure 8b). Almost half of the hospitalizations occurred among adults 45-64 years (29; 48.3%). Four ICU admissions were reported in week 04: three cases 45-64 years of age and one case ≥65 years of age. No deaths were reported (Figure 8b).
    To date this season, 645 influenza-associated hospitalizations have been reported by the PCIRN-SOS network, 619 (96.0%) with influenza A, predominantly A(H1N1)pdm09(Table 5). ICU admission was required for 101 hospitalizations, the majority of which were influenza A. Three quarters of hospitalizations and over 80% of ICU admissions were ≥45 years of age. Of the 67 ICU admissions with available information, 83.5% (56/67) were reported to have at least one comorbidity. Of the 86 ICU admissions with information on influenza vaccination, 58 (67%) reported not having been vaccinated this season. Twenty deaths have been reported, all with influenza A (13 A(H1N1)pdm09 and 7 A(unsubtyped)); ten cases 45-64 years of age, and ten cases ≥65 years of age (Figure 9b).
    Note: PCIRN-SOS conducted passive surveillance from April 30th to November 14th, 2013. Cases reported during this period were identified by laboratory detection of influenza among patients admitted to participating hospitals. Active surveillance began November 15th during which time PCIRN site coordinators investigate cases potentially related to influenza. Data from both active and passive surveillance reported during the 2013-14 season are included in this report. The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION id=t4 class=alignCenter>Table 4 - Cumulative numbers of paediatric hospitalizations with influenza reported by the IMPACT network, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=dr1 rowSpan=3>Age groups </TH><TH id=dc1 colSpan=6>Cumulative (Aug. 25, 2013 to January 25, 2014) </TH></TR><TR class=bg-colour-yellow><TH id=dc2 colSpan=4 headers=dc1>Influenza A </TH><TH id=dc7 headers=dc1>B </TH><TH id=dc8 headers=dc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=dc3 headers="dc1 dc2">A Total </TH><TH id=dc4 class="lightred " headers="dc1 dc2">A(H1) pdm09 </TH><TH id=dc5 class="lightred " headers="dc1 dc2">A(H3) </TH><TH id=dc6 class="lightred " headers="dc1 dc2">A (UnS) </TH><TD class=alignCenter headers="dc1 dc7">Total</TD><TD class=alignCenter headers="dc1 dc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=dr2 class=alignLeft headers=dr1>0-5m </TH><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc3">71 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc4">19 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc6">52 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc7">2 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc8">73 (20%) </TD></TR><TR><TH id=dr3 class=alignLeft headers=dr1>6-23m </TH><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc3">97 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc4">33 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc6">64 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc7">4 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc8">101 (28%) </TD></TR><TR><TH id=dr4 class=alignLeft headers=dr1>2-4y </TH><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc3">99 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc4">35 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc5">2 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc6">62 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc7">7 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc8">106 (30%) </TD></TR><TR><TH id=dr5 class=alignLeft headers=dr1>5-9y </TH><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc3">51 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc4">18 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc6">33 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc7">4 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc8">55 (15%) </TD></TR><TR><TH id=dr6 class=alignLeft headers=dr1>10-16y </TH><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc3">22 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc4">10 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc6">12 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc7">2 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc8">24 (7%) </TD></TR><TR><TH id=dr7 class=alignLeft headers=dr1>Total </TH><TD class=alignRight headers="dr1 dr7 dc1 dc2 dc3">340 </TD><TD class="alignRight lightred" headers="dr1 dr7 dc1 dc2 dc4">115 </TD><TD class="alignRight lightred" headers="dr1 dr7 dc1 dc2 dc5">2 </TD><TD class="alignRight lightred" headers="dr1 dr7 dc1 dc2 dc6">223 </TD><TD class=alignRight headers="dr1 dr7 dc1 dc7">19 </TD><TD class=alignRight headers="dr1 dr7 dc1 dc8">359 </TD></TR><TR><TH id=dr8 class=alignLeft headers=dr1>% <SUP>1</SUP> </TH><TD class=alignRight headers="dr1 dr8 dc1 dc2 dc3">94.7% </TD><TD class="alignRight lightred" headers="dr1 dr8 dc1 dc2 dc4">33.8% </TD><TD class="alignRight lightred" headers="dr1 dr8 dc1 dc2 dc5">0.6% </TD><TD class="alignRight lightred" headers="dr1 dr8 dc1 dc2 dc6">65.6% </TD><TD class=alignRight headers="dr1 dr8 dc1 dc7">5.3% </TD><TD class=alignRight headers="dr1 dr8 dc1 dc8">100.0% </TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 5 - Cumulative numbers of adult hospitalizations with influenza
    reported by the PCIRN-SOS network, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=er1 rowSpan=3>Age groups </TH><TH id=ec1 class=noWrap colSpan=6>Cumulative (Aug. 25, 2013 to January 25, 2014)<SUP>*</SUP></TH></TR><TR class=bg-colour-yellow><TH id=ec2 colSpan=4 headers=ec1>Influenza A </TH><TH id=ec7 headers=ec1>B </TH><TH id=ec8 headers=ec1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=ec3 headers="ec1 ec2">A Total </TH><TH id=ec4 class="lightred " headers="ec1 ec2">A(H1) pdm09 </TH><TH id=ec5 class="lightred " headers="ec1 ec2">A(H3) </TH><TH id=ec6 class="lightred " headers="ec1 ec2">A(UnS) </TH><TD class=alignCenter headers="ec1 ec7">Total</TD><TD class=alignCenter headers="ec1 ec8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP id=footnote_t5_1>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.

    <SUP id=footnote_t5_star>*</SUP> Fourteen cases for which the influenza type has not yet been reported, and four cases for which the age-group was not reported, are not included in Table 5.
    </TD></TR></TFOOT><TBODY><TR><TH id=er2 class=alignLeft headers=er1>16-20 </TH><TD class=alignRight headers="er1 er2 ec1 ec2 ec3">3 </TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec4">2 </TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec5">0 </TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec6">1 </TD><TD class=alignRight headers="er1 er2 ec1 ec7">1 </TD><TD class=alignRight headers="er1 er2 ec1 ec8">4 (1%) </TD></TR><TR><TH id=er3 class=alignLeft headers=er1>20-44 </TH><TD class=alignRight headers="er1 er3 ec1 ec2 ec3">143 </TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec4">73 </TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec5">2 </TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec6">68 </TD><TD class=alignRight headers="er1 er3 ec1 ec7">2 </TD><TD class=alignRight headers="er1 er3 ec1 ec8">145 (23%) </TD></TR><TR><TH id=er4 class=alignLeft headers=er1>45-64 </TH><TD class=alignRight headers="er1 er4 ec1 ec2 ec3">248 </TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec4">97 </TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec5">3 </TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec6">148 </TD><TD class=alignRight headers="er1 er4 ec1 ec7">4 </TD><TD class=alignRight headers="er1 er4 ec1 ec8">252 (40%) </TD></TR><TR><TH id=er5 class=alignLeft headers=er1>65+ </TH><TD class=alignRight headers="er1 er5 ec1 ec2 ec3">220 </TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec4">98 </TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec5">9 </TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec6">113 </TD><TD class=alignRight headers="er1 er5 ec1 ec7">13 </TD><TD class=alignRight headers="er1 er5 ec1 ec8">233 (37%) </TD></TR><TR><TH id=er6 class=alignLeft headers=er1>Total </TH><TD class=alignRight headers="er1 er6 ec1 ec2 ec3">614 </TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec4">270 </TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec5">14 </TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec6">330 </TD><TD class=alignRight headers="er1 er6 ec1 ec7">20 </TD><TD class=alignRight headers="er1 er6 ec1 ec8">634 </TD></TR><TR><TH id=er7 class=alignLeft headers=er1>% <SUP>1</SUP></TH><TD class=alignRight headers="er1 er7 ec1 ec2 ec3">97% </TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec4">44% </TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec5">2% </TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec6">54% </TD><TD class=alignRight headers="er1 er7 ec1 ec7">3% </TD><TD class=alignRight headers="er1 er7 ec1 ec8">100% </TD></TR></TBODY></TABLE>
    Figure 8. Number of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)


    Text equivalent for figure 8aNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    * See footnote above following the section related to PCIRN-SOS data.
    Text equivalent for figure 8bNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Adult hospitalizations (>16 year of age, PCIRN-SOS)
    Figure 9. Percentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)

    Text equivalent for figure 9aPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Text equivalent for figure 9bPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Top of Page

    Provincial/Territorial Influenza Hospitalizations and Deaths

    In week 04, 302 laboratory-confirmed influenza-associated hospitalizations were reported from participating provinces and territories.<SUP>*</SUP> The majority were cases of influenza A (293, 97.0%), of which 169 (57.7%) were A(H1N1)pdm09, 11 (3.8%) were A(H3N2), and 113 (38.6%) were A(unsubtyped). Among the 20 ICU admissions reported in week 04, 14 (70%) were adults 20-64 years of age. Twenty-six deaths were reported, half of which were adults 20-64 years of age. The number of new influenza-associated hospitalizations and deaths reported for the current week may include cases from Ontario that occurred in previous weeks, as a result of retrospective updates to the cumulative total.
    To date this season, 2,298 influenza-associated hospitalizations have been reported, 97.7% with influenza A. The majority (58%) of hospitalizations have been cases 45 years of age of older (Table 6). A total of 217 ICU admissions have been reported this season: 77% were among adults 20-64 years of age. One hundred and thirteen deaths have been reported. The highest proportion of deaths has been among adults 20-64 years of age (51%), followed by adults ≥65 years of age (37%). Influenza B has been detected infrequently among severe cases of influenza to date this season: in only 2.3% of hospitalizations, 1.1% of ICU admissions, and 1.0% of deaths. It is important to note that the hospitalization or death does not have to be attributable to influenza, a positive laboratory test is sufficient for reporting. Detailed clinical information (e.g. underlying medical conditions) is not known for these cases.
    * Note: Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not distinguished among hospital admissions reported from Ontario. Data may also include cases reported by the IMPACT and PCIRN networks.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION id=t6 class=alignCenter>Table 6. Cumulative number of hospitalizations with influenza reported by the participating provinces and territories, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=fr1 rowSpan=3>Age groups </TH><TH id=fc1 colSpan=6>Cumulative (Aug. 25, 2013 to January 25, 2014)* </TH></TR><TR class=bg-colour-yellow><TH id=fc2 colSpan=4 headers=fc1>Influenza A </TH><TH id=fc7 headers=fc1>B </TH><TH id=fc8 headers=fc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=fc3 headers="fc1 fc2">A Total </TH><TH id=fc4 class=lightred headers="fc1 fc2">A(H1) pdm09 </TH><TH id=fc5 class=lightred headers="fc1 fc2">A(H3) </TH><TH id=fc6 class=lightred headers="fc1 fc2">A (UnS) </TH><TD class=alignCenter headers="fc1 fc7">Total</TD><TD class=alignCenter headers="fc1 fc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=8><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    * Six cases for which age information is not available have not been included in Table 6.
    </TD></TR></TFOOT><TBODY><TR><TH id=fr2 class=alignLeft headers=fr1>0-4 years </TH><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc3">393 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc4">205 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc5">5 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc6">183 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc7">14 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc8">407 (18%) </TD></TR><TR><TH id=fr3 class=alignLeft headers=fr1>5-14 years </TH><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc3">80 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc4">46 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc5">3 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc6">31 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc7">3 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc8">83 (4%) </TD></TR><TR><TH id=fr4 class=alignLeft headers=fr1>15-19 years </TH><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc3">25 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc4">16 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc5">1 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc6">8 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc7">1 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc8">26 (1%) </TD></TR><TR><TH id=fr5 class=alignLeft headers=fr1>20-44 years </TH><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc3">395 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc4">303 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc5">3 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc6">89 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc7">3 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc8">398 (18%) </TD></TR><TR><TH id=fr6 class=alignLeft headers=fr1>45-64 years </TH><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc3">739 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc4">498 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc5">12 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc6">229 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc7">7 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc8">746 (33%) </TD></TR><TR><TH id=fr7 class=alignLeft headers=fr1>65+ years </TH><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc3">564 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc4">334 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc5">37 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc6">193 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc7">25 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc8">589 (26%) </TD></TR><TR><TH id=fr8 class=alignLeft headers=fr1>Total </TH><TD class=alignRight headers="fr1 fr8 fc1 fc2 fc3">2196 </TD><TD class="alignRight lightred" headers="fr1 fr8 fc1 fc2 fc4">1402 </TD><TD class="alignRight lightred" headers="fr1 fr8 fc1 fc2 fc5">61 </TD><TD class="alignRight lightred" headers="fr1 fr8 fc1 fc2 fc6">733 </TD><TD class=alignRight headers="fr1 fr8 fc1 fc7">53 </TD><TD class=alignRight headers="fr1 fr8 fc1 fc8">2249 </TD></TR><TR><TH id=fr9 class=alignLeft headers=fr1>Percentage <SUP>1</SUP> </TH><TD class=alignRight headers="fr1 fr9 fc1 fc2 fc3">97.6% </TD><TD class="alignRight lightred" headers="fr1 fr9 fc1 fc2 fc4">63.8% </TD><TD class="alignRight lightred" headers="fr1 fr9 fc1 fc2 fc5">2.8% </TD><TD class="alignRight lightred" headers="fr1 fr9 fc1 fc2 fc6">33.4% </TD><TD class=alignRight headers="fr1 fr9 fc1 fc7">2.4% </TD><TD class=alignRight headers="fr1 fr9 fc1 fc8">100% </TD></TR></TBODY></TABLE>
    See additional data on Reported Influenza Hospitalizations and Deaths in Canada: 2009-10 to 2013-14 on the Public Health Agency of Canada website.

    .../

    Leave a comment:


  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Week 3

    FluWatch report: January 12 to January 18, 2014 (Week 03)

    Posted 2014-01-24For readers interested in the <ABBR title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A title="Flu Watch (Version PDF, 113 KB - 6 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w03_14/pdf/fw2014-03-eng.pdf">FluWatch report: January 12 to January 18, 2014 (Week 03) (<ABBR title="Portable Document Format">PDF</ABBR> Version - 291 <ABBR title=Kilobytes>KB</ABBR> - 10 pages)

    ?? Help with PDF documents


    Overall Summary
    • In week 03, overall laboratory detections of influenza decreased slightly, reflecting decreased activity in some regions that experienced an earlier start to the influenza season, and increases in activity in other regions. Prescriptions for antiviral medications to treat influenza have also decreased.
    • The influenza A(H1N1)pdm09 virus is the most common influenza virus detected thus far this season, accounting for more than 90% of influenza viruses detected. Adults 20-64 years of age have been the most impacted thus far this influenza season, as reflected by laboratory detections of influenza, hospitalizations and antiviral prescriptions for treatment of influenza.
    • The number of Canadians seeking medical attention for influenza-like-illness continued to increase in week 03, as did paediatric hospitalizations.
    Influenza/ILI Activity (geographic spread)

    In week 03, three regions in Alberta reported widespread activity, and 19 regions (in BC(1), AB(2), SK(1), ON(7), QC(2), NB(3), NT(2) and NU(1)) reported localized activity (Figure 1).
    Figure 1. Map of overall influenza/ILI activity level by province and territory, Canada, Week 03





    Note: Influenza/ILI activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates and reported outbreaks. Please refer to detailed definitions at the end of the report. Maps from previous weeks, including any retrospective updates, are available on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada
    Influenza and Other Respiratory Virus Detections

    The number of positive influenza tests decreased from 3,615 in week 02 to 3,364 in week 03. The percentage of positive influenza tests decreased slightly from 28.2% to 27.2% (Figure 2). Cumulative influenza virus detections to date have been predominantly influenza A (95%). Among subtyped influenza A viruses, 97% (7,068/7,282) were A(H1N1)pdm09 (Table 1). Detailed information on age and type/subtype has been received for 8,793 cases to date this season. A significantly greater proportion of laboratory detections of influenza have been reported in adults 20-64 years of age compared to those ≥65 years of age this season compared to the 2012-13 season (Table 2).
    Figure 2. Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14

    Text equivalent for figure 2Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14
    In week 03, the number of positive tests for RSV decreased slightly, but the percentage of positive tests decreased for the second week in a row. RSV in Canada shows a seasonal pattern with a broad peak over the winter months. The number of positive tests for coronavirus increased, while detections of other respiratory viruses were stable in week 03 compared to the previous week (Figure 3).
    For more details, see the weekly Respiratory Virus Detections in Canada Report.
    Figure 3. Number of positive laboratory tests for other respiratory viruses by report week, Canada, 2013-14


    Top of Page

    RSV: Respiratory syncytial virus; hMPV: Human metapneumovirus
    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 1: Weekly and cumulative numbers of positive influenza specimens
    by type, subtype and province, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=ar1 rowSpan=3>Reporting provinces <SUP>1</SUP></TH><TH id=ac1 colSpan=5>Weekly
    (January 12, 2013 to January 18, 2014)
    </TH><TH id=ac8 colSpan=5>Cumulative
    (August 25, 2013 to January 18, 2014)
    </TH></TR><TR class=bg-colour-yellow><TH id=ac2 colSpan=4 headers=ac1>Influenza A</TH><TH id=ac7 headers=ac1>B</TH><TH id=ac9 colSpan=4 headers=ac8>Influenza A</TH><TH id=ac14 headers=ac8>B</TH></TR><TR class=bg-colour-grey-light><TH id=ac3 headers="ac1 ac2">A Total</TH><TH id=ac4 class=lightred headers="ac1 ac2">A(H1)pdm09</TH><TH id=ac5 class=lightred headers="ac1 ac2">A(H3)</TH><TH id=ac6 class=lightred headers="ac1 ac2">A(UnS)</TH><TH class=alignCenter headers="ac1 ac7">B Total</TH><TH id=ac10 headers="ac8 ac9">A Total</TH><TH id=ac11 class=lightred headers="ac8 ac9">A(H1)pdm09</TH><TH id=ac12 class=lightred headers="ac8 ac9">A(H3)</TH><TH id=ac13 class=lightred headers="ac8 ac9">A(UnS)</TH><TD class=alignCenter headers="ac8 ac14">B Total</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=11><SUP>1 </SUP>Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.
    <SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=ar2 class=alignLeft headers=ar1>BC</TH><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac3">442 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac4">376 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac5">16 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac6">50 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac7">12 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac10">1281 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac11">1152 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac12">45 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac13">84 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac14">31 </TD></TR><TR><TH id=ar3 class=alignLeft headers=ar1>AB</TH><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac3">469 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac4">407 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac5">4 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac6">58 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac7">9 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac10">2831 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac11">2696 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac12">28 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac13">107 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac14">36 </TD></TR><TR><TH id=ar4 class=alignLeft headers=ar1>SK</TH><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac3">225 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac4">176 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac6">49 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac10">950 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac11">660 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac13">290 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac14">1 </TD></TR><TR><TH id=ar5 class=alignLeft headers=ar1>MB</TH><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac3">124 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac4">28 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac6">96 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac7">4 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac10">244 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac11">127 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac13">117 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac14">13 </TD></TR><TR><TH id=ar6 class=alignLeft headers=ar1>ON</TH><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac3">824 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac4">366 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac5">11 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac6">447 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac7">19 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac10">3497 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac11">1750 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac12">136 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac13">1611 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac14">73 </TD></TR><TR><TH id=ar7 class=alignLeft headers=ar1>QC</TH><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac3">712 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac4">66 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac5">1 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac6">645 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac7">107 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac10">2122 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac11">224 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac12">2 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac13">1896 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac14">366 </TD></TR><TR><TH id=ar8 class=alignLeft headers=ar1>NB</TH><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac3">310 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac4">168 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac6">142 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac10">545 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac11">312 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac12">1 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac13">232 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac14">1 </TD></TR><TR><TH id=ar9 class=alignLeft headers=ar1>NS</TH><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac3">14 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac4">12 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac6">2 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac10">44 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac11">24 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac12">2 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac13">18 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac14">0 </TD></TR><TR><TH id=ar10 class=alignLeft headers=ar1>PE</TH><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac3">18 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac4">18 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac6">0 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac10">19 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac11">19 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac13">0 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac14">0 </TD></TR><TR><TH id=ar11 class=alignLeft headers=ar1>NL</TH><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac3">48 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac4">29 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac6">19 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac7">27 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac10">130 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac11">104 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac13">26 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac14">53 </TD></TR><TR><TH id=ar12 class=alignLeft headers=ar1>Canada</TH><TD class=alignRight headers="ar1 ar12 ac1 ac2 ac3">3186 </TD><TD class="lightred alignRight" headers="ar1 ar12 ac1 ac2 ac4">1646 </TD><TD class="lightred alignRight" headers="ar1 ar12 ac1 ac2 ac5">32 </TD><TD class="lightred alignRight" headers="ar1 ar12 ac1 ac2 ac6">1508 </TD><TD class=alignRight headers="ar1 ar12 ac1 ac7">178 </TD><TD class=alignRight headers="ar1 ar12 ac8 ac9 ac10">11663 </TD><TD class="lightred alignRight" headers="ar1 ar12 ac8 ac9 ac11">7068 </TD><TD class="lightred alignRight" headers="ar1 ar12 ac8 ac9 ac12">214 </TD><TD class="lightred alignRight" headers="ar1 ar12 ac8 ac9 ac13">4381 </TD><TD class=alignRight headers="ar1 ar12 ac8 ac14">574 </TD></TR><TR><TH id=ar13 class=alignLeft headers=ar1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="ar1 ar13 ac1 ac2 ac3">94.7% </TD><TD class="lightred alignRight" headers="ar1 ar13 ac1 ac2 ac4">51.7% </TD><TD class="lightred alignRight" headers="ar1 ar13 ac1 ac2 ac5">1.0% </TD><TD class="lightred alignRight" headers="ar1 ar13 ac1 ac2 ac6">47.3% </TD><TD class=alignRight headers="ar1 ar13 ac1 ac7">5.3% </TD><TD class=alignRight headers="ar1 ar13 ac8 ac9 ac10">95.3% </TD><TD class="lightred alignRight" headers="ar1 ar13 ac8 ac9 ac11">60.6% </TD><TD class="lightred alignRight" headers="ar1 ar13 ac8 ac9 ac12">1.8% </TD><TD class="lightred alignRight" headers="ar1 ar13 ac8 ac9 ac13">37.6% </TD><TD class=alignRight headers="ar1 ar13 ac8 ac14">4.7% </TD></TR></TBODY></TABLE>

    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 2. Weekly and cumulative numbers of positive influenza specimens by type, subtype and age-group reported through case-based laboratory reporting<SUP>3</SUP>, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=br1 rowSpan=3>Age groups (years)</TH><TH id=bc1 colSpan=5>Weekly
    (January 12 to January 18, 2014)
    </TH><TH id=bc8 colSpan=7>Cumulative
    (August 25, 2013 to January 18, 2014)
    </TH></TR><TR class=bg-colour-yellow><TH id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH id=bc7 headers=bc1>B</TH><TH id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH id=bc14 headers=bc8>B</TH><TH id=bc15 colSpan=2 headers=bc8>Influenza A and B</TH></TR><TR class=bg-colour-grey-light><TH id=bc3 headers="bc1 bc2">A Total</TH><TH id=bc4 class="lightred " headers="bc1 bc2">A(H1) pdm09</TH><TH id=bc5 class="lightred " headers="bc1 bc2">A(H3)</TH><TH id=bc6 class="lightred " headers="bc1 bc2">A (UnS)</TH><TD class=alignCenter headers="bc1 bc7">Total</TD><TH id=bc10 headers="bc8 bc9">A Total</TH><TH id=bc11 class="lightred " headers="bc8 bc9">A(H1) pdm09</TH><TH id=bc12 class="lightred " headers="bc8 bc9">A(H3)</TH><TH id=bc13 class="lightred " headers="bc8 bc9">A (UnS)</TH><TD class=alignCenter headers="bc8 bc14">Total</TD><TH id=bc16 headers="bc8 bc15">#</TH><TH id=bc17 headers="bc8 bc15">%</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=13><SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    <SUP>3 </SUP>Table 2 includes specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=br2 class=alignLeft headers=br1><5</TH><TD class=alignRight headers="br1 br2 bc1 bc2 bc3">341 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc4">115 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc5">2 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc6">224 </TD><TD class=alignRight headers="br1 br2 bc1 bc7">20 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc10">1378 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc11">862 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc12">16 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc13">500 </TD><TD class=alignRight headers="br1 br2 bc8 bc14">53 </TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc16">1431 </TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc17">16.2% </TD></TR><TR><TH id=br3 class=alignLeft headers=br1>5-19</TH><TD class=alignRight headers="br1 br3 bc1 bc2 bc3">133 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc4">57 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc5">1 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc6">75 </TD><TD class=alignRight headers="br1 br3 bc1 bc7">15 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc10">601 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc11">432 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc12">10 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc13">159 </TD><TD class=alignRight headers="br1 br3 bc8 bc14">51 </TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc16">652 </TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc17">7.4% </TD></TR><TR><TH id=br4 class=alignLeft headers=br1>20-44</TH><TD class=alignRight headers="br1 br4 bc1 bc2 bc3">443 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc4">188 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc6">255 </TD><TD class=alignRight headers="br1 br4 bc1 bc7">16 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc10">2759 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc11">1816 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc12">16 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc13">927 </TD><TD class=alignRight headers="br1 br4 bc8 bc14">92 </TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc16">2851 </TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc17">32.2% </TD></TR><TR><TH id=br5 class=alignLeft headers=br1>45-64</TH><TD class=alignRight headers="br1 br5 bc1 bc2 bc3">387 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc4">177 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc6">210 </TD><TD class=alignRight headers="br1 br5 bc1 bc7">26 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc10">2370 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc11">1542 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc12">22 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc13">806 </TD><TD class=alignRight headers="br1 br5 bc8 bc14">134 </TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc16">2504 </TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc17">28.3% </TD></TR><TR><TH id=br6 class=alignLeft headers=br1>65+</TH><TD class=alignRight headers="br1 br6 bc1 bc2 bc3">247 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc4">78 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc5">1 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc6">168 </TD><TD class=alignRight headers="br1 br6 bc1 bc7">44 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc10">1171 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc11">622 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc12">36 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc13">513 </TD><TD class=alignRight headers="br1 br6 bc8 bc14">184 </TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc16">1355 </TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc17">15.3% </TD></TR><TR><TH id=br7 class=alignLeft headers=br1>Unknown</TH><TD class=alignRight headers="br1 br7 bc1 bc2 bc3">9 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc4">9 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc6">0 </TD><TD class=alignRight headers="br1 br7 bc1 bc7">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc10">52 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc11">40 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc12">4 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc13">8 </TD><TD class=alignRight headers="br1 br7 bc8 bc14">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc16">52 </TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc17">0.6% </TD></TR><TR><TH id=br8 class=alignLeft headers=br1>Total</TH><TD class=alignRight headers="br1 br8 bc1 bc2 bc3">1,560 </TD><TD class="lightred alignRight" headers="br1 br8 bc1 bc2 bc4">624 </TD><TD class="lightred alignRight" headers="br1 br8 bc1 bc2 bc5">4 </TD><TD class="lightred alignRight" headers="br1 br8 bc1 bc2 bc6">932 </TD><TD class=alignRight headers="br1 br8 bc1 bc7">121 </TD><TD class=alignRight headers="br1 br8 bc8 bc9 bc10">8331 </TD><TD class="lightred alignRight" headers="br1 br8 bc8 bc9 bc11">5314 </TD><TD class="lightred alignRight" headers="br1 br8 bc8 bc9 bc12">104 </TD><TD class="lightred alignRight" headers="br1 br8 bc8 bc9 bc13">2913 </TD><TD class=alignRight headers="br1 br8 bc8 bc14">514 </TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc16">8845 </TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc17">100.0% </TD></TR><TR><TH id=br9 class=alignLeft headers=br1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="br1 br9 bc1 bc2 bc3">92.8% </TD><TD class="lightred alignRight" headers="br1 br9 bc1 bc2 bc4">40.0% </TD><TD class="lightred alignRight" headers="br1 br9 bc1 bc2 bc5">0.3% </TD><TD class="lightred alignRight" headers="br1 br9 bc1 bc2 bc6">59.7% </TD><TD class=alignRight headers="br1 br9 bc1 bc7">7.2% </TD><TD class=alignRight headers="br1 br9 bc8 bc9 bc10">94.2% </TD><TD class="lightred alignRight" headers="br1 br9 bc8 bc9 bc11">63.8% </TD><TD class="lightred alignRight" headers="br1 br9 bc8 bc9 bc12">1.2% </TD><TD class="lightred alignRight" headers="br1 br9 bc8 bc9 bc13">35.0% </TD><TD class=alignRight headers="br1 br9 bc8 bc14">5.8% </TD><TD class=alignRight></TD><TD class=alignRight></TD></TR></TBODY></TABLE>

    Top of Page

    Influenza Strain Characterizations

    During the 2013-2014 influenza season, the National Microbiology Laboratory (NML) has antigenically characterized 428 influenza viruses [29 A(H3N2), 356 A(H1N1)pdm09 and 43 influenza B]. The vast majority (98.8%) of viruses were similar to the strains recommended by the WHO for the 2013-14 seasonal influenza vaccine. Two A(H1N1)pdm09 viruses showed reduced titres to antiserum against the reference A/California/07/2009 strain. Five influenza B viruses were similar to the strain recommended by the WHO for the 2011-12 vaccine (Figure 4).
    Figure 4. Influenza strain characterizations, Canada, 2013-14, N = 428

    The NML receives a proportion of the number of influenza positive specimens from provincial laboratories for strain characterization and antiviral resistance testing. Characterization data reflect the results of haemagglutination inhibition (HAI) testing compared to the reference influenza strains recommended by WHO.
    The recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b (e.g. A/Texas/50/2012), and a B/Massachusetts/2/2012-like virus (Yamagata lineage).


    Text equivalent for figure 4Influenza strain characterizations, Canada, 2013-2014, N =3
    Antiviral Resistance

    During the 2013-2014 influenza season, NML has tested 326 influenza viruses for resistance to oseltamivir and 320 viruses for resistance to zanamivir, and all were sensitive. All 254 influenza A viruses tested for amantadine resistance were resistant (Table 3).
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=cr1 rowSpan=2>Virus type and subtype</TH><TH id=cc1 colSpan=2>Oseltamivir</TH><TH id=cc4 colSpan=2>Zanamivir</TH><TH id=cc7 colSpan=2>Amantadine</TH></TR><TR class=bg-colour-yellow><TH id=cc2 headers=cc1># tested</TH><TH id=cc3 headers=cc1># resistant (%)</TH><TH id=cc5 headers=cc4># tested</TH><TH id=cc6 headers=cc4># resistant (%)</TH><TH id=cc8 headers=cc7># tested</TH><TH id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH id=cr2 class="alignLeft lightred" headers=cr1>A (H3N2)</TH><TD class=alignRight headers="cr1 cr2 cc1 cc2">25 </TD><TD class=alignRight headers="cr1 cr2 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr2 cc4 cc5">25 </TD><TD class=alignRight headers="cr1 cr2 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr2 cc7 cc8">3 </TD><TD class=alignRight headers="cr1 cr2 cc7 cc9">31 (100%) </TD></TR><TR><TH id=cr3 class="alignLeft lightred" headers=cr1>A (H1N1)</TH><TD class=alignRight headers="cr1 cr3 cc1 cc2">262 </TD><TD class=alignRight headers="cr1 cr3 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr3 cc4 cc5">256 </TD><TD class=alignRight headers="cr1 cr3 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr3 cc7 cc8">223 </TD><TD class=alignRight headers="cr1 cr3 cc7 cc9">223(100%) </TD></TR><TR><TH id=cr4 class="alignLeft lightred" headers=cr1>B</TH><TD class=alignRight headers="cr1 cr4 cc1 cc2">39 </TD><TD class=alignRight headers="cr1 cr4 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr4 cc4 cc5">39 </TD><TD class=alignRight headers="cr1 cr4 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr4 cc7 cc8">NA <SUP>*</SUP></TD><TD class=alignRight headers="cr1 cr4 cc7 cc9">NA <SUP>*</SUP></TD></TR><TR><TH id=cr5 class="alignLeft lightred" headers=cr1>TOTAL</TH><TD class=alignRight headers="cr1 cr5 cc1 cc2">326 </TD><TD class=alignRight headers="cr1 cr5 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr5 cc4 cc5">320 </TD><TD class=alignRight headers="cr1 cr5 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr5 cc7 cc8">254 </TD><TD class=alignRight headers="cr1 cr5 cc7 cc9">254 (100%) </TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate increased from 51.2/1,000 in week 02 to 66.8/1,000 in week 03; which is above the expected range for week 03 (Figure 5).
    Figure 5. Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Note: No data available for mean rate for weeks 19 to 39 for the 1996-1997 through 2002-2003 seasons. Delays in the reporting of data may cause data to change retrospectively. The calculation of the average ILI consultation rate over 17 seasons was aligned with influenza activity in each season. In BC, AB, and SK, data is compiled by a provincial sentinel surveillance program for reporting to FluWatch. The number of sentinel physicians in each province or territory is as follows: BC(21), AB(80), SK(11), MB(18), ON(169), QC(14), NB(29), NS(26), PE(4), NL(16), NU(1), NT(14), YT(13). Not all sentinel physicians report every week.
    Text equivalent for figure 5Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Top of Page

    Influenza Outbreak Surveillance

    In week 03, nine new influenza outbreaks were reported: four in hospitals and five in long-term care facilities (Figure 6). In addition, three outbreaks of influenza-like-illness were reported in week 03: two in schools and one in another facility or community.
    Figure 6. Overall number of new influenza outbreaks by report week, Canada, 2013-2014

    1 All provinces and territories except NU report outbreaks in long-term care facilities. All provinces and territories with the exception of NU and QC report outbreaks in hospitals. Outbreaks of influenza or influenza-like-illness in other facilities are reported to FluWatch but reporting varies between jurisdictions. Outbreak definitions are included at the end of the report.
    Text equivalent for figure 6 Overall number of new influenza outbreaks by report week, Canada, 2013-2014
    Pharmacy Surveillance

    The rate of prescriptions for influenza antivirals continues to follow a trend consistent with the timing and demographics of laboratory detections of influenza this season. In week 03, the largest proportion of prescriptions for antivirals was among children 2-18 years of age followed by adults 19-64 years of age (Figure 7).
    Figure 7. Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Note: Pharmacy sales data are provided to the Public Health Agency of Canada by Rx Canada Inc. and sourced from major retail drug chains representing over 3,000 stores nationwide (excluding Nunavut) in 85% of Health Regions. Data provided include the number of new antiviral prescriptions (for Tamiflu and Relenza) and the total number of new prescriptions dispensed by Province/Territory and age group. Age-groups: Infant: 0-2y, Child: 2-18y; Adult: 19-64y, Senior: ≥65y.
    Text equivalent for figure 7Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Top of Page

    Sentinel Hospital Influenza Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)
    In week 03, 60 new laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalizations were reported by the Immunization Monitoring Program Active (IMPACT) network, compared to 55 in week 02. All but two of the hospitalizations in week 03 were cases with influenza A (Figure 8a). Fifty (83%) of the cases were <5 years of age. Nine ICU admissions were reported in week 03, one child under 6 months of age, two children 6-23 months of age, two 2-4 years of age, and four 5-9 years of age; all with influenza A. No deaths were reported.
    To date this season, a total of 310 influenza-associated paediatric hospitalizations have been reported by the IMPACT network, 95% of which have been influenza A, and 98% of those subtyped were A(H1N1)pdm09 (Table 4). Two hundred and fifty one cases (81%) have been under 5 years of age. Forty ICU admissions have been reported; all but two cases with influenza A, and the majority A(H1N1)pdm09. The highest proportion of ICU admissions have been among children aged 6-23 months (32.4%) (Figure 9a). Among the 33 ICU cases with available data, 25 were reported to have comorbidities or concurrent infection. No deaths have been reported.
    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    Adult Influenza Hospitalizations and Deaths (PCIRN)
    In week 03, 69 new laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations reported through active surveillance by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network, compared to 121 in week 02. Among cases in week 03, 68 (98.6%) were influenza A, of which four were A(H1N1)pdm09 and 64 were A(unsubtyped). Almost half of the hospitalizations occurred among adults 45-64 years (32; 46.4%). Five ICU admissions were reported in week 03: one case 20-44 years of age, three cases 45-64 years of age and one case ≥65 years of age. One death was reported in an adult 45-64 years of age with influenza A(unsubtyped) (Figure 8b).
    To date this season, 532 influenza-associated hospitalizations have been reported by the PCIRN-SOS network, 504 (94.7%) with influenza A, predominantly A(H1N1)pdm09. The majority (76.5%) have been adults over 45 years of age (Table 5). ICU admission was required for 66 hospitalizations: all but four were influenza A (36 A(H1N1)pdm09 and 26 A(unsubtyped)). Three quarters of the ICU admissions were >45 years of age. Of the 45 ICU admissions with information on influenza vaccination, 32 (71%) reported not having been vaccinated this season. Six deaths have been reported: one case ≥65 years of age with A(H1N1)pdm09, one case ≥65 years of age with A(unsubtyped), three cases 45-64 years of age, one with A(H1N1)pdm09 and two with influenza A(unsubtyped), and one case 20-44 years of age with influenza A(H1N1)pdm09 (Figure 9b).
    Note: PCIRN-SOS conducted passive surveillance from April 30th to November 14th, 2013. Cases reported during this period were identified by laboratory detection of influenza among patients admitted to participating hospitals. Active surveillance began November 15th during which time PCIRN site coordinators investigate cases potentially related to influenza. Data from both active and passive surveillance reported during the 2013-14 season are included in this report. The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION id=t4 class=alignCenter>Table 4 - Cumulative numbers of paediatric hospitalizations with influenza reported by the IMPACT network, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=dr1 rowSpan=3>Age groups </TH><TH id=dc1 colSpan=6>Cumulative (Aug. 25, 2013 to January18, 2014) </TH></TR><TR class=bg-colour-yellow><TH id=dc2 colSpan=4 headers=dc1>Influenza A </TH><TH id=dc7 headers=dc1>B </TH><TH id=dc8 headers=dc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=dc3 headers="dc1 dc2">A Total </TH><TH id=dc4 class="lightred " headers="dc1 dc2">A(H1) pdm09 </TH><TH id=dc5 class="lightred " headers="dc1 dc2">A(H3) </TH><TH id=dc6 class="lightred " headers="dc1 dc2">A (UnS) </TH><TD class=alignCenter headers="dc1 dc7">Total</TD><TD class=alignCenter headers="dc1 dc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=dr2 class=alignLeft headers=dr1>0-5m </TH><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc3">63 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc4">16 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc6">47 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc7">2 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc8">65 (21%) </TD></TR><TR><TH id=dr3 class=alignLeft headers=dr1>6-23m </TH><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc3">84 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc4">29 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc6">55 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc7">3 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc8">87 (28%) </TD></TR><TR><TH id=dr4 class=alignLeft headers=dr1>2-4y </TH><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc3">93 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc4">32 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc5">2 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc6">59 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc7">6 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc8">99 (32%) </TD></TR><TR><TH id=dr5 class=alignLeft headers=dr1>5-9y </TH><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc3">35 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc4">12 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc6">23 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc7">3 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc8">38 (12%) </TD></TR><TR><TH id=dr6 class=alignLeft headers=dr1>10-16y </TH><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc3">19 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc4">9 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc6">10 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc7">2 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc8">21 (7%) </TD></TR><TR><TH id=dr7 class=alignLeft headers=dr1>Total </TH><TD class=alignRight headers="dr1 dr7 dc1 dc2 dc3">294 </TD><TD class="lightred alignRight" headers="dr1 dr7 dc1 dc2 dc4">98 </TD><TD class="lightred alignRight" headers="dr1 dr7 dc1 dc2 dc5">2 </TD><TD class="lightred alignRight" headers="dr1 dr7 dc1 dc2 dc6">194 </TD><TD class=alignRight headers="dr1 dr7 dc1 dc7">16 </TD><TD class=alignRight headers="dr1 dr7 dc1 dc8">310 </TD></TR><TR><TH id=dr8 class=alignLeft headers=dr1>% <SUP>1</SUP> </TH><TD class=alignRight headers="dr1 dr8 dc1 dc2 dc3">94.8% </TD><TD class="lightred alignRight" headers="dr1 dr8 dc1 dc2 dc4">33.3% </TD><TD class="lightred alignRight" headers="dr1 dr8 dc1 dc2 dc5">0.7% </TD><TD class="lightred alignRight" headers="dr1 dr8 dc1 dc2 dc6">66.0% </TD><TD class=alignRight headers="dr1 dr8 dc1 dc7">5.2% </TD><TD class=alignRight headers="dr1 dr8 dc1 dc8">100.0% </TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 5 - Cumulative numbers of adult hospitalizations with influenza
    reported by the PCIRN-SOS network, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=er1 rowSpan=3>Age groups </TH><TH id=ec1 class=noWrap colSpan=6>Cumulative (Aug. 25, 2013 to January 18, 2014)<SUP>*</SUP></TH></TR><TR class=bg-colour-yellow><TH id=ec2 colSpan=4 headers=ec1>Influenza A </TH><TH id=ec7 headers=ec1>B </TH><TH id=ec8 headers=ec1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=ec3 headers="ec1 ec2">A Total </TH><TH id=ec4 class="lightred " headers="ec1 ec2">A(H1) pdm09 </TH><TH id=ec5 class="lightred " headers="ec1 ec2">A(H3) </TH><TH id=ec6 class="lightred " headers="ec1 ec2">A(UnS) </TH><TD class=alignCenter headers="ec1 ec7">Total</TD><TD class=alignCenter headers="ec1 ec8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP id=footnote_t5_1>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.

    <SUP id=footnote_t5_star>*</SUP> Fourteen cases for which the influenza type has not yet been reported, and four cases for which the age-group was not reported, are not included in Table 5.
    </TD></TR></TFOOT><TBODY><TR><TH id=er2 class=alignLeft headers=er1>16-20 </TH><TD class=alignRight headers="er1 er2 ec1 ec2 ec3">4 </TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec4">2 </TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec5">0 </TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec6">2 </TD><TD class=alignRight headers="er1 er2 ec1 ec7">0 </TD><TD class=alignRight headers="er1 er2 ec1 ec8">4 (1%) </TD></TR><TR><TH id=er3 class=alignLeft headers=er1>20-44 </TH><TD class=alignRight headers="er1 er3 ec1 ec2 ec3">113 </TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec4">44 </TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec5">1 </TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec6">68 </TD><TD class=alignRight headers="er1 er3 ec1 ec7">2 </TD><TD class=alignRight headers="er1 er3 ec1 ec8">115 (22%) </TD></TR><TR><TH id=er4 class=alignLeft headers=er1>45-64 </TH><TD class=alignRight headers="er1 er4 ec1 ec2 ec3">204 </TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec4">75 </TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec5">2 </TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec6">127 </TD><TD class=alignRight headers="er1 er4 ec1 ec7">4 </TD><TD class=alignRight headers="er1 er4 ec1 ec8">208 (40%) </TD></TR><TR><TH id=er5 class=alignLeft headers=er1>65+ </TH><TD class=alignRight headers="er1 er5 ec1 ec2 ec3">179 </TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec4">62 </TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec5">6 </TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec6">111 </TD><TD class=alignRight headers="er1 er5 ec1 ec7">8 </TD><TD class=alignRight headers="er1 er5 ec1 ec8">187 (36%) </TD></TR><TR><TH id=er6 class=alignLeft headers=er1>Total </TH><TD class=alignRight headers="er1 er6 ec1 ec2 ec3">500 </TD><TD class="lightred alignRight" headers="er1 er6 ec1 ec2 ec4">183 </TD><TD class="lightred alignRight" headers="er1 er6 ec1 ec2 ec5">9 </TD><TD class="lightred alignRight" headers="er1 er6 ec1 ec2 ec6">308 </TD><TD class=alignRight headers="er1 er6 ec1 ec7">14 </TD><TD class=alignRight headers="er1 er6 ec1 ec8">514 </TD></TR><TR><TH id=er7 class=alignLeft headers=er1>% <SUP>1</SUP></TH><TD class=alignRight headers="er1 er7 ec1 ec2 ec3">97% </TD><TD class="lightred alignRight" headers="er1 er7 ec1 ec2 ec4">37% </TD><TD class="lightred alignRight" headers="er1 er7 ec1 ec2 ec5">2% </TD><TD class="lightred alignRight" headers="er1 er7 ec1 ec2 ec6">62% </TD><TD class=alignRight headers="er1 er7 ec1 ec7">3% </TD><TD class=alignRight headers="er1 er7 ec1 ec8">100% </TD></TR></TBODY></TABLE>
    Figure 8. Number of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)


    Text equivalent for figure 8aNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    * See footnote above following the section related to PCIRN-SOS data.
    Text equivalent for figure 8bNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Adult hospitalizations (>16 year of age, PCIRN-SOS)
    Figure 9. Percentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)

    Text equivalent for figure 9aPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Text equivalent for figure 9bPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Top of Page

    Provincial/Territorial Influenza Hospitalizations and Deaths

    In week 03, 396 laboratory-confirmed influenza-associated hospitalizations were reported from participating provinces and territories.* The majority were cases of influenza A (387, 97.7%), of which 204 (52.7%) were A(H1N1)pdm09, four were A(H3N2), and 179 (46.3%) were A(unsubtyped). Among the 12 ICU admissions reported in week 03, 10 were adults 20-64 years of age. Thirteen deaths were reported, nine of which were adults 20-64 years of age. The number of new influenza-associated hospitalizations and deaths reported for the current week may include cases from Ontario that occurred in previous weeks, as a result of retrospective updates to the cumulative total.
    To date this season, 1875 influenza-associated hospitalizations have been reported, 97.7% with influenza A (Table 6). The majority of hospitalizations have been cases 45-64 years of age. A total of 182 ICU admissions have been reported this season, all but one with influenza A; and 76% were among adults 20-64 years of age. Eighty-four deaths have been reported, and all but one with influenza A. The highest proportion of deaths has been among adults 20-64 years of age (52%), followed by adults ≥65 years of age (38%). It is important to note that the hospitalization or death does not have to be attributable to influenza, a positive laboratory test is sufficient for reporting. Detailed clinical information (e.g. underlying medical conditions) is not known for these cases.
    * Note: Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not distinguished among hospital admissions reported from Ontario. Data may also include cases reported by the IMPACT and PCIRN networks.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION id=t6 class=alignCenter>Table 6. Cumulative number of hospitalizations with influenza reported by the participating provinces and territories, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=fr1 rowSpan=3>Age groups </TH><TH id=fc1 colSpan=6>Cumulative (Aug. 25, 2013 to January 18, 2014)* </TH></TR><TR class=bg-colour-yellow><TH id=fc2 colSpan=4 headers=fc1>Influenza A </TH><TH id=fc7 headers=fc1>B </TH><TH id=fc8 headers=fc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=fc3 headers="fc1 fc2">A Total </TH><TH id=fc4 class=lightred headers="fc1 fc2">A(H1) pdm09 </TH><TH id=fc5 class=lightred headers="fc1 fc2">A(H3) </TH><TH id=fc6 class=lightred headers="fc1 fc2">A (UnS) </TH><TD class=alignCenter headers="fc1 fc7">Total</TD><TD class=alignCenter headers="fc1 fc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=8><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    * Six cases for which age information is not available have not been included in Table 6.
    </TD></TR></TFOOT><TBODY><TR><TH id=fr2 class=alignLeft headers=fr1>0-4 years </TH><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc3">345 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc4">181</TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc5">4 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc6">160 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc7">13 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc8">358 (19%) </TD></TR><TR><TH id=fr3 class=alignLeft headers=fr1>5-14 years </TH><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc3">68 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc4">39 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc5">3 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc6">26 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc7">3 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc8">71 (4%) </TD></TR><TR><TH id=fr4 class=alignLeft headers=fr1>15-19 years </TH><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc3">22 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc4">14 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc5">1 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc6">7 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc7">0 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc8">22 (1%) </TD></TR><TR><TH id=fr5 class=alignLeft headers=fr1>20-44 years </TH><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc3">326 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc4">250 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc5">2 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc6">74 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc7">3 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc8">329 (18%) </TD></TR><TR><TH id=fr6 class=alignLeft headers=fr1>45-64 years </TH><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc3">614 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc4">410 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc5">11 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc6">193 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc7">5 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc8">619 (33%) </TD></TR><TR><TH id=fr7 class=alignLeft headers=fr1>65+ years </TH><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc3">451 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc4">266 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc5">29 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc6">156 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc7">19 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc8">470 (25%) </TD></TR><TR><TH id=fr8 class=alignLeft headers=fr1>Total </TH><TD class=alignRight headers="fr1 fr8 fc1 fc2 fc3">1826 </TD><TD class="lightred alignRight" headers="fr1 fr8 fc1 fc2 fc4">1160 </TD><TD class="lightred alignRight" headers="fr1 fr8 fc1 fc2 fc5">50 </TD><TD class="lightred alignRight" headers="fr1 fr8 fc1 fc2 fc6">616 </TD><TD class=alignRight headers="fr1 fr8 fc1 fc7">43 </TD><TD class=alignRight headers="fr1 fr8 fc1 fc8">1869 </TD></TR><TR><TH id=fr9 class=alignLeft headers=fr1>Percentage <SUP>1</SUP> </TH><TD class=alignRight headers="fr1 fr9 fc1 fc2 fc3">97.7% </TD><TD class="lightred alignRight" headers="fr1 fr9 fc1 fc2 fc4">63.5% </TD><TD class="lightred alignRight" headers="fr1 fr9 fc1 fc2 fc5">2.7% </TD><TD class="lightred alignRight" headers="fr1 fr9 fc1 fc2 fc6">33.7% </TD><TD class=alignRight headers="fr1 fr9 fc1 fc7">2.3% </TD><TD class=alignRight headers="fr1 fr9 fc1 fc8">100% </TD></TR></TBODY></TABLE>
    See additional data on Reported Influenza Hospitalizations and Deaths in Canada: 2009-10 to 2013-14 on the Public Health Agency of Canada website.

    .../

    Leave a comment:


  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Week 2

    FluWatch report: January 5 to January 11, 2014 (Week 02)

    Posted 2014-01-17For readers interested in the <ABBR title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A title="Flu Watch (Version PDF, 113 KB - 6 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w02_14/pdf/fw2014-02-eng.pdf">FluWatch report: January 5 to January 11, 2014 (Week 02) (<ABBR title="Portable Document Format">PDF</ABBR> Version - 291 <ABBR title=Kilobytes>KB</ABBR> - 10 pages)

    ?? Help with PDF documents


    Overall Summary
    • Influenza activity in Canada continued to increase in week 02, with most indicators following a similar trend to the 2012-13 season but lagging by 2-3 weeks. However, over 90% of laboratory detections this season have been A(H1N1)pdm09 compared to 10% in 2012-13.
    • Surveillance of laboratory detections, hospitalizations with influenza and prescriptions for influenza antivirals all show a greater proportion of cases among adults 20-64 years of age compared to those ≥65 years of age, which is a change from the demographics of the 2012-13 season.
    • At this point, it is too early in the season to predict the total number of cases that may be seen, or when flu season will peak.
    Influenza/ILI Activity (geographic spread)

    In week 02, three regions in Alberta and one in Quebec reported widespread activity, and 13 regions (in ON(7), QC(2), NS(1), NB(1) and NT(2)) reported localized activity (Figure 1).
    Figure 1. Map of overall influenza/ILI activity level by province and territory, Canada, Week 02





    Note: Influenza/ILI activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates and reported outbreaks. Please refer to detailed definitions at the end of the report. Maps from previous weeks, including any retrospective updates, are available on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada
    Influenza and Other Respiratory Virus Detections

    The number of positive influenza tests continued to increase, from 2,304 in week 01 to 3,403 in week 02. However, due to an increase in the number of tests performed, the percentage of positive influenza tests was stable at 28.7% (Figure 2). Cumulative influenza virus detections to date have been predominantly influenza A (96%). Among subtyped influenza A viruses, 97% (5,215/5,386) were A(H1N1)pdm09 (Table 1). Detailed information on age and type/subtype has been received for 7,467 cases to date this season. A significantly greater proportion of laboratory detections of influenza have been reported in adults 20-64 years of age compared to those ≥65 years of age this season compared to the 2012-13 season (Table 2). This is expected given the predominance of A(H1N1)pdm09 this season compared to 2012-13 when A(H3N2) was the dominant circulating subtype.
    Figure 2. Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14

    Text equivalent for figure 2Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14
    In week 02, the number of positive tests for RSV decreased very slightly. RSV in Canada shows a seasonal pattern with a broad peak over the winter months. The number of positive tests for coronavirus and human metapneumovirus increased, while detections of rhinovirus and parainfluenza were stable compared to the previous week (Figure 3).
    For more details, see the weekly Respiratory Virus Detections in Canada Report.
    Figure 3. Number of positive laboratory tests for other respiratory viruses by report week, Canada, 2013-14


    Top of Page

    RSV: Respiratory syncytial virus; hMPV: Human metapneumovirus
    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 1: Weekly and cumulative numbers of positive influenza specimens
    by type, subtype and province, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=ar1 rowSpan=3>Reporting provinces <SUP>1</SUP></TH><TH id=ac1 colSpan=5>Weekly
    (January 5, 2013 to January 11, 2014)
    </TH><TH id=ac8 colSpan=5>Cumulative
    (August 25, 2013 to January 11, 2014)
    </TH></TR><TR class=bg-colour-yellow><TH id=ac2 colSpan=4 headers=ac1>Influenza A</TH><TH id=ac7 headers=ac1>B</TH><TH id=ac9 colSpan=4 headers=ac8>Influenza A</TH><TH id=ac14 headers=ac8>B</TH></TR><TR class=bg-colour-grey-light><TH id=ac3 headers="ac1 ac2">A Total</TH><TH id=ac4 class=lightred headers="ac1 ac2">A(H1)pdm09</TH><TH id=ac5 class=lightred headers="ac1 ac2">A(H3)</TH><TH id=ac6 class=lightred headers="ac1 ac2">A(UnS)</TH><TH class=alignCenter headers="ac1 ac7">B Total</TH><TH id=ac10 headers="ac8 ac9">A Total</TH><TH id=ac11 class=lightred headers="ac8 ac9">A(H1)pdm09</TH><TH id=ac12 class=lightred headers="ac8 ac9">A(H3)</TH><TH id=ac13 class=lightred headers="ac8 ac9">A(UnS)</TH><TD class=alignCenter headers="ac8 ac14">B Total</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=11><SUP>1 </SUP>Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.
    <SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=ar2 class=alignLeft headers=ar1>BC</TH><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac3">463 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac4">405 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac5">11 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac6">47 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac7">6 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac10">887 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac11">779 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac12">26 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac13">82 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac14">21 </TD></TR><TR><TH id=ar3 class=alignLeft headers=ar1>AB</TH><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac3">800 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac4">684 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac5">5 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac6">111 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac7">4 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac10">2332 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac11">2169 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac12">20 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac13">143 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac14">25 </TD></TR><TR><TH id=ar4 class=alignLeft headers=ar1>SK</TH><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac3">360 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac4">254 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac6">106 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac7">1 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac10">725 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac11">484 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac13">241 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac14">1 </TD></TR><TR><TH id=ar5 class=alignLeft headers=ar1>MB</TH><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac3">63 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac4">62 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac6">1 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac7">3 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac10">120 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac11">99 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac13">21 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac14">9 </TD></TR><TR><TH id=ar6 class=alignLeft headers=ar1>ON</TH><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac3">859 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac4">269 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac5">15 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac6">575 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac7">19 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac10">2590 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac11">1319 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac12">121 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac13">1150 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac14">56 </TD></TR><TR><TH id=ar7 class=alignLeft headers=ar1>QC</TH><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac3">607 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac4">67 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac6">540 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac7">91 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac10">1410 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac11">158 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac12">1 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac13">1251 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac14">259 </TD></TR><TR><TH id=ar8 class=alignLeft headers=ar1>NB</TH><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac3">194 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac4">139 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac6">55 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac7">1 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac10">235 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac11">144 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac12">1 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac13">90 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac14">1 </TD></TR><TR><TH id=ar9 class=alignLeft headers=ar1>NS</TH><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac3">13 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac4">10 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac5">1 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac6">2 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac10">30 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac11">12 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac12">2 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac13">16 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac14">0 </TD></TR><TR><TH id=ar10 class=alignLeft headers=ar1>PE</TH><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac3">0 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac4">0 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac6">0 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac10">1 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac11">1 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac13">0 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac14">0 </TD></TR><TR><TH id=ar11 class=alignLeft headers=ar1>NL</TH><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac3">44 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac4">15 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac6">29 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac7">20 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac10">82 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac11">50 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac13">32 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac14">26 </TD></TR><TR><TH id=ar12 class=alignLeft headers=ar1>Canada</TH><TD class=alignRight headers="ar1 ar12 ac1 ac2 ac3">3403 </TD><TD class="lightred alignRight" headers="ar1 ar12 ac1 ac2 ac4">1905 </TD><TD class="lightred alignRight" headers="ar1 ar12 ac1 ac2 ac5">32 </TD><TD class="lightred alignRight" headers="ar1 ar12 ac1 ac2 ac6">1466 </TD><TD class=alignRight headers="ar1 ar12 ac1 ac7">145 </TD><TD class=alignRight headers="ar1 ar12 ac8 ac9 ac10">8412 </TD><TD class="lightred alignRight" headers="ar1 ar12 ac8 ac9 ac11">5215 </TD><TD class="lightred alignRight" headers="ar1 ar12 ac8 ac9 ac12">171 </TD><TD class="lightred alignRight" headers="ar1 ar12 ac8 ac9 ac13">3026 </TD><TD class=alignRight headers="ar1 ar12 ac8 ac14">398 </TD></TR><TR><TH id=ar13 class=alignLeft headers=ar1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="ar1 ar13 ac1 ac2 ac3">95.9% </TD><TD class="lightred alignRight" headers="ar1 ar13 ac1 ac2 ac4">56.0% </TD><TD class="lightred alignRight" headers="ar1 ar13 ac1 ac2 ac5">0.9% </TD><TD class="lightred alignRight" headers="ar1 ar13 ac1 ac2 ac6">43.1% </TD><TD class=alignRight headers="ar1 ar13 ac1 ac7">4.1% </TD><TD class=alignRight headers="ar1 ar13 ac8 ac9 ac10">95.5% </TD><TD class="lightred alignRight" headers="ar1 ar13 ac8 ac9 ac11">62.0% </TD><TD class="lightred alignRight" headers="ar1 ar13 ac8 ac9 ac12">2.0% </TD><TD class="lightred alignRight" headers="ar1 ar13 ac8 ac9 ac13">36.0% </TD><TD class=alignRight headers="ar1 ar13 ac8 ac14">4.5% </TD></TR></TBODY></TABLE>

    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 2. Weekly and cumulative numbers of positive influenza specimens by type, subtype and age-group reported through case-based laboratory reporting<SUP>3</SUP>, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=br1 rowSpan=3>Age groups (years)</TH><TH id=bc1 colSpan=5>Weekly
    (January 5 to January 11, 2014)
    </TH><TH id=bc8 colSpan=7>Cumulative
    (August 25, 2013 to January 11, 2014)
    </TH></TR><TR class=bg-colour-yellow><TH id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH id=bc7 headers=bc1>B</TH><TH id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH id=bc14 headers=bc8>B</TH><TH id=bc15 colSpan=2 headers=bc8>Influenza A and B</TH></TR><TR class=bg-colour-grey-light><TH id=bc3 headers="bc1 bc2">A Total</TH><TH id=bc4 class="lightred " headers="bc1 bc2">A(H1) pdm09</TH><TH id=bc5 class="lightred " headers="bc1 bc2">A(H3)</TH><TH id=bc6 class="lightred " headers="bc1 bc2">A (UnS)</TH><TD class=alignCenter headers="bc1 bc7">Total</TD><TH id=bc10 headers="bc8 bc9">A Total</TH><TH id=bc11 class="lightred " headers="bc8 bc9">A(H1) pdm09</TH><TH id=bc12 class="lightred " headers="bc8 bc9">A(H3)</TH><TH id=bc13 class="lightred " headers="bc8 bc9">A (UnS)</TH><TD class=alignCenter headers="bc8 bc14">Total</TD><TH id=bc16 headers="bc8 bc15">#</TH><TH id=bc17 headers="bc8 bc15">%</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=13><SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    <SUP>3 </SUP>Table 2 includes specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=br2 class=alignLeft headers=br1><5</TH><TD class=alignRight headers="br1 br2 bc1 bc2 bc3">244 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc4">104 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc5">1 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc6">139 </TD><TD class=alignRight headers="br1 br2 bc1 bc7">2 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc10">1132 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc11">616 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc12">16 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc13">500 </TD><TD class=alignRight headers="br1 br2 bc8 bc14">53 </TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc16">1185 </TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc17">15.8% </TD></TR><TR><TH id=br3 class=alignLeft headers=br1>5-19</TH><TD class=alignRight headers="br1 br3 bc1 bc2 bc3">104 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc4">56 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc6">48 </TD><TD class=alignRight headers="br1 br3 bc1 bc7">3 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc10">488 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc11">319 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc12">10 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc13">159 </TD><TD class=alignRight headers="br1 br3 bc8 bc14">51 </TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc16">539 </TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc17">7.2% </TD></TR><TR><TH id=br4 class=alignLeft headers=br1>20-44</TH><TD class=alignRight headers="br1 br4 bc1 bc2 bc3">589 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc4">314 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc5">1 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc6">274 </TD><TD class=alignRight headers="br1 br4 bc1 bc7">22 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc10">2336 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc11">1393 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc12">16 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc13">927 </TD><TD class=alignRight headers="br1 br4 bc8 bc14">92 </TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc16">2428 </TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc17">32.3% </TD></TR><TR><TH id=br5 class=alignLeft headers=br1>45-64</TH><TD class=alignRight headers="br1 br5 bc1 bc2 bc3">507 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc4">252 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc5">4 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc6">251 </TD><TD class=alignRight headers="br1 br5 bc1 bc7">25 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc10">1978 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc11">1150 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc12">22 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc13">806 </TD><TD class=alignRight headers="br1 br5 bc8 bc14">134 </TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc16">2112 </TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc17">28.1% </TD></TR><TR><TH id=br6 class=alignLeft headers=br1>65+</TH><TD class=alignRight headers="br1 br6 bc1 bc2 bc3">247 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc4">87 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc5">7 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc6">153 </TD><TD class=alignRight headers="br1 br6 bc1 bc7">38 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc10">1019 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc11">470 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc12">36 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc13">513 </TD><TD class=alignRight headers="br1 br6 bc8 bc14">184 </TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc16">1203 </TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc17">16.0% </TD></TR><TR><TH id=br7 class=alignLeft headers=br1>Unknown</TH><TD class=alignRight headers="br1 br7 bc1 bc2 bc3">14 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc4">13 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc6">1 </TD><TD class=alignRight headers="br1 br7 bc1 bc7">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc10">52 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc11">40 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc12">4 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc13">8 </TD><TD class=alignRight headers="br1 br7 bc8 bc14">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc16">52 </TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc17">0.7% </TD></TR><TR><TH id=br8 class=alignLeft headers=br1>Total</TH><TD class=alignRight headers="br1 br8 bc1 bc2 bc3">1,705 </TD><TD class="lightred alignRight" headers="br1 br8 bc1 bc2 bc4">826 </TD><TD class="lightred alignRight" headers="br1 br8 bc1 bc2 bc5">13 </TD><TD class="lightred alignRight" headers="br1 br8 bc1 bc2 bc6">866 </TD><TD class=alignRight headers="br1 br8 bc1 bc7">90 </TD><TD class=alignRight headers="br1 br8 bc8 bc9 bc10">7005 </TD><TD class="lightred alignRight" headers="br1 br8 bc8 bc9 bc11">3988 </TD><TD class="lightred alignRight" headers="br1 br8 bc8 bc9 bc12">104 </TD><TD class="lightred alignRight" headers="br1 br8 bc8 bc9 bc13">2913 </TD><TD class=alignRight headers="br1 br8 bc8 bc14">514 </TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc16">7519 </TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc17">100.0% </TD></TR><TR><TH id=br9 class=alignLeft headers=br1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="br1 br9 bc1 bc2 bc3">95.0% </TD><TD class="lightred alignRight" headers="br1 br9 bc1 bc2 bc4">48.4% </TD><TD class="lightred alignRight" headers="br1 br9 bc1 bc2 bc5">0.8% </TD><TD class="lightred alignRight" headers="br1 br9 bc1 bc2 bc6">50.8% </TD><TD class=alignRight headers="br1 br9 bc1 bc7">5.0% </TD><TD class=alignRight headers="br1 br9 bc8 bc9 bc10">93.2% </TD><TD class="lightred alignRight" headers="br1 br9 bc8 bc9 bc11">56.9% </TD><TD class="lightred alignRight" headers="br1 br9 bc8 bc9 bc12">1.5% </TD><TD class="lightred alignRight" headers="br1 br9 bc8 bc9 bc13">41.6% </TD><TD class=alignRight headers="br1 br9 bc8 bc14">6.8% </TD><TD class=alignRight></TD><TD class=alignRight></TD></TR></TBODY></TABLE>

    Top of Page

    Influenza Strain Characterizations

    During the 2013-2014 influenza season, the National Microbiology Laboratory (NML) has antigenically characterized 303 influenza viruses [24 A(H3N2), 243 A(H1N1)pdm09 and 36 influenza B]. The vast majority (98.3%) of viruses were similar to the strains recommended by the WHO for the 2013-14 seasonal influenza vaccine. Two A(H1N1)pdm09 viruses showed reduced titres to antiserum against the reference A/California/07/2009 strain. Five influenza B viruses were similar to the strain recommended by the WHO for the 2011-12 vaccine (Figure 4).
    Figure 4. Influenza strain characterizations, Canada, 2013-14, N = 303

    The NML receives a proportion of the number of influenza positive specimens from provincial laboratories for strain characterization and antiviral resistance testing. Characterization data reflect the results of haemagglutination inhibition (HAI) testing compared to the reference influenza strains recommended by WHO.
    The recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b (e.g. A/Texas/50/2012), and a B/Massachusetts/2/2012-like virus (Yamagata lineage).


    Text equivalent for figure 4Influenza strain characterizations, Canada, 2013-2014, N =3
    Antiviral Resistance

    During the 2013-2014 influenza season, NML has tested 257 influenza viruses for resistance to oseltamivir and 255 viruses for resistance to zanamivir, and all were sensitive. All 167 influenza A viruses tested for amantadine resistance were resistant (Table 3).
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=cr1 rowSpan=2>Virus type and subtype</TH><TH id=cc1 colSpan=2>Oseltamivir</TH><TH id=cc4 colSpan=2>Zanamivir</TH><TH id=cc7 colSpan=2>Amantadine</TH></TR><TR class=bg-colour-yellow><TH id=cc2 headers=cc1># tested</TH><TH id=cc3 headers=cc1># resistant (%)</TH><TH id=cc5 headers=cc4># tested</TH><TH id=cc6 headers=cc4># resistant (%)</TH><TH id=cc8 headers=cc7># tested</TH><TH id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH id=cr2 class="alignLeft lightred" headers=cr1>A (H3N2)</TH><TD class=alignRight headers="cr1 cr2 cc1 cc2">23 </TD><TD class=alignRight headers="cr1 cr2 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr2 cc4 cc5">23 </TD><TD class=alignRight headers="cr1 cr2 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr2 cc7 cc8">29 </TD><TD class=alignRight headers="cr1 cr2 cc7 cc9">29 (100%) </TD></TR><TR><TH id=cr3 class="alignLeft lightred" headers=cr1>A (H1N1)</TH><TD class=alignRight headers="cr1 cr3 cc1 cc2">201 </TD><TD class=alignRight headers="cr1 cr3 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr3 cc4 cc5">199 </TD><TD class=alignRight headers="cr1 cr3 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr3 cc7 cc8">138 </TD><TD class=alignRight headers="cr1 cr3 cc7 cc9">138 (100%) </TD></TR><TR><TH id=cr4 class="alignLeft lightred" headers=cr1>B</TH><TD class=alignRight headers="cr1 cr4 cc1 cc2">33 </TD><TD class=alignRight headers="cr1 cr4 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr4 cc4 cc5">33 </TD><TD class=alignRight headers="cr1 cr4 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr4 cc7 cc8">NA <SUP>*</SUP></TD><TD class=alignRight headers="cr1 cr4 cc7 cc9">NA <SUP>*</SUP></TD></TR><TR><TH id=cr5 class="alignLeft lightred" headers=cr1>TOTAL</TH><TD class=alignRight headers="cr1 cr5 cc1 cc2">257 </TD><TD class=alignRight headers="cr1 cr5 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr5 cc4 cc5">255 </TD><TD class=alignRight headers="cr1 cr5 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr5 cc7 cc8">167 </TD><TD class=alignRight headers="cr1 cr5 cc7 cc9">167 (100%) </TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate increased slightly from 48.8/1,000 in week 01 to 50.3 in week 02, which is above the expected range for week 02 but in keeping with the trend at this time of year (Figure 5).
    Figure 5. Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Note: No data available for mean rate for weeks 19 to 39 for the 1996-1997 through 2002-2003 seasons. Delays in the reporting of data may cause data to change retrospectively. The calculation of the average ILI consultation rate over 17 seasons was aligned with influenza activity in each season. In BC, AB, and SK, data is compiled by a provincial sentinel surveillance program for reporting to FluWatch. The number of sentinel physicians in each province or territory is as follows: BC(21), AB(80), SK(11), MB(18), ON(169), QC(14), NB(29), NS(26), PE(4), NL(16), NU(1), NT(14), YT(13). Not all sentinel physicians report every week.
    Text equivalent for figure 5Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Top of Page

    Influenza Outbreak Surveillance

    In week 02, eight new influenza outbreaks were reported: five in long-term care facilities and three in hospitals (Figure 6). In addition, six outbreaks of influenza-like-illness were reported in week 02: one in a school and five in other facilities or communities.
    Figure 6. Overall number of new influenza outbreaks by report week, Canada, 2013-2014

    1 All provinces and territories except NU report outbreaks in long-term care facilities. All provinces and territories with the exception of NU and QC report outbreaks in hospitals. Outbreaks of influenza or influenza-like-illness in other facilities are reported to FluWatch but reporting varies between jurisdictions. Outbreak definitions are included at the end of the report.
    Text equivalent for figure 6 Overall number of new influenza outbreaks by report week, Canada, 2013-2014
    Pharmacy Surveillance

    The rate of prescriptions for influenza antivirals continues to follow a trend consistent with the timing and demographics of laboratory detections of influenza this season. The largest proportions of prescriptions for antivirals are among adults 19-64 years of age and children 2-18 years of age (Figure 7).
    Figure 7. Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Note: Pharmacy sales data are provided to the Public Health Agency of Canada by Rx Canada Inc. and sourced from major retail drug chains representing over 3,000 stores nationwide (excluding Nunavut) in 85% of Health Regions. Data provided include the number of new antiviral prescriptions (for Tamiflu and Relenza) and the total number of new prescriptions dispensed by Province/Territory and age group. Age-groups: Infant: 0-2y, Child: 2-18y; Adult: 19-64y, Senior: ≥65y.
    Text equivalent for figure 7Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Top of Page

    Sentinel Hospital Influenza Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)
    In week 02, 47 new laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalizations were reported by the Immunization Monitoring Program Active (IMPACT) network, compared to 43 in week 01. All 47 hospitalizations in week 02 were cases with influenza A; 23% of these were A(H1N1)pdm09 and the remainder were A(unsubtyped) (Figure 8a). All but seven of the cases were <5 years of age. Three ICU admissions were reported in week 02, one child under 6 months of age, one child 6-23 months of age, and one 5-9 years of age; all with influenza A. No deaths were reported.
    To date this season, a total of 235 influenza-associated paediatric hospitalizations have been reported by the IMPACT network, 95% of which have been influenza A, and the majority of those subtyped were A(H1N1)pdm09 (Table 4). One hundred and eighty-eight cases have been under 5 years of age. Thirty ICU admissions have been reported; all but two cases with influenza A, and the majority A(H1N1)pdm09. The highest proportion of ICU admissions have been among children aged 6-23 months (33.3%) (Figure 9a). Among the 25 ICU cases with available data, 20 were reported to have comorbidities or concurrent infection. No deaths have been reported.
    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    Adult Influenza Hospitalizations and Deaths (PCIRN)
    In week 02, 82 new laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations reported through active surveillance by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network, compared to 129 in week 01. Among cases in week 02, 77 (93.9%) were influenza A, of which 22 (28.6%) were A(H1N1)pdm09 and 55 (71.4%) were A(unsubtyped). The highest proportion of hospitalizations occurred among adults 45-64 years (36; 43.9%) followed by adults aged ≥65 years of age (29; 35.4%). Seven ICU admissions were reported in week 02: one case 20-44 years of age, and six cases 45-64 years of age. One death was reported in an adult ≥65 years of age with influenza A(H1N1)pdm09 (Figure 8b).
    To date this season, 399 influenza-associated hospitalizations have been reported by the PCIRN-SOS network, 384 (96.2%) with influenza A, predominantly A(H1N1)pdm09. The majority (74.2%) have been adults over 45 years of age (Table 5). As observed in other surveillance indicators, a significantly greater proportion of cases have been under 65 years of age this season compared to the 2012-13 season. ICU admission was required for 61 hospitalizations: 59 of which were cases of influenza A (37 A(H1N1)pdm09 and 22 A(unsubtyped)); 46 (75.4%) of the ICU admissions were >45 years of age. A greater proportion of cases reported this season have been admitted to the ICU compared to the 2012-13 season. Of the 24 ICU admissions with information on influenza vaccination, 17 reported not having been vaccinated this season. Five deaths have been reported: two cases ≥65 years of age with A(H1N1)pdm09, one case ≥65 years of age with A(unsubtyped), one case 45-64 years of age with influenza A(unsubtyped), and one case 20-44 years of age with influenza A(H1N1)pdm09 (Figure 9b).
    Note: PCIRN-SOS conducted passive surveillance from April 30th to November 14th, 2013. Cases reported during this period were identified by laboratory detection of influenza among patients admitted to participating hospitals. Active surveillance began November 15th during which time PCIRN site coordinators investigate cases potentially related to influenza. Data from both active and passive surveillance reported during the 2013-14 season are included in this report. The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION id=t4 class=alignCenter>Table 4 - Cumulative numbers of paediatric hospitalizations with influenza reported by the IMPACT network, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=dr1 rowSpan=3>Age groups </TH><TH id=dc1 colSpan=6>Cumulative (Aug. 25, 2013 to January11, 2014) </TH></TR><TR class=bg-colour-yellow><TH id=dc2 colSpan=4 headers=dc1>Influenza A </TH><TH id=dc7 headers=dc1>B </TH><TH id=dc8 headers=dc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=dc3 headers="dc1 dc2">A Total </TH><TH id=dc4 class="lightred " headers="dc1 dc2">A(H1) pdm09 </TH><TH id=dc5 class="lightred " headers="dc1 dc2">A(H3) </TH><TH id=dc6 class="lightred " headers="dc1 dc2">A (UnS) </TH><TD class=alignCenter headers="dc1 dc7">Total</TD><TD class=alignCenter headers="dc1 dc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=dr2 class=alignLeft headers=dr1>0-5m </TH><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc3">49 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc4">13 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc6">36 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc7">1 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc8">50 (21%) </TD></TR><TR><TH id=dr3 class=alignLeft headers=dr1>6-23m </TH><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc3">59 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc4">26 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc6">33 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc7">2 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc8">61 (26%) </TD></TR><TR><TH id=dr4 class=alignLeft headers=dr1>2-4y </TH><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc3">72 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc4">27 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc5">1 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc6">44 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc7">5 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc8">77 (33%) </TD></TR><TR><TH id=dr5 class=alignLeft headers=dr1>5-9y </TH><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc3">26 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc4">10 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc6">16 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc7">3 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc8">29 (12%) </TD></TR><TR><TH id=dr6 class=alignLeft headers=dr1>10-16y </TH><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc3">16 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc4">7 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc6">9 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc7">2 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc8">18 (8%) </TD></TR><TR><TH id=dr7 class=alignLeft headers=dr1>Total </TH><TD class=alignRight headers="dr1 dr7 dc1 dc2 dc3">222 </TD><TD class="lightred alignRight" headers="dr1 dr7 dc1 dc2 dc4">83 </TD><TD class="lightred alignRight" headers="dr1 dr7 dc1 dc2 dc5">1 </TD><TD class="lightred alignRight" headers="dr1 dr7 dc1 dc2 dc6">138 </TD><TD class=alignRight headers="dr1 dr7 dc1 dc7">13 </TD><TD class=alignRight headers="dr1 dr7 dc1 dc8">235 </TD></TR><TR><TH id=dr8 class=alignLeft headers=dr1>% <SUP>1</SUP> </TH><TD class=alignRight headers="dr1 dr8 dc1 dc2 dc3">94.5% </TD><TD class="lightred alignRight" headers="dr1 dr8 dc1 dc2 dc4">37.4% </TD><TD class="lightred alignRight" headers="dr1 dr8 dc1 dc2 dc5">0.5% </TD><TD class="lightred alignRight" headers="dr1 dr8 dc1 dc2 dc6">62.2% </TD><TD class=alignRight headers="dr1 dr8 dc1 dc7">5.5% </TD><TD class=alignRight headers="dr1 dr8 dc1 dc8">100.0% </TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 5 - Cumulative numbers of adult hospitalizations with influenza
    reported by the PCIRN-SOS network, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=er1 rowSpan=3>Age groups </TH><TH id=ec1 class=noWrap colSpan=6>Cumulative (Aug. 25, 2013 to January 11, 2014)<SUP>*</SUP></TH></TR><TR class=bg-colour-yellow><TH id=ec2 colSpan=4 headers=ec1>Influenza A </TH><TH id=ec7 headers=ec1>B </TH><TH id=ec8 headers=ec1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=ec3 headers="ec1 ec2">A Total </TH><TH id=ec4 class="lightred " headers="ec1 ec2">A(H1) pdm09 </TH><TH id=ec5 class="lightred " headers="ec1 ec2">A(H3) </TH><TH id=ec6 class="lightred " headers="ec1 ec2">A(UnS) </TH><TD class=alignCenter headers="ec1 ec7">Total</TD><TD class=alignCenter headers="ec1 ec8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP id=footnote_t5_1>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.

    <SUP id=footnote_t5_star>*</SUP> Four cases for which the influenza type has not yet been reported, and one case for which the age-group was not reported are not included in Table 5.
    </TD></TR></TFOOT><TBODY><TR><TH id=er2 class=alignLeft headers=er1>16-20 </TH><TD class=alignRight headers="er1 er2 ec1 ec2 ec3">6 </TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec4">2 </TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec5">0 </TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec6">4 </TD><TD class=alignRight headers="er1 er2 ec1 ec7">0 </TD><TD class=alignRight headers="er1 er2 ec1 ec8">6 (2%) </TD></TR><TR><TH id=er3 class=alignLeft headers=er1>20-44 </TH><TD class=alignRight headers="er1 er3 ec1 ec2 ec3">94 </TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec4">36 </TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec5">1 </TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec6">57 </TD><TD class=alignRight headers="er1 er3 ec1 ec7">0 </TD><TD class=alignRight headers="er1 er3 ec1 ec8">94 (24%) </TD></TR><TR><TH id=er4 class=alignLeft headers=er1>45-64 </TH><TD class=alignRight headers="er1 er4 ec1 ec2 ec3">152 </TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec4">56 </TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec5">1 </TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec6">95 </TD><TD class=alignRight headers="er1 er4 ec1 ec7">4 </TD><TD class=alignRight headers="er1 er4 ec1 ec8">156 (40%) </TD></TR><TR><TH id=er5 class=alignLeft headers=er1>65+ </TH><TD class=alignRight headers="er1 er5 ec1 ec2 ec3">131 </TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec4">51 </TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec5">4 </TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec6">76 </TD><TD class=alignRight headers="er1 er5 ec1 ec7">7 </TD><TD class=alignRight headers="er1 er5 ec1 ec8">138 (35%) </TD></TR><TR><TH id=er6 class=alignLeft headers=er1>Total </TH><TD class=alignRight headers="er1 er6 ec1 ec2 ec3">383 </TD><TD class="lightred alignRight" headers="er1 er6 ec1 ec2 ec4">145 </TD><TD class="lightred alignRight" headers="er1 er6 ec1 ec2 ec5">6 </TD><TD class="lightred alignRight" headers="er1 er6 ec1 ec2 ec6">232 </TD><TD class=alignRight headers="er1 er6 ec1 ec7">11 </TD><TD class=alignRight headers="er1 er6 ec1 ec8">394 </TD></TR><TR><TH id=er7 class=alignLeft headers=er1>% <SUP>1</SUP></TH><TD class=alignRight headers="er1 er7 ec1 ec2 ec3">97% </TD><TD class="lightred alignRight" headers="er1 er7 ec1 ec2 ec4">38% </TD><TD class="lightred alignRight" headers="er1 er7 ec1 ec2 ec5">2% </TD><TD class="lightred alignRight" headers="er1 er7 ec1 ec2 ec6">61% </TD><TD class=alignRight headers="er1 er7 ec1 ec7">3% </TD><TD class=alignRight headers="er1 er7 ec1 ec8">100% </TD></TR></TBODY></TABLE>
    Figure 8. Number of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)


    Text equivalent for figure 8aNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    * See footnote above following the section related to PCIRN-SOS data.
    Text equivalent for figure 8bNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Adult hospitalizations (>16 year of age, PCIRN-SOS)
    Figure 9. Percentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)

    Text equivalent for figure 9aPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Text equivalent for figure 9bPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Top of Page

    Provincial/Territorial Influenza Hospitalizations and Deaths

    In week 02, 426 new laboratory-confirmed influenza-associated hospitalizations were reported from participating provinces and territories.<SUP>*</SUP> The majority were cases of influenza A (420, 99%), of which 215 (51.2%) were A(H1N1)pdm09, 16 (3.8%) were A(H3N2), and 189 (45.0%) were A(unsubtyped). There were 19 ICU admissions in week 02, all with influenza A.? Sixty-eight percent of the ICU admissions were among adults 20-64 years of age. Twenty-seven deaths were reported, all but two in adults 20 years of age and older, all with influenza A. The number of new influenza-associated hospitalizations and deaths reported for the current week may include cases from Ontario that occurred in previous weeks, as a result of retrospective updates to the cumulative total.
    To date this season, 1301 influenza-associated hospitalizations have been reported, 97.6% with influenza A (Table 6). Nearly 60% of hospitalizations have been cases 45 years of age or older. To date, a significantly greater proportion of adult cases (≥20 years of age) have been 20-64 years of age this season compared to the 2012-13 season which is consistent with the predominant circulation of A(H1N1)pdm09 this season. One hundred and thirty-five ICU admissions have been reported this season, all cases of influenza A; and 79% were among adults 20-64 years of age. Sixty deaths have been reported, and all but one were cases of influenza A. The highest proportion of deaths has been among adults 20-64 years of age (48.3%), followed by adults ≥65 years of age (43.3%). It is important to note that the hospitalization or death does not have to be attributable to influenza, a positive laboratory test is sufficient for reporting. Detailed clinical information (e.g. underlying medical conditions) is not known for these cases.
    * Note: Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not distinguished among hospital admissions reported from Ontario. Data may also include cases reported by the IMPACT and PCIRN networks.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION id=t6 class=alignCenter>Table 6. Cumulative number of hospitalizations with influenza reported by the participating provinces and territories, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=fr1 rowSpan=3>Age groups </TH><TH id=fc1 colSpan=6>Cumulative (Aug. 25, 2013 to January 11, 2014)* </TH></TR><TR class=bg-colour-yellow><TH id=fc2 colSpan=4 headers=fc1>Influenza A </TH><TH id=fc7 headers=fc1>B </TH><TH id=fc8 headers=fc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=fc3 headers="fc1 fc2">A Total </TH><TH id=fc4 class=lightred headers="fc1 fc2">A(H1) pdm09 </TH><TH id=fc5 class=lightred headers="fc1 fc2">A(H3) </TH><TH id=fc6 class=lightred headers="fc1 fc2">A (UnS) </TH><TD class=alignCenter headers="fc1 fc7">Total</TD><TD class=alignCenter headers="fc1 fc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=8><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    * Two cases for which age information is not available have not been included in Table 6.
    </TD></TR></TFOOT><TBODY><TR><TH id=fr2 class=alignLeft headers=fr1>0-4 years </TH><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc3">242 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc4">120 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc5">4 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc6">118 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc7">12 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc8">254 (20%) </TD></TR><TR><TH id=fr3 class=alignLeft headers=fr1>5-14 years </TH><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc3">53 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc4">33 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc5">2 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc6">18 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc7">4 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc8">57 (4%) </TD></TR><TR><TH id=fr4 class=alignLeft headers=fr1>15-19 years </TH><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc3">19 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc4">11 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc5">1 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc6">7 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc7">0 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc8">19 (1%) </TD></TR><TR><TH id=fr5 class=alignLeft headers=fr1>20-44 years </TH><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc3">220 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc4">143 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc5">2 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc6">75 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc7">1 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc8">221 (17%) </TD></TR><TR><TH id=fr6 class=alignLeft headers=fr1>45-64 years </TH><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc3">430 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc4">257 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc5">9 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc6">164 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc7">2 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc8">432 (33%) </TD></TR><TR><TH id=fr7 class=alignLeft headers=fr1>65+ years </TH><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc3">304 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc4">166 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc5">25 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc6">113 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc7">12 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc8">316 (24%) </TD></TR><TR><TH id=fr8 class=alignLeft headers=fr1>Total </TH><TD class=alignRight headers="fr1 fr8 fc1 fc2 fc3">1268 </TD><TD class="lightred alignRight" headers="fr1 fr8 fc1 fc2 fc4">730 </TD><TD class="lightred alignRight" headers="fr1 fr8 fc1 fc2 fc5">43 </TD><TD class="lightred alignRight" headers="fr1 fr8 fc1 fc2 fc6">495 </TD><TD class=alignRight headers="fr1 fr8 fc1 fc7">31 </TD><TD class=alignRight headers="fr1 fr8 fc1 fc8">1299 </TD></TR><TR><TH id=fr9 class=alignLeft headers=fr1>Percentage <SUP>1</SUP> </TH><TD class=alignRight headers="fr1 fr9 fc1 fc2 fc3">97.6% </TD><TD class="lightred alignRight" headers="fr1 fr9 fc1 fc2 fc4">57.6% </TD><TD class="lightred alignRight" headers="fr1 fr9 fc1 fc2 fc5">3.4% </TD><TD class="lightred alignRight" headers="fr1 fr9 fc1 fc2 fc6">39.0% </TD><TD class=alignRight headers="fr1 fr9 fc1 fc7">2.4% </TD><TD class=alignRight headers="fr1 fr9 fc1 fc8">100% </TD></TR></TBODY></TABLE>
    See additional data on Reported Influenza Hospitalizations and Deaths in Canada: 2009-10 to 2013-14 on the Public Health Agency of Canada website.

    .../

    Leave a comment:


  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Week 1

    FluWatch report: December 29, 2013 to January 4, 2014 (Week 01)

    Posted 2014-01-10For readers interested in the <ABBR title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A title="Flu Watch (Version PDF, 113 KB - 6 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w01_14/pdf/fw2014-01-eng.pdf">FluWatch report: December 29, 2013 to January 4, 2014 (Week 01) (<ABBR title="Portable Document Format">PDF</ABBR> Version - 291 <ABBR title=Kilobytes>KB</ABBR> - 10 pages)

    ?? Help with PDF documents


    Overall Summary
    • Influenza activity in Canada continued to increase in week 01 with increases in laboratory detections of influenza, ILI consultations, hospitalizations with influenza and prescriptions for influenza antivirals. A(H1N1)pdm09 remains the predominant virus subtype this season.
    • A greater proportion of cases have been reported among adults 20-64 years of age compared to those ≥65 years of age, which is a change from the demographics of the 2012-13 season when A(H3N2) was predominant.
    • A fatal case of A(H5N1) was reported in Alberta on 8 January 2014 in a patient with a travel history to China. Close contacts have shown no signs of infection and continue to be monitored. The risk to Canadians of transmission of A(H5N1) from this case is very low.
    Influenza/ILI Activity (geographic spread)

    In week 01, two regions in Alberta continued to report widespread activity, and 12 regions (in AB(1), SK(1), MB(1) ON(4), QC(3), NS(1) and NT(1)) reported localized activity (Figure 1).
    Figure 1. Map of overall influenza/ILI activity level by province and territory, Canada, Week 01





    Note: Influenza/ILI activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates and reported outbreaks. Please refer to detailed definitions at the end of the report. Maps from previous weeks, including any retrospective updates, are available on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada
    Influenza and Other Respiratory Virus Detections

    The number of positive influenza tests continued to increase, from 1,201 in week 52 to 2,308 in week 01, bringing the percentage of positive influenza tests to 28.4% (Figure 2). Cumulative influenza virus detections to date have been predominantly influenza A (95%). Among subtyped influenza A viruses, 96% (3,035/3,164) were A(H1N1)pdm09 (Table 1). Detailed information on age and type/subtype has been received for 3,842 cases to date this season. A significantly greater proportion of laboratory detections of influenza have been reported in adults 20-64 years of age compared to those ≥65 years of age this season compared to the 2012-13 season (Table 2). This is expected given the predominance of A(H1N1)pdm09 this season compared to 2012-13 when A(H3N2) was the dominant circulating subtype.
    Figure 2. Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14

    Text equivalent for figure 2Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14
    In week 01, the number of positive tests for RSV continued to increase, and RSV remained the second most frequently detected virus, after influenza. The number of positive tests for coronavirus and human metapneumovirus increased, while detections of rhinovirus and parainfluenza were stable in week 01, compared to week 52 (Figure 3).
    For more details, see the weekly Respiratory Virus Detections in Canada Report.
    Figure 3. Number of positive laboratory tests for other respiratory viruses by report week, Canada, 2013-14


    Top of Page

    RSV: Respiratory syncytial virus; hMPV: Human metapneumovirus
    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 1: Weekly and cumulative numbers of positive influenza specimens
    by type, subtype and province, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=ar1 rowSpan=3>Reporting provinces <SUP>1</SUP></TH><TH id=ac1 colSpan=5>Weekly
    (December 29, 2013 to January 4, 2014)
    </TH><TH id=ac8 colSpan=5>Cumulative
    (August 25, 2013 to January 4, 2014)
    </TH></TR><TR class=bg-colour-yellow><TH id=ac2 colSpan=4 headers=ac1>Influenza A</TH><TH id=ac7 headers=ac1>B</TH><TH id=ac9 colSpan=4 headers=ac8>Influenza A</TH><TH id=ac14 headers=ac8>B</TH></TR><TR class=bg-colour-grey-light><TH id=ac3 headers="ac1 ac2">A Total</TH><TH id=ac4 class=lightred headers="ac1 ac2">A(H1)pdm09</TH><TH id=ac5 class=lightred headers="ac1 ac2">A(H3)</TH><TH id=ac6 class=lightred headers="ac1 ac2">A(UnS)</TH><TH class=alignCenter headers="ac1 ac7">B Total</TH><TH id=ac10 headers="ac8 ac9">A Total</TH><TH id=ac11 class=lightred headers="ac8 ac9">A(H1)pdm09</TH><TH id=ac12 class=lightred headers="ac8 ac9">A(H3)</TH><TH id=ac13 class=lightred headers="ac8 ac9">A(UnS)</TH><TD class=alignCenter headers="ac8 ac14">B Total</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=11><SUP>1 </SUP>Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.
    <SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=ar2 class=alignLeft headers=ar1>BC</TH><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac3">207</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac4">85</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac6">122</TD><TD class=alignRight headers="ar1 ar2 ac1 ac7">4</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac10">415</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac11">274</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac12">12</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac13">129</TD><TD class=alignRight headers="ar1 ar2 ac8 ac14">15</TD></TR><TR><TH id=ar3 class=alignLeft headers=ar1>AB</TH><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac3">630</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac4">502</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac5">2</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac6">126</TD><TD class=alignRight headers="ar1 ar3 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac10">1503</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac11">1348</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac12">14</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac13">141</TD><TD class=alignRight headers="ar1 ar3 ac8 ac14">21</TD></TR><TR><TH id=ar4 class=alignLeft headers=ar1>SK</TH><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac3">198</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac4">138</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac6">60</TD><TD class=alignRight headers="ar1 ar4 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac10">365</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac11">230</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac12">0</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac13">135</TD><TD class=alignRight headers="ar1 ar4 ac8 ac14">0</TD></TR><TR><TH id=ar5 class=alignLeft headers=ar1>MB</TH><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac3">29</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac4">16</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac6">13</TD><TD class=alignRight headers="ar1 ar5 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac10">57</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac11">37</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac12">0</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac13">20</TD><TD class=alignRight headers="ar1 ar5 ac8 ac14">6</TD></TR><TR><TH id=ar6 class=alignLeft headers=ar1>ON</TH><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac3">676</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac4">300</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac5">17</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac6">359</TD><TD class=alignRight headers="ar1 ar6 ac1 ac7">10</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac10">1702</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac11">1033</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac12">100</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac13">569</TD><TD class=alignRight headers="ar1 ar6 ac8 ac14">37</TD></TR><TR><TH id=ar7 class=alignLeft headers=ar1>QC</TH><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac3">426</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac4">58</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac6">368</TD><TD class=alignRight headers="ar1 ar7 ac1 ac7">65</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac10">793</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac11">91</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac12">1</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac13">701</TD><TD class=alignRight headers="ar1 ar7 ac8 ac14">167</TD></TR><TR><TH id=ar8 class=alignLeft headers=ar1>NB</TH><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac3">29</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac4">4</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac6">25</TD><TD class=alignRight headers="ar1 ar8 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac10">41</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac11">5</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac12">1</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac13">35</TD><TD class=alignRight headers="ar1 ar8 ac8 ac14">0</TD></TR><TR><TH id=ar9 class=alignLeft headers=ar1>NS</TH><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac3">9</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac6">9</TD><TD class=alignRight headers="ar1 ar9 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac10">17</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac11">2</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac12">1</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac13">14</TD><TD class=alignRight headers="ar1 ar9 ac8 ac14">0</TD></TR><TR><TH id=ar10 class=alignLeft headers=ar1>PE</TH><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac3">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac10">1</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac11">1</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac12">0</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac13">0</TD><TD class=alignRight headers="ar1 ar10 ac8 ac14">0</TD></TR><TR><TH id=ar11 class=alignLeft headers=ar1>NL</TH><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac3">23</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac6">23</TD><TD class=alignRight headers="ar1 ar11 ac1 ac7">2</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac10">38</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac11">14</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac12">0</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac13">24</TD><TD class=alignRight headers="ar1 ar11 ac8 ac14">6</TD></TR><TR><TH id=ar12 class=alignLeft headers=ar1>Canada</TH><TD class=alignRight headers="ar1 ar12 ac1 ac2 ac3">2227</TD><TD class="lightred alignRight" headers="ar1 ar12 ac1 ac2 ac4">1103</TD><TD class="lightred alignRight" headers="ar1 ar12 ac1 ac2 ac5">19</TD><TD class="lightred alignRight" headers="ar1 ar12 ac1 ac2 ac6">1105</TD><TD class=alignRight headers="ar1 ar12 ac1 ac7">81</TD><TD class=alignRight headers="ar1 ar12 ac8 ac9 ac10">4932</TD><TD class="lightred alignRight" headers="ar1 ar12 ac8 ac9 ac11">3035</TD><TD class="lightred alignRight" headers="ar1 ar12 ac8 ac9 ac12">129</TD><TD class="lightred alignRight" headers="ar1 ar12 ac8 ac9 ac13">1768</TD><TD class=alignRight headers="ar1 ar12 ac8 ac14">252</TD></TR><TR><TH id=ar13 class=alignLeft headers=ar1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="ar1 ar13 ac1 ac2 ac3">96.5%</TD><TD class="lightred alignRight" headers="ar1 ar13 ac1 ac2 ac4">49.5%</TD><TD class="lightred alignRight" headers="ar1 ar13 ac1 ac2 ac5">0.9%</TD><TD class="lightred alignRight" headers="ar1 ar13 ac1 ac2 ac6">49.6%</TD><TD class=alignRight headers="ar1 ar13 ac1 ac7">3.5%</TD><TD class=alignRight headers="ar1 ar13 ac8 ac9 ac10">95.1%</TD><TD class="lightred alignRight" headers="ar1 ar13 ac8 ac9 ac11">61.5%</TD><TD class="lightred alignRight" headers="ar1 ar13 ac8 ac9 ac12">2.6%</TD><TD class="lightred alignRight" headers="ar1 ar13 ac8 ac9 ac13">35.8%</TD><TD class=alignRight headers="ar1 ar13 ac8 ac14">4.9%</TD></TR></TBODY></TABLE>

    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 2. Weekly and cumulative numbers of positive influenza specimens by type, subtype and age-group reported through case-based laboratory reporting<SUP>3</SUP>, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=br1 rowSpan=3>Age groups (years)</TH><TH id=bc1 colSpan=5>Weekly
    (December 29, 2013 to January 4, 2014)
    </TH><TH id=bc8 colSpan=7>Cumulative
    (August 25, 2013 to January 4, 2014)
    </TH></TR><TR class=bg-colour-yellow><TH id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH id=bc7 headers=bc1>B</TH><TH id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH id=bc14 headers=bc8>B</TH><TH id=bc15 colSpan=2 headers=bc8>Influenza A and B</TH></TR><TR class=bg-colour-grey-light><TH id=bc3 headers="bc1 bc2">A Total</TH><TH id=bc4 class="lightred " headers="bc1 bc2">A(H1) pdm09</TH><TH id=bc5 class="lightred " headers="bc1 bc2">A(H3)</TH><TH id=bc6 class="lightred " headers="bc1 bc2">A (UnS)</TH><TD class=alignCenter headers="bc1 bc7">Total</TD><TH id=bc10 headers="bc8 bc9">A Total</TH><TH id=bc11 class="lightred " headers="bc8 bc9">A(H1) pdm09</TH><TH id=bc12 class="lightred " headers="bc8 bc9">A(H3)</TH><TH id=bc13 class="lightred " headers="bc8 bc9">A (UnS)</TH><TD class=alignCenter headers="bc8 bc14">Total</TD><TH id=bc16 headers="bc8 bc15">#</TH><TH id=bc17 headers="bc8 bc15">%</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=13><SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    <SUP>3 </SUP>Table 2 includes specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=br2 class=alignLeft headers=br1><5</TH><TD class=alignRight headers="br1 br2 bc1 bc2 bc3">120</TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc4">49</TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc6">71</TD><TD class=alignRight headers="br1 br2 bc1 bc7">3</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc10">625</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc11">356</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc12">15</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc13">254</TD><TD class=alignRight headers="br1 br2 bc8 bc14">42</TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc16">667</TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc17">17.2%</TD></TR><TR><TH id=br3 class=alignLeft headers=br1>5-19</TH><TD class=alignRight headers="br1 br3 bc1 bc2 bc3">25</TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc4">11</TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc6">14</TD><TD class=alignRight headers="br1 br3 bc1 bc7">4</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc10">281</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc11">195</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc12">6</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc13">80</TD><TD class=alignRight headers="br1 br3 bc8 bc14">43</TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc16">324</TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc17">8.4%</TD></TR><TR><TH id=br4 class=alignLeft headers=br1>20-44</TH><TD class=alignRight headers="br1 br4 bc1 bc2 bc3">240</TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc4">102</TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc6">138</TD><TD class=alignRight headers="br1 br4 bc1 bc7">11</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc10">1161</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc11">716</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc12">11</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc13">434</TD><TD class=alignRight headers="br1 br4 bc8 bc14">51</TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc16">1212</TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc17">31.3%</TD></TR><TR><TH id=br5 class=alignLeft headers=br1>45-64</TH><TD class=alignRight headers="br1 br5 bc1 bc2 bc3">206</TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc4">70</TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc6">136</TD><TD class=alignRight headers="br1 br5 bc1 bc7">21</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc10">968</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc11">558</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc12">16</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc13">394</TD><TD class=alignRight headers="br1 br5 bc8 bc14">77</TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc16">1045</TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc17">27.0%</TD></TR><TR><TH id=br6 class=alignLeft headers=br1>65+</TH><TD class=alignRight headers="br1 br6 bc1 bc2 bc3">119</TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc4">37</TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc5">1</TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc6">81</TD><TD class=alignRight headers="br1 br6 bc1 bc7">22</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc10">480</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc11">221</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc12">24</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc13">235</TD><TD class=alignRight headers="br1 br6 bc8 bc14">114</TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc16">594</TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc17">15.4%</TD></TR><TR><TH id=br7 class=alignLeft headers=br1>Unknown</TH><TD class=alignRight headers="br1 br7 bc1 bc2 bc3">1</TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc4">0</TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc6">1</TD><TD class=alignRight headers="br1 br7 bc1 bc7">0</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc10">26</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc11">16</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc12">4</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc13">6</TD><TD class=alignRight headers="br1 br7 bc8 bc14">0</TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc16">26</TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc17">0.7%</TD></TR><TR><TH id=br8 class=alignLeft headers=br1>Total</TH><TD class=alignRight headers="br1 br8 bc1 bc2 bc3">711</TD><TD class="lightred alignRight" headers="br1 br8 bc1 bc2 bc4">269</TD><TD class="lightred alignRight" headers="br1 br8 bc1 bc2 bc5">1</TD><TD class="lightred alignRight" headers="br1 br8 bc1 bc2 bc6">441</TD><TD class=alignRight headers="br1 br8 bc1 bc7">61</TD><TD class=alignRight headers="br1 br8 bc8 bc9 bc10">3541</TD><TD class="lightred alignRight" headers="br1 br8 bc8 bc9 bc11">2062</TD><TD class="lightred alignRight" headers="br1 br8 bc8 bc9 bc12">76</TD><TD class="lightred alignRight" headers="br1 br8 bc8 bc9 bc13">1403</TD><TD class=alignRight headers="br1 br8 bc8 bc14">327</TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc16">3868</TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc17">100.0%</TD></TR><TR><TH id=br9 class=alignLeft headers=br1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="br1 br9 bc1 bc2 bc3">92.1%</TD><TD class="lightred alignRight" headers="br1 br9 bc1 bc2 bc4">37.8%</TD><TD class="lightred alignRight" headers="br1 br9 bc1 bc2 bc5">0.1%</TD><TD class="lightred alignRight" headers="br1 br9 bc1 bc2 bc6">62.0%</TD><TD class=alignRight headers="br1 br9 bc1 bc7">7.9%</TD><TD class=alignRight headers="br1 br9 bc8 bc9 bc10">91.5%</TD><TD class="lightred alignRight" headers="br1 br9 bc8 bc9 bc11">58.2%</TD><TD class="lightred alignRight" headers="br1 br9 bc8 bc9 bc12">2.1%</TD><TD class="lightred alignRight" headers="br1 br9 bc8 bc9 bc13">39.6%</TD><TD class=alignRight headers="br1 br9 bc8 bc14">8.5%</TD><TD class=alignRight></TD><TD class=alignRight></TD></TR></TBODY></TABLE>

    Top of Page

    Influenza Strain Characterizations

    During the 2013-2014 influenza season, the National Microbiology Laboratory (NML) has antigenically characterized 234 influenza viruses [22 A(H3N2), 179 A(H1N1)pdm09 and 33 influenza B]. The vast majority (97.9%) of viruses were similar to the strains recommended by the WHO for the 2013-14 seasonal influenza vaccine. Two A(H1N1)pdm09 viruses showed reduced titres to antiserum against the reference A/California/07/2009 strain. Five influenza B viruses were similar to the strain recommended by the WHO for the 2011-12 vaccine (Figure 4).
    Figure 4. Influenza strain characterizations, Canada, 2013-14, N = 234

    The NML receives a proportion of the number of influenza positive specimens from provincial laboratories for strain characterization and antiviral resistance testing. Characterization data reflect the results of haemagglutination inhibition (HAI) testing compared to the reference influenza strains recommended by WHO.
    The recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b (e.g. A/Texas/50/2012), and a B/Massachusetts/2/2012-like virus (Yamagata lineage).


    Text equivalent for figure 4Influenza strain characterizations, Canada, 2013-2014, N =3
    Antiviral Resistance

    During the 2013-2014 influenza season, NML has tested 197 influenza viruses for resistance to oseltamivir and for resistance to zanamivir, and all were sensitive. All 166 influenza A viruses tested for amantadine resistance were resistant (Table 3).
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=cr1 rowSpan=2>Virus type and subtype</TH><TH id=cc1 colSpan=2>Oseltamivir</TH><TH id=cc4 colSpan=2>Zanamivir</TH><TH id=cc7 colSpan=2>Amantadine</TH></TR><TR class=bg-colour-yellow><TH id=cc2 headers=cc1># tested</TH><TH id=cc3 headers=cc1># resistant (%)</TH><TH id=cc5 headers=cc4># tested</TH><TH id=cc6 headers=cc4># resistant (%)</TH><TH id=cc8 headers=cc7># tested</TH><TH id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH id=cr2 class="alignLeft lightred" headers=cr1>A (H3N2)</TH><TD class=alignRight headers="cr1 cr2 cc1 cc2">23 </TD><TD class=alignRight headers="cr1 cr2 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr2 cc4 cc5">23 </TD><TD class=alignRight headers="cr1 cr2 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr2 cc7 cc8">29 </TD><TD class=alignRight headers="cr1 cr2 cc7 cc9">29 (100%) </TD></TR><TR><TH id=cr3 class="alignLeft lightred" headers=cr1>A (H1N1)</TH><TD class=alignRight headers="cr1 cr3 cc1 cc2">143 </TD><TD class=alignRight headers="cr1 cr3 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr3 cc4 cc5">143 </TD><TD class=alignRight headers="cr1 cr3 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr3 cc7 cc8">137 </TD><TD class=alignRight headers="cr1 cr3 cc7 cc9">137 (100%) </TD></TR><TR><TH id=cr4 class="alignLeft lightred" headers=cr1>B</TH><TD class=alignRight headers="cr1 cr4 cc1 cc2">31 </TD><TD class=alignRight headers="cr1 cr4 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr4 cc4 cc5">31 </TD><TD class=alignRight headers="cr1 cr4 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr4 cc7 cc8">NA <SUP>*</SUP></TD><TD class=alignRight headers="cr1 cr4 cc7 cc9">NA <SUP>*</SUP></TD></TR><TR><TH id=cr5 class="alignLeft lightred" headers=cr1>TOTAL</TH><TD class=alignRight headers="cr1 cr5 cc1 cc2">197 </TD><TD class=alignRight headers="cr1 cr5 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr5 cc4 cc5">197 </TD><TD class=alignRight headers="cr1 cr5 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr5 cc7 cc8">166 </TD><TD class=alignRight headers="cr1 cr5 cc7 cc9">166 (100%) </TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate increased from 36.2/1,000 in week 52 to 48.5/1,000 in week 01, but is still within the expected range for this time of year (Figure 5).
    Figure 5. Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Note: No data available for mean rate for weeks 19 to 39 for the 1996-1997 through 2002-2003 seasons. Delays in the reporting of data may cause data to change retrospectively. The calculation of the average ILI consultation rate over 17 seasons was aligned with influenza activity in each season. In BC, AB, and SK, data is compiled by a provincial sentinel surveillance program for reporting to FluWatch. The number of sentinel physicians in each province or territory is as follows: BC(21), AB(80), SK(11), MB(18), ON(169), QC(14), NB(29), NS(26), PE(4), NL(16), NU(1), NT(14), YT(13). Not all sentinel physicians report every week.
    Text equivalent for figure 5Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Top of Page

    Influenza Outbreak Surveillance

    In week 01, nine new influenza outbreaks were reported: eight in long-term care facilities and one in a hospital (Figure 6).
    Figure 6. Overall number of new influenza outbreaks by report week, Canada, 2013-2014

    1 All provinces and territories except NU report outbreaks in long-term care facilities. All provinces and territories with the exception of NU and QC report outbreaks in hospitals. Outbreaks of influenza or influenza-like-illness in other facilities are reported to FluWatch but reporting varies between jurisdictions. Outbreak definitions are included at the end of the report.
    Text equivalent for figure 6 Overall number of new influenza outbreaks by report week, Canada, 2013-2014
    Pharmacy Surveillance

    The rate of prescriptions for influenza antivirals followed a trend consistent with laboratory detections of influenza this season, compared with the two previous seasons. The largest proportions of prescriptions for antivirals are among adults 19-64 years of age and children 2-18 years of age. This is in keeping with the age-distribution observed among laboratory detections and hospitalizations during the season to date (Figure 7).
    Figure 7. Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Note: Pharmacy sales data are provided to the Public Health Agency of Canada by Rx Canada Inc. and sourced from major retail drug chains representing over 3,000 stores nationwide (excluding Nunavut) in 85% of Health Regions. Data provided include the number of new antiviral prescriptions (for Tamiflu and Relenza) and the total number of new prescriptions dispensed by Province/Territory and age group. Age-groups: Infant: 0-2y, Child: 2-18y; Adult: 19-64y, Senior: ≥65y.
    Text equivalent for figure 7Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Top of Page

    Sentinel Hospital Influenza Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)
    In week 01, 40 new laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalizations were reported by the Immunization Monitoring Program Active (IMPACT) network, compared to 53 in week 52. All 40 hospitalizations in week 01 were cases with influenza A; 30% of these were A(H1N1)pdm09 and the remainder were A(unsubtyped) (Figure 8a). All but three of the cases were <5 years of age: of these, 13 (32.5%) were under 6 months of age, 9 (22.5%) 6-23 months of age, and 15 (37.5%) 2-4 years of age. Six ICU admissions were reported in week 01, two children 6-23 months of age, one 2-4 years of age, and three 5-9 years of age; all with influenza A. No deaths were reported.
    To date this season, a total of 183 influenza-associated paediatric hospitalizations have been reported by the IMPACT network, 93% of which have been influenza A, and the majority of those subtyped were A(H1N1)pdm09 (Table 4). Eighty-five (46.4%) cases have been children under 2 years of age, and 143 (78.1%) have been under 5 years of age. Twenty-four ICU admissions have been reported; all but two cases with influenza A, and the majority A(H1N1)pdm09. The age-distribution is as follows: two children under 6 months of age, nine children 6-23 months of age, six 2-4 years of age, two 5-9 years of age, and five 10-16 years of age (Figure 9a). Among the 22 ICU cases with available data, 16 were reported to have comorbidities or concurrent infection. No deaths have been reported.

    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.

    Adult Influenza Hospitalizations and Deaths (PCIRN)
    The number of new laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations reported through active* surveillance by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network increased from 63 in week 52 to 89 in week 01. Among cases in week 01, 86 (96.6%) were influenza A, of which 19 (22.1%) were A(H1N1)pdm09 and 67 (77.9%) were A(unsubtyped). The highest proportion of hospitalizations occurred among adults ≥65 years of age (36; 40.4%), followed by adults aged 45-64 years (31; 34.8%). Nineteen ICU admissions were reported in week 01: five (26.3%) cases 20-44 years of age, and eight (36.8%) cases in each of the age-groups 45-64 years and ≥65 years of age. One death was reported, in an adult ≥65 years of age with influenza A(unsubtyped) (Figure 8b).

    To date this season, 270 influenza-associated hospitalizations have been reported by the PCIRN-SOS network, 261 (96.7%) with influenza A, predominantly A(H1N1)pdm09. The majority (71%) have been adults over 45 years of age (Table 5). ICU admission was required for 48 hospitalizations: 47 of which were cases of influenza A (25 A(H1N1)pdm09 and 22 A(unsubtyped)); 34 (70.8%) of the ICU admissions were >45 years of age. Of the 18 cases with information on influenza vaccination, 14 reported not having been vaccinated this season. One death has been reported, a case ≥65 years of age with A(unsubtyped) (Figure 9b).

    Note: PCIRN-SOS conducted passive surveillance from April 30th to November 14th, 2013. Cases reported during this period were identified by laboratory detection of influenza among patients admitted to participating hospitals. Active surveillance began November 15th during which time PCIRN site coordinators investigate cases potentially related to influenza. Data from both active and passive surveillance reported during the 2013-14 season are included in this report. The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 4 - Cumulative numbers of paediatric hospitalizations with influenza reported by the IMPACT network, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=dr1 rowSpan=3>Age groups </TH><TH id=dc1 colSpan=6>Cumulative (Aug. 25, 2013 to January 4, 2014) </TH></TR><TR class=bg-colour-yellow><TH id=dc2 colSpan=4 headers=dc1>Influenza A </TH><TH id=dc7 headers=dc1>B </TH><TH id=dc8 headers=dc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=dc3 headers="dc1 dc2">A Total </TH><TH id=dc4 class="lightred " headers="dc1 dc2">A(H1) pdm09 </TH><TH id=dc5 class="lightred " headers="dc1 dc2">A(H3) </TH><TH id=dc6 class="lightred " headers="dc1 dc2">A (UnS) </TH><TD class=alignCenter headers="dc1 dc7">Total</TD><TD class=alignCenter headers="dc1 dc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=dr2 class=alignLeft headers=dr1>0-5m </TH><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc3">37 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc4">10 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc6">27 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc7">1 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc8">38 (21%) </TD></TR><TR><TH id=dr3 class=alignLeft headers=dr1>6-23m </TH><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc3">46 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc4">23 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc6">23 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc7">1 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc8">47 (26%) </TD></TR><TR><TH id=dr4 class=alignLeft headers=dr1>2-4y </TH><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc3">53 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc4">20 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc5">1 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc6">32 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc7">5 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc8">58 (32%) </TD></TR><TR><TH id=dr5 class=alignLeft headers=dr1>5-9y </TH><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc3">22 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc4">10 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc6">12 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc7">3 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc8">25 (14%) </TD></TR><TR><TH id=dr6 class=alignLeft headers=dr1>10-16y </TH><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc3">13 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc4">7 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc6">6 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc7">2 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc8">15 (8%) </TD></TR><TR><TH id=dr7 class=alignLeft headers=dr1>Total </TH><TD class=alignRight headers="dr1 dr7 dc1 dc2 dc3">171 </TD><TD class="lightred alignRight" headers="dr1 dr7 dc1 dc2 dc4">70 </TD><TD class="lightred alignRight" headers="dr1 dr7 dc1 dc2 dc5">1 </TD><TD class="lightred alignRight" headers="dr1 dr7 dc1 dc2 dc6">100 </TD><TD class=alignRight headers="dr1 dr7 dc1 dc7">12 </TD><TD class=alignRight headers="dr1 dr7 dc1 dc8">183 </TD></TR><TR><TH id=dr8 class=alignLeft headers=dr1>% <SUP>1</SUP> </TH><TD class=alignRight headers="dr1 dr8 dc1 dc2 dc3">93.4% </TD><TD class="lightred alignRight" headers="dr1 dr8 dc1 dc2 dc4">40.9% </TD><TD class="lightred alignRight" headers="dr1 dr8 dc1 dc2 dc5">0.6% </TD><TD class="lightred alignRight" headers="dr1 dr8 dc1 dc2 dc6">58.5% </TD><TD class=alignRight headers="dr1 dr8 dc1 dc7">6.6% </TD><TD class=alignRight headers="dr1 dr8 dc1 dc8">100.0% </TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 5 - Cumulative numbers of adult hospitalizations with influenza
    reported by the PCIRN-SOS network, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=er1 rowSpan=3>Age groups </TH><TH id=ec1 class=noWrap colSpan=6>Cumulative (Aug. 25, 2013 to January 4, 2014) </TH></TR><TR class=bg-colour-yellow><TH id=ec2 colSpan=4 headers=ec1>Influenza A </TH><TH id=ec7 headers=ec1>B </TH><TH id=ec8 headers=ec1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=ec3 headers="ec1 ec2">A Total </TH><TH id=ec4 class="lightred " headers="ec1 ec2">A(H1) pdm09 </TH><TH id=ec5 class="lightred " headers="ec1 ec2">A(H3) </TH><TH id=ec6 class="lightred " headers="ec1 ec2">A(UnS) </TH><TD class=alignCenter headers="ec1 ec7">Total</TD><TD class=alignCenter headers="ec1 ec8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=er2 class=alignLeft headers=er1>16-20 </TH><TD class=alignRight headers="er1 er2 ec1 ec2 ec3">5 </TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec4">2 </TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec5">0 </TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec6">3 </TD><TD class=alignRight headers="er1 er2 ec1 ec7">0 </TD><TD class=alignRight headers="er1 er2 ec1 ec8">5 (2%) </TD></TR><TR><TH id=er3 class=alignLeft headers=er1>20-44 </TH><TD class=alignRight headers="er1 er3 ec1 ec2 ec3">73 </TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec4">23 </TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec5">1 </TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec6">49 </TD><TD class=alignRight headers="er1 er3 ec1 ec7">0 </TD><TD class=alignRight headers="er1 er3 ec1 ec8">73 (27%) </TD></TR><TR><TH id=er4 class=alignLeft headers=er1>45-64 </TH><TD class=alignRight headers="er1 er4 ec1 ec2 ec3">100 </TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec4">32 </TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec5">1 </TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec6">67 </TD><TD class=alignRight headers="er1 er4 ec1 ec7">4 </TD><TD class=alignRight headers="er1 er4 ec1 ec8">104 (39%) </TD></TR><TR><TH id=er5 class=alignLeft headers=er1>65+ </TH><TD class=alignRight headers="er1 er5 ec1 ec2 ec3">83 </TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec4">34 </TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec5">4 </TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec6">45 </TD><TD class=alignRight headers="er1 er5 ec1 ec7">4 </TD><TD class=alignRight headers="er1 er5 ec1 ec8">87 (32%) </TD></TR><TR><TH id=er6 class=alignLeft headers=er1>Total </TH><TD class=alignRight headers="er1 er6 ec1 ec2 ec3">261 </TD><TD class="lightred alignRight" headers="er1 er6 ec1 ec2 ec4">91 </TD><TD class="lightred alignRight" headers="er1 er6 ec1 ec2 ec5">6 </TD><TD class="lightred alignRight" headers="er1 er6 ec1 ec2 ec6">164 </TD><TD class=alignRight headers="er1 er6 ec1 ec7">8 </TD><TD class=alignRight headers="er1 er6 ec1 ec8">269 </TD></TR><TR><TH id=er7 class=alignLeft headers=er1>%<SUP>1</SUP> </TH><TD class=alignRight headers="er1 er7 ec1 ec2 ec3">97% </TD><TD class="lightred alignRight" headers="er1 er7 ec1 ec2 ec4">35% </TD><TD class="lightred alignRight" headers="er1 er7 ec1 ec2 ec5">2% </TD><TD class="lightred alignRight" headers="er1 er7 ec1 ec2 ec6">63% </TD><TD class=alignRight headers="er1 er7 ec1 ec7">3% </TD><TD class=alignRight headers="er1 er7 ec1 ec8">100% </TD></TR></TBODY></TABLE>
    Figure 8. Number of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)


    Text equivalent for figure 8aNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    * See footnote above following the section related to PCIRN-SOS data.
    Text equivalent for figure 8bNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Adult hospitalizations (>16 year of age, PCIRN-SOS)
    Figure 9. Percentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)

    Text equivalent for figure 9aPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Text equivalent for figure 9bPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Top of Page

    Provincial/Territorial Influenza Hospitalizations and Deaths

    In week 01, 236 new laboratory-confirmed influenza-associated hospitalizations were reported from participating provinces and territories.* The majority were cases of influenza A (97%), of which 102 (44.5%) were A(H1N1)pdm09, five were A(H3N2), and 122 were A(unsubtyped). There were 13 ICU admissions in week 01, all with influenza A. More than three quarters of the ICU admissions were among adults 20-64 years of age. Twelve deaths were reported in adults 20 years of age and older, all with influenza A. The number of new influenza-associated hospitalizations and deaths reported for the current week may include cases from Ontario that occurred in previous weeks, as a result of retrospective updates to the cumulative total.
    To date this season, 882 influenza-associated hospitalizations have been reported, of which 97.2% had influenza A (Table 6). The largest proportion of hospitalizations has been among cases 45-64 years of age (33%). To date, a significantly greater proportion of adult cases (≥20 years of age) have been 20-64 years of age this season compared to the 2012-13 season which is consistent with the predominant circulation of A(H1N1)pdm09 this season. One hundred and eighteen ICU admissions have been reported this season, all cases of influenza A; and 77% were among adults aged 20-64 years. Thirty-three deaths have been reported, and all but one were cases of influenza A. The highest proportion of deaths has been among adults 20-64 years of age (64%), followed by adults ≥65 years of age (27%). It is important to note that the hospitalization or death does not have to be attributable to influenza, a positive laboratory test is sufficient for reporting. Detailed clinical information (e.g. underlying medical conditions) is not known for these cases.
    * Note: Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not distinguished among hospital admissions reported from Ontario. Data may also include cases reported by the IMPACT and PCIRN networks.

    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 6. Cumulative number of hospitalizations with influenza reported by the participating provinces and territories, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=fr1 rowSpan=3>Age groups </TH><TH id=fc1 colSpan=6>Cumulative (Aug. 25, 2013 to January 4, 2014)* </TH></TR><TR class=bg-colour-yellow><TH id=fc2 colSpan=4 headers=fc1>Influenza A </TH><TH id=fc7 headers=fc1>B </TH><TH id=fc8 headers=fc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=fc3 headers="fc1 fc2">A Total </TH><TH id=fc4 class=lightred headers="fc1 fc2">A(H1) pdm09 </TH><TH id=fc5 class=lightred headers="fc1 fc2">A(H3) </TH><TH id=fc6 class=lightred headers="fc1 fc2">A (UnS) </TH><TD class=alignCenter headers="fc1 fc7">Total</TD><TD class=alignCenter headers="fc1 fc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=8><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    * Two cases for which age information is not available have not been included in Table 6.
    </TD></TR></TFOOT><TBODY><TR><TH id=fr2 class=alignLeft headers=fr1>0-4 years </TH><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc3">167 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc4">94 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc5">4 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc6">69 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc7">12 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc8">179 (20%) </TD></TR><TR><TH id=fr3 class=alignLeft headers=fr1>5-14 years </TH><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc3">45 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc4">25 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc5">1 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc6">19 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc7">3 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc8">48 (5%) </TD></TR><TR><TH id=fr4 class=alignLeft headers=fr1>15-19 years </TH><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc3">13 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc4">7 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc5">0 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc6">6 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc7">0 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc8">13 (1%) </TD></TR><TR><TH id=fr5 class=alignLeft headers=fr1>20-44 years </TH><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc3">165 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc4">104 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc5">1 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc6">60 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc7">0 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc8">165 (19%) </TD></TR><TR><TH id=fr6 class=alignLeft headers=fr1>45-64 years </TH><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc3">289 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc4">177 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc5">9 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc6">103 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc7">1 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc8">290 (33%) </TD></TR><TR><TH id=fr7 class=alignLeft headers=fr1>65+ years </TH><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc3">176 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc4">110 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc5">12 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc6">54 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc7">9 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc8">185 (21%) </TD></TR><TR><TH id=fr8 class=alignLeft headers=fr1>Total </TH><TD class=alignRight headers="fr1 fr8 fc1 fc2 fc3">855 </TD><TD class="lightred alignRight" headers="fr1 fr8 fc1 fc2 fc4">517 </TD><TD class="lightred alignRight" headers="fr1 fr8 fc1 fc2 fc5">27 </TD><TD class="lightred alignRight" headers="fr1 fr8 fc1 fc2 fc6">311 </TD><TD class=alignRight headers="fr1 fr8 fc1 fc7">25 </TD><TD class=alignRight headers="fr1 fr8 fc1 fc8">880 </TD></TR><TR><TH id=fr9 class=alignLeft headers=fr1>Percentage <SUP>1</SUP> </TH><TD class=alignRight headers="fr1 fr9 fc1 fc2 fc3">97.2% </TD><TD class="lightred alignRight" headers="fr1 fr9 fc1 fc2 fc4">60.5% </TD><TD class="lightred alignRight" headers="fr1 fr9 fc1 fc2 fc5">3.2% </TD><TD class="lightred alignRight" headers="fr1 fr9 fc1 fc2 fc6">36.4% </TD><TD class=alignRight headers="fr1 fr9 fc1 fc7">2.8% </TD><TD class=alignRight headers="fr1 fr9 fc1 fc8">100% </TD></TR></TBODY></TABLE>

    .../

    Leave a comment:


  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Weeks 51-52

    FluWatch report: December 15 to 28, 2013 (Weeks 51 & 52)

    Posted 2014-01-03For readers interested in the <ABBR title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A title="Flu Watch (Version PDF, 113 KB - 6 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w52_13/pdf/fw2013-51-52-eng.pdf">FluWatch report: December 15 to 28, 2013 (Weeks 51 & 52) (<ABBR title="Portable Document Format">PDF</ABBR> Version - 291 <ABBR title=Kilobytes>KB</ABBR> - 10 pages)

    ?? Help with PDF documents

    Overall Summary
    • Influenza activity in Canada continued to increase sharply in weeks 51 and 52 with increases in laboratory detections of influenza, ILI consultations, hospitalizations with influenza and prescriptions for influenza antivirals.
    • Influenza A has been identified in >90% of cases this season, and A(H1N1)pdm09 remains the predominant subtype, representing approximately 90% of subtyped influenza viruses.
    • A greater proportion of cases have been reported among adults 20-64 years of age compared to those ≥65 years of age, which is a change from the demographics of the 2012-13 season when A(H3N2) was predominant.

    Influenza/ILI Activity (geographic spread)

    In weeks 51 and 52, the same two regions in Alberta reported widespread activity. In week 51, three regions in Ontario reported localized activity and in week 52 six regions (in SK(1), ON(4), and NT(1)) reported localized activity (Figure 1). However, no data was received for 20 regions in each of weeks 51 and 52.
    Figure 1. Map of overall influenza/ILI activity level by province and territory, Canada, Week 52





    Note: Influenza/ILI activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates and reported outbreaks. Please refer to detailed definitions at the end of the report. Maps from previous weeks, including any retrospective updates, are available on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada
    Influenza and Other Respiratory Virus Detections

    The number of positive influenza tests continued to increase in weeks 51 and 52, from 382 in week 50 to 754 in week 51 and 1152 in week 52. The percentage of positive influenza tests increased to 17.3% in week 51 and 23.6% in week 52 (Figure 2). Cumulative influenza virus detections to date have been predominantly influenza A (94%). Among subtyped influenza A viruses, 94% (1731/1843) were A(H1N1)pdm09 (Table 1). Detailed information on age and type/subtype has been received for 2,819 cases to date this season. A significantly greater proportion of laboratory detections of influenza have been reported in adults 20-64 years of age compared to those ≥65 years of age this season compared to the 2012-13 season (Table 2). This is expected given the predominance of A(H1N1)pdm09 this season compared to 2012-13 when A(H3N2) was the dominant circulating subtype.
    Figure 2. Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14

    Text equivalent for figure 2Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14
    In weeks 51 and 52, the number of positive tests for RSV was stable. RSV was the second most frequently detected virus in week 52, after influenza. The number of positive tests for rhinovirus and parainfluenza decreased during this 2-week period, while detections of adenovirus, coronvirus and human metapneumovirus increased (Figure 3).
    For more details, see the weekly Respiratory Virus Detections in Canada Report.
    Figure 3. Number of positive laboratory tests for other respiratory viruses by report week, Canada, 2013-14


    Top of Page

    RSV: Respiratory syncytial virus; hMPV: Human metapneumovirus
    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 1: Weekly and cumulative numbers of positive influenza specimens
    by type, subtype and province, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=ar1 rowSpan=3>Reporting provinces <SUP>1</SUP></TH><TH id=ac1 colSpan=5>Weekly
    (December 22 to December 28, 2013)</TH><TH id=ac8 colSpan=5>Cumulative
    (August 25, 2013 to December 28, 2013)</TH></TR><TR class=bg-colour-yellow><TH id=ac2 colSpan=4 headers=ac1>Influenza A</TH><TH id=ac7 headers=ac1>B</TH><TH id=ac9 colSpan=4 headers=ac8>Influenza A</TH><TH id=ac14 headers=ac8>B</TH></TR><TR class=bg-colour-grey-light><TH id=ac3 headers="ac1 ac2">A Total</TH><TH id=ac4 class=lightred headers="ac1 ac2">A(H1)pdm09</TH><TH id=ac5 class=lightred headers="ac1 ac2">A(H3)</TH><TH id=ac6 class=lightred headers="ac1 ac2">A(UnS)</TH><TH class=alignCenter headers="ac1 ac7">B Total</TH><TH id=ac10 headers="ac8 ac9">A Total</TH><TH id=ac11 class=lightred headers="ac8 ac9">A(H1)pdm09</TH><TH id=ac12 class=lightred headers="ac8 ac9">A(H3)</TH><TH id=ac13 class=lightred headers="ac8 ac9">A(UnS)</TH><TD class=alignCenter headers="ac8 ac14">B Total</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=11><SUP>1 </SUP>Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.
    <SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.</TD></TR></TFOOT><TBODY><TR><TH id=ar2 class=alignLeft headers=ar1>BC</TH><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac3">66</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac4">39</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac5">5</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac6">22</TD><TD class=alignRight headers="ar1 ar2 ac1 ac7">2</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac10">229</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac11">134</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac12">15</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac13">80</TD><TD class=alignRight headers="ar1 ar2 ac8 ac14">10</TD></TR><TR><TH id=ar3 class=alignLeft headers=ar1>AB</TH><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac3">369</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac4">251</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac6">118</TD><TD class=alignRight headers="ar1 ar3 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac10">868</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac11">731</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac12">12</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac13">125</TD><TD class=alignRight headers="ar1 ar3 ac8 ac14">21</TD></TR><TR><TH id=ar4 class=alignLeft headers=ar1>SK</TH><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac3">84</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac4">39</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac6">45</TD><TD class=alignRight headers="ar1 ar4 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac10">167</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac11">92</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac12">0</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac13">75</TD><TD class=alignRight headers="ar1 ar4 ac8 ac14">0</TD></TR><TR><TH id=ar5 class=alignLeft headers=ar1>MB</TH><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac3">10</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac4">6</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac6">4</TD><TD class=alignRight headers="ar1 ar5 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac10">28</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac11">21</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac12">0</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac13">7</TD><TD class=alignRight headers="ar1 ar5 ac8 ac14">6</TD></TR><TR><TH id=ar6 class=alignLeft headers=ar1>ON</TH><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac3">387</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac4">256</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac5">17</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac6">114</TD><TD class=alignRight headers="ar1 ar6 ac1 ac7">5</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac10">1006</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac11">704</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac12">82</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac13">220</TD><TD class=alignRight headers="ar1 ar6 ac8 ac14">27</TD></TR><TR><TH id=ar7 class=alignLeft headers=ar1>QC</TH><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac3">179</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac4">24</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac6">155</TD><TD class=alignRight headers="ar1 ar7 ac1 ac7">28</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac10">365</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac11">31</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac12">1</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac13">331</TD><TD class=alignRight headers="ar1 ar7 ac8 ac14">102</TD></TR><TR><TH id=ar8 class=alignLeft headers=ar1>NB</TH><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac3">10</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac6">10</TD><TD class=alignRight headers="ar1 ar8 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac10">12</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac11">1</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac12">1</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac13">10</TD><TD class=alignRight headers="ar1 ar8 ac8 ac14">0</TD></TR><TR><TH id=ar9 class=alignLeft headers=ar1>NS</TH><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac3">4</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac6">4</TD><TD class=alignRight headers="ar1 ar9 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac10">8</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac11">2</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac12">1</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac13">5</TD><TD class=alignRight headers="ar1 ar9 ac8 ac14">0</TD></TR><TR><TH id=ar10 class=alignLeft headers=ar1>PE</TH><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac3">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac10">1</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac11">1</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac12">0</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac13">0</TD><TD class=alignRight headers="ar1 ar10 ac8 ac14">0</TD></TR><TR><TH id=ar11 class=alignLeft headers=ar1>NL</TH><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac3">6</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac4">5</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac6">1</TD><TD class=alignRight headers="ar1 ar11 ac1 ac7">2</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac10">15</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac11">14</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac12">0</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac13">1</TD><TD class=alignRight headers="ar1 ar11 ac8 ac14">4</TD></TR><TR><TH id=ar12 class=alignLeft headers=ar1>Canada</TH><TD class=alignRight headers="ar1 ar12 ac1 ac2 ac3">1115</TD><TD class="lightred alignRight" headers="ar1 ar12 ac1 ac2 ac4">620</TD><TD class="lightred alignRight" headers="ar1 ar12 ac1 ac2 ac5">22</TD><TD class="lightred alignRight" headers="ar1 ar12 ac1 ac2 ac6">473</TD><TD class=alignRight headers="ar1 ar12 ac1 ac7">37</TD><TD class=alignRight headers="ar1 ar12 ac8 ac9 ac10">2699</TD><TD class="lightred alignRight" headers="ar1 ar12 ac8 ac9 ac11">1731</TD><TD class="lightred alignRight" headers="ar1 ar12 ac8 ac9 ac12">112</TD><TD class="lightred alignRight" headers="ar1 ar12 ac8 ac9 ac13">854</TD><TD class=alignRight headers="ar1 ar12 ac8 ac14">170</TD></TR><TR><TH id=ar13 class=alignLeft headers=ar1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="ar1 ar13 ac1 ac2 ac3">96.8%</TD><TD class="lightred alignRight" headers="ar1 ar13 ac1 ac2 ac4">55.6%</TD><TD class="lightred alignRight" headers="ar1 ar13 ac1 ac2 ac5">2.0%</TD><TD class="lightred alignRight" headers="ar1 ar13 ac1 ac2 ac6">42.4%</TD><TD class=alignRight headers="ar1 ar13 ac1 ac7">3.2%</TD><TD class=alignRight headers="ar1 ar13 ac8 ac9 ac10">94.1%</TD><TD class="lightred alignRight" headers="ar1 ar13 ac8 ac9 ac11">64.1%</TD><TD class="lightred alignRight" headers="ar1 ar13 ac8 ac9 ac12">4.1%</TD><TD class="lightred alignRight" headers="ar1 ar13 ac8 ac9 ac13">31.6%</TD><TD class=alignRight headers="ar1 ar13 ac8 ac14">5.9%</TD></TR></TBODY></TABLE>

    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 2. Weekly and cumulative numbers of positive influenza specimens by type, subtype and age-group reported through case-based laboratory reporting<SUP>3</SUP>, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=br1 rowSpan=3>Age groups (years)</TH><TH id=bc1 colSpan=5>Weekly
    (December 22 to December 28, 2013)</TH><TH id=bc8 colSpan=7>Cumulative
    (August 25, 2013 to December 28, 2013)</TH></TR><TR class=bg-colour-yellow><TH id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH id=bc7 headers=bc1>B</TH><TH id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH id=bc14 headers=bc8>B</TH><TH id=bc15 colSpan=2 headers=bc8>Influenza A and B</TH></TR><TR class=bg-colour-grey-light><TH id=bc3 headers="bc1 bc2">A Total</TH><TH id=bc4 class="lightred " headers="bc1 bc2">A(H1) pdm09</TH><TH id=bc5 class="lightred " headers="bc1 bc2">A(H3)</TH><TH id=bc6 class="lightred " headers="bc1 bc2">A (UnS)</TH><TD class=alignCenter headers="bc1 bc7">Total</TD><TH id=bc10 headers="bc8 bc9">A Total</TH><TH id=bc11 class="lightred " headers="bc8 bc9">A(H1) pdm09</TH><TH id=bc12 class="lightred " headers="bc8 bc9">A(H3)</TH><TH id=bc13 class="lightred " headers="bc8 bc9">A (UnS)</TH><TD class=alignCenter headers="bc8 bc14">Total</TD><TH id=bc16 headers="bc8 bc15">#</TH><TH id=bc17 headers="bc8 bc15">%</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=13><SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    <SUP>3 </SUP>Table 2 includes specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.</TD></TR></TFOOT><TBODY><TR><TH id=br2 class=alignLeft headers=br1><5</TH><TD class=alignRight headers="br1 br2 bc1 bc2 bc3">152 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc4">68 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc6">84 </TD><TD class=alignRight headers="br1 br2 bc1 bc7">4 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc10">483 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc11">266 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc12">15 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc13">202 </TD><TD class=alignRight headers="br1 br2 bc8 bc14">37 </TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc16">520 </TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc17">18.3% </TD></TR><TR><TH id=br3 class=alignLeft headers=br1>5-19</TH><TD class=alignRight headers="br1 br3 bc1 bc2 bc3">54 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc4">24 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc6">30 </TD><TD class=alignRight headers="br1 br3 bc1 bc7">5 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc10">236 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc11">162 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc12">6 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc13">68 </TD><TD class=alignRight headers="br1 br3 bc8 bc14">37 </TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc16">273 </TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc17">9.6% </TD></TR><TR><TH id=br4 class=alignLeft headers=br1>20-44</TH><TD class=alignRight headers="br1 br4 bc1 bc2 bc3">271 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc4">132 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc5">3 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc6">136 </TD><TD class=alignRight headers="br1 br4 bc1 bc7">7 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc10">817 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc11">496 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc12">11 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc13">310 </TD><TD class=alignRight headers="br1 br4 bc8 bc14">39 </TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc16">856 </TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc17">30.1% </TD></TR><TR><TH id=br5 class=alignLeft headers=br1>45-64</TH><TD class=alignRight headers="br1 br5 bc1 bc2 bc3">196 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc4">85 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc5">1 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc6">110 </TD><TD class=alignRight headers="br1 br5 bc1 bc7">2 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc10">687 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc11">400 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc12">16 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc13">271 </TD><TD class=alignRight headers="br1 br5 bc8 bc14">52 </TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc16">739 </TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc17">26.0% </TD></TR><TR><TH id=br6 class=alignLeft headers=br1>65+</TH><TD class=alignRight headers="br1 br6 bc1 bc2 bc3">101 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc4">45 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc5">4 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc6">52 </TD><TD class=alignRight headers="br1 br6 bc1 bc7">9 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc10">340 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc11">157 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc12">24 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc13">159 </TD><TD class=alignRight headers="br1 br6 bc8 bc14">91 </TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc16">431 </TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc17">15.2% </TD></TR><TR><TH id=br7 class=alignLeft headers=br1>Unknown</TH><TD class=alignRight headers="br1 br7 bc1 bc2 bc3">6 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc4">3 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc6">3 </TD><TD class=alignRight headers="br1 br7 bc1 bc7">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc10">25 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc11">16 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc12">4 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc13">5 </TD><TD class=alignRight headers="br1 br7 bc8 bc14">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc16">25 </TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc17">0.9% </TD></TR><TR><TH id=br8 class=alignLeft headers=br1>Total</TH><TD class=alignRight headers="br1 br8 bc1 bc2 bc3">780 </TD><TD class="lightred alignRight" headers="br1 br8 bc1 bc2 bc4">357 </TD><TD class="lightred alignRight" headers="br1 br8 bc1 bc2 bc5">8 </TD><TD class="lightred alignRight" headers="br1 br8 bc1 bc2 bc6">415 </TD><TD class=alignRight headers="br1 br8 bc1 bc7">27 </TD><TD class=alignRight headers="br1 br8 bc8 bc9 bc10">2588 </TD><TD class="lightred alignRight" headers="br1 br8 bc8 bc9 bc11">1497 </TD><TD class="lightred alignRight" headers="br1 br8 bc8 bc9 bc12">76 </TD><TD class="lightred alignRight" headers="br1 br8 bc8 bc9 bc13">1,015 </TD><TD class=alignRight headers="br1 br8 bc8 bc14">256 </TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc16">2844 </TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc17">100.0% </TD></TR><TR><TH id=br9 class=alignLeft headers=br1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="br1 br9 bc1 bc2 bc3">96.7% </TD><TD class="lightred alignRight" headers="br1 br9 bc1 bc2 bc4">45.8% </TD><TD class="lightred alignRight" headers="br1 br9 bc1 bc2 bc5">1.0% </TD><TD class="lightred alignRight" headers="br1 br9 bc1 bc2 bc6">53.2% </TD><TD class=alignRight headers="br1 br9 bc1 bc7">3.3% </TD><TD class=alignRight headers="br1 br9 bc8 bc9 bc10">91.0% </TD><TD class="lightred alignRight" headers="br1 br9 bc8 bc9 bc11">57.8% </TD><TD class="lightred alignRight" headers="br1 br9 bc8 bc9 bc12">2.9% </TD><TD class="lightred alignRight" headers="br1 br9 bc8 bc9 bc13">39.2% </TD><TD class=alignRight headers="br1 br9 bc8 bc14">9.0% </TD><TD class=alignRight></TD><TD class=alignRight></TD></TR></TBODY></TABLE>

    Top of Page

    Influenza Strain Characterizations

    During the 2013-2014 influenza season, the National Microbiology Laboratory (NML) has antigenically characterized 155 influenza viruses [17 A(H3N2), 112 A(H1N1)pdm09 and 26 influenza B]. The vast majority (96.8%) of viruses were similar to the strains recommended by the WHO for the 2013-14 seasonal influenza vaccine. Two A(H1N1)pdm09 viruses showed reduced titres to antiserum against the reference A/California/07/2009 strain. Five influenza B viruses were similar to the strain recommended by the WHO for the 2011-12 vaccine (Figure 4).
    Figure 4. Influenza strain characterizations, Canada, 2013-14, N = 155

    The NML receives a proportion of the number of influenza positive specimens from provincial laboratories for strain characterization and antiviral resistance testing. Characterization data reflect the results of haemagglutination inhibition (HAI) testing compared to the reference influenza strains recommended by WHO.
    The recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b (e.g. A/Texas/50/2012), and a B/Massachusetts/2/2012-like virus (Yamagata lineage).


    Text equivalent for figure 4Influenza strain characterizations, Canada, 2013-2014, N =3
    Antiviral Resistance

    During the 2013-2014 influenza season, NML has tested 135 influenza viruses for resistance to oseltamivir and for resistance to zanamivir, and all were sensitive. Sixty-nine influenza A viruses were tested for amantadine resistance, and all were resistant (Table 3).
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=cr1 rowSpan=2>Virus type and subtype</TH><TH id=cc1 colSpan=2>Oseltamivir</TH><TH id=cc4 colSpan=2>Zanamivir</TH><TH id=cc7 colSpan=2>Amantadine</TH></TR><TR class=bg-colour-yellow><TH id=cc2 headers=cc1># tested</TH><TH id=cc3 headers=cc1># resistant (%)</TH><TH id=cc5 headers=cc4># tested</TH><TH id=cc6 headers=cc4># resistant (%)</TH><TH id=cc8 headers=cc7># tested</TH><TH id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH id=cr2 class="alignLeft lightred" headers=cr1>A (H3N2)</TH><TD class=alignRight headers="cr1 cr2 cc1 cc2">15 </TD><TD class=alignRight headers="cr1 cr2 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr2 cc4 cc5">15 </TD><TD class=alignRight headers="cr1 cr2 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr2 cc7 cc8">14 </TD><TD class=alignRight headers="cr1 cr2 cc7 cc9">14 (100%) </TD></TR><TR><TH id=cr3 class="alignLeft lightred" headers=cr1>A (H1N1)</TH><TD class=alignRight headers="cr1 cr3 cc1 cc2">95</TD><TD class=alignRight headers="cr1 cr3 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr3 cc4 cc5">95</TD><TD class=alignRight headers="cr1 cr3 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr3 cc7 cc8">55 </TD><TD class=alignRight headers="cr1 cr3 cc7 cc9">55 (100%) </TD></TR><TR><TH id=cr4 class="alignLeft lightred" headers=cr1>B</TH><TD class=alignRight headers="cr1 cr4 cc1 cc2">25 </TD><TD class=alignRight headers="cr1 cr4 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr4 cc4 cc5">25 </TD><TD class=alignRight headers="cr1 cr4 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr4 cc7 cc8">NA <SUP>*</SUP></TD><TD class=alignRight headers="cr1 cr4 cc7 cc9">NA <SUP>*</SUP></TD></TR><TR><TH id=cr5 class="alignLeft lightred" headers=cr1>TOTAL</TH><TD class=alignRight headers="cr1 cr5 cc1 cc2">135</TD><TD class=alignRight headers="cr1 cr5 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr5 cc4 cc5">135 </TD><TD class=alignRight headers="cr1 cr5 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr5 cc7 cc8">69 </TD><TD class=alignRight headers="cr1 cr5 cc7 cc9">69 (100%) </TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate jumped to 60.0/1,000 in week 50, returning to 37.0/1,000 in week 51 and increasing to 42.6/1,000 in week 52 (Figure 5).
    Figure 5. Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Note: No data available for mean rate for weeks 19 to 39 for the 1996-1997 through 2002-2003 seasons. Delays in the reporting of data may cause data to change retrospectively. The calculation of the average ILI consultation rate over 17 seasons was aligned with influenza activity in each season. In BC, AB, and SK, data is compiled by a provincial sentinel surveillance program for reporting to FluWatch. The number of sentinel physicians in each province or territory is as follows: BC(21), AB(80), SK(11), MB(18), ON(169), QC(14), NB(29), NS(26), PE(4), NL(16), NU(1), NT(14), YT(13). Not all sentinel physicians report every week.
    Text equivalent for figure 5Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Top of Page

    Influenza Outbreak Surveillance

    In week 51, three new influenza outbreaks were reported: one in a long-term care facility and two in hospitals. Three additional ILI outbreaks in other facilities or communities were also reported. In week 52, ten new influenza outbreaks were reported: eight in long-term care facilities and two in hospitals (Figure 6).
    Figure 6. Overall number of new influenza outbreaks by report week, Canada, 2013-2014

    1 All provinces and territories except NU report outbreaks in long-term care facilities. All provinces and territories with the exception of NU and QC report outbreaks in hospitals. Outbreaks of influenza or influenza-like-illness in other facilities are reported to FluWatch but reporting varies between jurisdictions. Outbreak definitions are included at the end of the report.
    Text equivalent for figure 6 Overall number of new influenza outbreaks by report week, Canada, 2013-2014
    Pharmacy Surveillance

    The number of prescriptions for influenza antivirals followed a trend consistent compared with previous seasons and other indicators of influenza circulation. The largest number of antiviral prescriptions is among adults 19-64 years of age, which is in keeping with the wide age range of this group as well as the age-distribution observed among laboratory detections and hospitalizations during the season to date (Figure 7).
    Figure 7. Number of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Note: Pharmacy sales data are provided to the Public Health Agency of Canada by Rx Canada Inc. and sourced from major retail drug chains representing over 3,000 stores nationwide (excluding Nunavut) in 85% of Health Regions. A delay in data reported from one retailer which provides approximately 50% of the national volume of prescriptions affects the data for the current and previous week. Data from Ontario, Saskatchewan and the Territories is most influenced by this delay.
    * Data provided include the number of new antiviral prescriptions (for Tamiflu and Relenza) and the total number of new prescriptions dispensed by Province/Territory and age group. Age-groups: Infant: 0-2y, Child: 2-18y; Adult: 19-64y, Senior: ≥65y.
    Text equivalent for figure 7Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Top of Page

    Sentinel Hospital Influenza Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)

    The number of new laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalizations reported by the Immunization Monitoring Program Active (IMPACT) network continued to increase from 14 in week 50 to 37 in week 51 and 50 in week 52. Among these 87 cases, 85 (97.7%) had influenza A, and of these 38 (44.7%) were A(H1N1)pdm09, one (1.2%) A(H3N2) and 46 (54.1%) A(unsubtyped) (Figure 8a). Thirteen cases (14.9%) were children under 6 months of age, 29 (33.3%) were 6-23 months of age, 26 (29.9%) were 2-4 years of age, 13 (14.9%) were 5-9 years of age and 6 (6.9%) were 10-16 years of age. Thirteen ICU admissions were reported in weeks 51 and 52, eight children 6-23 months of age, one 2-4 years of age, one 5-9 years of age, and three 10-16 years of age; all with influenza A.

    To date this season, a total of 140 influenza-associated paediatric hospitalizations have been reported by the IMPACT network, the large majority of which have been influenza A (Table 4). Sixty (42.9%) of cases have been children under 2 years of age, and a total of 103 (73.6%) have been under 5 years of age. Eighteen ICU admissions have been reported: two cases with influenza B and 16 with influenza A (seven A(H1N1)pdm09, one A(H3N2), eight A(unsubtyped)). The age-distribution is as follows: eight children 6-23 months of age, three 2-4 years of age, two 5-9 years of age, and five 10-16 years of age. Among the 15 ICU cases with available data, 11 were reported to have comorbidities or concurrent infection. No deaths have been reported (Figure 9a).

    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.

    Adult Influenza Hospitalizations and Deaths (PCIRN)

    The number of new laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations reported through active<SUP>*</SUP> surveillance by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network increased from 17 in week 50 to 40 in week 51, and decreased to 21 in week 52. Among the 61 cases in this 2-week period, 58 (95.1%) were influenza A, of which 7 (12.1%) were A(H1N1)pdm09, one (1.7%) was A(H3N2) and 50 (86.2%) were A(unsubtyped).

    The age-distribution is as follows: three (4.9%) cases <20 years of age, 18 (29.5%) cases 20-44 years of age, 21 (34.4%) cases 45-64 years of age and 19 (31.1%) cases ≥65 years of age. Eleven ICU admissions were reported in weeks 51 and 52: one (9.1%) case 20-44 years of age, eight (72.7%) cases 45-64 years of age, and two (18.2%) cases ≥65 years of age (Figure 8b).

    To date this season, 120 influenza-associated hospitalizations have been reported by the PCIRN-SOS network, 115 (95.8%) with influenza A, predominantly A(H1N1)pdm09. The majority (73%) have been adults over 45 years of age (Table 5). ICU admission was required for 17 hospitalizations: 16 cases with influenza A (6 A(H1N1)pdm09 and 10 A(unsubtyped)); 15 of the ICU admissions were >45 years of age. Of the 10 cases with information on influenza vaccination, 9 reported not having been vaccinated this season. No deaths have been reported (Figure 9b).

    Note: PCIRN-SOS conducted passive surveillance from April 30th to November 14th, 2013. Cases reported during this period were identified by laboratory detection of influenza among patients admitted to participating hospitals. Active surveillance began November 15th during which time PCIRN site coordinators investigate cases potentially related to influenza. Data from both active and passive surveillance reported during the 2013-14 season are included in this report. The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 4 - Cumulative numbers of paediatric hospitalizations with influenza reported by the IMPACT network, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=dr1 rowSpan=3>Age groups </TH><TH id=dc1 colSpan=6>Cumulative (Aug. 25, 2013 to December 28, 2013) </TH></TR><TR class=bg-colour-yellow><TH id=dc2 colSpan=4 headers=dc1>Influenza A </TH><TH id=dc7 headers=dc1>B </TH><TH id=dc8 headers=dc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=dc3 headers="dc1 dc2">A Total </TH><TH id=dc4 class="lightred " headers="dc1 dc2">A(H1) pdm09 </TH><TH id=dc5 class="lightred " headers="dc1 dc2">A(H3) </TH><TH id=dc6 class="lightred " headers="dc1 dc2">A (UnS) </TH><TD class=alignCenter headers="dc1 dc7">Total</TD><TD class=alignCenter headers="dc1 dc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=dr2 class=alignLeft headers=dr1>0-5m </TH><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc3">22 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc4">6 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc6">16 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc7">1 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc8">23 (16%) </TD></TR><TR><TH id=dr3 class=alignLeft headers=dr1>6-23m </TH><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc3">36 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc4">18 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc6">18 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc7">1 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc8">37 (26%) </TD></TR><TR><TH id=dr4 class=alignLeft headers=dr1>2-4y </TH><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc3">38 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc4">17 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc5">1 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc6">20 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc7">5 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc8">43 (31%) </TD></TR><TR><TH id=dr5 class=alignLeft headers=dr1>5-9y </TH><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc3">20 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc4">10 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc6">10 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc7">3 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc8">23 (16%) </TD></TR><TR><TH id=dr6 class=alignLeft headers=dr1>10-16y </TH><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc3">12 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc4">7 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc6">5 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc7">2 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc8">14 (10%) </TD></TR><TR><TH id=dr7 class=alignLeft headers=dr1>Total </TH><TD class=alignRight headers="dr1 dr7 dc1 dc2 dc3">128 </TD><TD class="lightred alignRight" headers="dr1 dr7 dc1 dc2 dc4">58 </TD><TD class="lightred alignRight" headers="dr1 dr7 dc1 dc2 dc5">1 </TD><TD class="lightred alignRight" headers="dr1 dr7 dc1 dc2 dc6">69 </TD><TD class=alignRight headers="dr1 dr7 dc1 dc7">12 </TD><TD class=alignRight headers="dr1 dr7 dc1 dc8">140 </TD></TR><TR><TH id=dr8 class=alignLeft headers=dr1>% <SUP>1</SUP> </TH><TD class=alignRight headers="dr1 dr8 dc1 dc2 dc3">91.4% </TD><TD class="lightred alignRight" headers="dr1 dr8 dc1 dc2 dc4">45.3% </TD><TD class="lightred alignRight" headers="dr1 dr8 dc1 dc2 dc5">0.8% </TD><TD class="lightred alignRight" headers="dr1 dr8 dc1 dc2 dc6">53.9% </TD><TD class=alignRight headers="dr1 dr8 dc1 dc7">8.6% </TD><TD class=alignRight headers="dr1 dr8 dc1 dc8">100.0% </TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 5 - Cumulative numbers of adult hospitalizations with influenza
    reported by the PCIRN-SOS network, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=er1 rowSpan=3>Age groups </TH><TH id=ec1 class=noWrap colSpan=6>Cumulative (Aug. 25, 2013 to December 28, 2013)<SUP>*</SUP> </TH></TR><TR class=bg-colour-yellow><TH id=ec2 colSpan=4 headers=ec1>Influenza A </TH><TH id=ec7 headers=ec1>B </TH><TH id=ec8 headers=ec1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=ec3 headers="ec1 ec2">A Total </TH><TH id=ec4 class="lightred " headers="ec1 ec2">A(H1) pdm09 </TH><TH id=ec5 class="lightred " headers="ec1 ec2">A(H3) </TH><TH id=ec6 class="lightred " headers="ec1 ec2">A(UnS) </TH><TD class=alignCenter headers="ec1 ec7">Total</TD><TD class=alignCenter headers="ec1 ec8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    * One case for which the influenza type has not yet been reported is not included in Table 5.
    </TD></TR></TFOOT><TBODY><TR><TH id=er2 class=alignLeft headers=er1>16-20 </TH><TD class=alignRight headers="er1 er2 ec1 ec2 ec3">5</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec4">1</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec5">0</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec6">4</TD><TD class=alignRight headers="er1 er2 ec1 ec7">0</TD><TD class=alignRight headers="er1 er2 ec1 ec8">5 (4%)</TD></TR><TR><TH id=er3 class=alignLeft headers=er1>20-44 </TH><TD class=alignRight headers="er1 er3 ec1 ec2 ec3">27</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec4">8</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec5">1</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec6">18</TD><TD class=alignRight headers="er1 er3 ec1 ec7">0</TD><TD class=alignRight headers="er1 er3 ec1 ec8">27 (23%)</TD></TR><TR><TH id=er4 class=alignLeft headers=er1>45-64 </TH><TD class=alignRight headers="er1 er4 ec1 ec2 ec3">43</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec4">14</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec5">1</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec6">28</TD><TD class=alignRight headers="er1 er4 ec1 ec7">2</TD><TD class=alignRight headers="er1 er4 ec1 ec8">45 (38%)</TD></TR><TR><TH id=er5 class=alignLeft headers=er1>65+ </TH><TD class=alignRight headers="er1 er5 ec1 ec2 ec3">40</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec4">14</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec5">4</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec6">22</TD><TD class=alignRight headers="er1 er5 ec1 ec7">2</TD><TD class=alignRight headers="er1 er5 ec1 ec8">42 (35%)</TD></TR><TR><TH id=er6 class=alignLeft headers=er1>Total </TH><TD class=alignRight headers="er1 er6 ec1 ec2 ec3">115</TD><TD class="lightred alignRight" headers="er1 er6 ec1 ec2 ec4">37</TD><TD class="lightred alignRight" headers="er1 er6 ec1 ec2 ec5">6</TD><TD class="lightred alignRight" headers="er1 er6 ec1 ec2 ec6">72</TD><TD class=alignRight headers="er1 er6 ec1 ec7">4</TD><TD class=alignRight headers="er1 er6 ec1 ec8">119</TD></TR><TR><TH id=er7 class=alignLeft headers=er1>%<SUP>1</SUP> </TH><TD class=alignRight headers="er1 er7 ec1 ec2 ec3">97%</TD><TD class="lightred alignRight" headers="er1 er7 ec1 ec2 ec4">32%</TD><TD class="lightred alignRight" headers="er1 er7 ec1 ec2 ec5">5%</TD><TD class="lightred alignRight" headers="er1 er7 ec1 ec2 ec6">63%</TD><TD class=alignRight headers="er1 er7 ec1 ec7">3%</TD><TD class=alignRight headers="er1 er7 ec1 ec8">100%</TD></TR></TBODY></TABLE>
    Figure 8. Number of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)


    Text equivalent for figure 8aNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    * See footnote above following the section related to PCIRN-SOS data.
    Text equivalent for figure 8bNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Adult hospitalizations (>16 year of age, PCIRN-SOS)
    Figure 9. Percentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)

    Text equivalent for figure 9aPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Text equivalent for figure 9bPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Top of Page

    Provincial/Territorial Influenza Hospitalizations and Deaths

    In weeks 51 and 52, 186 new laboratory-confirmed influenza-associated hospitalizations were reported from participating provinces and territories.* The cases were as follows: nine children less than 6 months of age, 18 children 6-23 months, 14 children 2-4 years, nine children 5-14 years, three children 15-19 years of age, 38 adults 20-44 years, 54 adults 45-64 years and 38 adults ≥65 years of age. Age was not reported for three cases, two with A(H1N1)pdm09 and one with A(unsubtyped). The majority were cases of influenza A (181, 97.3%), of which 74 were A(H1N1)pdm09, two were A(H3N2) and 105 were A(unsubtyped). Twelve ICU admissions were reported in weeks 51 and 52, all with influenza A (five with A(H1N1)pdm09, seven with A(unsubtyped)), in one child 6-23 months of age, one 5-14 years of age, two adults 20-44 years of age, six adults 45-64 years of age, and one adult ≥65 years of age. Age information was not reported for one ICU admission. Five deaths were reported: one adult 20-44 years of age and two 45-64 years of age with influenza A(H1N1)pdm09, and two adults ≥65 years of age, with influenza A(unsubtyped) and one with influenza B. The number of new influenza-associated hospitalizations and deaths reported for the current week may include cases from Ontario that occurred in previous weeks, as a result of retrospective updates to the cumulative total.

    To date this season, 486 influenza-associated hospitalizations have been reported, of which 475 (97.7%) had influenza A and among those 58.9% were A(H1N1)pdm09 (Table 6). Approximately half of cases (51.8%) were 20-64 years of age, and 22.6% were under 5 years of age. Fifty-nine ICU admissions have been reported this season, all cases of influenza A (44 A(H1N1)pdm09 and 15 A(unsubtyped)). The age-distribution of ICU admissions is as follows: five (8.5%) children 6-23 months, three (5.1%) 2-4 years of age, one (1.7%) 5-14 years of age, 15 (25.4%) adults 20-44 years of age, 30 (50.8%) adults 45-64 years of age, four (6.8%) adults ≥65 years of age, and one (1.7%) with missing age information.

    Seventeen deaths have been reported: two children 6-23 months, two adults 20-44 years of age, nine 45-64 years of age, and four ≥65 years of age. Thirteen deaths were associated with influenza A(H1N1)pdm09, three with A(unsubtyped), and one with influenza B. It is important to note that the hospitalization or death does not have to be attributable to influenza, a positive laboratory test is sufficient for reporting. Detailed clinical information (e.g. underlying medical conditions) is not known for these cases.

    * Note: Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not distinguished among hospital admissions reported from Ontario. Data may also include cases reported by the IMPACT and PCIRN networks.

    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 6. Cumulative number of hospitalizations with influenza reported by the participating provinces and territories, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=fr1 rowSpan=3>Age groups </TH><TH id=fc1 colSpan=6>Cumulative (Aug. 25, 2013 to December 28, 2013)<SUP> *</SUP></TH></TR><TR class=bg-colour-yellow><TH id=fc2 colSpan=4 headers=fc1>Influenza A </TH><TH id=fc7 headers=fc1>B </TH><TH id=fc8 headers=fc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=fc3 headers="fc1 fc2">A Total </TH><TH id=fc4 class=lightred headers="fc1 fc2">A(H1) pdm09 </TH><TH id=fc5 class=lightred headers="fc1 fc2">A(H3) </TH><TH id=fc6 class=lightred headers="fc1 fc2">A (UnS) </TH><TD class=alignCenter headers="fc1 fc7">Total</TD><TD class=alignCenter headers="fc1 fc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=8><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    * Three cases for which age information is not available have not been included in Table 6.
    </TD></TR></TFOOT><TBODY><TR><TH id=fr2 class=alignLeft headers=fr1>0-4 years </TH><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc3">106 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc4">54 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc5">4 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc6">48 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc7">3 </TD><TD class=alignRight headers="fr1 fr2 fc1 fc8">109 (23%) </TD></TR><TR><TH id=fr3 class=alignLeft headers=fr1>5-14 years </TH><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc3">28 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc4">15 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc5">1 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc6">12 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc7">2 </TD><TD class=alignRight headers="fr1 fr3 fc1 fc8">30 (6%) </TD></TR><TR><TH id=fr4 class=alignLeft headers=fr1>15-19 years </TH><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc3">6 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc4">4 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc5">0 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc6">2 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc7">0 </TD><TD class=alignRight headers="fr1 fr4 fc1 fc8">6 (1%) </TD></TR><TR><TH id=fr5 class=alignLeft headers=fr1>20-44 years </TH><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc3">92 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc4">56 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc5">0 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc6">36 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc7">0 </TD><TD class=alignRight headers="fr1 fr5 fc1 fc8">92 (19%) </TD></TR><TR><TH id=fr6 class=alignLeft headers=fr1>45-64 years </TH><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc3">157 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc4">103 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc5">8 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc6">46 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc7">1 </TD><TD class=alignRight headers="fr1 fr6 fc1 fc8">158 (33%) </TD></TR><TR><TH id=fr7 class=alignLeft headers=fr1>65+ years </TH><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc3">83 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc4">46 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc5">8 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc6">29 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc7">5 </TD><TD class=alignRight headers="fr1 fr7 fc1 fc8">88 (18%) </TD></TR><TR><TH id=fr8 class=alignLeft headers=fr1>Total </TH><TD class=alignRight headers="fr1 fr8 fc1 fc2 fc3">472</TD><TD class="lightred alignRight" headers="fr1 fr8 fc1 fc2 fc4">278 </TD><TD class="lightred alignRight" headers="fr1 fr8 fc1 fc2 fc5">21 </TD><TD class="lightred alignRight" headers="fr1 fr8 fc1 fc2 fc6">173 </TD><TD class=alignRight headers="fr1 fr8 fc1 fc7">11 </TD><TD class=alignRight headers="fr1 fr8 fc1 fc8">483 </TD></TR><TR><TH id=fr9 class=alignLeft headers=fr1>Percentage <SUP>1</SUP> </TH><TD class=alignRight headers="fr1 fr9 fc1 fc2 fc3">97.7% </TD><TD class="lightred alignRight" headers="fr1 fr9 fc1 fc2 fc4">58.9% </TD><TD class="lightred alignRight" headers="fr1 fr9 fc1 fc2 fc5">4.4% </TD><TD class="lightred alignRight" headers="fr1 fr9 fc1 fc2 fc6">36.7% </TD><TD class=alignRight headers="fr1 fr9 fc1 fc7">2.3% </TD><TD class=alignRight headers="fr1 fr9 fc1 fc8">100% </TD></TR></TBODY></TABLE>

    .../

    Leave a comment:


  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Week 50

    FluWatch report: December 8 to 14, 2013 (Week 50)

    Posted 2013-12-20For readers interested in the <ABBR title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A title="Flu Watch (Version PDF, 113 KB - 6 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w50_13/pdf/fw2013-50-eng.pdf">FluWatch report: December 8 to 14, 2013 (Week 50) (<ABBR title="Portable Document Format">PDF</ABBR> Version - 291 <ABBR title=Kilobytes>KB</ABBR> - 10 pages)

    ?? Help with PDF documents


    Overall Summary
    • Influenza activity in Canada continued to increase in week 50. The number of regions that reported sporadic or localized influenza/ILI activity increased, with activity reported in 8 of the 10 provinces.
    • Influenza A(H1N1)pdm09 remains the predominant influenza virus type this season.
    • The number of paediatric hospitalizations with influenza continued to increase, while adult hospitalizations decreased slightly in week 50; 98% of adult cases and 81% of paediatric cases from sentinel hospital surveillance were influenza A, predominantly A(H1N1)pdm09.
    Note: The FluWatch report will not be published on Friday, December 27th, 2013. A combined report for weeks 51 and 52 will be published on Friday, January 3rd, 2014.

    Influenza/ILI Activity (geographic spread)

    In week 50, four regions (in AB(1), ON(2) and QC(1)) reported localized activity and 25 regions (in BC(5), AB(4), SK(3), MB(1), ON(5), QC(4), NS(1), and NL(2)) reported sporadic activity (Figure 1).
    Figure 1. Map of overall influenza/ILI activity level by province and territory, Canada, Week 50





    Note: Influenza/ILI activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates and reported outbreaks. Please refer to detailed definitions at the end of the report. Maps from previous weeks, including any retrospective updates, are available on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada
    Influenza and Other Respiratory Virus Detections

    The number of positive influenza tests increased sharply, from 211 in week 49 to 367 in week 50, bringing the percentage of positive influenza tests to 9.6% (Figure 2). Cumulative influenza virus detections to date have been predominantly influenza A (89%). Among subtyped influenza A viruses, 88% (545/619) were A(H1N1)pdm09 (Table 1). Detailed information on age and type/subtype has been received for 909 cases to date this season. Consistent with demographics observed in recent seasons, a larger proportion of cases of A(H3N2) and influenza B were ≥65 years of age (32.7% and 37.5%, respectively) compared to cases of A(H1N1)pdm09 (15.3%).
    Figure 2. Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14

    Text equivalent for figure 2Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14
    In week 50, the number of positive tests for RSV continued to increase sharply. RSV was the second most frequently detected virus in week 50, after influenza; and followed by parainfluenza (Figure 3).
    For more details, see the weekly Respiratory Virus Detections in Canada Report.
    Figure 3. Number of positive laboratory tests for other respiratory viruses by report week, Canada, 2013-14


    Top of Page

    RSV: Respiratory syncytial virus; hMPV: Human metapneumovirus
    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 1: Weekly and cumulative numbers of positive influenza specimens
    by type, subtype and province, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=ar1 rowSpan=3>Reporting provinces <SUP>1</SUP></TH><TH id=ac1 colSpan=5>Weekly
    (December 8 to December 14, 2013)
    </TH><TH id=ac8 colSpan=5>Cumulative
    (August 25, 2013 to December 14, 2013)
    </TH></TR><TR class=bg-colour-yellow><TH id=ac2 colSpan=4 headers=ac1>Influenza A</TH><TH id=ac7 headers=ac1>B</TH><TH id=ac9 colSpan=4 headers=ac8>Influenza A</TH><TH id=ac14 headers=ac8>B</TH></TR><TR class=bg-colour-grey-light><TH id=ac3 headers="ac1 ac2">A Total</TH><TH id=ac4 class=lightred headers="ac1 ac2">A(H1)pdm09</TH><TH id=ac5 class=lightred headers="ac1 ac2">A(H3)</TH><TH id=ac6 class=lightred headers="ac1 ac2">A(UnS)</TH><TH class=alignCenter headers="ac1 ac7">B Total</TH><TH id=ac10 headers="ac8 ac9">A Total</TH><TH id=ac11 class=lightred headers="ac8 ac9">A(H1)pdm09</TH><TH id=ac12 class=lightred headers="ac8 ac9">A(H3)</TH><TH id=ac13 class=lightred headers="ac8 ac9">A(UnS)</TH><TD class=alignCenter headers="ac8 ac14">B Total</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=11><SUP>1 </SUP>Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.
    <SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=ar2 class=alignLeft headers=ar1>BC</TH><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac3">24 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac4">15 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac5">1 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac6">8 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac7">3 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac10">61 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac11">43 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac12">6 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac13">12 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac14">7 </TD></TR><TR><TH id=ar3 class=alignLeft headers=ar1>AB</TH><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac3">95 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac4">57 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac5">1 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac6">37 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac7">3 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac10">262 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac11">211 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac12">11 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac13">40 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac14">19 </TD></TR><TR><TH id=ar4 class=alignLeft headers=ar1>SK</TH><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac3">19 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac4">10 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac6">9 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac10">43 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac11">26 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac13">17 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac14">0 </TD></TR><TR><TH id=ar5 class=alignLeft headers=ar1>MB</TH><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac3">3 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac4">2 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac6">1 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac10">13 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac11">12 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac13">1 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac14">5 </TD></TR><TR><TH id=ar6 class=alignLeft headers=ar1>ON</TH><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac3">154 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac4">118 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac5">7 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac6">29 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac7">7 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac10">356 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac11">246 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac12">56 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac13">54 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac14">19 </TD></TR><TR><TH id=ar7 class=alignLeft headers=ar1>QC</TH><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac3">42 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac4">0 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac6">42 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac7">14 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac10">104 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac11">0 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac13">104 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac14">51 </TD></TR><TR><TH id=ar8 class=alignLeft headers=ar1>NB</TH><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac3">0 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac4">0 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac6">0 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac10">2 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac11">1 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac12">1 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac13">0 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac14">0 </TD></TR><TR><TH id=ar9 class=alignLeft headers=ar1>NS</TH><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac3">1 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac4">1 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac6">0 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac10">1 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac11">1 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac13">0 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac14">0 </TD></TR><TR><TH id=ar10 class=alignLeft headers=ar1>PE</TH><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac3">0 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac4">0 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac6">0 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac10">0 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac11">0 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac13">0 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac14">0 </TD></TR><TR><TH id=ar11 class=alignLeft headers=ar1>NL</TH><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac3">2 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac4">2 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac6">0 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac10">5 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac11">5 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac13">0 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac14">0 </TD></TR><TR><TH id=ar12 class=alignLeft headers=ar1>Canada</TH><TD class=alignRight headers="ar1 ar12 ac1 ac2 ac3">340 </TD><TD class="lightred alignRight" headers="ar1 ar12 ac1 ac2 ac4">205 </TD><TD class="lightred alignRight" headers="ar1 ar12 ac1 ac2 ac5">9 </TD><TD class="lightred alignRight" headers="ar1 ar12 ac1 ac2 ac6">126 </TD><TD class=alignRight headers="ar1 ar12 ac1 ac7">27 </TD><TD class=alignRight headers="ar1 ar12 ac8 ac9 ac10">847 </TD><TD class="lightred alignRight" headers="ar1 ar12 ac8 ac9 ac11">545 </TD><TD class="lightred alignRight" headers="ar1 ar12 ac8 ac9 ac12">74 </TD><TD class="lightred alignRight" headers="ar1 ar12 ac8 ac9 ac13">228 </TD><TD class=alignRight headers="ar1 ar12 ac8 ac14">101 </TD></TR><TR><TH id=ar13 class=alignLeft headers=ar1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="ar1 ar13 ac1 ac2 ac3">92.6% </TD><TD class="lightred alignRight" headers="ar1 ar13 ac1 ac2 ac4">60.3% </TD><TD class="lightred alignRight" headers="ar1 ar13 ac1 ac2 ac5">2.6% </TD><TD class="lightred alignRight" headers="ar1 ar13 ac1 ac2 ac6">37.1% </TD><TD class=alignRight headers="ar1 ar13 ac1 ac7">7.4% </TD><TD class=alignRight headers="ar1 ar13 ac8 ac9 ac10">89.3% </TD><TD class="lightred alignRight" headers="ar1 ar13 ac8 ac9 ac11">64.3% </TD><TD class="lightred alignRight" headers="ar1 ar13 ac8 ac9 ac12">8.7% </TD><TD class="lightred alignRight" headers="ar1 ar13 ac8 ac9 ac13">26.9% </TD><TD class=alignRight headers="ar1 ar13 ac8 ac14">10.7% </TD></TR></TBODY></TABLE>

    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 2. Weekly and cumulative numbers of positive influenza specimens by type, subtype and age-group reported through case-based laboratory reporting<SUP>3</SUP>, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=br1 rowSpan=3>Age groups (years)</TH><TH id=bc1 colSpan=5>Weekly
    (December 8 to December 14, 2013)
    </TH><TH id=bc8 colSpan=7>Cumulative
    (August 25, 2013 to December 14, 2013)
    </TH></TR><TR class=bg-colour-yellow><TH id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH id=bc7 headers=bc1>B</TH><TH id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH id=bc14 headers=bc8>B</TH><TH id=bc15 colSpan=2 headers=bc8>Influenza A and B</TH></TR><TR class=bg-colour-grey-light><TH id=bc3 headers="bc1 bc2">A Total</TH><TH id=bc4 class="lightred " headers="bc1 bc2">A(H1) pdm09</TH><TH id=bc5 class="lightred " headers="bc1 bc2">A(H3)</TH><TH id=bc6 class="lightred " headers="bc1 bc2">A (UnS)</TH><TD class=alignCenter headers="bc1 bc7">Total</TD><TH id=bc10 headers="bc8 bc9">A Total</TH><TH id=bc11 class="lightred " headers="bc8 bc9">A(H1) pdm09</TH><TH id=bc12 class="lightred " headers="bc8 bc9">A(H3)</TH><TH id=bc13 class="lightred " headers="bc8 bc9">A (UnS)</TH><TD class=alignCenter headers="bc8 bc14">Total</TD><TH id=bc16 headers="bc8 bc15">#</TH><TH id=bc17 headers="bc8 bc15">%</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=13><SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    <SUP>3 </SUP>Table 2 includes specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=br2 class=alignLeft headers=br1><5</TH><TD class=alignRight headers="br1 br2 bc1 bc2 bc3">34</TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc4">12</TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc5">2</TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc6">20</TD><TD class=alignRight headers="br1 br2 bc1 bc7">1</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc10">147</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc11">80</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc12">10</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc13">57</TD><TD class=alignRight headers="br1 br2 bc8 bc14">24</TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc16">171</TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc17">18.7%</TD></TR><TR><TH id=br3 class=alignLeft headers=br1>5-19</TH><TD class=alignRight headers="br1 br3 bc1 bc2 bc3">26</TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc4">12</TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc6">14</TD><TD class=alignRight headers="br1 br3 bc1 bc7">4</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc10">91</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc11">60</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc12">4</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc13">27</TD><TD class=alignRight headers="br1 br3 bc8 bc14">25</TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc16">116</TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc17">12.7%</TD></TR><TR><TH id=br4 class=alignLeft headers=br1>20-44</TH><TD class=alignRight headers="br1 br4 bc1 bc2 bc3">56</TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc4">17</TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc5">1</TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc6">38</TD><TD class=alignRight headers="br1 br4 bc1 bc7">5</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc10">206</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc11">117</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc12">4</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc13">85</TD><TD class=alignRight headers="br1 br4 bc8 bc14">14</TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc16">220</TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc17">24.0%</TD></TR><TR><TH id=br5 class=alignLeft headers=br1>45-64</TH><TD class=alignRight headers="br1 br5 bc1 bc2 bc3">49</TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc4">20</TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc6">29</TD><TD class=alignRight headers="br1 br5 bc1 bc7">5</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc10">203</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc11">113</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc12">15</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc13">75</TD><TD class=alignRight headers="br1 br5 bc8 bc14">27</TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc16">230</TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc17">25.1%</TD></TR><TR><TH id=br6 class=alignLeft headers=br1>65+</TH><TD class=alignRight headers="br1 br6 bc1 bc2 bc3">27</TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc4">12</TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc5">2</TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc6">13</TD><TD class=alignRight headers="br1 br6 bc1 bc7">4</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc10">118</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc11">44</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc12">16</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc13">58</TD><TD class=alignRight headers="br1 br6 bc8 bc14">54</TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc16">172</TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc17">18.8%</TD></TR><TR><TH id=br7 class=alignLeft headers=br1>Unknown</TH><TD class=alignRight headers="br1 br7 bc1 bc2 bc3">1</TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc4">0</TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc6">1</TD><TD class=alignRight headers="br1 br7 bc1 bc7">0</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc10">7</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc11">6</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc12">0</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc13">1</TD><TD class=alignRight headers="br1 br7 bc8 bc14">0</TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc16">7</TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc17">0.8%</TD></TR><TR><TH id=br8 class=alignLeft headers=br1>Total</TH><TD class=alignRight headers="br1 br8 bc1 bc2 bc3">193</TD><TD class="lightred alignRight" headers="br1 br8 bc1 bc2 bc4">73</TD><TD class="lightred alignRight" headers="br1 br8 bc1 bc2 bc5">5</TD><TD class="lightred alignRight" headers="br1 br8 bc1 bc2 bc6">115</TD><TD class=alignRight headers="br1 br8 bc1 bc7">19</TD><TD class=alignRight headers="br1 br8 bc8 bc9 bc10">772</TD><TD class="lightred alignRight" headers="br1 br8 bc8 bc9 bc11">420</TD><TD class="lightred alignRight" headers="br1 br8 bc8 bc9 bc12">49</TD><TD class="lightred alignRight" headers="br1 br8 bc8 bc9 bc13">303</TD><TD class=alignRight headers="br1 br8 bc8 bc14">144</TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc16">916</TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc17">100.0%</TD></TR><TR><TH id=br9 class=alignLeft headers=br1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="br1 br9 bc1 bc2 bc3">91.0%</TD><TD class="lightred alignRight" headers="br1 br9 bc1 bc2 bc4">37.8%</TD><TD class="lightred alignRight" headers="br1 br9 bc1 bc2 bc5">2.6%</TD><TD class="lightred alignRight" headers="br1 br9 bc1 bc2 bc6">59.6%</TD><TD class=alignRight headers="br1 br9 bc1 bc7">9.0%</TD><TD class=alignRight headers="br1 br9 bc8 bc9 bc10">84.3%</TD><TD class="lightred alignRight" headers="br1 br9 bc8 bc9 bc11">54.4%</TD><TD class="lightred alignRight" headers="br1 br9 bc8 bc9 bc12">6.3%</TD><TD class="lightred alignRight" headers="br1 br9 bc8 bc9 bc13">39.2%</TD><TD class=alignRight headers="br1 br9 bc8 bc14">15.7%</TD><TD class=alignRight></TD><TD class=alignRight></TD></TR></TBODY></TABLE>

    Top of Page

    Influenza Strain Characterizations

    During the 2013-2014 influenza season, the National Microbiology Laboratory (NML) has antigenically characterized 117 influenza viruses [14 A(H3N2), 79 A(H1N1)pdm09 and 24 influenza B]. The vast majority (95.7%) of viruses were similar to the strains recommended by the WHO for the 2013-14 seasonal influenza vaccine; five influenza B viruses were similar to the strain recommended by the WHO for the 2011-12 vaccine (Figure 4).
    Figure 4. Influenza strain characterizations, Canada, 2013-14, N = 117

    The NML receives a proportion of the number of influenza positive specimens from provincial laboratories for strain characterization and antiviral resistance testing. Characterization data reflect the results of haemagglutination inhibition (HAI) testing compared to the reference influenza strains recommended by WHO.
    The recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b (e.g. A/Texas/50/2012), and a B/Massachusetts/2/2012-like virus (Yamagata lineage).


    Text equivalent for figure 4Influenza strain characterizations, Canada, 2013-2014, N =3
    Antiviral Resistance

    During the 2013-2014 influenza season, NML has tested 118 influenza viruses for resistance to oseltamivir and 116 for resistance to zanamivir, and all were sensitive. Sixty-nine influenza A viruses were tested for amantadine resistance, and all were resistant (Table 3).
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=cr1 rowSpan=2>Virus type and subtype</TH><TH id=cc1 colSpan=2>Oseltamivir</TH><TH id=cc4 colSpan=2>Zanamivir</TH><TH id=cc7 colSpan=2>Amantadine</TH></TR><TR class=bg-colour-yellow><TH id=cc2 headers=cc1># tested</TH><TH id=cc3 headers=cc1># resistant (%)</TH><TH id=cc5 headers=cc4># tested</TH><TH id=cc6 headers=cc4># resistant (%)</TH><TH id=cc8 headers=cc7># tested</TH><TH id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH id=cr2 class="alignLeft lightred" headers=cr1>A (H3N2)</TH><TD class=alignRight headers="cr1 cr2 cc1 cc2">15 </TD><TD class=alignRight headers="cr1 cr2 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr2 cc4 cc5">15 </TD><TD class=alignRight headers="cr1 cr2 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr2 cc7 cc8">14 </TD><TD class=alignRight headers="cr1 cr2 cc7 cc9">14 (100%) </TD></TR><TR><TH id=cr3 class="alignLeft lightred" headers=cr1>A (H1N1)</TH><TD class=alignRight headers="cr1 cr3 cc1 cc2">78 </TD><TD class=alignRight headers="cr1 cr3 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr3 cc4 cc5">76 </TD><TD class=alignRight headers="cr1 cr3 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr3 cc7 cc8">55 </TD><TD class=alignRight headers="cr1 cr3 cc7 cc9">55 (100%) </TD></TR><TR><TH id=cr4 class="alignLeft lightred" headers=cr1>B</TH><TD class=alignRight headers="cr1 cr4 cc1 cc2">25 </TD><TD class=alignRight headers="cr1 cr4 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr4 cc4 cc5">25 </TD><TD class=alignRight headers="cr1 cr4 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr4 cc7 cc8">NA <SUP>*</SUP></TD><TD class=alignRight headers="cr1 cr4 cc7 cc9">NA <SUP>*</SUP></TD></TR><TR><TH id=cr5 class="alignLeft lightred" headers=cr1>TOTAL</TH><TD class=alignRight headers="cr1 cr5 cc1 cc2">118 </TD><TD class=alignRight headers="cr1 cr5 cc1 cc3">0 </TD><TD class=alignRight headers="cr1 cr5 cc4 cc5">116 </TD><TD class=alignRight headers="cr1 cr5 cc4 cc6">0 </TD><TD class=alignRight headers="cr1 cr5 cc7 cc8">69 </TD><TD class=alignRight headers="cr1 cr5 cc7 cc9">69 (100%) </TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate increased from 19.2/1,000 in week 49 to 25.7/1,000 in week 50 (Figure 5).
    Figure 5. Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Note: No data available for mean rate for weeks 19 to 39 for the 1996-1997 through 2002-2003 seasons. Delays in the reporting of data may cause data to change retrospectively. The calculation of the average ILI consultation rate over 17 seasons was aligned with influenza activity in each season. In BC, AB, and SK, data is compiled by a provincial sentinel surveillance program for reporting to FluWatch. The number of sentinel physicians in each province or territory is as follows: BC(21), AB(80), SK(11), MB(18), ON(169), QC(14), NB(29), NS(26), PE(4), NL(16), NU(1), NT(14), YT(13). Not all sentinel physicians report every week.
    Text equivalent for figure 5Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Top of Page

    Influenza Outbreak Surveillance

    In week 50, three new influenza outbreaks were reported: two in long-term care facilities and one in a hospital (Figure 6).
    Figure 6. Overall number of new influenza outbreaks by report week, Canada, 2013-2014

    1 All provinces and territories except NU report outbreaks in long-term care facilities. All provinces and territories with the exception of NU and QC report outbreaks in hospitals. Outbreaks of influenza or influenza-like-illness in other facilities are reported to FluWatch but reporting varies between jurisdictions. Outbreak definitions are included at the end of the report.
    Text equivalent for figure 6 Overall number of new influenza outbreaks by report week, Canada, 2013-2014
    Pharmacy Surveillance

    Pharmacy surveillance data on sales of influenza antivirals is not yet available for the 2013-14 season (Figure 7).
    Figure 7. Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Note: Pharmacy sales data are provided to the Public Health Agency of Canada by Rx Canada Inc. and sourced from major retail drug chains representing over 3,000 stores nationwide (excluding Nunavut) in 85% of Health Regions. Data provided include the number of new antiviral prescriptions (for Tamiflu and Relenza) and the total number of new prescriptions dispensed by Province/Territory and age group. Age-groups: Infant: 0-2y, Child: 2-18y; Adult: 19-64y, Senior: ≥65y.
    Text equivalent for figure 7Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Top of Page

    Sentinel Hospital Influenza Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)
    In week 50, 14 new laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalizations were reported by the Immunization Monitoring Program Active (IMPACT) network. Thirteen were cases of influenza A: five A(H1N1)pdm09 and eight A(unsubtyped). Three cases were children under 6 months of age, two were 6-23 months of age, five were 2-4 years of age, one was 5-9 years of age and three were 10-16 years of age (Figure 8a). Two ICU admissions were reported in week 50, one child 5-9 years of age with influenza B, and one 10-16 years of age with A(H1N1)pdm09.
    To date this season, a total of 53 influenza-associated paediatric hospitalizations have been reported by the IMPACT network, the majority of which have been influenza A (Table 4). Eighteen (34%) of cases have been children under 2 years of age. Five ICU admissions have been reported: two cases with influenza B and three with A(H1N1)pdm09, all children 2 years of age or older. No deaths have been reported (Figure 9a).

    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    Adult Influenza Hospitalizations and Deaths (PCIRN)
    In week 50, eight new laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations were reported through active<SUP>*</SUP> surveillance by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network: one adult <20 years of age, one 20-44 years of age, two 45-64 years of age and four ≥65 years of age. Influenza A was identified in eight cases: four A(H1N1)pdm09 and four A(unsubtyped). One ICU admission was reported in an adult ≥65 years of age with A(unsubtyped) (Figure 8b).
    To date this season, 41 influenza-associated hospitalizations have been reported by the PCIRN-SOS network, 40 with influenza A. The majority (78%) have been adults over 45 years of age (Table 5). ICU admission was required for three hospitalizations, all adults 45-64 years of age with influenza A. No deaths have been reported (Figure 9b).

    Note: PCIRN-SOS conducted passive surveillance from April 30th to November 14th, 2013. Cases reported during this period were identified by laboratory detection of influenza among patients admitted to participating hospitals. Active surveillance began November 15th during which time PCIRN site coordinators investigate cases potentially related to influenza. Data from both active and passive surveillance reported during the 2013-14 season are included in this report. The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 4 - Cumulative numbers of paediatric hospitalizations with influenza reported by the IMPACT network, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=dr1 rowSpan=3>Age groups </TH><TH id=dc1 colSpan=6>Cumulative (Aug. 25, 2013 to December 14, 2013) </TH></TR><TR class=bg-colour-yellow><TH id=dc2 colSpan=4 headers=dc1>Influenza A </TH><TH id=dc7 headers=dc1>B </TH><TH id=dc8 headers=dc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=dc3 headers="dc1 dc2">A Total </TH><TH id=dc4 class="lightred " headers="dc1 dc2">A(H1) pdm09 </TH><TH id=dc5 class="lightred " headers="dc1 dc2">A(H3) </TH><TH id=dc6 class="lightred " headers="dc1 dc2">A (UnS) </TH><TD class=alignCenter headers="dc1 dc7">Total</TD><TD class=alignCenter headers="dc1 dc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=dr2 class=alignLeft headers=dr1>0-5m </TH><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc3">9</TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc4">2</TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc5">0</TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc6">7</TD><TD class=alignRight headers="dr1 dr2 dc1 dc7">1</TD><TD class=alignRight headers="dr1 dr2 dc1 dc8">10 (19%)</TD></TR><TR><TH id=dr3 class=alignLeft headers=dr1>6-23m </TH><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc3">7</TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc4">4</TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc5">0</TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc6">3</TD><TD class=alignRight headers="dr1 dr3 dc1 dc7">1</TD><TD class=alignRight headers="dr1 dr3 dc1 dc8">8 (15%)</TD></TR><TR><TH id=dr4 class=alignLeft headers=dr1>2-4y </TH><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc3">12</TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc4">5</TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc5">0</TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc6">7</TD><TD class=alignRight headers="dr1 dr4 dc1 dc7">5</TD><TD class=alignRight headers="dr1 dr4 dc1 dc8">17 (32%)</TD></TR><TR><TH id=dr5 class=alignLeft headers=dr1>5-9y </TH><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc3">8</TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc4">4</TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc5">0</TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc6">4</TD><TD class=alignRight headers="dr1 dr5 dc1 dc7">2</TD><TD class=alignRight headers="dr1 dr5 dc1 dc8">10 (19%)</TD></TR><TR><TH id=dr6 class=alignLeft headers=dr1>10-16y </TH><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc3">7</TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc4">5</TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc5">0</TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc6">2</TD><TD class=alignRight headers="dr1 dr6 dc1 dc7">1</TD><TD class=alignRight headers="dr1 dr6 dc1 dc8">8 (15%)</TD></TR><TR><TH id=dr7 class=alignLeft headers=dr1>Total </TH><TD class=alignRight headers="dr1 dr7 dc1 dc2 dc3">43</TD><TD class="lightred alignRight" headers="dr1 dr7 dc1 dc2 dc4">20</TD><TD class="lightred alignRight" headers="dr1 dr7 dc1 dc2 dc5">0</TD><TD class="lightred alignRight" headers="dr1 dr7 dc1 dc2 dc6">23</TD><TD class=alignRight headers="dr1 dr7 dc1 dc7">10</TD><TD class=alignRight headers="dr1 dr7 dc1 dc8">53</TD></TR><TR><TH id=dr8 class=alignLeft headers=dr1>% <SUP>1</SUP> </TH><TD class=alignRight headers="dr1 dr8 dc1 dc2 dc3">81.1%</TD><TD class="lightred alignRight" headers="dr1 dr8 dc1 dc2 dc4">46.5%</TD><TD class="lightred alignRight" headers="dr1 dr8 dc1 dc2 dc5">0.0%</TD><TD class="lightred alignRight" headers="dr1 dr8 dc1 dc2 dc6">53.5%</TD><TD class=alignRight headers="dr1 dr8 dc1 dc7">18.9%</TD><TD class=alignRight headers="dr1 dr8 dc1 dc8">100.0%</TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 5 - Cumulative numbers of adult hospitalizations with influenza
    reported by the PCIRN-SOS network, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=er1 rowSpan=3>Age groups </TH><TH id=ec1 class=noWrap colSpan=6>Cumulative (Aug. 25, 2013 to December 14, 2013) </TH></TR><TR class=bg-colour-yellow><TH id=ec2 colSpan=4 headers=ec1>Influenza A </TH><TH id=ec7 headers=ec1>B </TH><TH id=ec8 headers=ec1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=ec3 headers="ec1 ec2">A Total </TH><TH id=ec4 class="lightred " headers="ec1 ec2">A(H1) pdm09 </TH><TH id=ec5 class="lightred " headers="ec1 ec2">A(H3) </TH><TH id=ec6 class="lightred " headers="ec1 ec2">A(UnS) </TH><TD class=alignCenter headers="ec1 ec7">Total</TD><TD class=alignCenter headers="ec1 ec8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=er2 class=alignLeft headers=er1>16-20 </TH><TD class=alignRight headers="er1 er2 ec1 ec2 ec3">2</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec4">1</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec5">0</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec6">1</TD><TD class=alignRight headers="er1 er2 ec1 ec7">0</TD><TD class=alignRight headers="er1 er2 ec1 ec8">2 (5%)</TD></TR><TR><TH id=er3 class=alignLeft headers=er1>20-44 </TH><TD class=alignRight headers="er1 er3 ec1 ec2 ec3">7</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec4">4</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec5">0</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec6">3</TD><TD class=alignRight headers="er1 er3 ec1 ec7">0</TD><TD class=alignRight headers="er1 er3 ec1 ec8">7 (17%)</TD></TR><TR><TH id=er4 class=alignLeft headers=er1>45-64 </TH><TD class=alignRight headers="er1 er4 ec1 ec2 ec3">16</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec4">7</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec5">1</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec6">8</TD><TD class=alignRight headers="er1 er4 ec1 ec7">1</TD><TD class=alignRight headers="er1 er4 ec1 ec8">17 (41%)</TD></TR><TR><TH id=er5 class=alignLeft headers=er1>65+ </TH><TD class=alignRight headers="er1 er5 ec1 ec2 ec3">15</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec4">6</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec5">2</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec6">7</TD><TD class=alignRight headers="er1 er5 ec1 ec7">0</TD><TD class=alignRight headers="er1 er5 ec1 ec8">15 (37%)</TD></TR><TR><TH id=er6 class=alignLeft headers=er1>Total </TH><TD class=alignRight headers="er1 er6 ec1 ec2 ec3">40</TD><TD class=alignRight headers="er1 er6 ec1 ec2 ec4">18</TD><TD class=alignRight headers="er1 er6 ec1 ec2 ec5">3</TD><TD class=alignRight headers="er1 er6 ec1 ec2 ec6">19</TD><TD class=alignRight headers="er1 er6 ec1 ec7">1</TD><TD class=alignRight headers="er1 er6 ec1 ec8">41</TD></TR><TR><TH id=er7 class=alignLeft headers=er1>%<SUP>1</SUP> </TH><TD class=alignRight headers="er1 er7 ec1 ec2 ec3">98%</TD><TD class=alignRight headers="er1 er7 ec1 ec2 ec4">45%</TD><TD class=alignRight headers="er1 er7 ec1 ec2 ec5">8%</TD><TD class=alignRight headers="er1 er7 ec1 ec2 ec6">48%</TD><TD class=alignRight headers="er1 er7 ec1 ec7">2%</TD><TD class=alignRight headers="er1 er7 ec1 ec8">100%</TD></TR></TBODY></TABLE>
    Figure 8. Number of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)


    Text equivalent for figure 8aNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    * See footnote above following the section related to PCIRN-SOS data.
    Text equivalent for figure 8bNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Adult hospitalizations (>16 year of age, PCIRN-SOS)
    Figure 9. Percentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)

    Text equivalent for figure 9aPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Text equivalent for figure 9bPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Top of Page

    Provincial/Territorial Influenza Hospitalizations and Deaths

    In week 50, 68 new laboratory-confirmed influenza-associated hospitalizations were reported from participating provinces and territories.*The cases were as follows: five children less than 6 months of age, three children 6-23 months, eight children 2-4 years, four children 5-14 years, 11 adults 20-44 years, 22 adults 45-64 years and 15 adults ≥65 years of age. All but two were cases of influenza A, of which 39 were A(H1N1)pdm09, one was A(H3N2) and 26 A(unsubtyped). No ICU admissions were reported. Three deaths were reported in adults 45-64 years of age with influenza A. The number of new influenza-associated hospitalizations and deaths reported for the current week may include cases from Ontario that occurred in previous weeks, as a result of retrospective updates to the cumulative total.
    To date this season, 161 influenza-associated hospitalizations have been reported, of which 152 (94.4%) had influenza A and among those 57% were A(H1N1)pdm09 (Table 6). More than half of cases (52.8%) were ≥45 years of age, and 23.6% were under 5 years of age. A greater proportion of cases under 20 years of age had influenza B (12%) compared to those 20 years of age or older (3%). Eight ICU admissions have been reported this season, all cases of influenza A (seven A(H1N1)pdm09 and one A(unsubtyped)). The cases were as follows: one child 2-4 years of age, one 5-14 years of age, one adult 20-44 years of age, four adults 45-64 years of age and one adult ≥65 years of age. Five deaths have been reported: four adults 45-64 years of age and one ≥65 years of age, all with A(H1N1)pdm09. It is important to note that the hospitalization or death does not have to be attributable to influenza, a positive laboratory test is sufficient for reporting. Detailed clinical information (e.g. underlying medical conditions) is not known for these cases.
    * Note: Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not distinguished among hospital admissions reported from Ontario. Data may also include cases reported by the IMPACT and PCIRN networks.

    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 6. Cumulative number of hospitalizations with influenza reported by the participating provinces and territories, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=fr1 rowSpan=3>Age groups </TH><TH id=fc1 colSpan=6>Cumulative (Aug. 25, 2013 to December 14, 2013) </TH></TR><TR class=bg-colour-yellow><TH id=fc2 colSpan=4 headers=fc1>Influenza A </TH><TH id=fc7 headers=fc1>B </TH><TH id=fc8 headers=fc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=fc3 headers="fc1 fc2">A Total </TH><TH id=fc4 class=lightred headers="fc1 fc2">A(H1) pdm09 </TH><TH id=fc5 class=lightred headers="fc1 fc2">A(H3) </TH><TH id=fc6 class=lightred headers="fc1 fc2">A (UnS) </TH><TD class=alignCenter headers="fc1 fc7">Total</TD><TD class=alignCenter headers="fc1 fc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=8><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=fr2 class=alignLeft headers=fr1>0-4 years </TH><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc3">33</TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc4">18</TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc5">1</TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc6">14</TD><TD class=alignRight headers="fr1 fr2 fc1 fc7">5</TD><TD class=alignRight headers="fr1 fr2 fc1 fc8">38 (24%)</TD></TR><TR><TH id=fr3 class=alignLeft headers=fr1>5-14 years </TH><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc3">10</TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc4">5</TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc5">0</TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc6">5</TD><TD class=alignRight headers="fr1 fr3 fc1 fc7">1</TD><TD class=alignRight headers="fr1 fr3 fc1 fc8">11 (7%)</TD></TR><TR><TH id=fr4 class=alignLeft headers=fr1>15-19 years </TH><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc3">2</TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc4">1</TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc5">0</TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc6">1</TD><TD class=alignRight headers="fr1 fr4 fc1 fc7">0</TD><TD class=alignRight headers="fr1 fr4 fc1 fc8">2 (1%)</TD></TR><TR><TH id=fr5 class=alignLeft headers=fr1>20-44 years </TH><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc3">25</TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc4">19</TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc5">0</TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc6">6</TD><TD class=alignRight headers="fr1 fr5 fc1 fc7">0</TD><TD class=alignRight headers="fr1 fr5 fc1 fc8">25 (16%)</TD></TR><TR><TH id=fr6 class=alignLeft headers=fr1>45-64 years </TH><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc3">49</TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc4">28</TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc5">7</TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc6">14</TD><TD class=alignRight headers="fr1 fr6 fc1 fc7">1</TD><TD class=alignRight headers="fr1 fr6 fc1 fc8">50 (31%)</TD></TR><TR><TH id=fr7 class=alignLeft headers=fr1>65+ years </TH><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc3">33</TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc4">15</TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc5">6</TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc6">12</TD><TD class=alignRight headers="fr1 fr7 fc1 fc7">2</TD><TD class=alignRight headers="fr1 fr7 fc1 fc8">35 (22%)</TD></TR><TR><TH id=fr8 class=alignLeft headers=fr1>Total </TH><TD class=alignRight headers="fr1 fr8 fc1 fc2 fc3">152</TD><TD class="lightred alignRight" headers="fr1 fr8 fc1 fc2 fc4">86</TD><TD class="lightred alignRight" headers="fr1 fr8 fc1 fc2 fc5">14</TD><TD class="lightred alignRight" headers="fr1 fr8 fc1 fc2 fc6">52</TD><TD class=alignRight headers="fr1 fr8 fc1 fc7">9</TD><TD class=alignRight headers="fr1 fr8 fc1 fc8">161</TD></TR><TR><TH id=fr9 class=alignLeft headers=fr1>Percentage <SUP>1</SUP> </TH><TD class=alignRight headers="fr1 fr9 fc1 fc2 fc3">94.4%</TD><TD class="lightred alignRight" headers="fr1 fr9 fc1 fc2 fc4">56.6%</TD><TD class="lightred alignRight" headers="fr1 fr9 fc1 fc2 fc5">9.2%</TD><TD class="lightred alignRight" headers="fr1 fr9 fc1 fc2 fc6">34.2%</TD><TD class=alignRight headers="fr1 fr9 fc1 fc7">5.6%</TD><TD class=alignRight headers="fr1 fr9 fc1 fc8">100%</TD></TR></TBODY></TABLE>

    .../

    Leave a comment:


  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Week 49

    FluWatch report: December 1 to 7, 2013 (Week 49)

    Posted 2013-12-12For readers interested in the <ABBR title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A title="Flu Watch (Version PDF, 113 KB - 6 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w49_13/pdf/fw2013-49-eng.pdf">FluWatch report: December 1 to 7, 2013 (Week 49) (<ABBR title="Portable Document Format">PDF</ABBR> Version - 291 <ABBR title=Kilobytes>KB</ABBR> - 10 pages)

    ?? Help with PDF documents

    Overall Summary
    • Influenza activity in Canada continued to increase in week 49 with three regions reporting localized influenza/ILI activity and 23 reporting sporadic activity.
    • Influenza A remains the predominant influenza virus type this season (87%), and among subtyped influenza A specimens, 83% were A(H1N1)pdm09.
    • The number of both paediatric and adult hospitalizations with influenza continued to increase; 97% of adult cases and 76% of paediatric cases from sentinel hospital surveillance were influenza A, predominantly A(H1N1)pdm09.
    • RSV detections continued to increase, and RSV was the most frequently detected respiratory virus in week 49.

    Influenza/ILI Activity (geographic spread)

    In week 49, two regions in Ontario and one in Quebec reported localized activity and 23 regions (in BC(5), AB(4), SK(3), MB(1), ON(5), QC(4) and YT(1)) reported sporadic activity (Figure 1).
    Figure 1. Map of overall influenza/ILI activity level by province and territory, Canada, Week 49





    Note: Influenza/ILI activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates and reported outbreaks. Please refer to detailed definitions at the end of the report. Maps from previous weeks, including any retrospective updates, are available on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada
    Influenza and Other Respiratory Virus Detections

    The number of positive influenza tests increased sharply, from 115 in week 48 to 200 in week 49, bringing the percentage of positive influenza tests to 6.1% (Figure 2). Cumulative influenza virus detections to date have been predominantly influenza A (87%). Among subtyped influenza A viruses, 83% (317/381) were A(H1N1)pdm09 (Table 1). Detailed information on age and type/subtype has been received for 619 cases to date this season. Consistent with demographics observed in recent seasons, a larger proportion of cases of A(H3N2) and influenza B were ≥65 years of age (37.5% and 38.1%, respectively) compared to cases of A(H1N1)pdm09 (9.0%).
    Figure 2. Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14

    Text equivalent for figure 2Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14
    In week 49, the number of positive tests for RSV continued to increase. Positive tests for rhinovirus continued to decline. RSV was the most frequently detected virus in week 49, followed by rhinovirus and parainfluenza (Figure 3).
    For more details, see the weekly Respiratory Virus Detections in Canada Report.
    Figure 3. Number of positive laboratory tests for other respiratory viruses by report week, Canada, 2013-14


    Top of Page

    RSV: Respiratory syncytial virus; hMPV: Human metapneumovirus
    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 1: Weekly and cumulative numbers of positive influenza specimens
    by type, subtype and province, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=ar1 rowSpan=3>Reporting provinces <SUP>1</SUP></TH><TH id=ac1 colSpan=5>Weekly
    (December 1 to December 7, 2013)</TH><TH id=ac8 colSpan=5>Cumulative
    (August 25, 2013 to December 7, 2013)</TH></TR><TR class=bg-colour-yellow><TH id=ac2 colSpan=4 headers=ac1>Influenza A</TH><TH id=ac7 headers=ac1>B</TH><TH id=ac9 colSpan=4 headers=ac8>Influenza A</TH><TH id=ac14 headers=ac8>B</TH></TR><TR class=bg-colour-grey-light><TH id=ac3 headers="ac1 ac2">A Total</TH><TH id=ac4 class=lightred headers="ac1 ac2">A(H1)pdm09</TH><TH id=ac5 class=lightred headers="ac1 ac2">A(H3)</TH><TH id=ac6 class=lightred headers="ac1 ac2">A(UnS)</TH><TH class=alignCenter headers="ac1 ac7">B Total</TH><TH id=ac10 headers="ac8 ac9">A Total</TH><TH id=ac11 class=lightred headers="ac8 ac9">A(H1)pdm09</TH><TH id=ac12 class=lightred headers="ac8 ac9">A(H3)</TH><TH id=ac13 class=lightred headers="ac8 ac9">A(UnS)</TH><TD class=alignCenter headers="ac8 ac14">B Total</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=11><SUP>1 </SUP>Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.
    <SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.</TD></TR></TFOOT><TBODY><TR><TH id=ar2 class=alignLeft headers=ar1>BC</TH><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac3">15 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac4">11 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac5">1 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac6">3 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar2 ac8 ac9 ac10">38 </TD><TD class=alignCenter headers="ar1 ar2 ac8 ac9 ac11">26 </TD><TD class=alignCenter headers="ar1 ar2 ac8 ac9 ac12">4 </TD><TD class=alignCenter headers="ar1 ar2 ac8 ac9 ac13">8 </TD><TD class=alignCenter headers="ar1 ar2 ac8 ac14">4 </TD></TR><TR><TH id=ar3 class=alignLeft headers=ar1>AB</TH><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac3">60 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac4">52 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac5">1 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac6">7 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac7">1 </TD><TD class=alignCenter headers="ar1 ar3 ac8 ac9 ac10">162 </TD><TD class=alignCenter headers="ar1 ar3 ac8 ac9 ac11">145 </TD><TD class=alignCenter headers="ar1 ar3 ac8 ac9 ac12">10 </TD><TD class=alignCenter headers="ar1 ar3 ac8 ac9 ac13">7 </TD><TD class=alignCenter headers="ar1 ar3 ac8 ac14">16 </TD></TR><TR><TH id=ar4 class=alignLeft headers=ar1>SK</TH><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac3">10 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac4">6 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac6">4 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar4 ac8 ac9 ac10">24 </TD><TD class=alignCenter headers="ar1 ar4 ac8 ac9 ac11">16 </TD><TD class=alignCenter headers="ar1 ar4 ac8 ac9 ac12">0 </TD><TD class=alignCenter headers="ar1 ar4 ac8 ac9 ac13">8 </TD><TD class=alignCenter headers="ar1 ar4 ac8 ac14">0 </TD></TR><TR><TH id=ar5 class=alignLeft headers=ar1>MB</TH><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac3">2 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac4">2 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac7">1 </TD><TD class=alignCenter headers="ar1 ar5 ac8 ac9 ac10">10 </TD><TD class=alignCenter headers="ar1 ar5 ac8 ac9 ac11">10 </TD><TD class=alignCenter headers="ar1 ar5 ac8 ac9 ac12">0 </TD><TD class=alignCenter headers="ar1 ar5 ac8 ac9 ac13">0 </TD><TD class=alignCenter headers="ar1 ar5 ac8 ac14">5 </TD></TR><TR><TH id=ar6 class=alignLeft headers=ar1>ON</TH><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac3">76 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac4">54 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac5">9 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac6">13 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar6 ac8 ac9 ac10">197 </TD><TD class=alignCenter headers="ar1 ar6 ac8 ac9 ac11">118 </TD><TD class=alignCenter headers="ar1 ar6 ac8 ac9 ac12">49 </TD><TD class=alignCenter headers="ar1 ar6 ac8 ac9 ac13">28 </TD><TD class=alignCenter headers="ar1 ar6 ac8 ac14">12 </TD></TR><TR><TH id=ar7 class=alignLeft headers=ar1>QC</TH><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac3">23 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac6">23 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac7">12 </TD><TD class=alignCenter headers="ar1 ar7 ac8 ac9 ac10">62 </TD><TD class=alignCenter headers="ar1 ar7 ac8 ac9 ac11">0 </TD><TD class=alignCenter headers="ar1 ar7 ac8 ac9 ac12">0 </TD><TD class=alignCenter headers="ar1 ar7 ac8 ac9 ac13">62 </TD><TD class=alignCenter headers="ar1 ar7 ac8 ac14">37 </TD></TR><TR><TH id=ar8 class=alignLeft headers=ar1>NB</TH><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac6">0</TD><TD class=alignCenter headers="ar1 ar8 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar8 ac8 ac9 ac10">2 </TD><TD class=alignCenter headers="ar1 ar8 ac8 ac9 ac11">1 </TD><TD class=alignCenter headers="ar1 ar8 ac8 ac9 ac12">1 </TD><TD class=alignCenter headers="ar1 ar8 ac8 ac9 ac13">0 </TD><TD class=alignCenter headers="ar1 ar8 ac8 ac14">0 </TD></TR><TR><TH id=ar9 class=alignLeft headers=ar1>NS</TH><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar9 ac8 ac9 ac10">0 </TD><TD class=alignCenter headers="ar1 ar9 ac8 ac9 ac11">0 </TD><TD class=alignCenter headers="ar1 ar9 ac8 ac9 ac12">0 </TD><TD class=alignCenter headers="ar1 ar9 ac8 ac9 ac13">0 </TD><TD class=alignCenter headers="ar1 ar9 ac8 ac14">0 </TD></TR><TR><TH id=ar10 class=alignLeft headers=ar1>PE</TH><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar10 ac8 ac9 ac10">0 </TD><TD class=alignCenter headers="ar1 ar10 ac8 ac9 ac11">0 </TD><TD class=alignCenter headers="ar1 ar10 ac8 ac9 ac12">0 </TD><TD class=alignCenter headers="ar1 ar10 ac8 ac9 ac13">0 </TD><TD class=alignCenter headers="ar1 ar10 ac8 ac14">0 </TD></TR><TR><TH id=ar11 class=alignLeft headers=ar1>NL</TH><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar11 ac8 ac9 ac10">3</TD><TD class=alignCenter headers="ar1 ar11 ac8 ac9 ac11">1 </TD><TD class=alignCenter headers="ar1 ar11 ac8 ac9 ac12">0 </TD><TD class=alignCenter headers="ar1 ar11 ac8 ac9 ac13">2 </TD><TD class=alignCenter headers="ar1 ar11 ac8 ac14">0 </TD></TR><TR><TH id=ar12 class=alignLeft headers=ar1>Canada</TH><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac3">186 </TD><TD class="lightred alignCenter" headers="ar1 ar12 ac1 ac2 ac4">125 </TD><TD class="lightred alignCenter" headers="ar1 ar12 ac1 ac2 ac5">11 </TD><TD class="lightred alignCenter" headers="ar1 ar12 ac1 ac2 ac6">50 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac7">14 </TD><TD class=alignCenter headers="ar1 ar12 ac8 ac9 ac10">498 </TD><TD class="lightred alignCenter" headers="ar1 ar12 ac8 ac9 ac11">317 </TD><TD class="lightred alignCenter" headers="ar1 ar12 ac8 ac9 ac12">64 </TD><TD class="lightred alignCenter" headers="ar1 ar12 ac8 ac9 ac13">115 </TD><TD class=alignCenter headers="ar1 ar12 ac8 ac14">74 </TD></TR><TR><TH id=ar13 class=alignLeft headers=ar1>Percentage<SUP>2</SUP></TH><TD class=alignCenter headers="ar1 ar13 ac1 ac2 ac3">93.0% </TD><TD class="lightred alignCenter" headers="ar1 ar13 ac1 ac2 ac4">67.2% </TD><TD class="lightred alignCenter" headers="ar1 ar13 ac1 ac2 ac5">5.9% </TD><TD class="lightred alignCenter" headers="ar1 ar13 ac1 ac2 ac6">26.9% </TD><TD class=alignCenter headers="ar1 ar13 ac1 ac7">7.0% </TD><TD class=alignCenter headers="ar1 ar13 ac8 ac9 ac10">87.1% </TD><TD class="lightred alignCenter" headers="ar1 ar13 ac8 ac9 ac11">63.7% </TD><TD class="lightred alignCenter" headers="ar1 ar13 ac8 ac9 ac12">12.9% </TD><TD class="lightred alignCenter" headers="ar1 ar13 ac8 ac9 ac13">23.1% </TD><TD class=alignCenter headers="ar1 ar13 ac8 ac14">12.9% </TD></TR></TBODY></TABLE>

    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 2. Weekly and cumulative numbers of positive influenza specimens by type, subtype and age-group reported through case-based laboratory reporting<SUP>3</SUP>, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=br1 rowSpan=3>Age groups (years)</TH><TH id=bc1 colSpan=5>Weekly
    (December 1 to December 7, 2013)</TH><TH id=bc8 colSpan=7>Cumulative
    (August 25, 2013 to December 7, 2013)</TH></TR><TR class=bg-colour-yellow><TH id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH id=bc7 headers=bc1>B</TH><TH id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH id=bc14 headers=bc8>B</TH><TH id=bc15 colSpan=2 headers=bc8>Influenza A and B</TH></TR><TR class=bg-colour-grey-light><TH id=bc3 headers="bc1 bc2">A Total</TH><TH id=bc4 class="lightred " headers="bc1 bc2">A(H1) pdm09</TH><TH id=bc5 class="lightred " headers="bc1 bc2">A(H3)</TH><TH id=bc6 class="lightred " headers="bc1 bc2">A (UnS)</TH><TD class=alignCenter headers="bc1 bc7">Total</TD><TH id=bc10 headers="bc8 bc9">A Total</TH><TH id=bc11 class="lightred " headers="bc8 bc9">A(H1) pdm09</TH><TH id=bc12 class="lightred " headers="bc8 bc9">A(H3)</TH><TH id=bc13 class="lightred " headers="bc8 bc9">A (UnS)</TH><TD class=alignCenter headers="bc8 bc14">Total</TD><TH id=bc16 headers="bc8 bc15">#</TH><TH id=bc17 headers="bc8 bc15">%</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=13><SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    <SUP>3 </SUP>Table 2 includes specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available. </TD></TR></TFOOT><TBODY><TR><TH id=br2 class=alignLeft headers=br1><5</TH><TD class=alignCenter headers="br1 br2 bc1 bc2 bc3">21 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc4">13 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc6">8 </TD><TD class=alignCenter headers="br1 br2 bc1 bc7">1 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc10">96 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc11">51 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc12">8 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc13">37 </TD><TD class=alignCenter headers="br1 br2 bc8 bc14">23 </TD><TD class=alignCenter headers="br1 br2 bc8 bc15 bc16">119 </TD><TD class=alignCenter headers="br1 br2 bc8 bc15 bc17">19.2% </TD></TR><TR><TH id=br3 class=alignLeft headers=br1>5-19</TH><TD class=alignCenter headers="br1 br3 bc1 bc2 bc3">16 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc4">11 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc6">5 </TD><TD class=alignCenter headers="br1 br3 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc10">54 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc11">35 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc12">3 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc13">16 </TD><TD class=alignCenter headers="br1 br3 bc8 bc14">21 </TD><TD class=alignCenter headers="br1 br3 bc8 bc15 bc16">75 </TD><TD class=alignCenter headers="br1 br3 bc8 bc15 bc17">12.1% </TD></TR><TR><TH id=br4 class=alignLeft headers=br1>20-44</TH><TD class=alignCenter headers="br1 br4 bc1 bc2 bc3">35 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc4">22 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc6">13 </TD><TD class=alignCenter headers="br1 br4 bc1 bc7">3 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc10">130 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc11">79 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc12">4 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc13">47 </TD><TD class=alignCenter headers="br1 br4 bc8 bc14">8 </TD><TD class=alignCenter headers="br1 br4 bc8 bc15 bc16">138 </TD><TD class=alignCenter headers="br1 br4 bc8 bc15 bc17">22.3% </TD></TR><TR><TH id=br5 class=alignLeft headers=br1>45-64</TH><TD class=alignCenter headers="br1 br5 bc1 bc2 bc3">30 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc4">23 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc6">7 </TD><TD class=alignCenter headers="br1 br5 bc1 bc7">3 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc10">134 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc11">75 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc12">15 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc13">44 </TD><TD class=alignCenter headers="br1 br5 bc8 bc14">21 </TD><TD class=alignCenter headers="br1 br5 bc8 bc15 bc16">155 </TD><TD class=alignCenter headers="br1 br5 bc8 bc15 bc17">25.0% </TD></TR><TR><TH id=br6 class=alignLeft headers=br1>65+</TH><TD class=alignCenter headers="br1 br6 bc1 bc2 bc3">14 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc4">5 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc6">9 </TD><TD class=alignCenter headers="br1 br6 bc1 bc7">2 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc10">83 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc11">24 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc12">18 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc13">41 </TD><TD class=alignCenter headers="br1 br6 bc8 bc14">45 </TD><TD class=alignCenter headers="br1 br6 bc8 bc15 bc16">128 </TD><TD class=alignCenter headers="br1 br6 bc8 bc15 bc17">20.7% </TD></TR><TR><TH id=br7 class=alignLeft headers=br1>Unknown</TH><TD class=alignCenter headers="br1 br7 bc1 bc2 bc3">2 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc4">2 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc6">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc10">4 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc11">4 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc12">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc13">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc14">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc15 bc16">4 </TD><TD class=alignCenter headers="br1 br7 bc8 bc15 bc17">0.6% </TD></TR><TR><TH id=br8 class=alignLeft headers=br1>Total</TH><TD class=alignCenter headers="br1 br8 bc1 bc2 bc3">118 </TD><TD class="lightred alignCenter" headers="br1 br8 bc1 bc2 bc4">76 </TD><TD class="lightred alignCenter" headers="br1 br8 bc1 bc2 bc5">0 </TD><TD class="lightred alignCenter" headers="br1 br8 bc1 bc2 bc6">42 </TD><TD class=alignCenter headers="br1 br8 bc1 bc7">9 </TD><TD class=alignCenter headers="br1 br8 bc8 bc9 bc10">501 </TD><TD class="lightred alignCenter" headers="br1 br8 bc8 bc9 bc11">268 </TD><TD class="lightred alignCenter" headers="br1 br8 bc8 bc9 bc12">48 </TD><TD class="lightred alignCenter" headers="br1 br8 bc8 bc9 bc13">185</TD><TD class=alignCenter headers="br1 br8 bc8 bc14">118 </TD><TD class=alignCenter headers="br1 br8 bc8 bc15 bc16">619 </TD><TD class=alignCenter headers="br1 br8 bc8 bc15 bc17">100.0% </TD></TR><TR><TH id=br9 class=alignLeft headers=br1>Percentage<SUP>2</SUP></TH><TD class=alignCenter headers="br1 br9 bc1 bc2 bc3">92.9% </TD><TD class="lightred alignCenter" headers="br1 br9 bc1 bc2 bc4">64.4% </TD><TD class="lightred alignCenter" headers="br1 br9 bc1 bc2 bc5">0.0% </TD><TD class="lightred alignCenter" headers="br1 br9 bc1 bc2 bc6">35.6% </TD><TD class=alignCenter headers="br1 br9 bc1 bc7">7.1% </TD><TD class=alignCenter headers="br1 br9 bc8 bc9 bc10">80.9% </TD><TD class="lightred alignCenter" headers="br1 br9 bc8 bc9 bc11">53.3% </TD><TD class="lightred alignCenter" headers="br1 br9 bc8 bc9 bc12">9.6% </TD><TD class="lightred alignCenter" headers="br1 br9 bc8 bc9 bc13">36.9% </TD><TD class=alignCenter headers="br1 br9 bc8 bc14">19.1% </TD><TD class=alignCenter></TD><TD class=alignCenter></TD></TR></TBODY></TABLE>

    Top of Page

    Influenza Strain Characterizations

    During the 2013-2014 influenza season, the National Microbiology Laboratory (NML) has antigenically characterized 82 influenza viruses [12 A(H3N2), 46 A(H1N1)pdm09 and 24 influenza B]. Seventy-seven (93.9%) viruses were similar to the strains recommended by the WHO for the 2013-14 seasonal influenza vaccine; five influenza B viruses were similar to the strain recommended by the WHO for the 2011-12 vaccine (Figure 4).
    Figure 4. Influenza strain characterizations, Canada, 2013-14, N = 82

    The NML receives a proportion of the number of influenza positive specimens from provincial laboratories for strain characterization and antiviral resistance testing. Characterization data reflect the results of haemagglutination inhibition (HAI) testing compared to the reference influenza strains recommended by WHO.
    The recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b (e.g. A/Texas/50/2012), and a B/Massachusetts/2/2012-like virus (Yamagata lineage).


    Text equivalent for figure 4Influenza strain characterizations, Canada, 2013-2014, N =3
    Antiviral Resistance

    During the 2013-2014 influenza season, NML has tested 75 influenza viruses for resistance to oseltamivir and for resistance to zanamivir, and all were sensitive. Fifty-four influenza A viruses were tested for amantadine resistance, and all were resistant (Table 3).
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=cr1 rowSpan=2>Virus type and subtype</TH><TH id=cc1 colSpan=2>Oseltamivir</TH><TH id=cc4 colSpan=2>Zanamivir</TH><TH id=cc7 colSpan=2>Amantadine</TH></TR><TR class=bg-colour-yellow><TH id=cc2 headers=cc1># tested</TH><TH id=cc3 headers=cc1># resistant (%)</TH><TH id=cc5 headers=cc4># tested</TH><TH id=cc6 headers=cc4># resistant (%)</TH><TH id=cc8 headers=cc7># tested</TH><TH id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH id=cr2 class="alignLeft lightred" headers=cr1>A (H3N2)</TH><TD class=alignCenter headers="cc1 cr2 cc2">10</TD><TD class=alignCenter headers="cc1 cr2 cc3">0</TD><TD class=alignCenter headers="cc4 cr2 cc5">10</TD><TD class=alignCenter headers="cc4 cr2 cc6">0</TD><TD class=alignCenter headers="cc7 cr2 cc8">14</TD><TD class=alignCenter headers="cc7 cr2 cc9">14(100%)</TD></TR><TR><TH id=cr3 class="alignLeft lightred" headers=cr1>A (H1N1)</TH><TD class=alignCenter headers="cc1 cr3 cc2">42</TD><TD class=alignCenter headers="cc1 cr3 cc3">0</TD><TD class=alignCenter headers="cc4 cr3 cc5">42</TD><TD class=alignCenter headers="cc4 cr3 cc6">0</TD><TD class=alignCenter headers="cc7 cr3 cc8">40</TD><TD class=alignCenter headers="cc7 cr3 cc9">40(100%)</TD></TR><TR><TH id=cr4 class="alignLeft lightred" headers=cr1>B</TH><TD class=alignCenter headers="cc1 cr4 cc2">23</TD><TD class=alignCenter headers="cc1 cr4 cc3">0</TD><TD class=alignCenter headers="cc4 cr4 cc5">23</TD><TD class=alignCenter headers="cc4 cr4 cc6">0</TD><TD class=alignCenter headers="cc7 cr4 cc8">NA <SUP>*</SUP></TD><TD class=alignCenter headers="cc7 cr4 cc9">NA <SUP>*</SUP></TD></TR><TR><TH id=cr5 class="alignLeft lightred" headers=cr1>TOTAL</TH><TD class=alignCenter headers="cc1 cr5 cc2">75</TD><TD class=alignCenter headers="cc1 cr5 cc3">0</TD><TD class=alignCenter headers="cr5 cc5">75</TD><TD class=alignCenter headers="cr5 cc6">0</TD><TD class=alignCenter headers="cc7 cr5 cc8">54</TD><TD class=alignCenter headers="cc7 cr5 cc9">54(100%)</TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate decreased from 24.9/1,000 in week 48 to 18.7/1,000 in week 49 (Figure 5).
    Figure 5. Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Note: No data available for mean rate for weeks 19 to 39 for the 1996-1997 through 2002-2003 seasons. Delays in the reporting of data may cause data to change retrospectively. The calculation of the average ILI consultation rate over 17 seasons was aligned with influenza activity in each season. In BC, AB, and SK, data is compiled by a provincial sentinel surveillance program for reporting to FluWatch. The number of sentinel physicians in each province or territory is as follows: BC(21), AB(80), SK(11), MB(18), ON(169), QC(14), NB(29), NS(26), PE(4), NL(16), NU(1), NT(14), YT(13). Not all sentinel physicians report every week.
    Text equivalent for figure 5Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Top of Page

    Influenza Outbreak Surveillance

    In week 49, one new influenza outbreak was reported in a hospital and one outbreak of influenza/ILI was reported in a school (Figure 6).
    Figure 6. Overall number of new influenza outbreaks by report week, Canada, 2013-2014

    1 All provinces and territories except NU report outbreaks in long-term care facilities. All provinces and territories with the exception of NU and QC report outbreaks in hospitals. Outbreaks of influenza or influenza-like-illness in other facilities are reported to FluWatch but reporting varies between jurisdictions. Outbreak definitions are included at the end of the report.
    Text equivalent for figure 6 Overall number of new influenza outbreaks by report week, Canada, 2013-2014
    Pharmacy Surveillance

    Pharmacy surveillance for sales of influenza antivirals has not yet begun for the 2013-14 influenza season (Figure 7).
    Figure 7. Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Note: Pharmacy sales data are provided to the Public Health Agency of Canada by Rx Canada Inc. and sourced from major retail drug chains representing over 3,000 stores nationwide (excluding Nunavut) in 85% of Health Regions. Data provided include the number of new antiviral prescriptions (for Tamiflu and Relenza) and the total number of new prescriptions dispensed by Province/Territory and age group. Age-groups: Infant: 0-2y, Child: 2-18y; Adult: 19-64y, Senior: ≥65y.
    Text equivalent for figure 7Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Top of Page

    Sentinel Hospital Influenza Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)
    In week 49, ten new laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalizations were reported by the Immunization Monitoring Program Active (IMPACT) network. All were cases of influenza A: seven A(H1N1)pdm09 and three A(unsubtyped). One case was a child under 6 months of age, two were 6-23 months of age, two were 2-4 years of age, three were 5-9 years of age and two was 10-16 years of age (Figure 8a). One ICU admission was reported in week 49, a child 10-16 years of age with A(H1N1)pdm09.
    To date this season, a total of 38 influenza-associated paediatric hospitalizations have been reported by the IMPACT network, the majority of which have been influenza A (Table 4). Twelve (31.6%) of cases have been children under 2 years of age. Three ICU admissions have been reported, two children 2-4 years of age, one with influenza A(H1N1)pdm09 and one with influenza B; and one child 10-16 years of age with A(H1N1)pdm09. No deaths have been reported (Figure 9a).

    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    Adult Influenza Hospitalizations and Deaths (PCIRN)
    In week 49, seven new laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations were reported through active* surveillance by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network: five cases 45-64 years of age and two ≥65 years of age. Influenza A was identified in six cases: three A(H1N1)pdm09 and three A(unsubtyped). One ICU admission was reported in an adult 45-64 years of age with A(H1N1)pdm09 (Figure 8b).
    To date this season, 29 influenza-associated hospitalizations have been reported by the PCIRN-SOS network, 28 with influenza A. The majority (79.3%) have been adults over 45 years of age (Table 5). ICU admission was required for two hospitalizations, both adults 45-64 years of age. No deaths have been reported (Figure 9b).

    Note: PCIRN-SOS conducted passive surveillance from April 30th to November 14th, 2013. Cases reported during this period were identified by laboratory detection of influenza among patients admitted to participating hospitals. Active surveillance began November 15th during which time PCIRN site coordinators investigate cases potentially related to influenza. Data from both active and passive surveillance reported during the 2013-14 season are included in this report. The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 4 - Cumulative numbers of paediatric hospitalizations with influenza reported by the IMPACT network, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=dr1 rowSpan=3>Age groups </TH><TH id=dc1 colSpan=6>Cumulative (Aug. 25, 2013 to December 7, 2013) </TH></TR><TR class=bg-colour-yellow><TH id=dc2 colSpan=4 headers=dc1>Influenza A </TH><TH id=dc7 headers=dc1>B </TH><TH id=dc8 headers=dc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=dc3 headers="dc1 dc2">A Total </TH><TH id=dc4 class="lightred " headers="dc1 dc2">A(H1) pdm09 </TH><TH id=dc5 class="lightred " headers="dc1 dc2">A(H3) </TH><TH id=dc6 class="lightred " headers="dc1 dc2">A (UnS) </TH><TD class=alignCenter headers="dc1 dc7">Total</TD><TD class=alignCenter headers="dc1 dc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.</TD></TR></TFOOT><TBODY><TR><TH id=dr2 class=alignLeft headers=dr1>0-5m </TH><TD class=alignCenter headers="dr1 dr2 dc1 dc2 dc3">6</TD><TD class=alignCenter headers="dr1 dr2 dc1 dc2 dc4">1</TD><TD class=alignCenter headers="dr1 dr2 dc1 dc2 dc5">0</TD><TD class=alignCenter headers="dr1 dr2 dc1 dc2 dc6">5</TD><TD class=alignCenter headers="dr1 dr2 dc1 dc7">1</TD><TD class=alignCenter headers="dr1 dr2 dc1 dc8">7 (18%)</TD></TR><TR><TH id=dr3 class=alignLeft headers=dr1>6-23m </TH><TD class=alignCenter headers="dr1 dr3 dc1 dc2 dc3">4</TD><TD class=alignCenter headers="dr1 dr3 dc1 dc2 dc4">3</TD><TD class=alignCenter headers="dr1 dr3 dc1 dc2 dc5">0</TD><TD class=alignCenter headers="dr1 dr3 dc1 dc2 dc6">1</TD><TD class=alignCenter headers="dr1 dr3 dc1 dc7">1</TD><TD class=alignCenter headers="dr1 dr3 dc1 dc8">5 (13%)</TD></TR><TR><TH id=dr4 class=alignLeft headers=dr1>2-4y </TH><TD class=alignCenter headers="dr1 dr4 dc1 dc2 dc3">7</TD><TD class=alignCenter headers="dr1 dr4 dc1 dc2 dc4">4</TD><TD class=alignCenter headers="dr1 dr4 dc1 dc2 dc5">0</TD><TD class=alignCenter headers="dr1 dr4 dc1 dc2 dc6">3</TD><TD class=alignCenter headers="dr1 dr4 dc1 dc7">5</TD><TD class=alignCenter headers="dr1 dr4 dc1 dc8">12 (32%)</TD></TR><TR><TH id=dr5 class=alignLeft headers=dr1>5-9y </TH><TD class=alignCenter headers="dr1 dr5 dc1 dc2 dc3">8</TD><TD class=alignCenter headers="dr1 dr5 dc1 dc2 dc4">4</TD><TD class=alignCenter headers="dr1 dr5 dc1 dc2 dc5">0</TD><TD class=alignCenter headers="dr1 dr5 dc1 dc2 dc6">4</TD><TD class=alignCenter headers="dr1 dr5 dc1 dc7">1</TD><TD class=alignCenter headers="dr1 dr5 dc1 dc8">9 (24%)</TD></TR><TR><TH id=dr6 class=alignLeft headers=dr1>10-16y </TH><TD class=alignCenter headers="dr1 dr6 dc1 dc2 dc3">4</TD><TD class=alignCenter headers="dr1 dr6 dc1 dc2 dc4">3</TD><TD class=alignCenter headers="dr1 dr6 dc1 dc2 dc5">0</TD><TD class=alignCenter headers="dr1 dr6 dc1 dc2 dc6">1</TD><TD class=alignCenter headers="dr1 dr6 dc1 dc7">1</TD><TD class=alignCenter headers="dr1 dr6 dc1 dc8">5 (13%)</TD></TR><TR><TH id=dr7 class=alignLeft headers=dr1>Total </TH><TD class=alignCenter headers="dr1 dr7 dc1 dc2 dc3">29</TD><TD class="lightred alignCenter" headers="dr1 dr7 dc1 dc2 dc4">15</TD><TD class="lightred alignCenter" headers="dr1 dr7 dc1 dc2 dc5">0</TD><TD class="lightred alignCenter" headers="dr1 dr7 dc1 dc2 dc6">14</TD><TD class=alignCenter headers="dr1 dr7 dc1 dc7">9</TD><TD class=alignCenter headers="dr1 dr7 dc1 dc8">38</TD></TR><TR><TH id=dr8 class=alignLeft headers=dr1>% <SUP>1</SUP> </TH><TD class=alignCenter headers="dr1 dr8 dc1 dc2 dc3">76.3%</TD><TD class="lightred alignCenter" headers="dr1 dr8 dc1 dc2 dc4">51.7%</TD><TD class="lightred alignCenter" headers="dr1 dr8 dc1 dc2 dc5">0.0%</TD><TD class="lightred alignCenter" headers="dr1 dr8 dc1 dc2 dc6">48.3%</TD><TD class=alignCenter headers="dr1 dr8 dc1 dc7">23.7%</TD><TD class=alignCenter headers="dr1 dr8 dc1 dc8">100.0%</TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 5 - Cumulative numbers of adult hospitalizations with influenza
    reported by the PCIRN-SOS network, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=er1 rowSpan=3>Age groups </TH><TH id=ec1 class=noWrap colSpan=6>Cumulative (Aug. 25, 2013 to December 7, 2013) </TH></TR><TR class=bg-colour-yellow><TH id=ec2 colSpan=4 headers=ec1>Influenza A </TH><TH id=ec7 headers=ec1>B </TH><TH id=ec8 headers=ec1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=ec3 headers="ec1 ec2">A Total </TH><TH id=ec4 class="lightred " headers="ec1 ec2">A(H1) pdm09 </TH><TH id=ec5 class="lightred " headers="ec1 ec2">A(H3) </TH><TH id=ec6 class="lightred " headers="ec1 ec2">A(UnS) </TH><TD class=alignCenter headers="ec1 ec7">Total</TD><TD class=alignCenter headers="ec1 ec8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.</TD></TR></TFOOT><TBODY><TR><TH id=er2 class=alignLeft headers=er1>16-20 </TH><TD class=alignCenter headers="er1 er2 ec1 ec2 ec3">0</TD><TD class=alignCenter headers="er1 er2 ec1 ec2 ec4">0</TD><TD class=alignCenter headers="er1 er2 ec1 ec2 ec5">0</TD><TD class=alignCenter headers="er1 er2 ec1 ec2 ec6">0</TD><TD class=alignCenter headers="er1 er2 ec1 ec7">0</TD><TD class=alignCenter headers="er1 er2 ec1 ec8">0</TD></TR><TR><TH id=er3 class=alignLeft headers=er1>20-44 </TH><TD class=alignCenter headers="er1 er3 ec1 ec2 ec3">6</TD><TD class=alignCenter headers="er1 er3 ec1 ec2 ec4">3</TD><TD class=alignCenter headers="er1 er3 ec1 ec2 ec5">0</TD><TD class=alignCenter headers="er1 er3 ec1 ec2 ec6">3</TD><TD class=alignCenter headers="er1 er3 ec1 ec7">0</TD><TD class=alignCenter headers="er1 er3 ec1 ec8">6(21%)</TD></TR><TR><TH id=er4 class=alignLeft headers=er1>45-64 </TH><TD class=alignCenter headers="er1 er4 ec1 ec2 ec3">13</TD><TD class=alignCenter headers="er1 er4 ec1 ec2 ec4">5</TD><TD class=alignCenter headers="er1 er4 ec1 ec2 ec5">1</TD><TD class=alignCenter headers="er1 er4 ec1 ec2 ec6">7</TD><TD class=alignCenter headers="er1 er4 ec1 ec7">1</TD><TD class=alignCenter headers="er1 er4 ec1 ec8">14 (48%)</TD></TR><TR><TH id=er5 class=alignLeft headers=er1>65+ </TH><TD class=alignCenter headers="er1 er5 ec1 ec2 ec3">9</TD><TD class=alignCenter headers="er1 er5 ec1 ec2 ec4">2</TD><TD class=alignCenter headers="er1 er5 ec1 ec2 ec5">2</TD><TD class=alignCenter headers="er1 er5 ec1 ec2 ec6">5</TD><TD class=alignCenter headers="er1 er5 ec1 ec7">0</TD><TD class=alignCenter headers="er1 er5 ec1 ec8">9 (31%)</TD></TR><TR><TH id=er6 class=alignLeft headers=er1>Total </TH><TD class=alignCenter headers="er1 er6 ec1 ec2 ec3">28</TD><TD class="lightred alignCenter" headers="er1 er6 ec1 ec2 ec4">10</TD><TD class="lightred alignCenter" headers="er1 er6 ec1 ec2 ec5">3</TD><TD class="lightred alignCenter" headers="er1 er6 ec1 ec2 ec6">15</TD><TD class=alignCenter headers="er1 er6 ec1 ec7">1</TD><TD class=alignCenter headers="er1 er6 ec1 ec8">29</TD></TR><TR><TH id=er7 class=alignLeft headers=er1>%<SUP>1</SUP> </TH><TD class=alignCenter headers="er1 er7 ec1 ec2 ec3">97%</TD><TD class="lightred alignCenter" headers="er1 er7 ec1 ec2 ec4">36%</TD><TD class="lightred alignCenter" headers="er1 er7 ec1 ec2 ec5">11%</TD><TD class="lightred alignCenter" headers="er1 er7 ec1 ec2 ec6">54%</TD><TD class=alignCenter headers="er1 er7 ec1 ec7">3%</TD><TD class=alignCenter headers="er1 er7 ec1 ec8">100%</TD></TR></TBODY></TABLE>
    Figure 8. Number of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)


    Text equivalent for figure 8aNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    * See footnote above following the section related to PCIRN-SOS data.
    Text equivalent for figure 8bNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Adult hospitalizations (>16 year of age, PCIRN-SOS)
    Figure 9. Percentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)

    Text equivalent for figure 9aPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Text equivalent for figure 9bPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Top of Page

    Provincial/Territorial Influenza Hospitalizations and Deaths

    In week 49, 37 new laboratory-confirmed influenza-associated hospitalizations were reported from participating provinces and territories.* The cases were as follows: two children less than 6 months of age, two children 6-23 months, three children 2-4 years, four children 5-14 years, six adults 20-44 years, thirteen adults 45-64 years and seven adults ≥65 years of age. All cases were influenza A, of which 22 were A(H1N1)pdm09, one A(H3N2) and 14 A(unsubtyped). Two ICU admissions were reported: one child 5-14 years with A(H1N1)pdm09 and one adult ≥65 years of age with A(unsubtyped). One death was reported in an adult ≥65 years of age with A(H1N1)pdm. The number of new influenza-associated hospitalizations and deaths reported for the current week may include cases from Ontario that occurred in previous weeks, as a result of retrospective updates to the cumulative total.
    To date this season, 107 influenza-associated hospitalizations have been reported, of which 100 (93.5%) had influenza A and among those 57% were A(H1N1)pdm09 (Table 6). More than half of cases (51.4%) were ≥45 years of age, and 21.5% were under 5 years of age. A greater proportion of cases under 20 years of age had influenza B (14%) compared to those 20 years of age or older (3%). Eight ICU admissions have been reported this season, all cases of influenza A (seven A(H1N1)pdm09 and one A(unsubtyped). The cases were as follows: one child 2-4 years of age, one 5-14 years of age, one adult 20-44 years of age, four adults 45-64 years of age and one adult ≥65 years of age. Two deaths have been reported: one adult 45-64 years of age and one ≥65 years of age, both with A(H1N1)pdm09. It is important to note that the hospitalization or death does not have to be attributable to influenza, a positive laboratory test is sufficient for reporting. Detailed clinical information (e.g. underlying medical conditions) is not known for these cases.
    * Note: Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not distinguished among hospital admissions reported from Ontario. Data may also include cases reported by the IMPACT and PCIRN networks.

    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 6. Cumulative number of hospitalizations with influenza reported by the participating provinces and territories, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=fr1 rowSpan=3>Age groups </TH><TH id=fc1 colSpan=6>Cumulative (Aug. 25, 2013 to December 7, 2013) </TH></TR><TR class=bg-colour-yellow><TH id=fc2 colSpan=4 headers=fc1>Influenza A </TH><TH id=fc7 headers=fc1>B </TH><TH id=fc8 headers=fc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=fc3 headers="fc1 fc2">A Total </TH><TH id=fc4 class=lightred headers="fc1 fc2">A(H1) pdm09 </TH><TH id=fc5 class=lightred headers="fc1 fc2">A(H3) </TH><TH id=fc6 class=lightred headers="fc1 fc2">A (UnS) </TH><TD class=alignCenter headers="fc1 fc7">Total</TD><TD class=alignCenter headers="fc1 fc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=8><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.</TD></TR></TFOOT><TBODY><TR><TH id=fr2 class=alignLeft headers=fr1>0-4 years </TH><TD class=alignCenter headers="fr1 fr2 fc1 fc2 fc3">19</TD><TD class=alignCenter headers="fr1 fr2 fc1 fc2 fc4">9</TD><TD class=alignCenter headers="fr1 fr2 fc1 fc2 fc5">1</TD><TD class=alignCenter headers="fr1 fr2 fc1 fc2 fc6">9</TD><TD class=alignCenter headers="fr1 fr2 fc1 fc7">4</TD><TD class=alignCenter headers="fr1 fr2 fc1 fc8">23 (21%)</TD></TR><TR><TH id=fr3 class=alignLeft headers=fr1>5-14 years </TH><TD class=alignCenter headers="fr1 fr3 fc1 fc2 fc3">9</TD><TD class=alignCenter headers="fr1 fr3 fc1 fc2 fc4">5</TD><TD class=alignCenter headers="fr1 fr3 fc1 fc2 fc5">0</TD><TD class=alignCenter headers="fr1 fr3 fc1 fc2 fc6">4</TD><TD class=alignCenter headers="fr1 fr3 fc1 fc7">1</TD><TD class=alignCenter headers="fr1 fr3 fc1 fc8">10 (9%)</TD></TR><TR><TH id=fr4 class=alignLeft headers=fr1>15-19 years </TH><TD class=alignCenter headers="fr1 fr4 fc1 fc2 fc3">2</TD><TD class=alignCenter headers="fr1 fr4 fc1 fc2 fc4">1</TD><TD class=alignCenter headers="fr1 fr4 fc1 fc2 fc5">0</TD><TD class=alignCenter headers="fr1 fr4 fc1 fc2 fc6">1</TD><TD class=alignCenter headers="fr1 fr4 fc1 fc7">0</TD><TD class=alignCenter headers="fr1 fr4 fc1 fc8">2(2%)</TD></TR><TR><TH id=fr5 class=alignLeft headers=fr1>20-44 years </TH><TD class=alignCenter headers="fr1 fr5 fc1 fc2 fc3">17</TD><TD class=alignCenter headers="fr1 fr5 fc1 fc2 fc4">15</TD><TD class=alignCenter headers="fr1 fr5 fc1 fc2 fc5">0</TD><TD class=alignCenter headers="fr1 fr5 fc1 fc2 fc6">2</TD><TD class=alignCenter headers="fr1 fr5 fc1 fc7">0</TD><TD class=alignCenter headers="fr1 fr5 fc1 fc8">17(16%)</TD></TR><TR><TH id=fr6 class=alignLeft headers=fr1>45-64 years </TH><TD class=alignCenter headers="fr1 fr6 fc1 fc2 fc3">32</TD><TD class=alignCenter headers="fr1 fr6 fc1 fc2 fc4">18</TD><TD class=alignCenter headers="fr1 fr6 fc1 fc2 fc5">7</TD><TD class=alignCenter headers="fr1 fr6 fc1 fc2 fc6">7</TD><TD class=alignCenter headers="fr1 fr6 fc1 fc7">1</TD><TD class=alignCenter headers="fr1 fr6 fc1 fc8">33 (31%)</TD></TR><TR><TH id=fr7 class=alignLeft headers=fr1>65+ years </TH><TD class=alignCenter headers="fr1 fr7 fc1 fc2 fc3">21</TD><TD class=alignCenter headers="fr1 fr7 fc1 fc2 fc4">9</TD><TD class=alignCenter headers="fr1 fr7 fc1 fc2 fc5">5</TD><TD class=alignCenter headers="fr1 fr7 fc1 fc2 fc6">7</TD><TD class=alignCenter headers="fr1 fr7 fc1 fc7">1</TD><TD class=alignCenter headers="fr1 fr7 fc1 fc8">22 (21%)</TD></TR><TR><TH id=fr8 class=alignLeft headers=fr1>Total </TH><TD class=alignCenter headers="fr1 fr8 fc1 fc2 fc3">100</TD><TD class="alignCenter lightred" headers="fr1 fr8 fc1 fc2 fc4">57</TD><TD class="alignCenter lightred" headers="fr1 fr8 fc1 fc2 fc5">13</TD><TD class="alignCenter lightred" headers="fr1 fr8 fc1 fc2 fc6">30</TD><TD class=alignCenter headers="fr1 fr8 fc1 fc7">7</TD><TD class=alignCenter headers="fr1 fr8 fc1 fc8">107</TD></TR><TR><TH id=fr9 class=alignLeft headers=fr1>Percentage <SUP>1</SUP> </TH><TD class=alignCenter headers="fr1 fr9 fc1 fc2 fc3">93.5%</TD><TD class="alignCenter lightred" headers="fr1 fr9 fc1 fc2 fc4">57.0%</TD><TD class="alignCenter lightred" headers="fr1 fr9 fc1 fc2 fc5">13.0%</TD><TD class="alignCenter lightred" headers="fr1 fr9 fc1 fc2 fc6">30.0%</TD><TD class=alignCenter headers="fr1 fr9 fc1 fc7">6.5%</TD><TD class=alignCenter headers="fr1 fr9 fc1 fc8">100%</TD></TR></TBODY></TABLE>

    .../

    Leave a comment:


  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Week 48

    FluWatch report: November 24 to 30, 2013 (Week 48)

    Posted 2013-12-06For readers interested in the <ABBR title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A title="Flu Watch (Version PDF, 316 KB - 10 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w48_13/pdf/fw2013-48-eng.pdf">FluWatch report: November 24 to 30, 2013 (Week 48) (<ABBR title="Portable Document Format">PDF</ABBR> Version - 316 <ABBR title=Kilobytes>KB</ABBR> - 10 pages)

    ?? Help with PDF documents


    Overall Summary
    • Influenza activity in Canada continued to increase in week 48.
    • Influenza A remained the predominant influenza virus type, with 77% of subtyped influenza A specimens to date identified as A(H1N1)pdm09.
    • Two regions reported localized influenza/ILI activity and 18 reported sporadic activity, and the ILI consultation rate continued to increase.
    • The number of both paediatric and adult hospitalizations with influenza increased in week 48.
    • RSV detections increased sharply in week 48, although rhinovirus remained the predominant virus detected.
    Influenza/ILI Activity (geographic spread)

    In week 48, two regions in Ontario reported localized activity and 18 regions (in BC(3), AB(4), SK(1), ON(4), and QC(6)) reported sporadic activity (Figure 1).
    Figure 1. Map of overall in8fluenza/ILI activity level by province and territory, Canada, Week 48





    Note: Influenza/ILI activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates and reported outbreaks. Please refer to detailed definitions at the end of the report. Maps from previous weeks, including any retrospective updates, are available on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada
    Influenza and Other Respiratory Virus Detections

    The number of positive influenza tests increased sharply, from 65 in week 47 to 114 in week 48, bringing the percentage of positive influenza tests to 3.7% (Figure 2). Cumulative influenza virus detections by type/subtype to date have been predominantly influenza A (84%) with more A(H1N1)pdm09 identified compared to A(H3) among those subtyped (Table 1). Detailed information on age and type/subtype has been received for 382 cases to date this season. The proportion of positive laboratory specimens by age-group is consistent with the expected pattern for seasonal influenza: 47% of laboratory detections were ≥45 years of age, and 20% were under 5 years of age. (Table 2).
    Figure 2. Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14

    Text equivalent for figure 2Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14
    In week 48, the number of positive tests for RSV increased sharply; detections of adenovirus and human metapneumovirus continued a slow increase; and detections of parainfluenza declined. Positive tests for rhinovirus continued to decline. Rhinovirus remained the predominant virus detected in week 48 (Figure 3).
    For more details, see the weekly Respiratory Virus Detections in Canada Report.
    Figure 3. Number of positive laboratory tests for other respiratory viruses by report week, Canada, 2013-14


    Top of Page

    RSV: Respiratory syncytial virus; hMPV: Human metapneumovirus
    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 1: Weekly and cumulative numbers of positive influenza specimens
    by type, subtype and province, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=ar1 rowSpan=3>Reporting provinces <SUP>1</SUP></TH><TH id=ac1 colSpan=5>Weekly
    (November 24 to November 30, 2013)
    </TH><TH id=ac8 colSpan=5>Cumulative
    (August 25, 2013 to November 30, 2013)
    </TH></TR><TR class=bg-colour-yellow><TH id=ac2 colSpan=4 headers=ac1>Influenza A</TH><TH id=ac7 headers=ac1>B</TH><TH id=ac9 colSpan=4 headers=ac8>Influenza A</TH><TH id=ac14 headers=ac8>B</TH></TR><TR class=bg-colour-grey-light><TH id=ac3 headers="ac1 ac2">A Total</TH><TH id=ac4 class=lightred headers="ac1 ac2">A(H1)pdm09</TH><TH id=ac5 class=lightred headers="ac1 ac2">A(H3)</TH><TH id=ac6 class=lightred headers="ac1 ac2">A(UnS)</TH><TH class=alignCenter headers="ac1 ac7">B Total</TH><TH id=ac10 headers="ac8 ac9">A Total</TH><TH id=ac11 class=lightred headers="ac8 ac9">A(H1)pdm09</TH><TH id=ac12 class=lightred headers="ac8 ac9">A(H3)</TH><TH id=ac13 class=lightred headers="ac8 ac9">A(UnS)</TH><TD class=alignCenter headers="ac8 ac14">B Total</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=11><SUP>1 </SUP>Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.
    <SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=ar2 class=alignLeft headers=ar1>BC</TH><TD class=alignRight>8</TD><TD class=alignRight>7</TD><TD class=alignRight>0</TD><TD class=alignRight>1</TD><TD class=alignRight>0</TD><TD class=alignRight>23</TD><TD class=alignRight>15</TD><TD class=alignRight>3</TD><TD class=alignRight>5</TD><TD class=alignRight>4</TD></TR><TR><TH id=ar3 class=alignLeft headers=ar1>AB</TH><TD class=alignRight>35</TD><TD class=alignRight>25</TD><TD class=alignRight>0</TD><TD class=alignRight>10</TD><TD class=alignRight>0</TD><TD class=alignRight>101</TD><TD class=alignRight>82</TD><TD class=alignRight>9</TD><TD class=alignRight>10</TD><TD class=alignRight>15</TD></TR><TR><TH id=ar4 class=alignLeft headers=ar1>SK</TH><TD class=alignRight>4</TD><TD class=alignRight>4</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>14</TD><TD class=alignRight>10</TD><TD class=alignRight>0</TD><TD class=alignRight>4</TD><TD class=alignRight>0</TD></TR><TR><TH id=ar5 class=alignLeft headers=ar1>MB</TH><TD class=alignRight>1</TD><TD class=alignRight>1</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>2</TD><TD class=alignRight>8</TD><TD class=alignRight>8</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>4</TD></TR><TR><TH id=ar6 class=alignLeft headers=ar1>ON</TH><TD class=alignRight>37</TD><TD class=alignRight>17</TD><TD class=alignRight>8</TD><TD class=alignRight>12</TD><TD class=alignRight>0</TD><TD class=alignRight>121</TD><TD class=alignRight>59</TD><TD class=alignRight>39</TD><TD class=alignRight>23</TD><TD class=alignRight>12</TD></TR><TR><TH id=ar7 class=alignLeft headers=ar1>QC</TH><TD class=alignRight>15</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>15</TD><TD class=alignRight>10</TD><TD class=alignRight>39</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>39</TD><TD class=alignRight>25</TD></TR><TR><TH id=ar8 class=alignLeft headers=ar1>NB</TH><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>2</TD><TD class=alignRight>1</TD><TD class=alignRight>1</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD></TR><TR><TH id=ar9 class=alignLeft headers=ar1>NS</TH><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD></TR><TR><TH id=ar10 class=alignLeft headers=ar1>PE</TH><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD></TR><TR><TH id=ar11 class=alignLeft headers=ar1>NL</TH><TD class=alignRight>2</TD><TD class=alignRight>0</TD><TD class=alignRight>0</TD><TD class=alignRight>2</TD><TD class=alignRight>0</TD><TD class=alignRight>3</TD><TD class=alignRight>1</TD><TD class=alignRight>0</TD><TD class=alignRight>2</TD><TD class=alignRight>0</TD></TR><TR><TH id=ar12 class=alignLeft headers=ar1>Canada</TH><TD class=alignRight>102</TD><TD class="alignRight lightred">54</TD><TD class="alignRight lightred">8</TD><TD class="alignRight lightred">40</TD><TD class=alignRight>12</TD><TD class=alignRight>311</TD><TD class="alignRight lightred">176</TD><TD class="alignRight lightred">52</TD><TD class="alignRight lightred">83</TD><TD class=alignRight>60</TD></TR><TR><TH id=ar13 class=alignLeft headers=ar1>Percentage<SUP>2</SUP></TH><TD class=alignRight>89.5%</TD><TD class="alignRight lightred">52.9%</TD><TD class="alignRight lightred">7.8%</TD><TD class="alignRight lightred">39.2%</TD><TD class=alignRight>10.5%</TD><TD class=alignRight>83.8%</TD><TD class="alignRight lightred">56.6%</TD><TD class="alignRight lightred">16.7%</TD><TD class="alignRight lightred">26.7%</TD><TD class=alignRight>16.2%</TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 2. Weekly and cumulative numbers of positive influenza specimens by type, subtype and age-group reported through case-based laboratory reporting<SUP>3</SUP>, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=br1 rowSpan=3>Age groups (years)</TH><TH id=bc1 colSpan=5>Weekly
    (November 24 to November 30, 2013)
    </TH><TH id=bc8 colSpan=7>Cumulative
    (August 25, 2013 to November 30, 2013)
    </TH></TR><TR class=bg-colour-yellow><TH id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH id=bc7 headers=bc1>B</TH><TH id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH id=bc14 headers=bc8>B</TH><TH id=bc15 colSpan=2 headers=bc8>Influenza A and B</TH></TR><TR class=bg-colour-grey-light><TH id=bc3 headers="bc1 bc2">A Total</TH><TH id=bc4 class="lightred " headers="bc1 bc2">A(H1) pdm09</TH><TH id=bc5 class="lightred " headers="bc1 bc2">A(H3)</TH><TH id=bc6 class="lightred " headers="bc1 bc2">A (UnS)</TH><TD class=alignCenter headers="bc1 bc7">Total</TD><TH id=bc10 headers="bc8 bc9">A Total</TH><TH id=bc11 class="lightred " headers="bc8 bc9">A(H1) pdm09</TH><TH id=bc12 class="lightred " headers="bc8 bc9">A(H3)</TH><TH id=bc13 class="lightred " headers="bc8 bc9">A (UnS)</TH><TD class=alignCenter headers="bc8 bc14">Total</TD><TH id=bc16 headers="bc8 bc15">#</TH><TH id=bc17 headers="bc8 bc15">%</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=13><SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    <SUP>3 </SUP>Table 2 includes specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=br2 class=alignLeft headers=br1><5</TH><TD class=alignRight headers="br1 br2 bc1 bc2 bc3">15 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc4">6 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc5">2 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc6">7 </TD><TD class=alignRight headers="br1 br2 bc1 bc7">1 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc10">59</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc11">26</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc12">6</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc13">27</TD><TD class=alignRight headers="br1 br2 bc8 bc14">17 </TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc16">76</TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc17">19.8% </TD></TR><TR><TH id=br3 class=alignLeft headers=br1>5-19</TH><TD class=alignRight headers="br1 br3 bc1 bc2 bc3">6 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc4">4 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc6">2 </TD><TD class=alignRight headers="br1 br3 bc1 bc7">0 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc10">32</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc11">22</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc12">1</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc13">9</TD><TD class=alignRight headers="br1 br3 bc8 bc14">16</TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc16">48</TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc17">12.5% </TD></TR><TR><TH id=br4 class=alignLeft headers=br1>20-44</TH><TD class=alignRight headers="br1 br4 bc1 bc2 bc3">23 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc4">12 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc6">11 </TD><TD class=alignRight headers="br1 br4 bc1 bc7">0 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc10">75 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc11">40</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc12">4</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc13">31</TD><TD class=alignRight headers="br1 br4 bc8 bc14">4</TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc16">79</TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc17">20.6% </TD></TR><TR><TH id=br5 class=alignLeft headers=br1>45-64</TH><TD class=alignRight headers="br1 br5 bc1 bc2 bc3">13 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc4">4 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc6">9 </TD><TD class=alignRight headers="br1 br5 bc1 bc7">0 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc10">83</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc11">40</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc12">15</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc13">28</TD><TD class=alignRight headers="br1 br5 bc8 bc14">14 </TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc16">97</TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc17">25.3% </TD></TR><TR><TH id=br6 class=alignLeft headers=br1>65+</TH><TD class=alignRight headers="br1 br6 bc1 bc2 bc3">11 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc4">3 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc6">8 </TD><TD class=alignRight headers="br1 br6 bc1 bc7">3 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc10">53</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc11">16 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc12">15 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc13">22</TD><TD class=alignRight headers="br1 br6 bc8 bc14">29</TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc16">82</TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc17">21.4% </TD></TR><TR><TH id=br7 class=alignLeft headers=br1>Unknown</TH><TD class=alignRight headers="br1 br7 bc1 bc2 bc3">1 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc4">1 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc6">0 </TD><TD class=alignRight headers="br1 br7 bc1 bc7">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc10">2</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc11">2 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc12">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc13">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc14">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc16">2 </TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc17">0.5% </TD></TR><TR><TH id=br8 class=alignLeft headers=br1>Total</TH><TD class=alignRight headers="br1 br8 bc1 bc2 bc3">69 </TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc4">30 </TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc5">2 </TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc6">37 </TD><TD class=alignRight headers="br1 br8 bc1 bc7">4 </TD><TD class=alignRight headers="br1 br8 bc8 bc9 bc10">304 </TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc11">146 </TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc12">41 </TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc13">117</TD><TD class=alignRight headers="br1 br8 bc8 bc14">80 </TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc16">384 </TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc17">100.0% </TD></TR><TR><TH id=br9 class=alignLeft headers=br1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="br1 br9 bc1 bc2 bc3">94.5% </TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc4">43.5% </TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc5">2.9% </TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc6">53.6% </TD><TD class=alignRight headers="br1 br9 bc1 bc7">5.5% </TD><TD class=alignRight headers="br1 br9 bc8 bc9 bc10">79.2% </TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc11">48.0% </TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc12">13.5% </TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc13">38.5% </TD><TD class=alignRight headers="br1 br9 bc8 bc14">20.8% </TD><TD class=alignRight></TD><TD class=alignRight></TD></TR></TBODY></TABLE>

    Top of Page

    Influenza Strain Characterizations

    During the 2013-2014 influenza season, the National Microbiology Laboratory (NML) has antigenically characterized 57 influenza viruses [6 A(H3N2), 35 A(H1N1)pdm09 and 16 influenza B]. Fifty-two (91.2%) viruses were similar to the strains recommended by the WHO for the 2013-14 seasonal influenza vaccine; five influenza B viruses were similar to the strain recommended by the WHO for the 2011-12 vaccine (Figure 4).
    Figure 4. Influenza strain characterizations, Canada, 2013-14, N = 57

    The NML receives a proportion of the number of influenza positive specimens from provincial laboratories for strain characterization and antiviral resistance testing. Characterization data reflect the results of haemagglutination inhibition (HAI) testing compared to the reference influenza strains recommended by WHO.
    The recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b (e.g. A/Texas/50/2012), and a B/Massachusetts/2/2012-like virus (Yamagata lineage).


    Text equivalent for figure 4Influenza strain characterizations, Canada, 2013-2014, N =3
    Antiviral Resistance

    During the 2013-2014 influenza season, NML has tested 47 influenza viruses for resistance to oseltamivir and 45 for resistance to zanamivir, and all were sensitive. Twenty-seven influenza A viruses were tested for amantadine resistance, and all were resistant (Table 3).
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=cr1 rowSpan=2>Virus type and subtype</TH><TH id=cc1 colSpan=2>Oseltamivir</TH><TH id=cc4 colSpan=2>Zanamivir</TH><TH id=cc7 colSpan=2>Amantadine</TH></TR><TR class=bg-colour-yellow><TH id=cc2 headers=cc1># tested</TH><TH id=cc3 headers=cc1># resistant (%)</TH><TH id=cc5 headers=cc4># tested</TH><TH id=cc6 headers=cc4># resistant (%)</TH><TH id=cc8 headers=cc7># tested</TH><TH id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH id=cr2 class="alignLeft bg-colour-blue" headers=cr1>A (H3N2)</TH><TD class=alignCenter headers="cr2 cc2">6</TD><TD class=alignCenter headers="cr2 cc3">0</TD><TD class=alignCenter headers="cr2 cc5">6</TD><TD class=alignCenter headers="cr2 cc6">0</TD><TD class=alignCenter headers="cr2 cc8">7</TD><TD class=alignCenter headers="cr2 cc9">7 (100%)</TD></TR><TR><TH id=cr3 class="alignLeft bg-colour-blue" headers=cr1>A (H1N1)</TH><TD class=alignCenter headers="cr3 cc2">27</TD><TD class=alignCenter headers="cr3 cc3">0</TD><TD class=alignCenter headers="cr3 cc5">25</TD><TD class=alignCenter headers="cr3 cc6">0</TD><TD class=alignCenter headers="cr3 cc8">20</TD><TD class=alignCenter headers="cr3 cc9">20 (100%)</TD></TR><TR><TH id=cr4 class="alignLeft bg-colour-blue" headers=cr1>B</TH><TD class=alignCenter headers="cr4 cc2">14</TD><TD class=alignCenter headers="cr4 cc3">0</TD><TD class=alignCenter headers="cr4 cc5">14</TD><TD class=alignCenter headers="cr4 cc6">0</TD><TD class=alignCenter headers="cr4 cc8">NA <SUP>*</SUP></TD><TD class=alignCenter headers="cr4 cc9">NA <SUP>*</SUP></TD></TR><TR><TH id=cr5 class="alignLeft bg-colour-blue" headers=cr1>TOTAL</TH><TD class=alignCenter headers="cr5 cc2">47</TD><TD class=alignCenter headers="cr5 cc3">0</TD><TD class=alignCenter headers="cr5 cc5">45</TD><TD class=alignCenter headers="cr5 cc6">0</TD><TD class=alignCenter headers="cr5 cc8">27</TD><TD class=alignCenter headers="cr5 cc9">27 (100%)</TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate increased from 21.3/1,000 in week 47 to 24.9/1,000 in week 48, following an upward trend in keeping with other surveillance indicators (Figure 5).
    Figure 5. Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Note: No data available for mean rate for weeks 19 to 39 for the 1996-1997 through 2002-2003 seasons. Delays in the reporting of data may cause data to change retrospectively. The calculation of the average ILI consultation rate over 17 seasons was aligned with influenza activity in each season. In BC, AB, and SK, data is compiled by a provincial sentinel surveillance program for reporting to FluWatch. The number of sentinel physicians in each province or territory is as follows: BC(21), AB(80), SK(11), MB(18), ON(169), QC(14), NB(29), NS(26), PE(4), NL(16), NU(1), NT(14), YT(13). Not all sentinel physicians report every week.
    Text equivalent for figure 5Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Top of Page

    Influenza Outbreak Surveillance

    No new influenza outbreaks were reported in week 48 (Figure 6).
    Figure 6. Overall number of new influenza outbreaks by report week, Canada, 2013-2014

    1 All provinces and territories except NU report outbreaks in long-term care facilities. All provinces and territories with the exception of NU and QC report outbreaks in hospitals. Outbreaks of influenza or influenza-like-illness in other facilities are reported to FluWatch but reporting varies between jurisdictions. Outbreak definitions are included at the end of the report.
    Text equivalent for figure 6 Overall number of new influenza outbreaks by report week, Canada, 2013-2014
    Pharmacy Surveillance

    Pharmacy surveillance for sales of influenza antivirals has not yet begun for the 2013-14 influenza season (Figure 7).
    Figure 7. Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Note: Pharmacy sales data are provided to the Public Health Agency of Canada by Rx Canada Inc. and sourced from major retail drug chains representing over 3,000 stores nationwide (excluding Nunavut) in 85% of Health Regions. Data provided include the number of new antiviral prescriptions (for Tamiflu and Relenza) and the total number of new prescriptions dispensed by Province/Territory and age group. Age-groups: Infant: 0-2y, Child: 2-18y; Adult: 19-64y, Senior: ≥65y.
    Text equivalent for figure 7Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Top of Page

    Sentinel Hospital Influenza Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)
    In week 48, nine new laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalizations were reported by the Immunization Monitoring Program Active (IMPACT) network: all cases of influenza A (four A(H1N1)pdm09 and five A(unsubtyped)). Four cases were children under 6 months of age, two cases were 6-23 months of age, and three cases were 2-9 years of age (Figure 8a).
    To date this season, a total of 28 influenza-associated paediatric hospitalizations have been reported by the IMPACT network (Table 4). Two ICU admissions were reported, both in children 2-4 years of age, one with influenza A(H1N1)pdm09 and one with influenza B. No deaths have been reported (Figure 9a).

    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    Adult Influenza Hospitalizations and Deaths (PCIRN)
    In week 48, eight new laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations were reported through active surveillance by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network: two cases 20-44 years of age, two cases 45-64 years of age and four ≥65 years of age. Influenza A was identified in all cases: four A(H1N1)pdm09, one A(H3N2) and three A(unsubtyped). No ICU admissions or deaths were reported in week 48 (Figure 8b).
    To date this season, 24 influenza-associated hospitalizations have been reported by the PCIRN-SOS network, all with influenza A. The majority (75%) have been adults over 45 years of age (Table 5). ICU admission was required for one hospitalization and no deaths have been reported (Figure 9b).

    Note: The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 4 - Cumulative numbers of paediatric hospitalizations with influenza reported by the IMPACT network, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=dr1 rowSpan=3>Age groups </TH><TH id=dc1 colSpan=6>Cumulative (Aug. 25, 2013 to November 30, 2013) </TH></TR><TR class=bg-colour-yellow><TH id=dc2 colSpan=4 headers=dc1>Influenza A </TH><TH id=dc7 headers=dc1>B </TH><TH id=dc8 headers=dc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=dc3 headers="dc1 dc2">A Total </TH><TH id=dc4 class=lightred headers="dc1 dc2">A(H1) pdm09 </TH><TH id=dc5 class=lightred headers="dc1 dc2">A(H3) </TH><TH id=dc6 class=lightred headers="dc1 dc2">A (UnS) </TH><TD class=alignCenter headers="dc1 dc7">Total</TD><TD class=alignCenter headers="dc1 dc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=dr2 class=alignLeft headers=dr1>0-5m </TH><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc3">5 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc4">1 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc6">4 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc7">1 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc8">6 (21%) </TD></TR><TR><TH id=dr3 class=alignLeft headers=dr1>6-23m </TH><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc3">2 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc4">1 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc6">1 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc7">1 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc8">3 (11%) </TD></TR><TR><TH id=dr4 class=alignLeft headers=dr1>2-4y </TH><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc3">5 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc4">2 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc6">3 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc7">5 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc8">10 (36%) </TD></TR><TR><TH id=dr5 class=alignLeft headers=dr1>5-9y </TH><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc3">5 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc4">3 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc6">2 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc7">1 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc8">6 (21%) </TD></TR><TR><TH id=dr6 class=alignLeft headers=dr1>10-16y </TH><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc3">2 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc4">1 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc6">1 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc7">1 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc8">3 (11%) </TD></TR><TR><TH id=dr7 class=alignLeft headers=dr1>Total </TH><TD class=alignRight headers="dr1 dr7 dc1 dc2 dc3">19 </TD><TD class="alignRight lightred" headers="dr1 dr7 dc1 dc2 dc4">8 </TD><TD class="alignRight lightred" headers="dr1 dr7 dc1 dc2 dc5">0 </TD><TD class="alignRight lightred" headers="dr1 dr7 dc1 dc2 dc6">11 </TD><TD class=alignRight headers="dr1 dr7 dc1 dc7">9 </TD><TD class=alignRight headers="dr1 dr7 dc1 dc8">28 </TD></TR><TR><TH id=dr8 class=alignLeft headers=dr1>% <SUP>1</SUP> </TH><TD class=alignRight headers="dr1 dr8 dc1 dc2 dc3">67.9% </TD><TD class="alignRight lightred" headers="dr1 dr8 dc1 dc2 dc4">42.1% </TD><TD class="alignRight lightred" headers="dr1 dr8 dc1 dc2 dc5">0.0% </TD><TD class="alignRight lightred" headers="dr1 dr8 dc1 dc2 dc6">57.9% </TD><TD class=alignRight headers="dr1 dr8 dc1 dc7">32.1% </TD><TD class=alignRight headers="dr1 dr8 dc1 dc8">100.0% </TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 5 - Cumulative numbers of adult hospitalizations with influenza
    reported by the PCIRN-SOS network, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=er1 rowSpan=3>Age groups </TH><TH id=ec1 class=noWrap colSpan=6>Cumulative (Aug. 25, 2013 to November 30, 2013) </TH></TR><TR class=bg-colour-yellow><TH id=ec2 colSpan=4 headers=ec1>Influenza A </TH><TH id=ec7 headers=ec1>B </TH><TH id=ec8 headers=ec1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=ec3 headers="ec1 ec2">A Total </TH><TH id=ec4 class=lightred headers="ec1 ec2">A(H1) pdm09 </TH><TH id=ec5 class=lightred headers="ec1 ec2">A(H3) </TH><TH id=ec6 class=lightred headers="ec1 ec2">A(UnS) </TH><TD class=alignCenter headers="ec1 ec7">Total</TD><TD class=alignCenter headers="ec1 ec8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=er2 class=alignLeft headers=er1>16-20 </TH><TD class=alignRight headers="er1 er2 ec1 ec2 ec3">0</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec4">0</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec5">0</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec6">0</TD><TD class=alignRight headers="er1 er2 ec1 ec7">0</TD><TD class=alignRight headers="er1 er2 ec1 ec8">0</TD></TR><TR><TH id=er3 class=alignLeft headers=er1>20-44 </TH><TD class=alignRight headers="er1 er3 ec1 ec2 ec3">6</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec4">3</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec5">0</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec6">3</TD><TD class=alignRight headers="er1 er3 ec1 ec7">0</TD><TD class=alignRight headers="er1 er3 ec1 ec8">6 (25%)</TD></TR><TR><TH id=er4 class=alignLeft headers=er1>45-64 </TH><TD class=alignRight headers="er1 er4 ec1 ec2 ec3">8</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec4">1</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec5">2</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec6">5</TD><TD class=alignRight headers="er1 er4 ec1 ec7">0</TD><TD class=alignRight headers="er1 er4 ec1 ec8">8 (33%)</TD></TR><TR><TH id=er5 class=alignLeft headers=er1>65+ </TH><TD class=alignRight headers="er1 er5 ec1 ec2 ec3">10</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec4">0</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec5">1</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec6">8</TD><TD class=alignRight headers="er1 er5 ec1 ec7">0</TD><TD class=alignRight headers="er1 er5 ec1 ec8">10 (42%)</TD></TR><TR><TH id=er6 class=alignLeft headers=er1>Total </TH><TD class=alignRight headers="er1 er6 ec1 ec2 ec3">24</TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec4">5</TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec5">3</TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec6">16</TD><TD class=alignRight headers="er1 er6 ec1 ec7">0</TD><TD class=alignRight headers="er1 er6 ec1 ec8">24</TD></TR><TR><TH id=er7 class=alignLeft headers=er1>%<SUP>1</SUP> </TH><TD class=alignRight headers="er1 er7 ec1 ec2 ec3">100%</TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec4">21%</TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec5">13%</TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec6">67%</TD><TD class=alignRight headers="er1 er7 ec1 ec7">0%</TD><TD class=alignRight headers="er1 er7 ec1 ec8">100%</TD></TR></TBODY></TABLE>
    Figure 8. Number of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)

    Text equivalent for figure 8aNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Text equivalent for figure 8bNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Adult hospitalizations (>16 year of age, PCIRN-SOS)
    Figure 9. Percentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)

    Text equivalent for figure 9aPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Text equivalent for figure 9bPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Top of Page

    Provincial/Territorial Influenza Hospitalizations and Deaths

    In week 48, 11 new laboratory-confirmed influenza-associated hospitalizations were reported from participating provinces and territories.<SUP>*</SUP> The cases were as follows: two children less than 6 months of age, one child 6-23 months, two children 5-14 years, three adults 20-44 years, two adults 45-64 years and one adult ≥65 years of age. All cases were influenza A, of which six were A(H1N1)pdm09 and five A(unsubtyped). No ICU admissions or deaths were reported.
    To date this season, 68 influenza-associated hospitalizations have been reported, of which 61 (90%) had influenza A (Table 6). More than half of cases (52%) were ≥45 years of age, and 24% were under 5 years of age. A greater proportion of cases under 20 years of age had influenza B (22%) compared to those 20 years of age or older (4%). Five ICU admissions have been reported this season, four in adults 45-64 years of age and one in a child 2-4 years of age, all with A(H1N1)pdm09. One death has been reported in an adult 45-64 years of age with A(H1N1)pdm09. It is important to note that the hospitalization or death does not have to be attributable to influenza, a positive laboratory test is sufficient for reporting. Detailed clinical information (e.g. underlying medical conditions) is not known for these cases.
    Note: Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not distinguished among hospital admissions reported from Ontario. The number of new influenza-associated hospitalizations and deaths reported for the current week may include cases from Ontario that occurred in previous weeks, as a result of retrospective updates to the cumulative total. Data may also include cases reported by the IMPACT and PCIRN networks.

    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 6. Cumulative number of hospitalizations with influenza reported by the participating provinces and territories, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=fr1 rowSpan=3>Age groups </TH><TH id=fc1 colSpan=6>Cumulative (Aug. 25, 2013 to November 30, 2013) </TH></TR><TR class=bg-colour-yellow><TH id=fc2 colSpan=4 headers=fc1>Influenza A </TH><TH id=fc7 headers=fc1>B </TH><TH id=fc8 headers=fc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=fc3 headers="fc1 fc2">A Total </TH><TH id=fc4 class=lightred headers="fc1 fc2">A(H1) pdm09 </TH><TH id=fc5 class=lightred headers="fc1 fc2">A(H3) </TH><TH id=fc6 class=lightred headers="fc1 fc2">A (UnS) </TH><TD class=alignCenter headers="fc1 fc7">Total</TD><TD class=alignCenter headers="fc1 fc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=8><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=fr2 class=alignLeft headers=fr1>0-4 years </TH><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc3">12</TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc4">6</TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc5">1</TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc6">5</TD><TD class=alignRight headers="fr1 fr2 fc1 fc7">4</TD><TD class=alignRight headers="fr1 fr2 fc1 fc8">16 (24%)</TD></TR><TR><TH id=fr3 class=alignLeft headers=fr1>5-14 years </TH><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc3">4</TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc4">1</TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc5">0</TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc6">3</TD><TD class=alignRight headers="fr1 fr3 fc1 fc7">1</TD><TD class=alignRight headers="fr1 fr3 fc1 fc8">5 (7%)</TD></TR><TR><TH id=fr4 class=alignLeft headers=fr1>15-19 years </TH><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc3">2</TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc4">1</TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc5">0</TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc6">1</TD><TD class=alignRight headers="fr1 fr4 fc1 fc7">0</TD><TD class=alignRight headers="fr1 fr4 fc1 fc8">2 (3%)</TD></TR><TR><TH id=fr5 class=alignLeft headers=fr1>20-44 years </TH><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc3">10</TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc4">8</TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc5">0</TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc6">2</TD><TD class=alignRight headers="fr1 fr5 fc1 fc7">0</TD><TD class=alignRight headers="fr1 fr5 fc1 fc8">10 (15%)</TD></TR><TR><TH id=fr6 class=alignLeft headers=fr1>45-64 years </TH><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc3">19</TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc4">10</TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc5">7</TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc6">2</TD><TD class=alignRight headers="fr1 fr6 fc1 fc7">1</TD><TD class=alignRight headers="fr1 fr6 fc1 fc8">20 (29%)</TD></TR><TR><TH id=fr7 class=alignLeft headers=fr1>65+ years </TH><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc3">14</TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc4">7</TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc5">4</TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc6">3</TD><TD class=alignRight headers="fr1 fr7 fc1 fc7">1</TD><TD class=alignRight headers="fr1 fr7 fc1 fc8">15 (22%)</TD></TR><TR><TH id=fr8 class=alignLeft headers=fr1>Total </TH><TD class=alignRight headers="fr1 fr8 fc1 fc2 fc3">61</TD><TD class="alignRight lightred" headers="fr1 fr8 fc1 fc2 fc4">33</TD><TD class="alignRight lightred" headers="fr1 fr8 fc1 fc2 fc5">12</TD><TD class="alignRight lightred" headers="fr1 fr8 fc1 fc2 fc6">16</TD><TD class=alignRight headers="fr1 fr8 fc1 fc7">7</TD><TD class=alignRight headers="fr1 fr8 fc1 fc8">68</TD></TR><TR><TH id=fr9 class=alignLeft headers=fr1>Percentage <SUP>1</SUP> </TH><TD class=alignRight headers="fr1 fr9 fc1 fc2 fc3">89.7%</TD><TD class="alignRight lightred" headers="fr1 fr9 fc1 fc2 fc4">54.1%</TD><TD class="alignRight lightred" headers="fr1 fr9 fc1 fc2 fc5">19.7%</TD><TD class="alignRight lightred" headers="fr1 fr9 fc1 fc2 fc6">26.2%</TD><TD class=alignRight headers="fr1 fr9 fc1 fc7">10.3%</TD><TD class=alignRight headers="fr1 fr9 fc1 fc8">100%</TD></TR></TBODY></TABLE>

    .../

    Leave a comment:


  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Week 47

    FluWatch report: November 17 to 23, 2013 (Week 47)

    Posted 2013-11-29For readers interested in the <ABBR style="BORDER-BOTTOM: 1px dashed; CURSOR: help" title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; COLOR: rgb(102,0,102); FONT-SIZE: 13px; TEXT-DECORATION: underline" title="Flu Watch (Version PDF, 316 KB - 10 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w47_13/pdf/fw2013-47-eng.pdf">FluWatch report: November 17 to 23, 2013 (Week 47) (<ABBR style="BORDER-BOTTOM: 1px dashed; CURSOR: help" title="Portable Document Format">PDF</ABBR> Version - 316 <ABBR style="BORDER-BOTTOM: 1px dashed; CURSOR: help" title=Kilobytes>KB</ABBR> - 10 pages)

    ?? Help with PDF documents


    Overall Summary
    • Influenza activity in Canada continued to increase in week 47, with a continuing predominance of influenza A.
    • Three regions reported localized influenza/ILI activity and 20 reported sporadic activity.
    • The ILI consultation rate increased after having been stable over the previous four weeks.
    • The number of both paediatric and adult hospitalizations with influenza increased in week 47.
    • Rhinovirus detections continued to decline while parainfluenza, RSV and adenovirus detections increased.

    Influenza/ILI Activity (geographic spread)

    In week 47, three regions in Ontario reported localized activity and 20 regions (in BC(4), AB(5), SK(2), MB(1), ON(3), and QC(5)) reported sporadic activity (Figure 1).
    Figure 1. Map of overall influenza/ILI activity level by province and territory, Canada, Week 47





    Note: Influenza/ILI activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates and reported outbreaks. Please refer to detailed definitions at the end of the report. Maps from previous weeks, including any retrospective updates, are available on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada
    Influenza and Other Respiratory Virus Detections

    The number of positive influenza tests continued to increase, from 59 in week 46 to 63 in week 47, bringing the percentage of positive influenza tests to 2.2% (Figure 2). Cumulative influenza virus detections by type/subtype to date have been predominantly influenza A (81%) with more A(H1N1)pdm09 identified compared to A(H3) among those subtyped (Table 1). Detailed information on age and type/subtype has been received for 243 cases to date this season. The proportion of cases by age-group is consistent with the expected pattern for seasonal influenza: 48% of laboratory detections were ≥45 years of age, and 19% were under 5 years of age. (Table 2).
    Figure 2. Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14
    Text equivalent for figure 2Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14
    In week 47, the number of positive tests for parainfluenza, RSV and adenovirus continued their slow increase. Positive tests for rhinovirus continued to decline. Rhinovirus and parainfluenza remained the two predominant viruses detected in week 47 (Figure 3).
    For more details, see the weekly Respiratory Virus Detections in Canada Report.
    Figure 3. Number of positive laboratory tests for other respiratory viruses by report week, Canada, 2013-14


    Top of Page
    RSV: Respiratory syncytial virus; hMPV: Human metapneumovirus
    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014
    <TABLE style="TEXT-TRANSFORM: none; TEXT-INDENT: 0px; WIDTH: 746px; LETTER-SPACING: normal; FONT: 13px Verdana, Arial, Helvetica, sans-serif; WHITE-SPACE: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px" class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION style="TEXT-ALIGN: center" class=alignCenter>Table 1: Weekly and cumulative numbers of positive influenza specimens
    by type, subtype and province, Canada, 2013-14
    </CAPTION><THEAD><TR style="BACKGROUND-COLOR: rgb(249,246,208)" class=bg-colour-yellow><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ar1 rowSpan=3>Reporting provinces <SUP style="LINE-HEIGHT: 0.65em">1</SUP></TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ac1 colSpan=5>Weekly
    (November 17 to November 23, 2013)
    </TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ac8 colSpan=5>Cumulative
    (August 25, 2013 to November 23, 2013)
    </TH></TR><TR style="BACKGROUND-COLOR: rgb(249,246,208)" class=bg-colour-yellow><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ac2 colSpan=4 headers=ac1>Influenza A</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ac7 headers=ac1>B</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ac9 colSpan=4 headers=ac8>Influenza A</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ac14 headers=ac8>B</TH></TR><TR style="BACKGROUND-COLOR: rgb(236,236,236)" class=bg-colour-grey-light><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ac3 headers="ac1 ac2">A Total</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ac4 class=lightred headers="ac1 ac2">A(H1)pdm09</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ac5 class=lightred headers="ac1 ac2">A(H3)</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ac6 class=lightred headers="ac1 ac2">A(UnS)</TH><TH style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" class=alignCenter headers="ac1 ac7">B Total</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ac10 headers="ac8 ac9">A Total</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ac11 class=lightred headers="ac8 ac9">A(H1)pdm09</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ac12 class=lightred headers="ac8 ac9">A(H3)</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ac13 class=lightred headers="ac8 ac9">A(UnS)</TH><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="ac8 ac14">B Total</TD></TR></THEAD><TFOOT><TR><TD style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 11px; VERTICAL-ALIGN: top" class=fontSize85 colSpan=11><SUP style="LINE-HEIGHT: 0.65em">1 </SUP>Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.
    <SUP style="LINE-HEIGHT: 0.65em">2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ar2 class=alignLeft headers=ar1>BC</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar2 ac1 ac2 ac3">5</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar2 ac1 ac2 ac4">3</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar2 ac1 ac2 ac5">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar2 ac1 ac2 ac6">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar2 ac1 ac7">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar2 ac8 ac9 ac10">11</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar2 ac8 ac9 ac11">5</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar2 ac8 ac9 ac12">3</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar2 ac8 ac9 ac13">3</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar2 ac8 ac14">4</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ar3 class=alignLeft headers=ar1>AB</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar3 ac1 ac2 ac3">16</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar3 ac1 ac2 ac4">11</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar3 ac1 ac2 ac5">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar3 ac1 ac2 ac6">4</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar3 ac1 ac7">3</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar3 ac8 ac9 ac10">64</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar3 ac8 ac9 ac11">51</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar3 ac8 ac9 ac12">9</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar3 ac8 ac9 ac13">4</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar3 ac8 ac14">15</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ar4 class=alignLeft headers=ar1>SK</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar4 ac1 ac2 ac3">2</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar4 ac1 ac2 ac4">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar4 ac1 ac2 ac5">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar4 ac1 ac2 ac6">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar4 ac1 ac7">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar4 ac8 ac9 ac10">10</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar4 ac8 ac9 ac11">6</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar4 ac8 ac9 ac12">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar4 ac8 ac9 ac13">4</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar4 ac8 ac14">0</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ar5 class=alignLeft headers=ar1>MB</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar5 ac1 ac2 ac3">3</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar5 ac1 ac2 ac4">3</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar5 ac1 ac2 ac5">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar5 ac1 ac2 ac6">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar5 ac1 ac7">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar5 ac8 ac9 ac10">7</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar5 ac8 ac9 ac11">7</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar5 ac8 ac9 ac12">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar5 ac8 ac9 ac13">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar5 ac8 ac14">2</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ar6 class=alignLeft headers=ar1>ON</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar6 ac1 ac2 ac3">23</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar6 ac1 ac2 ac4">11</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar6 ac1 ac2 ac5">5</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar6 ac1 ac2 ac6">7</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar6 ac1 ac7">4</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar6 ac8 ac9 ac10">83</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar6 ac8 ac9 ac11">41</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar6 ac8 ac9 ac12">28</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar6 ac8 ac9 ac13">14</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar6 ac8 ac14">12</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ar7 class=alignLeft headers=ar1>QC</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar7 ac1 ac2 ac3">3</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar7 ac1 ac2 ac4">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar7 ac1 ac2 ac5">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar7 ac1 ac2 ac6">3</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar7 ac1 ac7">3</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar7 ac8 ac9 ac10">24</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar7 ac8 ac9 ac11">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar7 ac8 ac9 ac12">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar7 ac8 ac9 ac13">24</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar7 ac8 ac14">15</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ar8 class=alignLeft headers=ar1>NB</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar8 ac1 ac2 ac3">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar8 ac1 ac2 ac4">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar8 ac1 ac2 ac5">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar8 ac1 ac2 ac6">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar8 ac1 ac7">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar8 ac8 ac9 ac10">2</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar8 ac8 ac9 ac11">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar8 ac8 ac9 ac12">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar8 ac8 ac9 ac13">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar8 ac8 ac14">0</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ar9 class=alignLeft headers=ar1>NS</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar9 ac1 ac2 ac3">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar9 ac1 ac2 ac4">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar9 ac1 ac2 ac5">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar9 ac1 ac2 ac6">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar9 ac1 ac7">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar9 ac8 ac9 ac10">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar9 ac8 ac9 ac11">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar9 ac8 ac9 ac12">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar9 ac8 ac9 ac13">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar9 ac8 ac14">0</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ar10 class=alignLeft headers=ar1>PE</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar10 ac1 ac2 ac3">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar10 ac1 ac2 ac4">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar10 ac1 ac2 ac5">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar10 ac1 ac2 ac6">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar10 ac1 ac7">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar10 ac8 ac9 ac10">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar10 ac8 ac9 ac11">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar10 ac8 ac9 ac12">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar10 ac8 ac9 ac13">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar10 ac8 ac14">0</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ar11 class=alignLeft headers=ar1>NL</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar11 ac1 ac2 ac3">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar11 ac1 ac2 ac4">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar11 ac1 ac2 ac5">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar11 ac1 ac2 ac6">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar11 ac1 ac7">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar11 ac8 ac9 ac10">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar11 ac8 ac9 ac11">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar11 ac8 ac9 ac12">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar11 ac8 ac9 ac13">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar11 ac8 ac14">0</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ar12 class=alignLeft headers=ar1>Canada</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar12 ac1 ac2 ac3">52</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac4">29</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac5">7</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac6">16</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar12 ac1 ac7">11</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar12 ac8 ac9 ac10">202</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac11">112</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac12">41</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac13">49</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar12 ac8 ac14">48</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ar13 class=alignLeft headers=ar1>Percentage<SUP style="LINE-HEIGHT: 0.65em">2</SUP></TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar13 ac1 ac2 ac3">82.5%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac4">55.8%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac5">13.5%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac6">30.8%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar13 ac1 ac7">17.5%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar13 ac8 ac9 ac10">80.8%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac11">55.4%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac12">20.3%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac13">24.3%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="ar1 ar13 ac8 ac14">19.2%</TD></TR></TBODY></TABLE>
    <TABLE style="TEXT-TRANSFORM: none; TEXT-INDENT: 0px; WIDTH: 746px; LETTER-SPACING: normal; FONT: 13px Verdana, Arial, Helvetica, sans-serif; WHITE-SPACE: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px" class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION style="TEXT-ALIGN: center" class=alignCenter>Table 2. Weekly and cumulative numbers of positive influenza specimens by type, subtype and age-group reported through case-based laboratory reporting<SUP style="LINE-HEIGHT: 0.65em">3</SUP>, Canada, 2013-14</CAPTION><THEAD><TR style="BACKGROUND-COLOR: rgb(249,246,208)" class=bg-colour-yellow><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=br1 rowSpan=3>Age groups (years)</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=bc1 colSpan=5>Weekly
    (November 17 to November 23, 2013)
    </TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=bc8 colSpan=7>Cumulative
    (August 25, 2013 to November 23, 2013)
    </TH></TR><TR style="BACKGROUND-COLOR: rgb(249,246,208)" class=bg-colour-yellow><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=bc7 headers=bc1>B</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=bc14 headers=bc8>B</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=bc15 colSpan=2 headers=bc8>Influenza A and B</TH></TR><TR style="BACKGROUND-COLOR: rgb(236,236,236)" class=bg-colour-grey-light><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=bc3 headers="bc1 bc2">A Total</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=bc4 class="lightred " headers="bc1 bc2">A(H1) pdm09</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=bc5 class="lightred " headers="bc1 bc2">A(H3)</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=bc6 class="lightred " headers="bc1 bc2">A (UnS)</TH><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="bc1 bc7">Total</TD><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=bc10 headers="bc8 bc9">A Total</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=bc11 class="lightred " headers="bc8 bc9">A(H1) pdm09</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=bc12 class="lightred " headers="bc8 bc9">A(H3)</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=bc13 class="lightred " headers="bc8 bc9">A (UnS)</TH><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="bc8 bc14">Total</TD><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=bc16 headers="bc8 bc15">#</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=bc17 headers="bc8 bc15">%</TH></TR></THEAD><TFOOT><TR><TD style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 11px; VERTICAL-ALIGN: top" class=fontSize85 colSpan=13><SUP style="LINE-HEIGHT: 0.65em">2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    <SUP style="LINE-HEIGHT: 0.65em">3 </SUP>Table 2 includes specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=br2 class=alignLeft headers=br1><5</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br2 bc1 bc2 bc3">7</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br2 bc1 bc2 bc4">2</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br2 bc1 bc2 bc5">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br2 bc1 bc2 bc6">4</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br2 bc1 bc7">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br2 bc8 bc9 bc10">34</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br2 bc8 bc9 bc11">15</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br2 bc8 bc9 bc12">4</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br2 bc8 bc9 bc13">15</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br2 bc8 bc14">13</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br2 bc8 bc15 bc16">47</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br2 bc8 bc15 bc17">19.3%</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=br3 class=alignLeft headers=br1>5-19</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br3 bc1 bc2 bc3">4</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br3 bc1 bc2 bc4">2</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br3 bc1 bc2 bc5">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br3 bc1 bc2 bc6">2</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br3 bc1 bc7">5</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br3 bc8 bc9 bc10">23</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br3 bc8 bc9 bc11">16</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br3 bc8 bc9 bc12">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br3 bc8 bc9 bc13">6</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br3 bc8 bc14">11</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br3 bc8 bc15 bc16">34</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br3 bc8 bc15 bc17">13.9%</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=br4 class=alignLeft headers=br1>20-44</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br4 bc1 bc2 bc3">6</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br4 bc1 bc2 bc4">4</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br4 bc1 bc2 bc5">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br4 bc1 bc2 bc6">2</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br4 bc1 bc7">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br4 bc8 bc9 bc10">41</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br4 bc8 bc9 bc11">22</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br4 bc8 bc9 bc12">4</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br4 bc8 bc9 bc13">15</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br4 bc8 bc14">3</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br4 bc8 bc15 bc16">44</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br4 bc8 bc15 bc17">18.0%</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=br5 class=alignLeft headers=br1>45-64</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br5 bc1 bc2 bc3">5</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br5 bc1 bc2 bc4">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br5 bc1 bc2 bc5">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br5 bc1 bc2 bc6">3</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br5 bc1 bc7">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br5 bc8 bc9 bc10">58</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br5 bc8 bc9 bc11">28</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br5 bc8 bc9 bc12">15</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br5 bc8 bc9 bc13">15</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br5 bc8 bc14">12</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br5 bc8 bc15 bc16">70</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br5 bc8 bc15 bc17">28.7%</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=br6 class=alignLeft headers=br1>65+</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br6 bc1 bc2 bc3">10</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br6 bc1 bc2 bc4">2</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br6 bc1 bc2 bc5">4</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br6 bc1 bc2 bc6">4</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br6 bc1 bc7">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br6 bc8 bc9 bc10">32</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br6 bc8 bc9 bc11">11</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br6 bc8 bc9 bc12">9</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br6 bc8 bc9 bc13">12</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br6 bc8 bc14">16</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br6 bc8 bc15 bc16">48</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br6 bc8 bc15 bc17">19.7%</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=br7 class=alignLeft headers=br1>Unknown</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br7 bc1 bc2 bc3">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br7 bc1 bc2 bc4">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br7 bc1 bc2 bc5">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br7 bc1 bc2 bc6">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br7 bc1 bc7">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br7 bc8 bc9 bc10">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br7 bc8 bc9 bc11">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br7 bc8 bc9 bc12">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br7 bc8 bc9 bc13">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br7 bc8 bc14">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br7 bc8 bc15 bc16">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br7 bc8 bc15 bc17">0.4%</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=br8 class=alignLeft headers=br1>Total</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br8 bc1 bc2 bc3">33</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="br1 br8 bc1 bc2 bc4">11</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="br1 br8 bc1 bc2 bc5">6</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="br1 br8 bc1 bc2 bc6">16</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br8 bc1 bc7">6</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br8 bc8 bc9 bc10">189</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="br1 br8 bc8 bc9 bc11">92</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="br1 br8 bc8 bc9 bc12">33</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="br1 br8 bc8 bc9 bc13">64</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br8 bc8 bc14">55</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br8 bc8 bc15 bc16">244</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br8 bc8 bc15 bc17">100.0%</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=br9 class=alignLeft headers=br1>Percentage<SUP style="LINE-HEIGHT: 0.65em">2</SUP></TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br9 bc1 bc2 bc3">84.6%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="br1 br9 bc1 bc2 bc4">33.3%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="br1 br9 bc1 bc2 bc5">18.2%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="br1 br9 bc1 bc2 bc6">48.5%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br9 bc1 bc7">15.4%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br9 bc8 bc9 bc10">77.5%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="br1 br9 bc8 bc9 bc11">48.7%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="br1 br9 bc8 bc9 bc12">17.5%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="br1 br9 bc8 bc9 bc13">33.9%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="br1 br9 bc8 bc14">22.5%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight></TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight></TD></TR></TBODY></TABLE>
    Influenza Strain Characterizations

    During the 2013-2014 influenza season, the National Microbiology Laboratory (NML) has antigenically characterized 32 influenza viruses [four A(H3N2), 17 A(H1N1)pdm09 and 11 influenza B]. Twenty-eight (87.5%) viruses were similar to the strains recommended by the WHO for the 2013-14 seasonal influenza vaccine; four influenza B viruses were similar to the strain recommended by the WHO for the 2011-12 vaccine (Figure 4).
    Figure 4. Influenza strain characterizations, Canada, 2013-14, N = 32

    The NML receives a proportion of the number of influenza positive specimens from provincial laboratories for strain characterization and antiviral resistance testing. Characterization data reflect the results of haemagglutination inhibition (HAI) testing compared to the reference influenza strains recommended by WHO.
    The recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b (e.g. A/Texas/50/2012), and a B/Massachusetts/2/2012-like virus (Yamagata lineage).


    Text equivalent for figure 4Influenza strain characterizations, Canada, 2013-2014, N =3
    Antiviral Resistance

    During the 2013-2014 influenza season, NML has tested 29 influenza viruses for resistance to oseltamivir and zanamivir, and all were sensitive. Thirteen influenza A viruses were tested for amantadine resistance, and all were resistant (Table 3).
    <TABLE style="TEXT-TRANSFORM: none; TEXT-INDENT: 0px; WIDTH: 746px; LETTER-SPACING: normal; FONT: 13px Verdana, Arial, Helvetica, sans-serif; WHITE-SPACE: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px" class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR style="BACKGROUND-COLOR: rgb(249,246,208)" class=bg-colour-yellow><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=cr1 rowSpan=2>Virus type and subtype</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=cc1 colSpan=2>Oseltamivir</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=cc4 colSpan=2>Zanamivir</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=cc7 colSpan=2>Amantadine</TH></TR><TR style="BACKGROUND-COLOR: rgb(249,246,208)" class=bg-colour-yellow><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=cc2 headers=cc1># tested</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=cc3 headers=cc1># resistant (%)</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=cc5 headers=cc4># tested</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=cc6 headers=cc4># resistant (%)</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=cc8 headers=cc7># tested</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 11px; VERTICAL-ALIGN: top" class=fontSize85 colSpan=7><SUP style="LINE-HEIGHT: 0.65em">*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH style="TEXT-ALIGN: left; BACKGROUND-COLOR: rgb(215,215,255); FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=cr2 class="alignLeft bg-colour-blue" headers=cr1>A (H3N2)</TH><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr2 cc2">4</TD><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr2 cc3">0</TD><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr2 cc5">4</TD><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr2 cc6">0</TD><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr2 cc8">6</TD><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr2 cc9">6(100%)</TD></TR><TR><TH style="TEXT-ALIGN: left; BACKGROUND-COLOR: rgb(215,215,255); FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=cr3 class="alignLeft bg-colour-blue" headers=cr1>A (H1N1)</TH><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr3 cc2">14</TD><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr3 cc3">0</TD><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr3 cc5">14</TD><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr3 cc6">0</TD><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr3 cc8">7</TD><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr3 cc9">7(100%)</TD></TR><TR><TH style="TEXT-ALIGN: left; BACKGROUND-COLOR: rgb(215,215,255); FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=cr4 class="alignLeft bg-colour-blue" headers=cr1>B</TH><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr4 cc2">11</TD><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr4 cc3">0</TD><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr4 cc5">11</TD><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr4 cc6">0</TD><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr4 cc8">NA <SUP style="LINE-HEIGHT: 0.65em">*</SUP></TD><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr4 cc9">NA <SUP style="LINE-HEIGHT: 0.65em">*</SUP></TD></TR><TR><TH style="TEXT-ALIGN: left; BACKGROUND-COLOR: rgb(215,215,255); FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=cr5 class="alignLeft bg-colour-blue" headers=cr1>TOTAL</TH><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr5 cc2">29</TD><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr5 cc3">0</TD><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr5 cc5">29</TD><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr5 cc6">0</TD><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr5 cc8">13</TD><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="cr5 cc9">13(100%)</TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate increased from 16.1/1,000 in week 46 to 24.3/1,000 in week 47, following an upwards trend in keeping with other surveillance indicators (Figure 5).
    Figure 5. Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014
    Note: No data available for mean rate for weeks 19 to 39 for the 1996-1997 through 2002-2003 seasons. Delays in the reporting of data may cause data to change retrospectively. The calculation of the average ILI consultation rate over 17 seasons was aligned with influenza activity in each season. In BC, AB, and SK, data is compiled by a provincial sentinel surveillance program for reporting to FluWatch. The number of sentinel physicians in each province or territory is as follows: BC(21), AB(80), SK(11), MB(18), ON(169), QC(14), NB(29), NS(26), PE(4), NL(16), NU(1), NT(14), YT(13). Not all sentinel physicians report every week.
    Text equivalent for figure 5Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014
    Influenza Outbreak Surveillance

    One new influenza outbreak in a long-term care facility was reported in week 47 (Figure 6).
    Figure 6. Overall number of new influenza outbreaks by report week, Canada, 2013-2014
    1 All provinces and territories except NU report outbreaks in long-term care facilities. All provinces and territories with the exception of NU and QC report outbreaks in hospitals. Outbreaks of influenza or influenza-like-illness in other facilities are reported to FluWatch but reporting varies between jurisdictions. Outbreak definitions are included at the end of the report.
    Text equivalent for figure 6Overall number of new influenza outbreaks by report week, Canada, 2013-2014
    Pharmacy Surveillance

    Pharmacy surveillance for sales of influenza antivirals has not yet begun for the 2013-14 influenza season (Figure 7).
    Figure 7. Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14
    Note: Pharmacy sales data are provided to the Public Health Agency of Canada by Rx Canada Inc. and sourced from major retail drug chains representing over 3,000 stores nationwide (excluding Nunavut) in 85% of Health Regions. Data provided include the number of new antiviral prescriptions (for Tamiflu and Relenza) and the total number of new prescriptions dispensed by Province/Territory and age group. Age-groups: Infant: 0-2y, Child: 2-18y; Adult: 19-64y, Senior: ≥65y.
    Text equivalent for figure 7Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14
    Sentinel Hospital Influenza Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)
    In week 47, six new laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalizations were reported by the Immunization Monitoring Program Active (IMPACT) network: two children in each of the age-groups 2-4 years, 5-9 years, and 10-16 years of age. Four cases had influenza A and two had influenza B (Figure 8a).
    To date this season, a total of 19 influenza-associated paediatric hospitalizations have been reported by the IMPACT network (Table 4). Two ICU admissions were reported, both in children 2-4 years of age, one with influenza A(H1N1)pdm09 and one with influenza B. No deaths have been reported (Figure 9a).

    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    Adult Influenza Hospitalizations and Deaths (PCIRN)
    Active surveillance of laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations reported by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network began on November 15th 2013. Five new hospitalizations were reported in week 47, two cases 45-64 years of age and three ≥65 years of age, all with influenza A. No ICU admissions or deaths were reported in week 47 (Figure 8b).
    To date this season, 16 influenza-associated hospitalizations have been reported by the PCIRN-SOS network, all with influenza A. The majority (75%) have been adults over 45 years of age (Table 5). ICU admission was required for one hospitalization and no deaths have been reported (Figure 9b).

    Note: The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    <TABLE style="TEXT-TRANSFORM: none; TEXT-INDENT: 0px; WIDTH: 746px; LETTER-SPACING: normal; FONT: 13px Verdana, Arial, Helvetica, sans-serif; WHITE-SPACE: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px" class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION style="TEXT-ALIGN: center" class=alignCenter>Table 4 - Cumulative numbers of paediatric hospitalizations with influenza reported by the IMPACT network, Canada, 2013-14</CAPTION><THEAD><TR style="BACKGROUND-COLOR: rgb(249,246,208)" class=bg-colour-yellow><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=dr1 rowSpan=3>Age groups</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=dc1 colSpan=6>Cumulative (Aug. 25, 2013 to November 23, 2013)</TH></TR><TR style="BACKGROUND-COLOR: rgb(249,246,208)" class=bg-colour-yellow><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=dc2 colSpan=4 headers=dc1>Influenza A</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=dc7 headers=dc1>B</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=dc8 headers=dc1>Influenza A and B</TH></TR><TR style="BACKGROUND-COLOR: rgb(236,236,236)" class=bg-colour-grey-light><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=dc3 headers="dc1 dc2">A Total</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=dc4 class=lightred headers="dc1 dc2">A(H1) pdm09</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=dc5 class=lightred headers="dc1 dc2">A(H3)</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=dc6 class=lightred headers="dc1 dc2">A (UnS)</TH><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="dc1 dc7">Total</TD><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="dc1 dc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 11px; VERTICAL-ALIGN: top" class=fontSize85 colSpan=7><SUP style="LINE-HEIGHT: 0.65em">1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=dr2 class=alignLeft headers=dr1>0-5m</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr2 dc1 dc2 dc3">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr2 dc1 dc2 dc4">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr2 dc1 dc2 dc5">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr2 dc1 dc2 dc6">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr2 dc1 dc7">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr2 dc1 dc8">2(11%)</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=dr3 class=alignLeft headers=dr1>6-23m</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr3 dc1 dc2 dc3">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr3 dc1 dc2 dc4">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr3 dc1 dc2 dc5">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr3 dc1 dc2 dc6">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr3 dc1 dc7">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr3 dc1 dc8">1 (5%)</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=dr4 class=alignLeft headers=dr1>2-4y</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr4 dc1 dc2 dc3">4</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr4 dc1 dc2 dc4">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr4 dc1 dc2 dc5">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr4 dc1 dc2 dc6">3</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr4 dc1 dc7">5</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr4 dc1 dc8">9 (47%)</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=dr5 class=alignLeft headers=dr1>5-9y</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr5 dc1 dc2 dc3">3</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr5 dc1 dc2 dc4">2</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr5 dc1 dc2 dc5">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr5 dc1 dc2 dc6">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr5 dc1 dc7">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr5 dc1 dc8">4 (21%)</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=dr6 class=alignLeft headers=dr1>10-16y</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr6 dc1 dc2 dc3">2</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr6 dc1 dc2 dc4">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr6 dc1 dc2 dc5">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr6 dc1 dc2 dc6">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr6 dc1 dc7">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr6 dc1 dc8">3 (16%)</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=dr7 class=alignLeft headers=dr1>Total</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr7 dc1 dc2 dc3">10</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="lightred alignRight" headers="dr1 dr7 dc1 dc2 dc4">4</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="lightred alignRight" headers="dr1 dr7 dc1 dc2 dc5">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="lightred alignRight" headers="dr1 dr7 dc1 dc2 dc6">6</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr7 dc1 dc7">9</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr7 dc1 dc8">19</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=dr8 class=alignLeft headers=dr1>% <SUP style="LINE-HEIGHT: 0.65em">1</SUP></TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr8 dc1 dc2 dc3">52.6%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="lightred alignRight" headers="dr1 dr8 dc1 dc2 dc4">40.0%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="lightred alignRight" headers="dr1 dr8 dc1 dc2 dc5">0.0%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="lightred alignRight" headers="dr1 dr8 dc1 dc2 dc6">60.0%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr8 dc1 dc7">47.4%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="dr1 dr8 dc1 dc8">100.0%</TD></TR></TBODY></TABLE>
    <TABLE style="TEXT-TRANSFORM: none; TEXT-INDENT: 0px; WIDTH: 746px; LETTER-SPACING: normal; FONT: 13px Verdana, Arial, Helvetica, sans-serif; WHITE-SPACE: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px" class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION style="TEXT-ALIGN: center" class=alignCenter>Table 5 - Cumulative numbers of adult hospitalizations with influenza
    reported by the PCIRN-SOS network, Canada, 2013-14
    </CAPTION><THEAD><TR style="BACKGROUND-COLOR: rgb(249,246,208)" class=bg-colour-yellow><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=er1 rowSpan=3>Age groups</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; WHITE-SPACE: nowrap; FONT-SIZE: 13px" id=ec1 class=noWrap colSpan=6>Cumulative (Aug. 25, 2013 to November 23, 2013)</TH></TR><TR style="BACKGROUND-COLOR: rgb(249,246,208)" class=bg-colour-yellow><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ec2 colSpan=4 headers=ec1>Influenza A</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ec7 headers=ec1>B</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ec8 headers=ec1>Influenza A and B</TH></TR><TR style="BACKGROUND-COLOR: rgb(236,236,236)" class=bg-colour-grey-light><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ec3 headers="ec1 ec2">A Total</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ec4 class=lightred headers="ec1 ec2">A(H1) pdm09</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ec5 class=lightred headers="ec1 ec2">A(H3)</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=ec6 class=lightred headers="ec1 ec2">A(UnS)</TH><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="ec1 ec7">Total</TD><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="ec1 ec8"># (%)</TD></TR></THEAD><TFOOT><TR><TD style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 11px; VERTICAL-ALIGN: top" class=fontSize85 colSpan=7><SUP style="LINE-HEIGHT: 0.65em">1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=er2 class=alignLeft headers=er1>16-20</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er2 ec1 ec2 ec3">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er2 ec1 ec2 ec4">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er2 ec1 ec2 ec5">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er2 ec1 ec2 ec6">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er2 ec1 ec7">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er2 ec1 ec8">0</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=er3 class=alignLeft headers=er1>20-44</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er3 ec1 ec2 ec3">4</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er3 ec1 ec2 ec4">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er3 ec1 ec2 ec5">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er3 ec1 ec2 ec6">3</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er3 ec1 ec7">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er3 ec1 ec8">4 (25%)</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=er4 class=alignLeft headers=er1>45-64</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er4 ec1 ec2 ec3">6</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er4 ec1 ec2 ec4">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er4 ec1 ec2 ec5">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er4 ec1 ec2 ec6">5</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er4 ec1 ec7">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er4 ec1 ec8">6 (38%)</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=er5 class=alignLeft headers=er1>65+</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er5 ec1 ec2 ec3">6</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er5 ec1 ec2 ec4">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er5 ec1 ec2 ec5">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er5 ec1 ec2 ec6">5</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er5 ec1 ec7">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er5 ec1 ec8">6 (38%)</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=er6 class=alignLeft headers=er1>Total</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er6 ec1 ec2 ec3">16</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="er1 er6 ec1 ec2 ec4">1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="er1 er6 ec1 ec2 ec5">2</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="er1 er6 ec1 ec2 ec6">13</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er6 ec1 ec7">0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er6 ec1 ec8">16</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=er7 class=alignLeft headers=er1>%<SUP style="LINE-HEIGHT: 0.65em">1</SUP></TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er7 ec1 ec2 ec3">100%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="er1 er7 ec1 ec2 ec4">6%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="er1 er7 ec1 ec2 ec5">13%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred" headers="er1 er7 ec1 ec2 ec6">81%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er7 ec1 ec7">0%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight headers="er1 er7 ec1 ec8">100%</TD></TR></TBODY></TABLE>
    Figure 8. Number of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)
    Text equivalent for figure 8aNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)
    Text equivalent for figure 8bNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Adult hospitalizations (>16 year of age, PCIRN-SOS)
    Figure 9. Percentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)
    Text equivalent for figure 9aPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)
    Text equivalent for figure 9bPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Adult hospitalizations (≥16 year of age, PCIRN-SOS)
    Provincial/Territorial Influenza Hospitalizations and Deaths

    In week 47, 21 new laboratory-confirmed influenza-associated hospitalizations were reported from participating provinces and territories.<SUP style="LINE-HEIGHT: 0.65em">*</SUP>Among these cases, ten (48%) were adults ≥45 years of age, and five (24%) were children <2 years of age. Twenty cases had influenza A, of which 65% were A(H1N1)pdm09. No ICU admissions or deaths were reported.
    To date this season, 57 influenza-associated hospitalizations have been reported, of which 50 (88%) had influenza A (Table 6). The majority of cases (56%) were ≥45 years of age, and 23% were under 5 years of age. A greater proportion of cases under 20 years of age had influenza B (29%) compared to those 20 years of age or older (5%). Four ICU admissions have been reported this season, three in adults 45-64 years of age and one in a child 2-4 years of age, all with A(H1N1)pdm09. No deaths have been reported. It is important to note that the hospitalization or death does not have to be attributable to influenza, a positive laboratory test is sufficient for reporting. Detailed clinical information (e.g. underlying medical conditions) is not known for these cases.
    Note: Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not distinguished among hospital admissions reported from Ontario. The number of new influenza-associated hospitalizations and deaths reported for the current week may include cases from Ontario that occurred in previous weeks, as a result of retrospective updates to the cumulative total. Data may also include cases reported by the IMPACT and PCIRN networks.
    <TABLE style="TEXT-TRANSFORM: none; TEXT-INDENT: 0px; WIDTH: 746px; LETTER-SPACING: normal; FONT: 13px Verdana, Arial, Helvetica, sans-serif; WHITE-SPACE: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px" class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION style="TEXT-ALIGN: center" class=alignCenter>Table 6. Cumulative number of hospitalizations with influenza reported by the participating provinces and territories, Canada, 2013-14</CAPTION><THEAD><TR style="BACKGROUND-COLOR: rgb(249,246,208)" class=bg-colour-yellow><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=fr1 rowSpan=3>Age groups</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=fc1 colSpan=6>Cumulative (Aug. 25, 2013 to November 23, 2013)</TH></TR><TR style="BACKGROUND-COLOR: rgb(249,246,208)" class=bg-colour-yellow><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=fc2 colSpan=4 headers=fc1>Influenza A</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=fc7 headers=fc1>B</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=fc8 headers=fc1>Influenza A and B</TH></TR><TR style="BACKGROUND-COLOR: rgb(236,236,236)" class=bg-colour-grey-light><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=fc3 headers="fc1 fc2">A Total</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=fc4 class=lightred headers="fc1 fc2">A(H1) pdm09</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=fc5 class=lightred headers="fc1 fc2">A(H3)</TH><TH style="FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=fc6 class=lightred headers="fc1 fc2">A (UnS)</TH><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="fc1 fc7">Total</TD><TD style="TEXT-ALIGN: center; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignCenter headers="fc1 fc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 11px; VERTICAL-ALIGN: top" class=fontSize85 colSpan=8><SUP style="LINE-HEIGHT: 0.65em">1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=fr2 class=alignLeft headers=fr1>0-4 years</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>9</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>6</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>2</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>4</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>13 (23%)</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=fr3 class=alignLeft headers=fr1>5-14 years</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>2 (4%)</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=fr4 class=alignLeft headers=fr1>15-19 years</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>2</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>2 (4%)</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=fr5 class=alignLeft headers=fr1>20-44 years</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>8</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>6</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>2</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>0</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>8 (14%)</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=fr6 class=alignLeft headers=fr1>45-64 years</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>17</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>8</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>7</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>2</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>18 (32%)</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=fr7 class=alignLeft headers=fr1>65+ years</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>13</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>6</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>4</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>3</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>1</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>14 (25%)</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=fr8 class=alignLeft headers=fr1>Total</TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>50</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred">27</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred">12</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred">11</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>7</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>57</TD></TR><TR><TH style="TEXT-ALIGN: left; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px" id=fr9 class=alignLeft headers=fr1>Percentage <SUP style="LINE-HEIGHT: 0.65em">1</SUP></TH><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>87.7%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred">54.0%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred">24.0%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class="alignRight lightred">22.0%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>12.3%</TD><TD style="TEXT-ALIGN: right; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 13px; VERTICAL-ALIGN: top" class=alignRight>100%</TD></TR></TBODY></TABLE>


    .../
    http://www.phac-aspc.gc.ca/fluwatch/13-14/w47_13/index-eng.php

    Leave a comment:

Working...
X